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Abstract 
 
Chapter 1. Catalytic directing group, I, which was designed with the ability to form a 
reversible covalent bond with a substrate and bind a metal, was shown to direct the 
hydroformylation of allylic amines. The efficient regioselective hydroformylation of a 
variety of 1,2-disubstituted allylic sulfonamides to form β-amino-aldehydes under mild 
conditions has been shown. 
 
Chapter 2. Building off of the successful application of I, enantioenriched catalytic 
directing group, II, was designed and synthesized. It retained the essential features to 
direct hydroformylation to obtain good regioselectivity while also providing a chiral 
environment to induce absolute stereocontrol. Under mild conditions, a variety of 
disubstituted olefins react to give good yields and excellent enantioselectivites. Thus, the 
first enantioselective reaction performed with a catalytic directing group was 
demonstrated. 
 
 Chapter 3. A new set of organocatalysts was developed that benefits from reversible 
covalent bonding and induced intramolecularity. The desymmetrization of meso-1,2-diols 
was accomplished using organocatalyst III, which was synthesized easily and cheaply. 
Experimental results indicate that the selectivity and increased reactivity are a result of 
the ability of III to pre-organize the substrate through a reversible, covalent bond. A 
variety of cyclic and acylic substrates were shown to react efficiently with good 
enantioselectivities under mild conditions. The catalyst’s ability to functionalize cis-1,2-
diols selectively indicated it might be successfully applied to site selective catalysis. 
Thus, the selective functionalization of a secondary alcohol in the presence of a primary 
alcohol was developed using a combination of binding selectivity and stereoselectivity. 
The (S)-enantiomer forms the secondary functionalized product while the (R)-enantiomer 
forms the primary functionalized product with high selectivity. As the enantiomers 
preferentially form different functionalized products, a regiodivergent reaction on a 
racemic mixture resulted giving two valuable enriched products. 
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Chapter One: Regioselective Hydroformylation 
1.1 Directing Groups 
 
 Obtaining selectivity in organic chemistry is a large area of research which 
scientists have addressed with multiple approaches. In some cases, electronic effects have 
been used to obtain selectivity. For instance, in hydroformylation, it is known that aryl 
substrates preferentially form the product with the aldehyde proximal to the phenyl ring 
(Scheme 1.1).1 However, selectivity can also be influenced by steric effects. In the case 
Scheme 1.1 Hydroformylation of a 1,2-Disubstituted Aryl Olefin. 
 
of the hydroformylation of aryl olefins, the selectivity can be overturned using a 1,1-
disubstituted aryl olefin (Scheme 1.2).1 Another reliable method that has been developed 
to obtain selectivity is the use of directing groups.2   
Scheme 1.2 Hydroformylation of a 1,1-Disubstituted Aryl Olefin. 
 
 
1Carrilho, R. M. B.; Neves, A. C. B.; Lourenço, M. A. O.; Abreu, A. R.; Rosado, M. T. S.; Abreu, P. E.; 
Eusébio, M. E. S.; Kollár, L.; Bayón, J. C.; Pereira, M. M. J. Organomet. Chem. 2012, 698, 28-34.              
2(a) Hoveyda, A.; Evans, D.; Fu, G. Chem. Rev. 1993, 93, 1307-1370. (b) Itami, K.; Yoshida, J. Synlett  
2006, 2, 157-180. (c) Oestreich, M. Eur. J. Org. Chem. 2005, 5, 783-792. (d) Kakiuchi, F.; Chatani, N. Adv. 
Syn. Catal. 2003, 345, 1077-1101.  
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 Directing groups are functional groups within a substrate that are able to pre-
associate with a reagent in the reaction in order to affect the outcome.2a As well as 
increasing selectivity, sometimes directed reactions are accelerated due to their 
intramolecular-like reactivity.3 Thus, directing groups have allowed for some difficult 
intermolecular reactions to be possible. Directing groups have been used in a variety of 
transformations such as oxidations, reductions, and C-C bond forming reactions.2 The 
directing group can be a common functional group (“useful directing groups”) within the 
substrate (Section 1.2) or a less common group that can be installed prior to the reaction 
and removed after the desired transformation is complete (Section 1.3) 
1.2 Useful Directing Groups 
 One excellent example of a directed reaction using a common functional group is 
the Sharpless asymmetric epoxidation.4 For example, 1.1 is shown to give 1.2 in high 
yield and enantioselectivity (Scheme 1.3). Although 1.1 has two trisubstituted olefins that 
can be oxidized, only the olefin proximal to the alcohol reacts. The high site selectivity 
and enantioselectivity are a result of the alcohol binding to the titanium catalyst and 
directing oxidation to the top face of the allylic olefin. As a testament to the importance 
of the reaction, Sharpless received the 2001 Nobel Prize in Chemistry for his work in this 
area. 
 
 
3Tan, K. L. ACS Catal. 2011, 1, 877-886.                                                                                                      
4(a) Katsuki, T.; Sharpless, K. B. J. Am. Chem. Soc. 1980, 102, 5974-5976. (b) Finn, M. G.; Sharpless, K. 
B. J. Am. Chem. Soc. 1991, 113, 113-126. 
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Scheme 1.3 Sharpless Asymmetric Epoxidation. 
 
 Sharing the 2001 Nobel Prize with Sharpless was Knowles for the asymmetric 
reduction of enamides, such as 1.3, using very low catalyst loadings and mild conditions.5 
The reaction proceeds through a chelated intermediate in which the acetamide directs the 
rhodium catalyst to the top face of the olefin, forming 1.4. This powerful method was 
used to synthesize ʟ-DOPA, a drug used in the treatment of Parkinson’s disease (Scheme 
1.4). 
Scheme 1.4 The Monsanto L-DOPA Process.  
  
 More recently, selective catalytic C-H bond activation is another challenging 
problem that has interested many researchers. Directing groups have been used 
effectively to control site selectivity in C-H activation reactions. In an example by Murai, 
the ketone in 1.5 is able to direct the ruthenium catalyst to activate the ortho-C-H bond  
5Vineyard, B. D.; Knowles, W. S.; Sabacky, M. J. J. Mol. Cat. 1983, 19, 159-169. 
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and insert ethylene to obtain 1.6 quantitatively (Scheme 1.5).6 Subsequently, directing 
group strategies have become ubiquitous in C-H activation.7 
Scheme 1.5 Selective ortho-C-H Activation. 
 
 These examples demonstrate that common functional groups are able to facilitate 
very powerful and diverse transformations that are sometimes difficult or not possible 
otherwise. 
1.3 Removable Directing Groups 
 Some reactions cannot be directed by the functional groups that exist in the 
substrate so a directing group has to be installed prior to the reaction and removed after 
the desired transformation has occurred. While this is not ideal because it adds additional 
steps and creates stoichiometric byproducts, it has allowed for the expansion of the scope 
of reactions that can be directed.8 
 Fortunately, some directing groups can be removed with a simple work-up, such  
6Murai, S.; Kaiuchi, F.; Sekine, S.; Tanaka, Y.; Kamatani, A.; Sonoda, M.; Chatani, N. Nature 1993, 366, 
529-531.                                                                                                                                                         
7For reviews on directed C-H functionalization, see: (a) Ritleng, V.; Sirlin,C.; Pfeffer, M. Chem. Rev. 2002, 
102, 1731-1770. (b) Kakiuchi, F.; Murai, S. Acc. Chem. Res. 2002, 35, 826-834. (c) Kakiuchi, F.; Chatani, 
N. Adv. Synth. Catal. 2003, 345, 1077-1101. (d) Dick, A.; Sanford, M. Tetrahedron 2006, 62, 2439-2463. 
(e) Arockiam, P. B.; Bruneau, C.; Dixneuf, P. H. Chem. Rev. 2012, 112, 5879-5918.                                 
8Rousseau, G.; Breit, B. Angew. Chem., Int. Ed. 2011, 50, 2450-2494. 
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as in Scheme 1.6. Jun showed that, in this case, the ketimine is necessary to direct the 
ortho-C-H activation for the selective alkylation of 1.7. After the reaction, the imine can 
be cleaved easily with aqueous acid to give 1.8 (Scheme 1.6).9 
Scheme 1.6 Selective ortho-Alkylation by C-H Activation. 
 
 Because amines are known to be ligands in palladium catalysis, Hallberg used a 
proline based directing group to add aryl groups to the top face of the olefin in 1.9 
creating quaternary centers with high enantioselectivities.10 This group could also be 
removed easily by acid hydrolysis to give the corresponding ketone 1.10 (Scheme 1.7). 
Scheme 1.7 Formation of Quaternary Centers by Heck Reaction. 
 
 Designing a practical removable directing group for reactions that typically utilize 
a phosphine ligand is more challenging. However, during the synthesis of (+)-
phyllanthocin, Burke installed a triarylphosphine directing group, using an ester 
9Jun, C.; Hong, J.; Kim, Y.; Chung, K. Angew. Chem., Int. Ed. 2000, 39, 3440-3442.                                         
10Nilsson, P.; Larhed, M.; Hallberg, A. J. Am. Chem. Soc. 2003, 125, 3430-3431. 
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linkage.11 The phosphine was incorporated into the molecule in order to increase the 
selectivity of the hydroformylation of 1.11. Impressively, when the phosphine is meta, 
the directing group is able to deliver the rhodium to the bottom face of the olefin resulting 
in good regio- and diasteroselective ratios for 1.12 (Scheme 1.8, Eq 1). 
Scheme 1.8 Examples of Directed Regio- and Diastereoselective Hydroformylation.  
 
 Subsequently, Jackson and Perlmutter,12 Leighton,13 and Breit14 demonstrated that 
phosphorus-based stoichiometric directing groups are successful in the highly regio- and  
 
11Burke, S. D.; Cobb, J. E.; Takeuchi, K. J. Org. Chem. 1990, 55, 2138-2151.                                                                   
12R. W. Jackson, P. Perlmutter and E. E. Tasdelen, J. Chem. Soc., Chem. Commun., 1990, 763-764. 
13Krauss, I. J.; Wang, C. C. Y.; Leighton, J. L. J. Am. Chem. Soc. 2001, 123, 11514 – 11515.                  
14(a) Breit, B. Angew. Chem., Int. Ed. 1996, 35, 2835-2837. (b) Breit, B. Liebigs Ann. 1997, 1841-1851. (c) 
Breit, B.; Heckmann, G.; Zahn, S. K. Chem. Eur. J. 2003, 9, 425-434. (d) Breit, B.; Demel, P.; Gebert, A. 
Chem. Commun. 2004, 114 – 115.  
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diastereoselective hydroformylation of terminal and disubstituted allylic alcohols 
(Scheme 1.8, Eq 2 and Eq 3). 
 While it is clear from these examples that removable directing groups are 
powerful tools, it is at the cost of additional synthetic steps for their installation and 
removal, as well as the creation of stoichiometric byproducts.  
1.4 Developing a Catalytic Directing Group 
 In order to address the disadvantages of removable directing groups, the Tan 
group developed a catalytic directing group. Using a directing group catalytically 
maintains the benefits of a directed reaction while improving the overall efficiency of the 
process by eliminating installation and removal steps.8  
 Previously, other groups have shown the use of catalytic directing groups. For 
example, Lewis showed C-H activation and deuterium incorporation into phenol using a 
catalytic amount of a phosphite (Scheme 1.9, Eq 1).15a Lewis and Smith expanded this 
work to the coupling of olefins to phenol, and Cole-Hamilton developed a more efficient 
system using a rhodium catalyst (Scheme 1.9, Eq 2).15b,16 Bedford was able to achieve 
coupling of phenolic derivatives with aryl halides under similar conditions. (Scheme 1.9, 
Eq 3).17 
 
 
 
15(a) Lewis, L. N. Inorg. Chem. 1985, 24, 4433–4435. (b) Lewis, L. N.; Smith, J. F.; J. Am. Chem. Soc. 
1986, 108, 2728-2735.                                                                                                                          
16Carrion, M. C.; Cole-Hamilton, D. J. Chem. Commun. 2006, 43, 4527–4529.                                 
17Bedford, R. B.; Coles, S. J.; Hursthouse, M. B.; Limmert, M. E. Angew. Chem., Int. Ed. 2003, 42, 112–
114. Bedford, R. B.; Limmert, M. E. J. Org. Chem. 2003, 68, 8669–8682. 
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Scheme 1.9 C-H Activation using a Catalytic Directing Group. 
 
 Jun and coworkers showed the use of 2-amino-3-picoline as a catalytic directing 
group to prevent decarbonylation in the hydroacylation of aldehydes with terminal olefins 
(Scheme 1.10).18 
Scheme 1.10 Hydroacylation with a Catalytic Directing Group. 
 
 Similar to previous strategies, to maximize efficiency, our catalytic directing 
group was designed to be an organic scaffold with the ability to bind the substrate  
18Jun, C. H.; Lee, D. Y.; Lee, H.; Hong, J. B. Angew. Chem., Int.Ed. 2000, 39, 3070–3072. 
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covalently and reversibly under mild conditions while, simultaneously, binding a metal. 
Thus, under the reaction conditions, the substrate binds to the organic scaffold allowing 
for a directed reaction to proceed. Upon release of the product, the directing group is 
regenerated, rendering the process catalytic (Figure 1.1).  
Figure 1.1 General Catalytic Directing Group Cycle. 
 
 Catalytic directing group I was designed with a simple organic backbone and a 
hemiaminal as the substrate-binding site, in which the lone pair on the amine can assist 
with alcohol expulsion prior to binding another alcohol (Scheme 1.11). A phosphorus 
atom was also incorporated into the molecule to act as a metal-binding site.  
Scheme 1.11 Alcohol Exchange with I. 
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 Taking inspiration from Burke’s application of a phosphorus-based removable 
directing group to hydroformylation,11 our group decided to use hydroformylation as a 
testing ground for the feasibility of this concept. Hydroformylation is the efficient 
addition of hydrogen and carbon monoxide across an olefin yielding valuable aldehyde 
products.19 However, two products are possible, the iso and normal isomers (Figure 1.2). 
In the case of terminal olefins, the normal product is usually favored for steric reasons. 
For unactivated 1,2-disubstituted olefins, a product mixture of around 1:1 is often 
obtained.20 
Figure 1.2 Hydroformylation Reaction. 
  
 Our group believed that applying a catalytic directing group could alter the 
reaction’s regio- and stereoselectivity. Lightburn applied I to the hydroformylation of 
homoallylic alcohols with good yields, regioselectivities, and diastereoselectivities 
(Scheme 1.12).21 It is believed that the reaction is regioselective for the iso product due to 
the energy difference between the ring sizes (seven vs. eight) of the two chelated 
intermediates in the hydride insertion step. The seven-membered chelate, 1.13, is favored  
19(a) Rhodium Catalyzed Hydroformylation; Van Leeuwen, P. W. N. M., Claver, C., Eds.; Springer-Verlag: 
New York, 2002. (b) Frohning, C. D. Kohlpaintner, C. W. Bohnen, H. W. In Applied Homogeneous 
Catalysis with Organometallic Compounds; Cornils, B., Herrmann, W. A., Eds.; Wiley: Weinheim, 
Germany, 2002; Vol. 1, p 31.                                                                                                                    
20Breit, B.; Seiche, W. Synthesis 2001, 1, 1-36.                                                                                                                                    
21Lightburn, T. E.; Dombrowski, M. T.; Tan, K. L. J. Am. Chem. Soc. 2008, 130, 9210-9211.  
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over 1.14 which leads to the iso product being formed (Figure 1.3). The iso product 
cyclizes under the reaction conditions and was oxidized to the lactone for ease of 
isolation and characterization. 
Scheme 1.12 Tan’s Regio- and Diastereoselective Hydroformylation of Homoallylic Alcohols. 
 
 At the same time, the Breit group published a paper using a simple phosphinite as 
a catalytic directing group in the hydroformylation of homoallylic alcohols with good 
yields and regioselectivities.22 The phosphinite also reversibly binds alcohols and may 
achieve selectivity through the energy difference between the two chelated intermediates 
in the hydride insertion step (Scheme 1.13). Mechanistic studies for both systems need to 
be performed to verify this hypothesis.  
Scheme 1.13 Breit’s Regioselective Hydroformylation of Homoallylic Alcohols. 
 
 The Breit group has since expanded the use of this phosphinite to other substrates. 
22(a) Grünanger, C. U.; Breit, B. Angew. Chem., Int. Ed. 2008, 47, 7346-7349. (b) Smejkal, T.; Breit, B. 
Angew. Chem., Int. Ed. 2008, 47, 311-315.  
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The regio- and diastereoselective hydroformylation of bishomoallylic alcohols and cyclic 
dienes occurs with high yields.23a,b The application of this catalytic directing group to the 
hydroformylation of 1,1-disubstituted olefins also allows the formation of quaternary 
carbon centers with good yields and regioselectivities.23c 
Figure 1.3 Catalytic Cycle of the Directed Hydroformylation. 
 
 23(a) Grünanger, C. U.; Breit, B. Angew. Chem. Int. Ed. 2010, 49, 967 – 970. (b) Usui, I.; Nomura, K.; 
Breit, B. Org. Lett., 2011, 13, 612-615. (c) Ueki, Y.; Ito, H.; Usui, I.; Breit, B. Chem. Eur. J. 2011, 17, 
8555-8558. 
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1.5 Regioselective Hydroformylation of Sulfonamides24 
 Since homoallylic alcohols were able to bind I and undergo selective 
hydroformylation,20 we were interested in expanding the substrates that could bind I to 
undergo directed hydroformylation. In particular, we were interested in applying this 
methodology to the hydroformylation of allylic amines to form β-amino-aldehydes. Much 
like the reaction with homoallylic alcohols, the substrate could exchange onto I under the 
reaction conditions, the phosphorus could bind the rhodium catalyst to undergo 
hydroformylation, and another molecule of substrate could exchange off the product 
(Figure 1.4). 
 Investigations began with varying the protecting group on nitrogen. For the 
reaction to work, the exchange of amines with I would need to be faster than the 
hydroformylation without substrate-bound I, which will afford unselective background 
reaction. It was expected that the protecting group would greatly affect the rate of 
exchange with I. Carbamates and amides were quickly ruled out as potential substrates 
because they did not exchange with I. Sulfonamides, however, exchanged under mild 
conditions with I to give 1.16. The more electron-withdrawing sulfonamides have greatly 
increased exchange rates with the 3,5-bis(trifluoromethyl)benzenesulfonamide reaching 
69% conversion after 6 hours (Table 1.1). The increased exchange rate is most likely 
because the electron-withdrawing sulfonamides have lower pKas.
25 
 
24Worthy, A. D.; Gagnon, M. M.; Dombrowski, M. T.; Tan, K. L. Org. Lett. 2009, 11, 2764-2767.  
25Eckert, F.; Leito, I.; Kaljurand, I.; Kütt, A.; Klamt, A.; Diedenhofen, M. J. Comp. Chem. 2009, 30, 799-
810. 
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Figure 1.4 Catalytic Cycle of Allylic Amine Hydroformylation. 
 
 The self-exchange between substrates was tested to make sure that the exchange 
occurring during the reaction would be rapid. First 1.15 was exchanged onto I to give 
1.16. When 1.17 was added at room temperature, the exchange was fast showing a ratio 
of 53:47 (1.16 to 1.18) after just 1 hour. An equilibrium ratio of 43:57 (1.16 to 1.18) was 
expected given the steric and electronic similarity of 1.15 and 1.17 (Scheme 1.14). 
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Table 1.1 Sulfonamide Exchange Rates. 
 
Scheme 1.14 Exchange Between Substrates. 
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 We were also concerned that the product, 1.19, may inhibit the reaction. 
However, when I was exchanged with 1.19, it was found that 1.20 was unfavorable to 
form and ligand decomposition occurs over time (Table 1.2). Decomposed ligand appears 
by 31P NMR as oxidation of the phosphorus atom which is believed to occur through the 
exchange intermediate seen in Scheme 1.11 and 1.15. The iminium ion intermediate is in 
resonance with the phosphonium ion which can be attacked by water or a molecule of 
substrate. In the case of an oxygen based nucleophile, protonation of the resulting ylide 
would give the proposed structure of decomposed ligand, I-decomp (Scheme 1.15). A 
crystal structure of the decomposed ligand confirmed the identity of I-decomp (Figure 
1.5). During the reaction with 1.15, however, the decomposition is likely the 
corresponding sulfonamide derivative.  
Table 1.2 Product Exchange with I. 
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Scheme 1.15 Ligand Decomposition Pathway. 
 
Figure 1.5 Crystal Structure of Decomposed Ligand (CCDC # 837337). 
 
 Since 1.20 formed at room temperature over a few hours, a competition 
experiment between 1.19 and 1.15 was performed to see which would be favored to bind 
I. By first reacting 1.19 and I to form 1.20 and then adding 1.15, it was determined that 
1.16 is more stable than 1.20. Within five minutes of adding 1.15, 1.20 is no longer 
detectable by 31P NMR. 1.20 was exchanged completely with 1.15 to form 1.16 (Table 
1.3).    
 
 
Chapter 1, Page 18 
 
Table 1.3 Product vs. Substrate Exchange Competition. 
 
 In order to be thorough, the experiment was run reversing the addition of 1.15 and 
1.19. By first reacting 1.15 and I to form 1.16 and then adding 1.19 (at time=0 min), it 
was reaffirmed that 1.16 is more stable than 1.20. 1.20 did not form, and 1.16 
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decomposed over time (Table 1.4). We believe the increased sterics of 1.19 compared to 
1.15 is the reason for its more unfavorable binding. 
Table 1.4 Substrate vs. Product Exchange Competition. 
 
 After determining that sulfonamides were promising substrates based on 
exchange data, optimization of the regioselective hydroformylation of 1.15 was started. 
Hydroformylation of 1.15 using 4% PPh3 as a ligand gave a 50:50 ratio of iso:normal 
products. As PPh3 is incapable of binding the substrate, this gave the inherent selectivity 
of the hydroformylation of 1.15. As a terminal substrate usually strongly favors the 
normal product, we believe the sulfonamide moiety itself can direct the hydroformylation  
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to some degree.26 Using 10% of I gave a 60:40 of iso:normal products with good 
conversion. Encouraged by the increase in the ratio of iso product formed using I, the 
ligand loading was increased to 20% and 40% to test if the maximum selectivity had been 
reached. Fortunately, it was found that increasing the amount of I resulted in higher 
selectivity for the iso product (Table 1.5). 
Table 1.5 Ligand Loading Screen. 
 
 However, to develop a practical and efficient methodology, we optimized the 
conditions at lower ligand loadings. Previous exchange results had showed that while 
initial exchange of I with 1.15 was slow compared to the reaction time (Table 1.1), the 
exchange between substrate bound ligand, 1.16, and 1.17 was much faster (Scheme 1.14). 
26 For examples of amide directed hydroformylation see: (a) Ojima, I.; Zhang, Z. J. Org. Chem. 1988, 53, 
4422-4425. (b) Ojima, I.; Zhang, Z. J. Organomet. Chem. 1991, 417, 253-276. (c) Ojima, I.; Korda, A.; 
Shay, W. R. J. Org. Chem. 1991, 56, 2024-2030. (d) Dickson, R. S.; Bowen, J.; Campi, E. M.; Jackson, W. 
R.; Jonasson, C. A. M.; McGrath, F. J.; Paslow, D. J.; Polas, A.; Renton, P.; Gladiali, S. J. Mol. Cat. A 
1999, 150, 122-146. 
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Therefore, the exchange of I and 1.15 was carried out prior to the hydroformylation 
reaction. Exchanging 5% of I with 1.15 prior to hydroformylation gave similar results to 
using 20% I without the pre-exchange procedure (Table 1.5 and Table 1.6). Impressively, 
when 10% of I was used, a ratio of 90:10 (1.19:1.21) was obtained with good conversion 
(Table 1.6).   
Table 1.6 Ligand Loading Screen with Pre-exchange of I and 1.15. 
 
 Having developed an effective procedure, the temperature of the reaction was 
screened in order to discover the mildest conditions that would still afford high levels of 
selectivity. At 35 °C, the conversion and regioselectivity are low. Increasing the 
temperature to 45 °C increases the conversion as well as the regioselectivity. The 
increased regioselectivity can be attributed to an increased exchange rate between I and 
1.15 that occurs with increased temperature. Using 20% I, there is no effect to increasing 
the temperature to 55 °C from 45 °C, as both entries give optimal conversion and 
selectivities (Table 1.7). 
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Table 1.7 Temperature Screen. 
 
 The effect of adding acid, which was previously shown to accelerate the exchange 
between I and alcohol substrates, was also examined.13 In this case using 0.2% p-
toluenesulfonic acid gave lower regioselectivity for 1.19 (Table 1.8). Because 1.15  
Table 1.8 Acid Loading Screen. 
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already contains an acidic proton, adding p-TsOH was not necessary. Making the 
exchange rate faster increases the concentration of the exchange intermediate through 
which I can decompose (Scheme 1.11 and 1.15). The decomposition of I results in lower 
regioselectivities because directed reaction does not occur without I.  
 The amount of rhodium was screened knowing that it would have an effect on the 
rate of selective reaction with I, as well as the unselective, undirected background 
reaction. At low loadings of rhodium, the directed reaction is able to outcompete the 
background reaction most effectively, resulting in high regioselectivities; however, the 
efficiency of the reactions suffers. At 2 mol % rhodium, the balance between complete 
conversion and high selectivity was reached (Table 1.9).  
Table 1.9 Rhodium Loading Screen. 
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 A pressure screen showed the most dramatic effect on selectivity. At 200 psi and 
above, the conversion is complete. (For a direct comparison of selectivites, reactions with 
PPh3 and I without the pre-exchange were run at 200 psi.) The regioselectivity shows a 
strong dependence on pressure, with 400 psi being the optimal pressure (Table 1.10). It is 
possible that the increased CO pressure inhibits olefin binding to rhodium which would 
slow the background reaction.27 Because 1.16 can chelate the metal, the directed reaction 
would be more competitive under those circumstances. Another possibility is that high 
H2/CO pressure changes the rate and selectivity determining step in the reaction.
28 
Table 1.10 Pressure Screen. 
 
27(a) van Leeuwen, P. W. N. M.; Casey, C. P.; Whiteker, G. T. Rhodium Catalyzed Hydroformylation; 
Leeuwen, P. W. N. M., Claver, C., Eds.; Kluwer Academic Publishers: Norwell, MA, 2001; Chapter 4, pp 
63-106. (b) van Rooy, A.; Orij, E. N.; Kamer, P. C. J.; van Leeuwen, P. W. N. M. Organometallics 1995, 
14, 34-43.                                                                                                                                                                                                                                             
28(a) Ghio, C.; Lazzaroni, R.; Alagona, G. Eur. J. Inorg. Chem. 2009, 1, 98-103. (b) Watkins, A. L.; Landis, 
C. R. J. Am. Chem. Soc. 2010, 132, 10306-10317. 
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 With the optimal conditions established, the substrate scope was expanded to 1,2-
disubstituted olefins. The more reactive terminal olefin, 1.15, resulting in a ratio of 97:3 
favoring 1.19 indicated that the disubstituted olefins would also be highly regioselective. 
Accordingly, the alkyl substrates all react with excellent regioselectivities in good yields 
(Table 1.11, Products 1.19, 1.22, and 1.23). A substrate containing a free alcohol was not 
successful as the alcohol can also bind to I, but the protected alcohol substrate gives 
similar results to the other alkyl substrates (Table 1.11, 1.24). In general, styrene 
substrates prefer to form the aldehyde at the position proximal to the aryl group.29 Using I 
completely overturned this inherent preference with both electron-withdrawing and 
donating aryl substrates (Table 1.11, Products 1.25-1.28). An ester substrate, which 
yields mostly reduced olefin when PPh3 is used as the ligand, gives high selectivity for 
the 1,4 dicarbonyl product, 1.29, when I is used with less than 10% reduced starting 
material (Table 1.11). The high selectivity is impressive as esters are known to direct 
hydroformylation.30 This demonstrates the ability of I to overcome a stoichiometric 
directing group. A skipped diene substrate gives greater than 95:5 selectivity in the 
presence of I leaving the distal olefin untouched. The hydroformylation of this diene with 
PPh3 gives a very complex mixture of aldehyde products (Table 11, Product 1.30). 
 
 
 
29(a) Tolman, C. A.; Faller, J. W. In Homogeneous Catalysis with Metal Phosphine Complexes; Pignolet, L. 
H., Ed.; Plenum: New York, 1983; pp 81-109. (b) van der Veen, L. A.; Boele, M. D. K.; Bregman, F. R.; 
Kamer, P. C. J.; van Leeuwen, P. W. N. M.; Goubitz, K.; Fraanje, J.; Schenk, H.; Bo, C. J. Am. Chem. Soc. 
1998, 120, 11616-11626.                                                                                                                              
30Neibecker, D.; Réau, R. Angew. Chem., Int. Ed. 1989, 28, 500-501. 
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Table 1.11 Substrate Scope of Hydroformylation of Allylic Sulfonamides.  
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1.6 Conclusions 
 Using catalytic directing group, I, the efficient regioselective hydroformylation of 
substituted allylic sulfonamides to form β-amino-aldehydes under mild conditions has 
been shown. A complete reversal of the inherent selectivity is obtained in many cases, as 
well as, excellent site selectivity in the case of 1.30.  
1.7 Experimental 
General Considerations 
Unless otherwise noted, all reagents were obtained from commercial suppliers and used 
without further purification. Lithium reagents were titrated against 2-pentanol or 2,6-di-
tert-butyl-4-methylphenol (BHT) using 1,10-phenanthroline as the indicator. Flash 
column chromatography was performed using EMD Silica Gel 60 (230-400 mesh) and 
ACS grade solvents as received from Fisher Scientific. All experiments were performed in 
oven or flame-dried glassware under an atmosphere of nitrogen or argon using standard 
syringe and cannula techniques, except where otherwise noted. All reactions were run 
with dry, degassed solvents dispensed from a Glass Contour Solvent Purification System 
(SG Water, USA LLC). 1H, 13C, and 31P NMR were performed on either a Varian Gemini-
2000 400 MHz or a Varian Unity 300 MHz instrument. Deuterated solvents were 
purchased from Cambridge Isotope Labs and stored over 3Å molecular sieves. C6D6 was 
degassed by three successive freeze-pump-thaw cycles and stored over 3Å molecular 
sieves in a dry box under a nitrogen atmosphere. All NMR chemical shifts are reported in 
ppm relative to residual solvent for 1H and 13C and external standard (neat H3PO4) for 
31P 
Chapter 1, Page 28 
 
NMR. Coupling constants are reported in Hz. All IR spectra were gathered on a Bruker 
Alpha FT-IR equipped with a single crystal diamond ATR module and values are reported 
in cm-1. Analytical supercritical fluid chromatography (SFC) was performed on a Berger 
Instruments Supercritical Chromatograph equipped with an Alcott auto sampler and a 
Knauer UV detector using methanol as the modifier. An achiral Princeton SFC 4.6x150 
mm silica column (henceforth Silica) with 60Å mesh silica, 6µ particle size was used for 
analysis of some compounds. All SFC retention times are reported as tr. HRMS and X-ray 
crystal structure data were generated in Boston College facilities. Hydroformylation was 
performed in an Argonaut Technologies Endeavor® Catalyst Screening System using 1:1 
H2/CO supplied by Airgas, Inc. 
Substrate Syntheses and Characterization 
The following compounds were made according to literature procedures and matched 
reported spectra: (E)-ethyl-3-cyclohexylacrylate,31-33 (E)-3-cyclohexyl-2-propen-1-ol,34-
36
 (E)-but-2-en-1-amine, 37-39 (E)-3-phenylprop-2-en-1-amine,40-41 
 31Charette, A. B.; Molinaro, C.; Brochu, C. J. Am. Chem. Soc. 2001, 123, 12168-12175.                                   
32Aggarwal, V. K.; Fulton, J. R.; Sheldon, C. G.; de Vicente, J. J. Am. Chem. Soc. 2003, 125, 6034-6035. 
33Nishizawa, M.; Hirakawa, H.; Nakagawa, Y.; Yamamoto, H.; Namba, K.; Imagawa, H. Org. Lett. 2007, 
9, 5577-5580.                                                                                                                                                                                                           
34Takeuchi, R.; Ue, N.; Tanabe, K.; Yamashita, K.; Shiga, N. J. Am. Chem. Soc. 2001, 123, 9525-9534. 
35Lombardo, M.; Morganti, S.; Trombini, C. J. Org. Chem. 2000, 65, 8767-8773.                                                              
36Chini, M.; Crotti, P.; Flippin, L. A.; Gardelli, C.; Giovani, E.; Macchia, F.; Pineschi, M. J. Org. Chem. 
1993, 58, 1221-1227.                                                                                                                                        
37Calsen, P. H. J.; Jorgensen, K. B. J. Heterocycl. Chem. 1997, 34, 797-806.                                                                   
38Nishikawa, Y.; Nakamura, Y.; Kawaguchi, S. Bull. Chem. Soc. Jpn. 1972, 45, 155-160.                                             
39Hamada, J.; Tsunashima, S.; Sato, S. Bull. Chem. Soc. Jpn. 1983, 56, 662-666.                                                                   
40Moody, C. J.; Rahimtoola, K. F.; Porter, B.; Ross, B. C. J. Org. Chem. 1992, 57, 2105-2114.                     
41Bartoli, G.; Di Antonio, G.; Giovannini, R.; Giuli, S.; Lanari, S.; Paoletti, M.; Marcantoni, E. J. Org. 
Chem. 2008, 73, 1919-1924.  
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1,4-but-2-enediol cyclic sulfite,42-45 2-isopropoxy-2,3-dihydro-1H-
benzo[d][1,3]azaphosphole (I),21 (E)-but-2-en-1-ol,46 (E)-1-bromobut-2-ene,47 (E)-hept-
5-en-2-yn-1-ol48 and (2E,5E)-hepta-2,5-dien-1-ol.49 
 
 
 
N-allyl-3,5-bis(trifluoromethyl)benzenesulfonamide.50 To a flame-dried round-bottom 
flask was added 3,5-bis(trifluoromethyl)benzenesulfonyl chloride (4.01 g, 12.8 mmol) 
and CH2Cl2 (50 mL). The solution was cooled to 0 °C and allyl amine (4.78 mL, 63.9 
mmol) was added dropwise. The solution was allowed to warm to room temperature. The 
reaction was diluted with CH2Cl2 (20 mL) and washed with 1:1 brine/H2O (2x30 mL) and 
brine (1x30 mL). The organic layers were combined, dried over Na2SO4, filtered, and 
concentrated. Chromatography (15% EtOAc/Hex) afforded a white solid (4.15 g, 97%). 
SFC (AS-H, 1.0 mL/min, 1.0% MeOH, 220 nm, 150 bar, 50 °C) tr = 7.44 min; 
42Chaudhari, S. S.; Akamanchi, K. G. Synlett 1999, 11, 1763-1765.                                                                                  
43Shellhamer, D. F.; Anstine, D. T.; Gallego, K. M.; Ganesh, B. R.; Hanson, A. A.; Hanson, K. A.; 
Henderson, R. D.; Prince, J. M.;  Heasley, V. L. J. Chem. Soc. Perkin Trans. 2 1995, 7, 1569-1570. 
44Friedrich, M.; Savchenko, A. I.; Wachtler, A.; de Meijere, A. Eur. J. Org. Chem. 2003, 11, 2138-2143. 
45Morino, Y.; Hidaka, I.; Oderaotoshi, Y.; Komatsu, M.; Minakata, S. Tetrahedron 2006, 62, 12247-12251. 
46Haynes, R. K.; Au-Yeung, T.; Chan, W.; Lam, W.; Li, Z.; Yeung, L.; Chan, A. S. C.; Li, P.; Koen, M.; 
Mitchell, C. R.; Vonwiller, S. C. Eur. J. Org. Chem. 2000, 18, 3205-3216.                                                     
47Loughin, W. A.; Haynes, R. K. Aust. J. Chem. 1995, 48, 651-661.                                                                                                                  
48Davies, S. G.; Haggitt, J. R.; Ichihara, O.; Kelly, R. J.; Leech, M. A.; Price, M. A. J.; Roberts, P. M.; 
Smith, A. D. Org. Biomol. Chem. 2004, 2, 2630-2649.                                                                                                                                
49Pickard, S. T.; Smith, H. E.; Polavarapu, P. L.; Black, T. M.; Rauk, A.; Yang, D. J. Am. Chem. Soc. 1992, 
114, 6850-6857.                                                                                                                                       
50Brummond, K. M.; Chen, H.; Mitasev, B.; Casarez, A. D. Org. Lett. 2004, 6, 2161-2163. 
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1H NMR (CDCl3, 400 MHz)  8.32 (s, 2H), 8.08 (s, 1H), 5.66-5.75 (m, 1H), 5.13-5.22 
(m, 2H), 4.91 (t, 1H, J = 5.9), 3.72 (ddd, 2H, J = 12.0, 6.0, 1.3); 13C NMR (CDCl3, 100 
MHz)  143.4, 133.1 (q, J = 34.5), 132.3, 127.5, 126.4, 122.6 (q, J = 273.6), 118.6, 46.0; 
IR: 3274, 3087, 1626, 1430, 1362, 1340, 1281, 1196, 1175, 1160, 1132, 1110, 906, 886, 
697, 682, 645, 589, 515 cm–1; HRMS (DART-TOF) calcd. for C11H10F6NO2S [M+H]
+: 
334.0336, found: 334.0340. 
 
 
 
 
 
cis/trans-(1:4.5 mixture)-N-(but-2-enyl)-3,5-
bis(trifluoromethyl)benzenesulfonamide. To a flame-dried round-bottom flask was 
added but-2-en-1-amine hydrochloride (4.11 g, 37.5 mmol), triethylamine (713 µL, 5.12 
mmol) and CH2Cl2 (150 mL). The solution was cooled to 0 °C and 3,5-
bis(trifluoromethyl)benzenesulfonyl chloride (11.7 g, 37.5 mmol) was added. The 
reaction was allowed to warm to room temperature. The solution was diluted with 
EtOAc (50 mL) and washed with 1:1 brine/H2O (2x50 mL) and brine (1x50 mL). The 
organic phase was dried over Na2SO4, filtered, and concentrated. Chromatography 
(CH2Cl2) afforded a white solid (5.36 g, 41%). SFC (AS-H, 1.0 mL/min, 1.0% MeOH, 
220 nm, 150 bar, 50 °C) tr = 8.67 min; 
1H NMR (CDCl3, 400 MHz)  8.30 (s, 2H), 8.07 
(s, 1H), 5.58-5.67 (m, 1H), 5.27-5.34 (m, 1H), 4.62 (s, 1H), 3.75 (app. t, 0.4H, J = 6.4), 
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3.65 (ddd, 2H, J = 12.5, 6.2, 1.1), 1.61 (d, 3H, J = 5.3); 13C NMR (CDCl3, 100 MHz)  
143.7, 133.1 (q, J = 33.7), 131.1, 127.6, 126.3, 125.0, 122.6 (q, J = 272.8), 45.7, 17.7; 
IR: 3277, 3058, 1626, 1359, 1342, 1279, 1265, 1161, 1141, 1110, 904, 735, 698, 681, 
590, 414 cm-1; HRMS (DART-TOF) calcd. for C12H12F6NO2S [M+H]
+: 348.0493, 
found: 348.0502.  
 
3,5-bis(trifluoromethyl)benzenesulfonamide.51 3,5-
bis(trifluoromethyl)benzenesulfonyl chloride (1.0 g, 3.2 mmol) was suspended in water 
in a round-bottom flask. Ammonium hydroxide (1.3 mL, 32 mmol) was added. The 
mixture was heated to 100 °C. After reaching 100 °C, the reaction was cooled to room 
temperature and concentrated. Excess water was removed by azeotroping the product 
with toluene three times to yield a white solid (1.0 g, 100%). 1H NMR (CDCl3, 300 
MHz)  8.39 (s, 2H), 8.09 (s, 1H), 4.99 (s, 2H); IR: 3356, 3262, 1323, 1312, 1277, 
1266, 1198, 1163, 1131, 907, 731, 699, 682 cm-1; HRMS (DART-TOF) calcd. for 
C8H6F6NO2S [M+H]
+: 294.0023, found: 294.0037.  
51Yuriev, E.; Kong, D. C. M.; Iskander, M. N. Eur. J. Med. Chem. 2004, 39, 835-847. 
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(E)-N-(3-cyclohexylallyl)-3,5-bis(trifluoromethyl)benzenesulfonamide.52 3,5-
bis(trifluoromethyl)benzenesulfonamide (658 mg, 4.69 mmol), (E)-3-cyclohexyl-2-
propen-1-ol (2.75 g, 9.38 mmol) and triphenylphosphine (2.46 g, 9.38 mmol) were 
dissolved in CH2Cl2 (94 mL) in a round-bottom flask. DIAD (1.90 g, 9.38 mmol) was 
added, and the reaction was stirred at room temperature for 2.5 h. The reaction was 
concentrated. Chromatography (2-25% EtOAc/Hex) yielded a white solid (371 mg, 
19%). SFC (AS-H, 2.0 mL/min, 0.5% MeOH, 220 nm, 150 bar, 50 °C) tr = 9.87 min; 
1H NMR (CDCl3, 400 MHz)  8.31 (s, 2H), 8.07 (s, 1H), 5.52 (dd, 1H, J = 15.5, 6.5), 
5.22 (dtd, 1H, J = 15.4, 6.4, 1.1), 4.75 (t, 1H, J = 5.8), 3.64 (t, 2H, J = 6.2), 1.82-1.85 
(m, 1H), 1.55-1.69 (m, 5H), 1.03-1.26 (m, 3H), 0.86-0.96 (m, 2H); 13C NMR (CDCl3, 
100 MHz)  143.6, 141.9, 133.0 (q, J = 34.5), 127.5, 126.3, 122.6 (q, J = 272.7), 121.2, 
45.8, 40.3, 32.6, 26.2, 26.0; IR: 3291, 2928, 2855, 1450, 1424, 1360, 1279, 1161, 1142, 
1114, 905, 699, 682, 593 cm-1; HRMS (DART-TOF) calcd. for C17H20F6NO2S [M+H]
+: 
416.1119, found: 416.1127. 
(Z)-2-(4-(tert-butyldimethylsilyloxy)but-2-enyl)isoindoline-1,3-dione. Potassium  
52Guisado, C.; Waterhouse, J. E.; Price, W. S.; Jorgensen, M. R.; Miller, A. D. Org. Biomol. Chem. 
2005, 3. 1049-1057. 
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phthalimide (15.2 g, 82.1 mmol) was added to 1,4-but-2-enediol cyclic sulfite (5.51 g, 
41.1 mmol) in DMF (22 mL). The suspension was stirred and heated to 100 °C for 1 
h. After cooling, the reaction was quenched with H2O (100 mL). The aqueous phase 
was extracted with Et2O (3x50 mL). The combined organic extracts were washed 
with H2O (1x50 mL), dried with anhydrous MgSO4, filtered, and concentrated. The 
resulting white solid was dissolved in CH2Cl2 (50 mL) and filtered to remove excess 
potassium phthalimide. The filtrate was concentrated to give a 3:1 ratio of product to 
potassium phthalimide and was used without further purification. In a flame-dried 100 
mL round bottom flask, the filtrate (6.36 g, 29.3 mmol) was dissolved in CH2Cl2 (49 
mL) and DMAP (183 mg, 1.50 mmol) was added. The solution was cooled to 0 °C, 
and triethylamine (4.90 mL, 35.2 mmol) was added. TBSCl (5.32 g, 35.3 mmol) was 
dissolved in CH2Cl2 (10 mL) and added slowly at 0 °C. The solution was allowed to 
warm to room temperature and stirred overnight at room temperature. Saturated 
aqueous NaHCO3 (20 mL) was added, and the solution was extracted with CH2Cl2 
(3x30 mL). The combined organics were washed with brine (1x50 mL), dried over 
MgSO4, filtered, and concentrated. Chromatography (10% EtOAc/Hex) afforded a 
white solid (6.63 g, 49% over two steps). 1H NMR (CDCl3, 400 MHz)  7.83-7.86 
(m, 2H), 7.70-7.73 (m, 2H), 5.63-5.75 (m, 1H), 5.47-5.55 (m, 1H), 4.45 (d, 2H, J = 
4.8), 4.33 (d, 2H, J = 7.1), 0.92 (s, 9H), 0.11 (s, 6H); 13C NMR (CDCl3, 100 MHz)  
168.0, 134.1, 134.0, 132.3, 123.7, 123.4, 59.6, 35.2, 26.2, 18.6, –4.8; IR: 3379, 2955, 
2920, 2857, 1773, 1716, 1430, 1089, 838, 779, 716 cm-1; HRMS (DART-TOF) calcd. 
for C18H26NO3Si [M+H]
+: 332.1682, found: 332.1675. 
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(Z)-N-(4-(tert-butyldimethylsilyloxy)but-2-enyl)-3,5-
bis(trifluoromethyl)benzenesulfonamide. (Z)-2-(4-(tert-butyldimethylsilyloxy)but-2-
enyl)isoindoline-1,3-dione (7.71 g, 23.3 mmol) and hydrazine hydrate (2.30 mL, 46.6 
mmol) were refluxed in EtOH (23 mL) for 30 minutes. After cooling to room 
temperature, the mixture was filtered, and the solid was washed with CH2Cl2 (3x30 mL). 
The filtrate was concentrated. The resulting oil (3.42 g, 17.0 mmol) was dissolved in 
CH2Cl2 (57 mL) in a round-bottom flask. The reaction was cooled to 0 °C, and 3,5-
bis(trifluoromethyl)benzenesulfonyl chloride (5.29 g, 17.0 mmol) was added. Hunig’s 
base (8.92 mL, 129 mmol) was added slowly, and the reaction was allowed to warm to 
room temperature. The reaction was diluted with CH2Cl2 (20 mL) and washed with 1:1 
brine/H2O (2x30 mL) and brine (1x30 mL). The organic phase was dried over Na2SO4, 
filtered, and concentrated. Chromatography (10% EtOAc/Hex) afforded an off-white 
solid (3.69 g, 39% over two steps). SFC (AS-H, 1.0 mL/min, 1.0% MeOH, 220 nm, 150 
bar, 50 °C) tr = 9.76; 
1H NMR (CDCl3, 400 MHz)  8.31 (s, 2H), 8.07 (s, 1H), 5.63-5.73 
(m, 1H), 5.38-5.42 (m, 1H), 5.18 (t, 1H, J = 5.7), 4.16 (d, 2H, J = 5.7), 3.76-3.79 (m, 2H), 
0.87 (s, 9H), 0.05 (s, 6H); 13C NMR (CDCl3, 100 MHz)  143.6, 133.7, 133.1 (q, J = 
34.5), 127.5, 126.2, 125.3, 122.6 (q, J = 273.6), 59.6, 40.6, 26.0, 18.4, –5.2; IR: 3293, 
2956, 2933, 2887, 2859, 1359, 1277, 1137, 1109, 1064, 905, 836, 699, 681, 590, 414; 
HRMS (DART-TOF) calcd. for C18H26F6NO3SSi [M+H]
+: 478.1307, found: 478.1328. 
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N-cinnamyl-3,5-bis(trifluoromethyl)benzenesulfonamide.50 The procedure for N-
allyl-3,5-bis(trifluoromethyl)benzenesulfonamide was followed. Chromatography (15% 
EtOAc/Hex) afforded a white solid (1.69 g, 50%). SFC (AS-H, 2.0 mL/min, 2.0% 
MeOH, 220 nm, 150 bar, 50 ˚C) tr = 16.69 min; 
1H NMR (CDCl3, 400 MHz) δ 8.25 (s, 
2H), 7.93 (s, 1H), 7.22-7.13 (m, 5H), 6.38 (d, 1H, J = 16.0), 5.91 (dt, 1H, J = 15.7, 6.4), 
4.85 (t, 1H, J = 6.0), 3.79 (dd, 2H, J = 6.2, 6.0); 13C NMR (CDCl3, 100 MHz)  143.5, 
135.6, 134.2, 133.1 (q, J = 34.5), 128.8, 128.4, 127.5, 126.5, 126.3, 123.0, 122.5 (q, J = 
273.6), 45.8; IR: 3281, 3091, 1361, 1340, 1157, 1139, 1110, 970, 907, 749, 696, 682, 
590 cm–1; HRMS (DART-TOF) calcd. for C17H13F6NO2S [M]
+: 409.0571, found: 
409.0588. 
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(E)-3,5-bis(trifluoromethyl)-N-(3-(4-
(trifluoromethyl)phenyl)allyl)benzenesulfonamide.53 To a flame-dried two-neck 
round-bottom flask fitted with a reflux condenser was added N-allyl-3,5-
bis(trifluoromethyl)benzenesulfonamide (1.51 g, 4.49 mmol) followed by palladium (II) 
acetate (50.5 mg, 0.225 mmol) and tri(o-tolyl)phosphine (137 mg, 451 μmol). The flask 
was temporarily placed under vacuum and refilled with nitrogen three times to remove any 
oxygen followed by addition of acetonitrile (8.4 mL), triethylamine (1.26 mL, 9.01 mmol) 
and 4-iodobenzotrifluoride (661 μL, 4.51 mmol). The reaction mixture was placed in a 
preheated oil bath and stirred for 3 h to yield an orange solution. The reaction was cooled 
below reflux and a second portion of each: palladium (II) acetate (25.3 mg, 0.113 mmol), 
tri(o-tolyl)phosphine (68.5 mg, 0.225 mmol) and 4-iodobenzotrifluoride (278 μL, 1.89 
mmol) was added and heated for an additional 16 h. The reaction mixture was diluted 
with H2O (28 mL) and extracted with EtOAc (3x20 mL). The organic layers were 
combined, dried over MgSO4, filtered, and concentrated to yield a yellow oil that was 
dry-loaded (CH2Cl2) onto silica gel. Chromatography (15-25% EtOAc/Hex) yielded a 
light yellow solid (925 mg, 47%). SFC (Silica, 5.0 mL/min, 1.0% MeOH, 220 nm, 150 
bar, 50 °C) tr = 5.07 min; 
1H NMR (CDCl3, 400 MHz)  8.24 (s, 2H), 7.96 (s, 1H), 7.46 
53Busacca, C. A.; Dong, Y. Tet. Lett. 1996, 37, 3947-3950. 
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(d, 2H, J = 8.4), 7.26 (d, 2H, J = 8.4), 6.45 (d, 1H, J = 16.0), 6.05 (dt, 1H, J = 6.0, 16.0), 
4.79 (t, 1H, J = 6.0), 3.83 (t, 2H, J = 6.0); 13C NMR (CDCl3, 100 MHz)  143.5, 139.1, 
133.3 (q, J = 34.5), 132.7, 130.4 (q, J = 35.2), 127.5, 126.8, 126.5, 126.0, 125.9, 124.2 
(q, J = 275.9), 122.5 (q, J = 273.6), 45.6; IR: 3290, 3089, 2925, 2854, 1618, 1416, 1360, 
1327, 1279, 1160, 1067, 725, 699, 682 cm–1; HRMS (DART-TOF) calcd. for 
C18H12F9NO2S [M]
+•: 477.0445, found: 477.0447. 
 
 
 
 
(E)-N-(3-(4-chlorophenyl)allyl)-3,5-bis(trifluoromethyl)benzenesulfonamide.53 The 
procedure for (E)-3,5-bis(trifluoromethyl)-N-(3-(4-
(trifluoromethyl)phenyl)allyl)benzenesulfonamide was followed except that 4-
bromochlorobenzene was used instead of 4-iodobenzotrifluoride. Chromatography (25% 
EtOAc/Hex) yielded a white solid (561 mg, 42%). SFC (Silica, 5.0 mL/min, 1.0% 
MeOH, 220 nm, 150 bar, 50 °C) tr = 4.8 min; 
1H NMR (CDCl3, 300 MHz)  8.32 (s, 2H), 
8.04 (s, 1H), 7.27 (d, 2H, J = 8.4), 7.17 (d, 2H, J = 8.4), 6.45 (d, 15.9, J = 15.9), 6.00 (dt, 
1H, J = 6.3, 15.9), 4.76 (t, 1H, 5.7), 3.85-3.90 (m, 2H); 13C NMR (CDCl3, 100 MHz)  
143.5, 134.2, 134.2, 132.7 (q, J = 34.5), 133.0, 129.0, 127.8, 127.6, 122.6 (q, J = 272.8), 
126.4, 123.8, 45.7; IR: 3159, 3085, 2960, 2924, 2853, 1625, 1593, 1492, 1427, 1318, 
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1296, 1159, 1096, 926, 698, 681, 592 cm–1; HRMS (DART-TOF) calcd. For 
C17H12ClF6NO2S [M]
+: 443.0182, found: 443.0190. 
 
 
 
 
(E)-N-(3-(4-methoxyphenyl)allyl)-3,5-bis(trifluoromethyl)benzenesulfonamide.53 
The procedure for (E)-3,5-bis(trifluoromethyl)-N-(3-(4-
(trifluoromethyl)phenyl)allyl)benzenesulfonamide was followed except that 4-
bromoanisole was used instead of 4-iodobenzotrifluoride. Chromatography (10-25% 
EtOAc/Hex) yielded an off-white solid (925 mg, 47%). SFC (Silica, 5.0 mL/min, 1.0% 
MeOH, 220 nm, 150 bar, 50 °C) tr = 4.84 min; 
1H NMR (Acetone d-6, 400 MHz)  
8.45 (s, 2H), 8.30 (s, 1H), 7.21 (d, 2H, J = 8.8), 6.84 (d, 2H, J = 8.8), 6.42 (d, 1H, J = 
16.0), 5.94 (dt, 1H, J = 6.4, 16.0), 3.84 (dd, 2H, J = 5.6, 6.4). 3.78 (s, 3H); 13C NMR 
(CDCl3, 100 MHz)  160.5, 145.4, 133.2, 133.1 (q, J = 33.7), 129.8, 128.5, 128.3, 
126.9, 123.8 (q, J = 272.8), 122.7, 114.8, 55.7, 46.3; IR: 3356, 3262, 2958, 2922, 2851, 
1626, 1607, 1364, 1323, 1277, 1163, 1132, 1030, 907, 845, 698 cm–1; HRMS (DART-
TOF) calcd. for C18H16F6NO3S [M+H]
+: 440.0753, found: 440.0753. 
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(E)-ethyl 4-(3,5-bis(trifluoromethyl)phenylsulfonamido)but-2-enoate.54 N-allyl-3,5-
bis(trifluoromethyl)benzenesulfonamide (4.1 g, 12 mmol) was dissolved in MeOH (40 
mL) and cooled to –78 °C. Ozone was bubbled through the solution until it turned blue. 
The excess ozone was bubbled out with nitrogen, and dimethyl sulfide (1.3 mL, 18 
mmol) was added. The solution was kept at –78 °C for 5 h then slowly allowed to warm 
to room temperature. The solvent was evaporated. The residue was dissolved in CHCl3 
(80 mL), washed with 2% HCl (30 mL) and saturated aqueous NaHCO3 (30 mL), and 
dried over MgSO4. The organic layer was filtered and concentrated. NaH (314 mg, 13.1 
mmol) was suspended in THF (45 mL) and triethylphosphonoacetate (2.67 g, 11.9 
mmol) in THF (5 mL) was added. The solution was stirred for 1.5 h. The crude 
ozonolysis product (4.1 g, 12 mmol) in THF (10 mL) was added, and the solution was 
stirred at room temperature overnight. The reaction was quenched with H2O (5 mL) and 
concentrated. The residue was dissolved in CHCl3 (60 mL), washed with 2% HCl (20 
mL) and saturated aqueous NaHCO3 (30 mL), dried over MgSO4, filtered, and 
concentrated. Chromatography (20% EtOAc/Hex) afforded a white solid. A minor 
impurity was removed by recrystallization (EtOH/Hex) to give a white solid (590 mg, 
12%). SFC (AS-H, 2.0 mL/min, 0.5% MeOH, 220 nm, 150 bar, 50 ˚C) tr = 17.99 min; 
1H  
54Liu, S.; Hanzlik, R. P. J. Med. Chem. 1992, 35, 1067-1075. 
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NMR (CDCl3, 400 MHz)  8.31 (s, 2H), 8.09 (s, 1H), 6.73 (dt, 1H, J = 15.6, 5.2), 5.93 
(dt, 1H, J = 16.0, 1.2), 5.11 (t, 1H, J = 5.8), 4.17 (q, 2H, J = 7.0), 3.87-3.91 (m, 2H,), 1.27 
(t, 3H, J = 6.8); 13C NMR (CDCl3, 100 MHz)  165.5, 143.2, 141.3, 133.3 (q, J = 34.5), 
127.5, 126.6, 123.8, 122.5 (q, J = 274.4), 61.1, 44.1, 14.3; IR: 3278, 3089, 2988, 1703, 
1360, 1279, 1162, 1139, 1113, 906, 699, 682, 592 cm–1; HRMS (DART-TOF) calcd. for 
C14H14F6NO4S [M+H]
+: 406.0548, found: 406.0554. 
Synthesis of N-((2E,5E)-hepta-2,5-dienyl)-3,5-bis(trifluoromethyl)benzenesulfonamide: 
 
 
 
 
 
 
N-((2E,5E)-hepta-2,5-dienyl)-3,5-bis(trifluoromethyl)benzenesulfonamide.52 The 
procedure for (E)-N-(3-cyclohexylallyl)-3,5-bis(trifluoromethyl)benzenesulfonamide 
was followed. Chromatography (2-7% EtOAc/Hex) afforded light yellow oil that 
solidified upon standing to yield a white solid (654 mg, 34%). 1H NMR (CDCl3, 300 
MHz)  8.30 (s, 2H), 8.07 (s, 1H), 5.59 (dt, 1H, J = 1.2, 5.1), 5.55-5.63 (m, 3H), 4.56 
(t, 1H, J = 6.0), 3.67 (dd, 2H, J = 1.2, 6.3), 2.59-2,62 (m, 2H), 1.61-1.64 (m, 3H); 13C 
NMR (CDCl3, 100 MHz)  143.7, 134.5, 133.1 (q, J = 35.4), 127.9, 127.6, 126.9, 
F3C
CF3
S
O
O
H
N
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126.3, 124.2, 122.6 (q, J = 273.5), 45.6, 35.1, 18.0; IR: 3289, 3088, 2924, 1625, 1426, 
1277, 1134, 1109, 969, 904, 843, 698, 680, 631, 589 cm–1; HRMS (DART-TOF) 
calcd. for C15H16F6NO2S [M+H]
+: 388.0806, found: 388.0792. 
Authentic Linear Hydroformylation Product Synthesis and Characterization 
 
 
 
 
1-(3,5-bis(trifluoromethyl)benzenesulfonyl)pyrrolidin-2-one.55 Pyrrolidinone (401 
mg, 4.69 mmol) was brought up in THF (15 mL) and cooled to 0 °C. nBuLi (3.45 mL, 
5.17 mmol) was added via syringe. The reaction mixture was stirred at 0 °C for 40 
minutes. A cold solution of 3,5-bis(trifluoromethyl)benzenesulfonyl chloride (1.48 g, 
4.75 mmol) in THF (6 mL) was added via cannula. The reaction was stirred at 0 °C. 
After ~1 h, the   reaction was warmed to room temperature and concentrated. The 
concentrate was diluted with CH2Cl2 (15 mL), washed with H2O (3x10 mL), dried over 
MgSO4, filtered, and concentrated. Chromatography (20-100% EtOAc/Hex) yielded a 
white solid (958 mg, 80%). 1H NMR (CDCl3, 400 MHz)  8.52 (s, 2H), 8.15 (s, 1H), 
3.97 (t, 2H, J = 7.1), 2.51 (t, 2H, J = 8.1), 2.17 (tt, 2H, J = 7.7, 7.5); 13C NMR (CDCl3,  
55Harling, J. D.; Steel, P. G.; Woods, T. M.; Yufit, D. S. Org. Biomol. Chem. 2007, 5, 3472-3476. 
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100 MHz)  173.6, 140.8, 133.0 (q, J = 34.5), 128.8, 127.7, 122.5 (q, J = 272.8), 47.6, 
32.1, 18.6; IR: 3095, 2994, 2915, 1750, 1626, 1362, 1279, 1165, 1133, 1109, 965, 906, 
696, 682, 634, 593, 540, 415 cm-1; HRMS (DART-TOF) cald. for C12H10F6NO3S 
[M+H]+: 362.0256, found: 362.0287. 
 
 
 
1-(3,5-bis(trifluoromethyl)benzenesulfonyl)pyrrolidin-2-ol.56 1-(3,5-
bis(trifluoromethyl)benzenesulfonyl)pyrrolidin-2-one (250 mg, 0.69 mmol) was 
dissolved in CH2Cl2 (3.5 mL) and cooled to –78 °C under Ar. With stirring, the reaction 
mixture was treated with DIBAL (140 µL, 0.76 mmol) dropwise, stirred for 1 h at –78 
°C, and 1 h at room temperature. The reaction was cooled to –78 °C, quenched with 
MeOH (520 µL) and allowed to warm to room temperature slowly overnight. The 
reaction was poured on to a 1M aqueous solution of Rochelle’s salt (15 mL). This 
mixture was extracted with CH2Cl2 (3x40 mL). The combined organic layers were 
washed with brine (30 mL), dried with MgSO4, filtered, and concentrated. 
Chromatography (25% EtOAc/Hex) afforded a white solid (160 mg, 64%). SFC (AS-H, 
1.0 mL/min, 1.0% MeOH, 220 nm, 150 bar, 50 °C) tr = 6.48 min; 
1H NMR (CDCl3, 400 
MHz)  8.34 (s, 2H), 8.08 (s, 1H), 5.56-5.57 (m, 1H), 3.54 (s, 1H), 3.20 (s, 1H), 3.03 (s, 
1H), 2.12-2.21 (m, 1H), 1.90-1.99 (m, 3H); 13C NMR (CDCl3, 100 MHz)  143.1, 133.9 
(q, J = 34.5), 128.3, 127.1, 123.3 (q, J = 272.8), 84.4, 47.6, 34.4, 23.2; IR: 3502, 3090,  
56Unthank, M. G.; Hussain, N.; Aggarwal, V. K. Angew. Chem., Int. Ed. 2006, 45, 7066-7069. 
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2986, 1361, 1280, 1158, 1136, 1114, 907, 731, 700, 682, 652, 600 cm-1; HRMS (ESI) 
calcd. for C12H11F6NO3S [M+Na]
+: 386.0262, found: 386.0267. 
Exchange Reactions with Sulfonamides (Table 1.1) 
 
General Exchange Reaction Procedure: In a dry glovebox, the sulfonamide, 1.15, (0.10 
mmol) was mixed with I (0.01 mmol) in benzene (1.0 mL) and heated to 45 °C. The 
reaction progress was followed by 31P NMR. 31P NMR of I: –22.1 ppm. 
Table 1.1, Entry 1: N-allyl-4-methoxybenzenesulfonamide (23 mg, 1.0 x 10-1 mmol) and 
ligand I (2.9 mg, 1.0 x 10-2 mmol) were mixed in benzene (1.0 mL) and heated to 45 °C. 
31P NMR: –18.7 ppm. 
Table 1.1, Entry 2: N-allyl-4-methylbenzenesulfonamide (21 mg, 1.0 x 10-1 mmol) 
and ligand I (2.9 mg, 1.0 x 10-2 mmol) were mixed in benzene (1.0 mL) and heated to 
45 °C. 31P NMR:  –18.8 ppm. 
Table 1.1, Entry 3: N-allyl-4-nitrobenzenesulfonamide (24 mg, 1.0 x 10-1 mmol) and 
ligand I (2.9 mg, 1.0 x 10-2 mmol) were mixed in benzene (1.0 mL) and heated to 45 
°C. 31P NMR:  –17.9 ppm. 
Table 1.1, Entry 4: N-allyl-3,5-bis(trifluoromethyl)benzenesulfonamide (33 mg, 1.0 
x 10-1 mmol) and ligand I (2.9 mg, 1.0 x 10-2 mmol) were mixed in benzene (1.0 mL) 
and heated to 45 °C. 31P NMR: –17.8 ppm. 
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Exchange Reaction Between Substrates (Scheme 1.14)  
In a dry glovebox, N-allyl-3,5-bis(trifluoromethyl)benzenesulfonamide, 1.15, (17 mg, 
5.0 x 10-2 mmol) and I (2.9 mg, 1 x 10-2 mmol) were mixed in benzene d-6 (0.6 mL) 
and heated to 55 °C. Reaction was followed by 31P NMR. After 48 h, the reaction was 
complete. The reaction was concentrated and redissolved in benzene d-6 (1.0 mL) 
with (E)-N-(but-2-en-1-yl)-3,5-bis(trifluoromethyl)benzenesulfonamide, 1.17 (18 mg, 
5.0 x 10-2 mmol). The reaction was monitored by 31P NMR. After 1 h at room 
temperature, the ratio between 1.16 and 1.18 was 53:47. At equilibrium (after 22 h), 
the ratio was 43:57, respectively. 
Exchange Reaction with Product (Table 1.2) 
 In a dry glovebox, N-(2-methyl-3-oxopropyl)-3,5-
bis(trifluoromethyl)benzenesulfonamide, 1.19, (18 mg, 5.0 x 10-2 mmol) and I (2.9 
mg, 1.0 x 10-2 mmol) were mixed in benzene d-6 (0.6 mL). The reaction was 
monitored by 31P NMR at room temperature for 24 h.  
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Crystal Structure of I-decomp (CCDC # 837337) (Figure 1.5) 
 
Table 1.12 Crystal data and structure refinement for I-decomp. 
Identification code    C14H14NOP 
Empirical formula    C14H14NOP 
Formula weight    243.23 
Temperature     100(2) K 
Wavelength     0.71073 Å 
Crystal system    Monoclinic 
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Space group     P 1 21/c 1 
Unit cell dimensions     a= 9.7934(11) Å  a = 90°.                  
      b = 10.0938(11) Å  b= 108.5370(10)°. 
      c = 12.8098(14) Å  g = 90°. 
Volume      1200.6(2) Å3 
Z       4 
Density (calculated)     1.346 Mg/m3 
Absorption coefficient    0.211 mm-1 
F(000)      512 
Crystal size      0.17 x 0.16 x 0.10 mm3 
Theta range for data collection  2.19 to 28.30°. 
Index ranges     -13<=h<=l3, -13<=k<=l3, -16<=1<=17 
Reflections collected     14018 
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Independent reflections    2941 [R(int) = 0.0188] 
Completeness to theta = 28 .30°   98.6% 
Absorption correction    Semi-empirical from equivalents 
Max. and min. transmission    0.9793 and 0.9651 
Refinement method     Full-matrix least-squares on F2 
Data/ restraints/ parameters    2941/ 14/ 196 
Goodness-of-fit on F2    1.065 
Final R indices [I>2sigma(I)]   R1 = 0.0362, wR2 = 0.0954 
R indices (all data)     R1 = 0.0372, wR2 = 0.0964 
Extinction coefficient    na 
Largest diff. peak and hole   0.556 and -0.222 e. Å -3 
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Table 1.13 Bond lengths [Å] and angles [°] for I-decomp. 
P(l)-O(1)      1.4894(9) 
P(l)-C(7)      1.7778(11) 
P(1)-C(1)      1.7935(12) 
P(l)-C(14)      1.8246(12) 
N(1)-C(8)      1.3897(15) 
N(l)-C(l3)      1.4546(15) 
N(1)-C(14)      1.4621(15) 
C(1)-C(6)      1.3939(16) 
C(l)-C(2)      1.3946(16) 
C(2)-C(3)      1.3901(17) 
C(2)-H(2)      0.966(13) 
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C(3)-C(4)      1.3889(19) 
C(3)-H(3)      0.960(13) 
C(4)-C(5)      1.3834(19) 
C(4)-H(4)      0.931(14) 
C(5)-C(6)      1.3915(17) 
C(5)-H(5)      0.944(13) 
C(6)-H(6)      0.937(13) 
C(7)-C(12)      1.3910(15) 
C(7)-C(8)      1.4069(15) 
C(8)-C(9)      1.4036(16) 
C(9)-C(10)      1.3873(18) 
C(9)-H(9)      0.932(13) 
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C(10)-C(11)     1.3881(18) 
C(10)-H(10)      0.957(13) 
C(11)-C(l2)      1.3895(17) 
C(11)-H(11)      0.924(13) 
C(l2)-H(12)      0.957(13) 
C(13)-H(13A)     0.985(14) 
C(13)-H(13B)     0.955(14) 
C(13)-H(l3C)      0.980(14) 
C(l4)-H(l4A)      0.955(13) 
C(l4)-H(14B)      0.976(12) 
O(1)-P(1)-C(7)     115.94(5) 
O(1)-P(1)-C(1)     112.20(5) 
Chapter 1, Page 51 
 
C(7)-P(1)-C(l)     109.96(5) 
O(1)-P(1)-C(14)     115.89(5) 
C(7)-P(1)-C(14)     90.48(5) 
C(1)-P(1)-C(14)     110.52(5) 
C(8)-N(1)-C(13)     120.06(10) 
C(8)-N(1)-C(14)     111.64(9) 
C(13)-N(1)-C(14)     115.92(9) 
C(6)-C(1)-C(2)     119.78(11) 
C(6)-C(1)-P(1)     118.59(9) 
C(2)-C(1)-P(1)     121.59(9) 
C(3)-C(2)-C(1)     120.12(11) 
C(3)-C(2)-H(2)     120.1(10) 
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C(1)-C(2)-H(2)     119.8(10) 
C(4)-C(3)-C(2)     119.71(12) 
C(4)-C(3)-H(3)     119.8(10) 
C(2)-C(3)-H(3)     120.4(10) 
C(5)-C(4)-C(3)     120.49(12) 
C(5)-C(4)-H(4)     121.2(11) 
C(3)-C(4)-H(4)     118.3(11) 
C(4)-C(5)-C(6)     120.03(11) 
C(4)-C(5)-H(5)     119.6(10) 
C(6)-C(5)-H(5)     120.4(10) 
C(5)-C(6)-C(1)     119.88(11) 
C(5)-C(6)-H(6)     121.7(10) 
Chapter 1, Page 53 
 
C(l)-C(6)-H(6)     118.4(10) 
C(12)-C(7)-C(8)     121.12(10) 
C(l2)-C(7)-P(l)     130.09(9) 
C(8)-C(7)-P(1)     108.38(8) 
N(1)-C(8)-C(9)     125.51(11) 
N(l)-C(8)-C(7)     114.92(10) 
C(9)-C(8)-C(7)     119.52(11) 
C(10)-C(9)-C(8)     118.14(11) 
C(10)-C(9)-H(9)     120.5(10) 
C(8)-C(9)-H(9)     121.3(10) 
C(9)-C(10)-C(11)     122.51(11) 
C(9)-C(10)-H(10)     119.4(10) 
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C(11)-C(10)-H(10)     118.0(10) 
C(10)-C(11)-C(12)     119.46(11) 
C(10)-C(11)-H(11)     118.5(10) 
C(12)-C(11)-H(11)     122.0(10) 
C(11)-C(12)-C(7)     119.21(11) 
C(11)-C(12)-H(12)     122.4(9) 
C(7)-C(12)-H(12)     118.4(9) 
N(1)-C(13)-H(13A)     111.6(11) 
N(1)-C(13)-H(13B)     109.4(11) 
H(l3A)-C(13)-H(l3B)    108.0(15) 
N(l)-C(l3)-H(13C)     110.6(11) 
H(13A)-C(13)-H(13C)    108.4(15) 
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H(13B)-C(13)-H(l3C)    108.7(15) 
N(l)-C(14)-P(l)     103.58(7) 
N(l)-C(l4)-H(l4A)     111.5(10) 
P(1)-C(14)-H(14A)     111.4(10) 
N(1)-C(14)-H(14B)     111.1 (9) 
P(1)-C(l4)-H(l4B)     108.1(9) 
H(14A)-C(14)-H(14B)    110.9(13) 
Exchange Reactions with Product/Substrate (Table 1.3)  
 In a dry glovebox, N-(2-methyl-3-oxopropyl)-3,5-
bis(trifluoromethyl)benzenesulfonamide, 1.19, (18 mg, 5.0 x 10-2 mmol) and I (2.9 
mg, 1.0 x 10-2 mmol) were mixed in benzene d-6 (0.6 mL) and heat to 45 °C for 2 h. 
N-allyl-3,5-bis(trifluoromethyl)benzenesulfonamide, 1.15, (17 mg, 5.0 x 10-2 mmol) 
was added with benzene (0.4 mL). The reaction was monitored by 31P NMR at room 
temperature for 5 h. 
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Exchange with Substrate/Product (Table 1.4) 
 In a dry glovebox, N-allyl-3,5-bis(trifluoromethyl)benzenesulfonamide, 1.15, 
(17 mg, 5.0 x 10-2 mmol) and I (2.9 mg, 1.0 x 10-2 mmol) were mixed in benzene d-6 
(0.6 mL) and heated to 45 °C for 24 h. The reaction was complete. The reaction was 
concentrated and N-(2-methyl-3-oxopropyl)-3,5-
bis(trifluoromethyl)benzenesulfonamide, 1.19, (18 mg, 5.0 x 10-2 mmol) was added 
with benzene (1.0 mL). The reaction was monitored by 31P NMR at room temperature 
for 4 days. 
Optimization of Branch Selective Hydroformylation 
General Optimization Procedure. The Endeavor was charged with 500 μL of 
benzene per reaction well to fill the void volume between reactor wall and reaction 
tube, and oven-dried glass reaction vials were placed in the Endeavor. The Endeavor 
was sealed and purged with nitrogen (4x100 psi). The necessary injection(s) were made 
(see below). The Endeavor was purged with nitrogen (1x100 psi), stirring was started 
at 250 rpm, and the Endeavor was heated to 45 °C and held for 10 minutes. Stirring 
was stopped, the Endeavor was charged with H2/CO, stirring was re-initiated at 700 
rpm, and the Endeavor was maintained at a constant temperature of 45 °C and pressure 
of H2/CO for 16 h. The Endeavor was vented to ambient pressure and cooled to 
ambient temperature. The reaction vials were removed from the Endeavor, a solution of 
1,3,5-trimethoxybenzene (100 µL, 0.2 M) was added, and the sample was concentrated. 
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1H NMRs were taken to determine conversion and selectivities. The reaction was 
chromatographed to determine isolated yield. SFC analysis of the products was used to 
determine regioselectivities. 
Ligand Loading Screen (Table 1.5) 
Table 1.5, Entry 1: The General Optimization Procedure was followed. A solution of 
N-allyl-3,5-bis(trifluoromethyl)benzenesulfonamide, 1.15, (67 mg, 2.0 x 10-1 mmol), 
triphenylphosphine (4.0 mol %, 2.1 mg, 8.0 x 10-3 mmol) and 
dicarbonylacetylacetonato rhodium (I) (2.0 mol %, 1.1 mg, 4.0 x 10-3 mmol) in 
benzene (1.50 mL) was prepared in a dry box and injected into the Endeavor via 
syringe. An additional 500 µL of benzene was added to wash the injection port. The 
Endeavor was kept at a constant H2/CO pressure of 200 psi. 
Table 1.5, Entry 2: The General Optimization Procedure was followed. A solution 
of N-allyl-3,5-bis(trifluoromethyl)benzenesulfonamide, 1.15, (67 mg, 2.0 x 10-1 
mmol), ligand I (10 mol %, 5.7 mg, 2.0 x 10-2 mmol) and dicarbonylacetylacetonato 
rhodium (I) (2.0 mol %, 1.1 mg, 4.0 x 10-3 mmol) in benzene (1.50 mL) was prepared 
in a dry box and injected into the Endeavor via syringe. An additional 500 µL of 
benzene was added to wash the injection port. The Endeavor was kept at a constant 
H2/CO pressure of 200 psi. 
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Table 1.5, Entry 3: The General Optimization Procedure was followed. N-allyl-3,5-
bis(trifluoromethyl)benzenesulfonamide, 1.15, (67 mg, 2.0 x 10-1 mmol 2.0 x 10-1 
mmol) and ligand 1 (20 mol %, 11 mg, 4.0 x 10-2 mmol) in benzene d-6 (600 µL) was 
heated to 55 ˚C for 6 h. The solution was concentrated in a dry box. The resulting white 
solid, dicarbonylacetylacetonato rhodium (I) (2.0 mol %, 1.1 mg, 4.0 x 10-3 mmol) and 
benzene (1.50 mL) were mixed in a dry box and injected into the Endeavor via syringe. 
An additional 500 µL of benzene was added to wash the injection port. The Endeavor 
was kept at a constant H2/CO pressure of 200 psi. 
Table 1.5, Entry 4: The General Optimization Procedure was followed. N-allyl-3,5-
bis(trifluoromethyl)benzenesulfonamide, 1.15, (67 mg, 2.0 x 10-1 mmol 2.0 x 10-1 
mmol) and ligand 1 (40 mol %, 23 mg, 8.0 x 10-2 mmol) in benzene d-6 (600 µL) was 
heated to 55 ˚C for 6 h. The solution was concentrated in a dry box. The resulting white 
solid, dicarbonylacetylacetonato rhodium (I) (2.0 mol %, 1.1 mg, 4.0 x 10-3 mmol) and 
benzene (1.50 mL) were mixed in a dry box and injected into the Endeavor via syringe. 
An additional 500 µL of benzene was added to wash the injection port. The Endeavor 
was kept at a constant H2/CO pressure of 200 psi. 
Ligand Loading Screen with Pre-exchange (Table 1.6)  
General Pre-exchange Procedure. N-allyl-3,5-
bis(trifluoromethyl)benzenesulfonamide, 1.15, (67 mg, 2.0 x 10-1 mmol) and I (10 mol 
%, 5.7 mg, 2.0 x 10-2 mmol) were dissolved in benzene d-6 in a dry box and heated to 
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55 °C for 6 h. After the solution was concentrated, dicarbonylacetylacetonato rhodium 
(I) (2.0 mol %, 1.1 mg, 4.0 x 10-3 mmol) in benzene (1.50 mL) was added to the 
residue in a dry box and injected into the Endeavor via syringe. An additional 500 µL 
of benzene was added to wash the injection port. The Endeavor was kept at 45 °C and a 
constant H2/CO pressure of 200 psi. 
Table 1.6, Entry 1: The General Optimization Procedure and the General Pre-
exchange Procedure were followed using 5 mol % I. (2.9 mg, 1.0 x 10-2 mmol).  
Table 1.6, Entry 2: The General Optimization Procedure and the General Pre-
exchange Procedure were followed. 
Temperature Screen (Table 1.7) 
Table 1.7, Entry 1: The General Optimization Procedure and the General Pre-
exchange Procedure were followed. The Endeavor was kept at 35 °C during the 
reaction.  
Table 1.7, Entry 2: The General Optimization Procedure and the General Pre-
exchange Procedure were followed. The Endeavor was kept at 45 °C during the 
reaction. 
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Table 1.7, Entry 3: The General Optimization Procedure and the General Pre-
exchange Procedure were followed using 20 mol % I (23 mg, 8.0 x 10-2 mmol) The 
Endeavor was kept at 45 °C during the reaction. 
Table 1.7, Entry 4: The General Optimization Procedure and the General Pre-
exchange Procedure were followed using 20 mol % I (23 mg, 8.0 x 10-2 mmol). The 
Endeavor was kept at 55 °C during the reaction. 
Acid Loading Screen (Table 1.8) 
Table 1.8, Entry 1: The General Optimization Procedure and the General Pre-
exchange Procedure were followed. 
Table 1.8, Entry 2: The General Optimization Procedure and the General Pre-
exchange Procedure were followed adding 0.2% p-TsOH (650 μL, 6.21 x 10-4 M) to 
the pre-exchange.  
Rhodium Loading Screen (Table 1.9) 
Table 1.9, Entry 1: The General Optimization Procedure and the General Pre-
exchange Procedure were followed using dicarbonylacetylacetonato rhodium (I) (0.5 
mol %, 0.26 mg, 1.0 x 10-3 mmol). 
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Table 1.9, Entry 2: The General Optimization Procedure and the General Pre-
exchange Procedure were followed using dicarbonylacetylacetonato rhodium (I) (1.0 
mol %, 0.52 mg, 2.0 x 10-3 mmol). 
Table 1.9, Entry 3: The General Optimization Procedure and the General Pre-
exchange Procedure were followed using dicarbonylacetylacetonato rhodium (I) (2.0 
mol %, 1.1 mg, 4.0 x 10-3 mmol). 
Table 1.9, Entry 4: The General Optimization Procedure and the General Pre-
exchange Procedure were followed using dicarbonylacetylacetonato rhodium (I) (3 mol 
%, 1.5 mg, 6.0 x 10-3 mmol). 
Table 1.9, Entry 5: The General Optimization Procedure and the General Pre-
exchange Procedure were followed using dicarbonylacetylacetonato rhodium (I) (4 mol 
%, 2.1 mg, 8.0 x 10-3 mmol). 
Pressure Screen (Table 1.10) 
Table 1.10, Entry 1: The General Optimization Procedure was followed. A solution of 
N-allyl-3,5-bis(trifluoromethyl)benzenesulfonamide (67 mg, 2.0 x 10-1 mmol), 
triphenylphosphine (4.0 mol %, 2.1 mg, 8.0 x 10-3 mmol) and 
dicarbonylacetylacetonato rhodium (I) (2.0 mol %, 1.1 mg, 4.0 x 10-3 mmol) in 
benzene (1.50 mL) was prepared in a dry box and injected into the Endeavor via 
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syringe. An additional 500 µL of benzene was added to wash the injection port. The 
Endeavor was kept at a constant H2/CO pressure of 200 psi. 
Table 1.10, Entry 2: The General Optimization Procedure was followed. A solution 
of N-allyl-3,5-bis(trifluoromethyl)benzenesulfonamide (67 mg, 2.0 x 10-1 mmol), I 
(10 mol %, 5.7 mg, 2.0 x 10-2 mmol) and dicarbonylacetylacetonato rhodium (I) (2.0 
mol %, 1.1 mg, 4.0 x 10-3 mmol) in benzene (1.50 mL) was prepared in a dry box and 
injected into the Endeavor via syringe. An additional 500 µL of benzene was added to 
wash the injection port. The Endeavor was kept at a constant H2/CO pressure of 200 
psi. 
Table 1.10, Entry 3: The General Optimization Procedure and the General Pre-
exchange Procedure were followed. N-allyl-3,5-
bis(trifluoromethyl)benzenesulfonamide (67 mg, 2.0 x 10-1 mmol) and ligand 1 (10 mol 
%, 5.7 mg, 2.0 x 10-2 mmol) in benzene d-6 (600 µL) was heated to 55 ˚C for 6 h. The 
solution was concentrated in a dry box. The residue, dicarbonylacetylacetonato 
rhodium (I) (2.0 mol %, 1.1 mg, 4.0 x 10-3 mmol) and benzene (1.50 mL) were mixed 
in a dry box and injected into the Endeavor via syringe. An additional 500 µL of 
benzene was added to wash the injection port. The Endeavor was kept at a constant 
H2/CO pressure of 200 psi. 
Table 1.10, Entry 4: The procedure for Table 10, Entry 3 was followed except the 
Endeavor was kept at a constant H2/CO pressure of 100 psi. 
Chapter 1, Page 63 
 
Table 1.10, Entry 5: The procedure for Table 10, Entry 3 was followed except the 
Endeavor was kept at a constant H2/CO pressure of 300 psi. 
Table 1.10, Entry 6: The procedure for Table 10, Entry 3 was followed except the 
Endeavor was kept at a constant H2/CO pressure of 400 psi. 
Hydroformylation Substrate Scope (Table 1.11) 
General Hydroformylation Procedure. The Endeavor was charged with 500 µL of 
benzene per reaction well to fill the void volume between reactor wall and reaction 
tube, and oven dried glass reaction vials were placed in the Endeavor. The Endeavor 
was sealed and purged with nitrogen (4x100 psi). The necessary injection(s) were made 
(see below). The Endeavor was purged with nitrogen (1x100 psi), stirring was started 
at 250 rpm, and the Endeavor was heated to and held at reaction temperature for 10 
minutes. Stirring was stopped, the Endeavor was charged with 400 psi H2/CO, stirring 
was reinitiated at 700 rpm, and the Endeavor was maintained at constant reaction 
temperature of 45 °C and pressure of 400 psi H2/CO for 16 h. The Endeavor was 
vented to ambient pressure and cooled to ambient temperature. The reaction vials were 
removed from the Endeavor and a solution of trimethoxybenzene (100 µL, 0.2 M) was 
added and the sample was concentrated. 1H NMRs were taken to determine conversion 
and selectivities. The reaction was chromatographed to determine isolated yield. SFC 
analysis of the products was used to determine regioselectivities. 
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Procedure A. A solution of N-allyl-3,5-bis(trifluoromethyl)benzenesulfonamide (67 
mg, 2.0 x 10-1 mmol), triphenylphosphine (4.0 mol %, 2.1 mg, 8.0 x 10-3 mmol), 
dicarbonylacetylacetonato rhodium (I) (2.0 mol %, 1.1 mg, 4 x 10-3 mmol), and 
benzene (1.50 mL) was prepared in a dry box and injected into the Endeavor via 
syringe. An additional 500 µL of benzene was added to wash the injection port. The 
Endeavor was heated to 45 °C. 
Procedure B. This procedure is identical to Procedure A except the Endeavor was 
heated to 40 °C. 
Procedure C. N-allyl-3,5-bis(trifluoromethyl)benzenesulfonamide (67 mg, 2.0 x 10-1 
mmol) and ligand I (10 mol %, 5.7 mg, 2.0 x 10-2 mmol) in benzene d-6 (600 µL) was 
heated to 45 °C for 6 h. The solution was concentrated in a dry box. The resulting 
white solid, dicarbonylacetylacetonato rhodium (I) (2.0 mol %, 1.0 mg, 4 x 10-3 mmol), 
and benzene (1.50 mL) were mixed in a dry box and injected into the Endeavor via 
syringe. An additional 500 µL of benzene was added to wash the injection port. The 
Endeavor was heated to 45 °C. 
Procedure D. This procedure is identical to Procedure C except the Endeavor was 
heated to 40 °C. 
Procedure E. A solution of (E)-3,5-bis(trifluoromethyl)-N-(3-(4-
(trifluoromethyl)phenyl)allyl)benzenesulfonamide (95 mg, 2.0 x 10-1 mmol), 
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triphenylphosphine (4.0 mol %, 2.1 mg, 8.0 x 10-3 mmol) and 
dicarbonylacetylacetonato rhodium (I) (2.0 mol %, 1.0 mg, 4.0 x 10-3 mmol) in 
tetrahydrofuran (100 µL) and benzene (1.4 mL) was prepared in a dry box and 
injected into the Endeavor via syringe. An additional 500 µL of benzene was added 
to wash the injection port. The Endeavor was heated to 45 °C. 
Procedure F. A solution of (E)-N-(3-(4-methoxyphenyl)allyl)-3,5-
bis(trifluoromethyl)benzenesulfonamide (88 mg, 2.0 x 10-1 mmol), triphenylphosphine 
(6.0 mol %, 3.1 mg, 1.2 x 10-2 mmol) and dicarbonylacetylacetonato rhodium (I) (3.0 
mol %, 1.3 mg, 6.0 x 10-3 mmol) in tetrahydrofuran (200 µL) and benzene (1.3 mL) 
was prepared in a dry box and injected into the Endeavor via syringe. An additional 
500 µL of benzene was added to wash the injection port. The Endeavor was heated to 
55 °C. 
Procedure G. A solution of N-((2E,5E)-hepta-2,5-dienyl)-3,5-
bis(trifluoromethyl)benzenesulfonamide (77 mg, 2.0 x 10-1 mmol) and ligand I (10 mol 
%, 5.7 mg, 2.0 x 10-2 mmol) in benzene d-6 (600 µL) was heated to 45 °C for 2 h. The 
solution was concentrated in a dry box. The resulting white solid, 
dicarbonylacetylacetonato rhodium (I) (2.0 mol %, 1.0 mg, 4.0 x 10-3 mmol), and 
benzene (1.50 mL) were mixed in a dry box and injected into the Endeavor via syringe. 
An additional 500 µL of benzene was added to wash the injection port. The Endeavor 
was heated to 45 °C for 5 h. 
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Procedure H. A solution of (E)-3,5-bis(trifluoromethyl)-N-(3-(4-
(trifluoromethyl)phenyl)allyl)benzenesulfonamide (38 mg, 8.0 x 10-2 mmol) and 
ligand I (10 mol %, 5.7 mg, 2.0 x 10-2 mmol) in benzene d-6 (500 µL) and 
tetrahydrofuran (100 µL) was heated to 55 °C for 16 h. The solution was concentrated 
in a dry box. The resulting white solid and dicarbonylacetylacetonato rhodium (I) 
(2.0 mol %, 1.0 mg, 4.0 x 10-3 mmol) were dissolved in benzene (1.40 mL) and 
tetrahydrofuran (100 µL) were mixed in a dry box and injected into the Endeavor via 
syringe. An additional 500 µL of benzene was added to wash the injection port. The 
Endeavor was heated to 45 °C. 
Procedure I. A solution of (E)-N-(3-(4-methoxyphenyl)allyl)-3,5-
bis(trifluoromethyl)benzenesulfonamide (35 mg, 8.0 x 10-2 mmol) and ligand I (10 mol 
%, 5.7 mg, 2.0 x 10-2 mmol) in benzene d-6 (400 µL) and tetrahydrofuran (200 µL) was 
heated to 55 °C for 16 h. The solution was concentrated in a dry box. The resulting white 
solid was combined with (E)-N-(3-(4-methoxyphenyl)allyl)-3,5-
bis(trifluoromethyl)benzenesulfonamide (53 mg, 1.2 x 10-1 mmol) and 
dicarbonylacetylacetonato rhodium (I) (3.0 mol %, 1.3 mg, 6.0 x 10-3 mmol) were 
dissolved in benzene (1.30 mL) and tetrahydrofuran (200 µL) were mixed in a dry box 
and injected into the Endeavor via syringe. An additional 500 µL of benzene was added 
to wash the injection port. The Endeavor was heated to 55 °C. 
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Hydroformylation Results and Product Characterization 
Table 1.11, Entry 1:  
N-allyl-3,5-bis(trifluoromethyl)benzenesulfonamide was hydroformylated using 
General Procedure C. Analysis of the crude reaction mixture by 1H NMR showed 
conversion and approximate selectivity. A mixture of normal and iso products was 
isolated as a white solid (58.2 mg, 80%) and analyzed by SFC (AS-H, 1.0 mL/min, 
1.0% MeOH, 220 nm, 150 bar, 50 °C) to determine the selectivity (97:3). 
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N-(2-methyl-3-oxopropyl)-3,5-bis(trifluoromethyl)benzenesulfonamide, 1.19. SFC 
(AS-H, 1.0 mL/min, 1.0% MeOH, 220 nm, 150 bar, 50 °C) tr = 9.54 min; 
1H NMR 
(CDCl3, 400 MHz)  9.63 (s, 1H), 8.30 (s, 2H), 8.09 (s, 1H), 5.22 (t, 1H, J = 6.1), 3.10-
3.24 (m, 2H), 2.73-2.78 (m, 1H), 1.24 (d, 3H, J = 7.5); 13C NMR (CDCl3, 100 MHz)  
203.5, 143.1, 133.2 (q, J = 34.3), 127.4, 126.4, 122.6 (q, J = 271.9), 46.7, 43.4, 11.5; 
IR: 3279, 2930, 1721, 1361, 1280, 1163, 1139, 1115, 906, 845, 699, 682, 591 cm-1; 
HRMS (DART-TOF) calcd. For C12H12F6NO3S [M+H]
+: 364.0442, found: 364.0454. 
 
 
 
 
 
 
 
1-(3,5-bis(trifluoromethyl)benzenesulfonyl)pyrrolidin-2-ol. See above for 
characterization data. 
 
Table 1.11, Entry 2:  
(E)-N-(but-2-enyl)-3,5-bis(trifluoromethyl)benzenesulfonamide was hydroformylated 
using General Procedure C. Analysis of the crude reaction mixture by 1H NMR showed 
conversion and selectivity. A mixture of normal and iso products was isolated as a 
white solid (63.8 mg, 85%) and analyzed by SFC (AS-H, 1.0 mL/min, 1.0% MeOH, 
220 nm, 150 bar, 50 °C) to determine the selectivity (99:1) 
Chapter 1, Page 69 
 
 
 
 
 
 
 
 
 
 
N-(2-formylbutyl)-3,5-bis(trifluoromethyl)benzenesulfonamide, 1.22. SFC (AS-H, 
1.0 mL/min, 1.0% MeOH, 220 nm, 150 bar, 50 °C) tr = 15.65; 
1H NMR (CDCl3, 400 
MHz)  9.66 (s, 1H), 8.30 (s, 2H), 8.30 (s, 2H), 8.09 (s, 1H), 5.20 (t, 1H, J = 6.6), 
3.16-3.24 (m, 2H), 2.55-2.61 (m, 1H), 1.79-1.86 (m, 1H), 1.55-1.62 (m, 1H), 1.05 (t, 
3H, J = 7.5); 13C NMR (CDCl3, 100 MHz)  178.2, 143.2, 133.2 (q, J = 34.5), 127.4, 
126.4, 122.6 (q, J = 272.8), 46.5, 43.4, 22.8, 11.4; IR: 3298, 2971, 2931, 1721, 1625, 
1460, 1427, 1360, 1279, 1167, 1137, 1114, 906, 844, 699, 682, 591 cm-1; HRMS 
(DART-TOF) calcd. for C13H14F6NO3S [M+H]
+: 378.0599, found: 378.0582. 
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1-(3,5-bis(trifluoromethyl)benzenesulfonyl)-3-methylpyrrolidin-2-ol. SFC (AS-H, 
1.0 mL/min, 1.0% MeOH, 220 nm, 150 bar, 50 °C) tr = 9.74 min; 
1H NMR (CDCl3, 400 
MHz, 1:1 diastereomer ratio)  8.34 (s, 3H), 8.08 (app d, 2H, J = 3.8), 5.35 (t, 1H, J = 
4.2), 5.13 (t, 1H, J = 3.5), 3.44-3.52 (m, 2H), 3.29-3.35 (m, 1H), 3.16-3.23 (m, 1H), 3.00 
(d, 1H, J = 3.1), 2.68 (d, 1H, 4.0), 2.23-2.25 (m, 2H), 1.97-2.07 (m, 3H), 1.81-1.85 (m, 
1H), 1.08 (d, 3H, J = 6.8), 0.85 (d, 3H, J = 7.2); 13C NMR (CDCl3, 100 MHz)  142.4, 
142.3, 133.1 (q, J = 34.5), 127.6, 126.3, 122.6 (q, J = 275.1), 90.5, 85.3, 46.9, 46.2, 
41.1, 39.5, 30.3, 30.1, 16.1, 13.0; IR: 3483, 3092, 2969, 2911, 1626, 1363, 1345, 1286, 
1183, 1150, 1130, 1107, 904, 696, 682, 650, 599 cm-1; HRMS (ESI) calcd. for 
C13H13F6NO3SNa [M+Na]
+: 400.0418 found: 400.0416. 
 
Table 1.11, Entry 3:  
(E)-N-(3-cyclohexylallyl)-3,5-bis(trifluoromethyl)benzenesulfonamide was 
hydroformylated using General Procedure C. Analysis of the crude reaction mixture 
by 1H NMR showed conversion and selectivity. A mixture of normal and iso products 
was isolated as a white solid (74.8 mg, 84%) and analyzed by SFC (AS-H, 2.0 
mL/min, 0.5% MeOH, 220  nm, 150 bar, 50 °C) to determine the selectivity (99:1). 
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N-(3-cyclohexyl-2-formylpropyl)-3,5-bis(trifluoromethyl)benzenesulfonamide, 
1.23.  SFC (AS-H, 2.0 mL/min, 0.5 % MeOH, 220 nm, 150 bar, 50 °C) tr = 10.89 min; 
1H NMR (CDCl3, 400 MHz)  9.60 (s, 1H), 8.30 (s, 2H), 8.09 (s, 1H), 5.22 (t, 1H, J = 
6.3), 3.08-3.22 (m, 2H), 2.71-2.72 (m, 1H), 1.67-1.74 (m, 4H), 1.52-1.57 (m, 2H), 1.14-
1.34 (m, 5H), 0.87-0.96 (m, 2H); 13C NMR (CDCl3, 100 MHz)  204.0, 143.2, 133.2 (q, 
J = 34.5), 127.4, 126.4, 122.6 (q, J = 273.6), 49.3, 42.0, 35.1, 33.8, 32.9, 26.5, 26.2; IR: 
3299, 2926,1723, 1360, 1279, 1163, 1140, 1114, 906, 845, 700, 682, 592 cm-1; HRMS 
(DART-TOF) calcd. for C18H22F6NO3S [M+H]
+: 446.1225, found: 446.1224. 
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1-(3,5-bis(trifluoromethyl)benzenesulfonyl)-3-cyclohexylpyrrolidin-2-ol. SFC (AS-H, 
2.0 mL/min, 0.5% MeOH, 220 nm, 150 bar, 50 °C) tr = 5.10; 
1H NMR (CDCl3, 300 
MHz, 1:1 diastereomer ratio)  8.34 (s, 2H), 8.07 (s, 1H), 5.47-5.49 (m, 1H), 5.33-5.35 
(m, 1H), 4.20-4.23 (m, 1H), 3.65-3.66 (m, 1H), 3.47-3.53 (m, 1H), 3.37 (dd, 1H, J = 8.3, 
8.0), 3.11-3.20 (m, 1H), 3.03-3.07 (m, 1H), 2.57-2.61 (m, 1H), 2.00-2.07 (m, 1H), 1.81-
1.88 (m, 2H), 1.60-1.69 (m, 6H), 1.54-1.56 (m, 3H), 1.41-1.47 (m, 3H), 1.09-1.11 (m, 
4H), 0.83-0.94 (m, 6H); IR: 3511, 2925, 2855, 1724, 1451, 1360, 1280, 1169, 1143, 
1061, 1034, 682, 594 cm-1; LRMS (DART-TOF) calcd. for C18H22F6NO3S [M+H]
+: 
446.1225; found: 446.1293. 
Table 1.11, Entry, 4:  
(Z)-N-(4-(tert-butyldimethylsilyloxy)but-2-enyl)-3,5-
bis(trifluoromethyl)benzenesulfonamide was hydroformylated using General 
Procedure D. Analysis of the crude reaction mixture by 1H NMR showed 
conversion and selectivity. A mixture of normal and iso products was isolated 
as a white solid (84.2 mg, 83%) and analyzed by SFC (AS-H, 1.0 mL/min, 
1.0% MeOH, 220 nm, 150 bar, 50 °C) to determine the selectivity (97:3).  
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N-(4-(tert-butyldimethylsilyloxy)-2-formylbutyl)-3,5-
bis(trifluoromethyl)benzenesulfonamide, 1.24. SFC (AS-H, 1.0 mL/min, 1.0% MeOH, 
220 nm, 150 bar, 50 °C) tr = 9.00 min; 
1H NMR (CDCl3, 400 MHz)  9.65 (s, 1H), 8.30 
(s, 2H), 8.07 (s, 1H), 5.70 (s, 1H), 3.73 (t, 2H, J = 5.6), 3.21-3.28 (m, 2H), 2.75-2.78 (m, 
1H), 1.96-2.01 (m, 1H), 1.82-1.88 (m, 1H), 0.85 (s, 9H), 0.03 (d, 6H, J = 2.8); 13C NMR 
(CDCl3, 100 MHz)  202.9, 142.9, 132.9 (q, J = 34.5), 127.1, 126.0, 122.3 (q, J = 273.6), 
59.9, 49.3, 41.4, 29.5, 25.6, 18.0, –5.7; IR: 3286, 3089, 2955, 2932, 2860, 1712, 1359, 
1278, 1137, 1108, 905, 835, 809, 777, 699, 681, 589, 413 cm-1; HRMS (DART-TOF) 
calcd. for C19H28F6NO4SSi [M+H]
+: 507.1413, found: 508.1429. 
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1-(3,5-bis(trifluoromethyl)benzenesulfonyl)-3-((tert- 
butyldimethylsilyloxy)methyl)pyrrolidin-2-ol. SFC (AS-H, 1.0 mL/min, 1.0% 
MeOH, 220 nm, 150 bar, 50 °C) tr = 6.06 min; 
1H NMR (CDCl3, 300 MHz, 1.1:1 
diastereomer ratio)  8.45 (s, 2H), 8.34 (s, 2H), 8.06 (app. d, 2H, J = 8.6), 5.65 (t, 1H, J 
= 4.8), 5.40 (t, 1H, J = 3.3), 3.97 (d, 1H, J = 4.6), 3.89-3.94 (m, 1H), 3.73-3.78 (m, 
1H), 3.34-3.48 (m, 6H), 3.10 (d, 1H, J = 3.4), 2.24-2.36 (m, 2H), 1.95-2.17 (m, 3H), 
1.71-1.80 (m, 1H), 0.83 (app. d, 18H, J = 11.3), 0.06 (d, 3H, J = 3.6), -0.03 (d, 3H, J = 
4.1); 13C NMR (CDCl3, 100 MHz)  142.6, 142.4, 133.1 (q, J = 34.5), 132.7 (q, J = 
34.5), 128.3, 127.6, 126.4, 126.1, 122.7 (q, J = 272.8), 122.6 (q, J = 273.6), 86.3, 85.1, 
61.8, 61.6, 49.6, 46.7, 46.3, 45.4, 25.9, 25.8, 25.3, 25.0, 18.4, 18.8, –5.4; IR: 3514, 
2956, 2932, 2859, 1360, 1280, 1169, 1142, 1110, 840, 779, 682, 641, 598 cm-1; HRMS 
(ESI) calcd. for C19H27F6NO4NaSSi [M+Na]
+: 530.1234, found: 530.1232. 
 
Table 1.11, Entry 5:  
N-cinnamyl-3,5-bis(trifluoromethyl)benzenesulfonamide was hydroformylated using 
General Procedure C. Analysis of the crude reaction mixture by 1H NMR showed 
conversion and selectivity. A mixture of normal and iso products was isolated as a 
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white solid (76.0 mg, 86%) and analyzed by SFC (Silica, 5.0 mL/min, 1.0% MeOH, 
220 nm, 150 bar, 50 °C) to determine the selectivity (99:1). 
 
 
 
 
 
 
 
 
 
 
 
 
N-(2-benzyl-3-oxopropyl)-3,5-bis(trifluoromethyl)benzenesulfonamide, 1.25. SFC 
(Silica, 5.0 mL/min, 1.0% MeOH, 220 nm, 150 bar, 50°C) tr= 5.30 min; 
1H NMR 
(CDCl3, 400 MHz)  9.72 (s, 1H), 8.23 (s, 2H), 8.06 (s, 1H), 7.26-7.36 (m, 3H), 7.18 (d, 
2H, J = 7.1), 5.20 (t, 1H, J = 6.6), 3.02-3.16 (m, 3H), 2.97-3.02 (m, 1H), 2.79 (dd, 1H, J 
= 14.0, 8.7); 13C NMR (CDCl3, 100 MHz)  203.2, 142.8, 136.7, 133.2 (q, J = 273.6), 
129.1, 128.9, 127.4, 126.5, 122.5 (q, J = 34.5), 53.3, 46.3, 41.5, 32.9; IR: 3292, 3089, 
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2889, 1720, 1360, 1280, 1162, 1140, 1114, 906, 844, 699, 682, 591 cm-1; HRMS 
(DART-TOF) calcd. for C18H16F6NO3S [M+H]
+: 440.0755, found: 440.0742. 
 
 
 
1-(3,5-bis(trifluoromethyl)benzenesulfonyl)-3-phenylpyrrolidin-2-ol. SFC (Silica, 5.0 
mL/min, 1.0% MeOH, 220 nm, 150 bar, 50°C) tr= 2.41 min; 
1H NMR (CDCl3, 300 
MHz)  8.27 (s, 2H), 8.04 (s, 1H), 7.20-7.22 (m, 3H), 7.03-7.06 (m, 2H), 5.51 (t, 1H, J = 
3.6), 3.54-3.67 (m, 2H), 3.34-3.40 (m, 1H), 3.21 (d, 1H, J = 3.2), 2.26-2.52 (m, 1H), 
2.06-2.18 (m, 1H); 13C NMR (CDCl3, 100 MHz)  142.1, 138.8, 133.1 (q, J = 33.5), 
129.0, 128.7, 127.5, 127.4, 126.8, 126.4, 122.5 (q, J = 272.8), 90.5, 84.7, 51.8, 50.3, 47.0, 
29.7, 27.0; IR: 3488, 3089, 2960, 1625, 1359, 1279, 1162, 1136, 1112, 1017, 699, 682, 
644, 596 cm-1; HRMS (ESI) calcd. for C18H15F6NO3S [M+Na]
+: 462.0575, found: 
462.0571. 
Table 1.11, Entry 6:  
(E)-3,5-bis(trifluoromethyl)-N-(3-(4-
(trifluoromethyl)phenyl)allyl)benzenesulfonamide was hydroformylated using General 
Procedure H. Analysis of the crude reaction mixture by 1H NMR showed conversion 
and selectivity. A mixture of normal and iso products was isolated as a white solid 
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(92.8 mg, 92%) and analyzed by SFC (Silica, 5.0 mL/min 1.0% MeOH, 220 nm, 150 
bar, 50 °C) to determine the selectivity (98:2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N-(2-formyl-3-(4-(trifluoromethyl)phenyl)propyl)-3,5-
bis(trifluoromethyl)benzenesulfonamide, 1.26. SFC (Silica, 5.0 mL/min, 1.0% MeOH, 
220 nm, 150 bar, 50 °C) tr = 11.01 min; 
1H NMR (Acetone d-6, 400 MHz)  9.41 (s, 1H), 
8.40 (s, 2H), 8.38 (s, 1H), 7.62 (d, 2H, J = 8.0), 7.48 (d, 2H, J = 8.4), 7.13 (s, 1H), 3.26-
3.37 (m, 2H), 3.21 (dd, 1H, J = 6.8, 14.0), 3.03-3.09 (m, 1H), 2.93 (dd, 1H, 7.6, 14.0); 13C 
NMR (Acetone d-6, 100 MHz)  203.1, 144.9, 133.8 (q, J = 33.7), 131.3, 129.7 (q, J = 
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32.1), 129.1, 127.9, 126.8, 126.7, 126.0 (q, J = 270.5), 124.4 (q, J = 272.0), 54.3, 42.8, 
33.2; IR: 3291, 3090, 2927, 2855, 1724, 1620, 1420, 1360, 1327, 1280, 1162, 1068, 1019, 
906, 845, 805, 699, 682, 630 cm–1; HRMS (DART-TOF) calcd. for C19H15F9NO3S 
[M+H]+: 508.0629, found: 508.0628. 
 
 
 
 
 
 
1-(3,5-bis(trifluoromethyl)benzenesulfonyl)-3-(4-(trifluoromethyl)phenyl)pyrrolidin-
2-ol. SFC (Silica, 5.0 mL/min, 1.0% MeOH, 220 nm, 150 bar, 50 °C) tr = 2.2 and 4.2 min 
(diastereomers); 1H NMR (Acetone d-6, 400 MHz, 46:54 diastereomer ratio)  8.55 (s, 
1.0H), 8.49 (s, 2.0H), 8.37 (s, 0.6H), 8.34 (s, 1.0H), 7.64 (d, 3.6H, J = 8.1), 7.57 (d, 1.4H, 
J = 8.1), 7.51 (d, 2.5H, J = 8.1), 5.79-5.84 (m, 1.5H), 5.61 (dd, 1.3H, J = 3.1, 5.9), 5.42 
(d, 0.4H, J = 6.2), 3.72-3.80 (m, 1.4H), 3.50-3.63 (m, 2.7H), 3.43-3.49 (m, 1.3H); 13C 
NMR (Acetone d-6, 100 MHz)  145.1, 143.5, 143.4, 142.5, 132.2 (q, J = 34.5), 129.9, 
128.7 (q, J = 20.1), 128.4, 128.1, 128.0, 126.3, 125.5, 124.8, 123.1 (q, J = 269.0), 89.9, 
84.8, 54.2, 52.9, 49.8, 46.7, 46.1, 27.1; IR: 3505, 3089, 2927, 1621, 1360, 1327, 1279, 
1163, 1126, 1069, 1046, 907, 844, 700, 682,649, 631 cm–1; HRMS (DART-TOF) calcd. 
for C19H15F9NO3S [M+H]
+: 508.0629, found: 508.0647. 
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Table 1.11, Entry 7:  
(E)-N-(3-(4-chlorophenyl)allyl)-3,5-bis(trifluoromethyl)benzenesulfonamide was 
hydroformylated using General Procedure H. Analysis of the crude reaction mixture 
by 1H NMR showed conversion and selectivity. A mixture of normal and iso products 
was isolated as a white solid (64.9 mg, 69%) and analyzed by SFC (Silica, 5.0 mL/min 
1.0% MeOH, 220 nm, 150 bar, 50 °C) to determine the selectivity (99:1). 
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N-(2-(4-chlorobenzyl)-3-oxopropyl)-3,5-bis(trifluoromethyl)benzenesulfonamide, 
1.27. SFC (Silica, 5.0 mL/min, 1.0% MeOH, 220 nm, 150 bar, 50 °C) tr = 9.80 min; 
1H 
NMR (Acetone d-6, 400 MHz)  9.72 (s, 1H), 8.41 (s, 2H), 8.38 (s, 1H), 7.23-7.30 (m, 
4H), 7.09 (s, 1H), 3.24-3.34 (m, 2H), 3.07-3.12 (m, 1H), 2.95-3.02 (m, 1H), 2.81-2.86 
(m, 1H); 13C NMR (Acetone d-6, 100 MHz)  203.2, 144.9, 138.7, 133.7 (q, J = 34.5), 
133.2, 133.1, 129.2, 130.0, 127.7, 124.3 (q, J = 272.8), 54.4, 42.6, 32.8; IR: 3293, 3089, 
2929, 1723, 1626, 1493, 1411, 1360, 1318, 1279, 1138, 1112, 906, 844, 722, 699, 630 
cm–1; HRMS (DART-TOF) calcd. for C18H15ClF6NO3S [M+H]
+: 474.0365, found: 
474.0381. 
 
 
 
 
 
 
 
 
 
 
1-(3,5-bis(trifluoromethyl)benzenesulfonyl)-3-(4-chlorophenyl)pyrrolidin-2-ol SFC 
(Silica, 5.0 mL/min, 1.0% MeOH, 220 nm, 150 bar, 50 °C) tr = 2.6 and 4.4 min 
(diastereomers); 1H NMR (CDCl3, 300 MHz, 10:1 diastereomer ratio)  8.41 (s, 0.2H), 
8.28 (s, 1.65H), 8.07 (s, 1.0H), 7.32 (d, 0.25H, J = 8.4), 7.19 (d, 2.0H, J = 8.6), 7.01 (d, 
1.9H, J = 8.6), 5.64 (dd, 0.1H, J = 3.3, 4.5), 5.47 (dd, 1.0H, J = 2.7, 3.3), 3.57 (dd, 2.0H, 
J = 2.4, 6.9), 3.46 (d, 1.1H, J = 3.3), 3.33 (dt, 1.2H, J = 3.6, 6.9), 2.57 (app. d, 0.1H, J = 
3.0), 2.41-2.52 (m, 1.0H), 2.21-2.30 (m, 0.2H), 2.03-2.14 (m, 1.0H); 13C NMR (CDCl3, 
100 MHz)  142.4, 142.2, 137.3, 134.5, 133.8, 133.5, 133.1 (q, J = 33.7), 132.9 (q, J = 
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34.5), 130.2, 129.1, 129.0. 128.3, 128.0, 127.5, 126.5, 122.7 (q, J = 273.5), 122.6 (q, J = 
272.8), 90.3, 84.5, 51.3, 49.8, 46.9, 46.4, 29.6, 27.5; IR: 3493, 3089, 2960, 1625, 1495, 
1360, 1279, 1163, 1138, 1015, 907, 844, 721, 699, 660, 626, 595 cm–1; HRMS (DART-
TOF) calcd. for C18H14ClF6NO3SNa [M+Na]
+: 496.019, found: 496.019. 
 
 
Table 1.11, Entry 8:  
(E)-N-(3-(4-methoxyphenyl)allyl)-3,5-bis(trifluoromethyl)benzenesulfonamide was 
hydroformylated using the corresponding General Procedure I. Analysis of the crude 
reaction mixture by 1H NMR showed conversion and selectivity. A mixture of normal 
and iso products was isolated as a white solid (81.4 mg, 87%) and analyzed by SFC 
(Silica, 5.0 mL/min 1.0% MeOH, 220 nm, 150 bar, 50 °C) to determine the selectivity 
(97:3)
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N-(2-formyl-3-(4-methoxyphenyl)propyl)-3,5-
bis(trifluoromethyl)benzenesulfonamide, 1.28. SFC (Silica, 5.0 mL/min, 1.0% MeOH, 
220 nm, 150 bar, 50 °C) tr = 8.8 min; 
1H NMR (Acetone d-6, 400 MHz) δ 9.69 (s, 1H), 
8.25 (s, 2H), 8.07 (s, 1H), 7.08 (d, 2H, J = 8.4), 6.85 (d, 2H, J = 8.4), 5.43 (t, 1H, J = 
6.4), 3.79 (s, 3H), 3.08-3.14 (m, 2H), 3.03 (dd, 1H, J = 6.4, 14.4), 2.90-2.97 (m, 1H), 
2.74 (dd, 1H, J = 8.4, 14.4); 13C NMR (Acetone d-6, 100 MHz) δ 203.5, 158.9, 142.9, 
133.2 (q, J = 34.5), 129.9, 128.6, 127.5, 126.5, 122.6 (q, J = 273.6), 114.6, 55.4, 53.5, 
41.5, 32.05; IR: 3295, 3086, 2936, 2840, 1721, 1613, 1585, 1513, 1422, 1359, 1277, 
1248, 1133, 1034, 905, 843, 808, 699, 681, 630, 589 cm–1; HRMS (DART-TOF) calcd. 
for C19H18F6NO4S [M+H]
+: 470.0861, found: 470.0844. 
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1-(3,5-bis(trifluoromethyl)benzenesulfonyl)-3-(4-methoxyphenyl)pyrrolidin-2-ol SFC 
(Silica, 5.0 mL/min, 1.0% MeOH, 220 nm, 150 bar, 50 °C) tr = 4.3 and 5.2 min 
(diastereomers); 1H NMR (Acetone d-6, 400 MHz, 1:1 diastereomer ratio) δ 8.55 (s, 
0.5H), 8.46 (s, 2.0H), 8.33-8.44 (m, 2.3H), 7.23 (d, 0.7H, J = 8.2), 7.15 (d, 2.2H, J = 8.4), 
6.80-6.87 (m, 3.3H), 5.62-5.67 (m, 1.2H), 5.50 (dd, 1.2H, J = 3.1, 6.0), 5.17 (d, 0.3H, J = 
6.4), 3.77 (s, 4.5H), 3.66-3.75 (m, 2.0H), 3.46-3.58 (m, 2.3H), 3.27 (dt, 1.9H, J = 2.8, 6.6), 
2.35-2.49 (m, 2.1H), 2.07-2.15 (m, 2.1H); 13C NMR (Acetone d-6, 100 MHz) δ 160.2, 
144.9, 133.2 (q, J = 33.7), 133.2 (q, J = 33.7), 131.4, 130.8, 129.8, 129.5, 129.5 (q, J = 
272.0), 129.1, 127.6, 115.5, 114.9, 91.9, 86.5, 56.1, 53.7, 50.8, 48.1, 47.4, 28.8; IR: 3495, 
3088, 2959, 2841, 1724, 1613, 1515, 1459, 1359, 1279, 1251, 1163, 1136, 1035, 906, 843, 
699, 682, 640, 594 cm–1; HRMS (ESI) calcd. for C19H17F6NO4SNa [M+Na]
+: 492.0680, 
found: 492.0690. 
 
Table 1.11, Entry 9:  
(E)-ethyl 4-(3,5-bis(trifluoromethyl)phenylsulfonamido)but-2-enoate was 
hydroformylated using General Procedure C. Analysis of the crude reaction mixture by 
1H NMR showed conversion and selectivity. A mixture of normal and iso products was 
isolated as a white solid (68.5 mg, 79%) and analyzed by SFC (AS-H, 2.0 mL/min, 
0.5% MeOH, 220 nm, 150 bar, 50 °C) to determine the selectivity (96:4 with 9% 
hydrogenated starting material). 
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Ethyl 4-(3,5-bis(trifluoromethyl)phenylsulfonamido)-3-formylbutanoate, 1.29. SFC 
(AS-H, 2.0 mL/min, 0.5% MeOH, 220 nm, 150 bar, 50 °C) tr =14.72 min; 
1H NMR 
(CDCl3, 400 MHz) δ 9.62 (s, 1H) 8.30 (s, 2H), 8.09 (s, 1H), 5.39 (t, 1H, J = 6.3), 4.19 
(q, 2H, J = 7.1), 3.31-3.34 (m, 2H), 3.00-3.06 (m, 1H), 2.66-2.81 (m, 2H), 1.25-1.31 (t, 
3H, J = 7.1); 13C NMR (CDCl3, 100 MHz) δ 201.2, 171.3, 142.9, 133.2 (q, J = 34.5), 
127.4, 126.5, 122.5 (q, J = 273.6), 61.8, 48.0, 41.7, 31.3, 14.3; IR: 3291, 3092, 2987, 
1728, 1360, 1280, 1163, 1139, 1114, 906, 844, 699, 682, 591, 414 cm-1; HRMS 
(DART-TOF) calcd. for C15H16F6NO5S [M+H]
+: 436.0653, found: 436.0639. 
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Ethyl 1-(3,5-bis(trifluoromethyl)benzenesulfonyl)-2-hydroxypyrrolidine-3-
carboxylate. SFC (AS-H, 2.0 mL/min, 0.5% MeOH, 220 nm, 150 bar, 50 °C) tr = 6.01 
min; 1H NMR (CDCl3, 300 MHz, 2:1 diastereomer ratio) δ 8.42 (s, 1H), 8.32 (s, 2H), 
8.08 (app d, 1.5H, J = 4.8), 5.81 (t, 0.5H), 5.69 (s, 1H), 4.21 (q, 1H, J = 7.1), 3.98 (q, 
2H, J = 7.2), 3.56-3.70 (m, 1H), 3.38-3.47 (m, 1H), 3.18-3.27 (m, 2H), 3.04 (app d, 2H, 
J = 7.5), 2.14-2.51 (m, 3H), 1.25-1.31 (m, 3H), 1.14 (t, 3H, J = 7.1); 13C NMR (CDCl3, 
100 MHz) δ 170.8, 170.6, 142.4, 141.5, 132.8 (q, J = 34.5), 128.2, 127.7, 126.5, 120.9 
(q, J = 271.3), 86.1, 83.0, 61.8, 61.5, 51.3, 49.0, 46.8, 46.0, 26.7, 25.2, 14.3, 14.1; IR: 
3487, 3089, 2984, 1733, 1625, 1360, 1280, 1165, 1138, 1056, 1033, 906, 845, 682, 640, 
596 cm-1; HRMS (ESI) calcd. for C15H15F6NO5SNa [M+Na]
+: 458.0473, found: 
458.0481. 
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Ethyl 4-(3,5-bis(trifluoromethyl)phenylsulfonamido)butanoate. SFC (AS-H, 2.0 
mL/min, 0.5% MeOH, 220 nm, 150 bar, 50 °C) tr = 7.90 min; 
1H NMR (CDCl3, 400 
MHz) δ 8.31 (s, 2H), 8.07 (s, 1H), 5.14 (s, 1H), 4.13 (q, 2H, J = 7.1), 3.11 (q, 2H, J = 
6.4, 6.2), 2.39 (t, 2H, J = 6.8), 1.85 (ttt, 2H, J = 13.4, 6.8, 6.6), 1.25 (t, 3H, J = 7.1); 
13C NMR (CDCl3, 100 MHz) δ 173.4, 143.2, 133.1 (q, J = 34.5), 127.4, 126.3, 122.6 
(q, J = 272.8), 61.1, 43.1, 31.5, 24.7, 14.3; IR: 3295, 2938, 1733, 1712, 1360, 1279, 
1161, 1137, 1114, 905, 682, 591 cm-1; HRMS (ESI) calcd. for C14H15F6NO4SNa 
[M+Na]+: 430.0524, found: 430.0525. 
 
Table 1.11, Entry 10: 
N-((2E,5E)-hepta-2,5-dienyl)-3,5-bis(trifluoromethyl)benzenesulfonamide was 
hydroformylated using the corresponding General Procedure G. Analysis of the crude 
reaction mixture by 1H NMR showed conversion and selectivity. A mixture of normal 
and iso products was isolated as a white solid (63.4 mg, 76%) with selectivity 
determined by NMR to be >95:5. 
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E)-N-(2-formylhept-5-enyl)-3,5-bis(trifluoromethyl)benzenesulfonamide, 1.30. 1H 
NMR (CDCl3, 300 MHz) δ 9.62 (s, 1H), 8.31 (s, 2H), 8.08 (s, 1H), 5.20-5.60 (m, 2H), 
3.09-3.22 (m, 2H), 2.62-2.64 (m, 1H), 2.07-2.20 (m, 2H), 1.67-1.9 (m, 1H), 1.65 (d, 3H, 
J = 5.99), 1.53-1.60 (m, 2H); 13C NMR (CDCl3, 100 MHz) δ 203.9, 143.2, 133.2 (q, J = 
34.5), 129.0, 128.2, 127.6, 126.4, 122.6. (q, J = 272.8), 51.0, 41.4, 29.8, 26.1, 18.0; IR: 
3295, 3087, 3936, 2859, 1721, 1625, 1453, 1359, 1278, 1138, 969, 906, 844, 699, 682, 
630 cm–1; HRMS (DART-TOF) calcd. for C16H18F6NO3S [M+H]
+: 418.0912, found: 
418.0898.  
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O
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Chapter Two: Enantioselective Hydroformylation 
2.1 Challenges in Enantioselective Hydroformylation 
 The efficient synthesis of valuable aldehydes through hydroformylation has led 
many to develop asymmetric methods.1 A useful method has to first overcome the 
fundamental challenges of controlling regioselectivity and increasing reactivity of 
substituted olefins under mild conditions before addressing enantiocontrol in 
hydroformylation. Numerous groups have used symmetrical (Scheme 2.1)2h,i or 
electronically activated substrates (Scheme 2.2)2 in order to circumvent the issue of  
Scheme 2.1 Reek’s Asymmetric Hydroformylation of Dihydrofurans. 
 
1For reviews on asymmetric hydroformylation, see: (a) Agbossou, F.; Carpentier, J. F.; Mortreux, A. Chem. 
Rev. 1995, 95, 2485–2506. (b) Dieguez, M.; Pamies, O.; Claver, C. Tetrahedron: Asymmetry 2004, 15, 
2113–2122. (c) Klosin, J.; Landis, C. R. Acc. Chem. Res. 2007, 40, 1251–1259. (d) Gual, A.; Godard, C.; 
Castillon, S.; Claver, C. Tetrahedron: Asymmetry 2010, 21, 1135–1146.                                                               
2(a) Sakai, N.; Mano, S.; Nozaki, K.; Takaya, H. J. Am. Chem. Soc. 1993, 115, 7033-7034. (b) Whiteker, G. 
T.; Babin, J. E. WO9393839, 1993. For recent examples, see: (c) Breeden, S.; Cole-Hamilton, D. J.; Foster, 
D. F.; Schwarz, G. J.; Wills, M. Angew. Chem., Int. Ed. 2000, 39, 4106–4108. (d) Clark, T. P.; Landis, C. 
R.; Freed, S. L.; Klosin, J.; Abboud, K. A. J. Am. Chem. Soc. 2005, 127, 5040–5042. (e) Yan, Y. J.; Zhang, 
X. M. J. Am. Chem. Soc. 2006, 128, 7198–7202. (f) Watkins, A. L.; Hashiguchi, B. G.; Landis, C. R. Org. 
Lett. 2008, 10, 4553–4556. (g) Zhao, B. G.; Peng, X. G.; Wang, Z.; Xia, C. G.; Ding, K. L. Chem. Eur. J. 
2008, 14, 7847–7857. (h) Mazuela, J.; Coll, M.; Pamies, O.; Dieguez, M. J. Org. Chem. 2009, 74, 5440–
5445. (i) Chikkali, S. H.; Bellini, R.; Berthon-Gelloz, G.; van der Vlugt, J. I.; deBruin, B.; Reek, J. N. H. 
Chem. Commun. 2010, 46, 1244–1246. (j) Zhang, X.; Cao, B.; Yan, Y.; Yu, S.; Ji, B.; Zhang, X. Chem. 
Eur. J. 2010, 16, 871–877. (k) McDonald, R. I.; Wong, G. W.; Neupane, R. P.; Stahl, S. S.; Landis, C. R. J. 
Am. Chem. Soc. 2010, 132, 14027–14029. 
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regioselectivity and are able to achieve high conversions and good enantioselectivities.2 
In the hydroformylation of activated substrates, Zhang has shown the utility of using 
mixed phosphine/ phosphoramidite ligands, which make highly active and selective 
complexes.2e,j For comparision, (R,S)-BINAPHOS, a similar mixed phosphine/phosphite  
Scheme 2.2 Asymmetric Hydroformylation of Activated Substrates. 
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ligand, is often used as a benchmark for reactivity and selectivity in these reactions.1c,2d,j 
Landis and others have developed diazaphospholane ligands which are also react 
efficiently and selectively (Scheme 2,2).2d,f,g  
 Recently, Clarke and co-workers published a method using another mixed 
phosphine/phosphite bidentate ligand to achieve iso-selective hydroformylation of alkyl 
substituted terminal alkenes, such as 2.1, with good yields and enantioselectivities 
(Scheme 2.3).3 The regioselectivity is also quite impressive considering the nature of the 
substrate. There is no explanation for the observed regioselectivity at this time. 
Scheme 2.3 Regioselective Hydroformylation of Unactivated Terminal Alkenes. 
  
 A bidentate phosphoramidite ligand able to supramolecularly control coordination 
to rhodium was recently developed by Reek. This approach allows for an alternate way to 
control the activity and selectivity of a hydroformylation catalyst.4 Hydroformylation of 
unactivated, substituted olefins has given promising regioselective and enantioselective 
results (Scheme 2.4). High regio- and enantioselectivites are also obtained when used in  
3Noonan, G. M.; Fuentes, J. A.; Cobley, C. J.; Clarke, M. L. Angew. Chem., Int. Ed. 2012, 51, 2477-2480. 
4(a) Bellini, R.; Chikkali, S. H.; Berthon-Gelloz, G.; Reek, J. N. H. Angew. Chem., Int. Ed. 2011, 50, 7342-
7345.  (b) Gadzikwa, T.; Bellini, R.; Dekker, H. L.; Reek, J. N. H. J. Am. Chem. Soc. 2012, 134, 2860-
2863.  (c) Bellini, R.; Reek, J. N. H. Chem. Eur. J. 2012, 18, 13510-13519. 
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the hydroformylation of styrene derivatives. 
Scheme 2.4 Supramolecular Ligands in Asymmetric Hydroformylation. 
 
 
 
 
 Our group and the Breit group have demonstrated that using a catalytic directing 
group is an effective solution to both hydroformylation challenges (Chapter 1).5 In order 
to expand our method to asymmetric catalysis, we developed an enantioenriched catalytic 
directing group. 
2.2 Developing an Enantioenriched Catalytic Directing Group 
 First attempts to develop an enantioenriched catalytic directing group were 
focused on resolving chiral, racemic catalytic directing group I. Taking advantage of its 
ability to bind alcohols, enantiopure alcohol 2.3 was exchanged with I with the aim that 
the resulting diastereomers, 2.4 and 2.5, would be separable. Surprisingly, a 69:31 
mixture of diastereomers resulted from the exchange of I with 2.3 (Scheme 2.5). 
5(a) Lightburn, T. E.; Dombrowski, M. T.; Tan, K. L. J. Am. Chem. Soc. 2008, 130, 9210-9211. (b) 
Grünanger, C. U.; Breit, B. Angew. Chem., Int. Ed. 2008, 47, 7346-7349. (c) Smejkal, T.; Breit, B. Angew. 
Chem., Int. Ed. 2008, 47, 311-315. (d) Worthy, A. D.; Gagnon, M. M.; Dombrowski, M. T.; Tan, K. L. Org 
Lett. 2009, 11, 2764-2767. 
Ligand 
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Calculations predict structure 2.4 to be 0.64 kcal/mol more stable than 2.5. That energy 
difference would translate into a 75:25 ratio of diastereomers, similar to the experimental 
results that are shown in Scheme 2.5. This indicates that the phosphorus center is 
inverting under the exchange conditions. Considering that the barrier to phosphorus 
inversion (MeP(o-tolyl)Ph) is ~30 kcal/mol, this was an unexpected result.6  
Scheme 2.5 Exchange of I with Enantiopure Alcohol 2.3. 
 
There are two possible mechanisms in which phosphorus inversion might occur under 
these mild reaction conditions. First, the cationic intermediate that is believed to exist 
during an exchange reaction is aromatic, which likely lowers the barrier to inversion 
through stabilization of the planar sp2 hybridized phosphorus.7 If the  basic phosphorus is 
protonated, it is possible that the ring can open generating a 2° phosphine which has a 
lower inversion barrier, especially in the presence of catalytic acid (Figure 2.1).8,9 
6Baechler, R. D.; Mislow, K. J. Am. Chem. Soc. 1970, 92, 3090-3093.                                                             
7(a) Egan, W.; Tang, R.; Zon, G.; Mislow, K. J. Am. Chem. Soc. 1970, 92, 1442-1444.  (b) Andose, J. D.; 
Rauk, A.; Mislow, K. J. Am. Chem. Soc. 1974, 96, 6904-6907. (c) Nyulászi, L. Tetrahedron 2000, 56, 79-
84.                                                                                                                                                                                       
8(a) Anderson, J. C.; Cubbon, R. J.; Harling, J. D. Tetrahedron: Asymmetry 2001, 12, 923-935. (b) 
Neidlein, R.; Greulich, P.; Kramer, W. Helv. Chim. Acta 1993, 76, 2407-2417. (c) Christoffers, J. Helv. 
Chim Acta 1998, 81, 845-852.                                                                                                                       
9(a) Bader, A.; Nullmeyers, T.; Pabel, M.; Salem, G.; Willis, A. C.; Wild, S. B. Inorg. Chem. 1995, 34, 384-
389. (b) Gagnaire, D.; St. Jacques, M. J. Phys. Chem. 1969, 73, 1678-1684. 
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Figure 2.1 Possible Mechanisms for Phosphorus Inversion. 
 
  
 We decided to use this interesting characteristic of I in the development of an 
enantioenriched catalytic directing group. If one diastereomer was at least 4 kcal/mol 
more stable than the others, it should be possible to equilibrate multiple diastereomers to 
a single stereoisomer. A set of tetrahydroquinoline ligands, which are based on catalytic 
directing group I, were modeled, computationally. The idea was that a set stereocenter 
next to the nitrogen might be able to gear the other two in the molecule. With a methyl 
group on the tetrahydroquinoline ring, the energy difference was 1.2 kcal/mol. This 
would lead to a ~90:10 mixture of the two lowest energy diastereomers in solution. When 
the group is changed to isopropyl, the energy difference between the two lowest energy 
diastereomers is 4.8 kcal/mol (Figure 2.2). If the calculations were correct, only one 
thermodynamically favored diastereomer should be present in solution. It is believed that 
the isopropyl group is able to gear the methoxy group down to avoid a syn-pentane-like 
interaction. The methoxy group, in turn, gears the phenyl up. Previously, it was seen with 
I that the C-O bond and phenyl group strongly prefer to be anti.5a,d 
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Figure 2.2 B3LYP, 6-31g** Energy Calculations. 
 
  
 Compound II was synthesized starting from 2-isopropylquinoline. An asymmetric 
hydrogenation of the quinoline was performed followed by crystallization of the (+)-3-
bromocamphor-8-sulfonic acid salt to enrich 2.6 to 98% ee. An ortho-lithiation and trap 
with PPh2Cl yielded 2.7. Lithium reduction of the phosphorus to remove a phenyl group 
followed by a kinetic closure with dichloromethyl methyl ether gave II-OMe as a 
mixture of four diastereomers (visible by 31P NMR). As predicted by calculations, 
equilibration of the four diastereomers to one, II-OiPr, occurred under mild exchange 
conditions (Scheme 2.6 and Figure 2.3 and 2.4). 
 
 
ΔE
calc
= 4.8 kcal/mol 
ΔE
calc
= 1.2 kcal/mol 
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Scheme 2.6 Synthesis of II. 
 
    
 
Figure 2.3 Four Diastereomers of II-OMe by 31P NMR.  
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 Figure 2.4 Single Diastereomer of II-OiPr by 31P NMR. 
 
 
  
 After complexation of II with trans-[Rh(CO)2Cl]2, a crystal structure of the 
complex was obtained which showed the isopropyl group next to the nitrogen gears the 
C-O bond down which in turn gears the P-Ph bond up (Figure 2.5), consistent with 
calculations. 
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Figure 2.5 Crystal Structure of [(II-OiPr)2Rh(CO)Cl]. 
 
 
2.3 Enantioselective Hydroformylation of p-Methoxyphenyl-protected Allylic Amines10 
 With II in hand, focus shifted to developing an enantioselective hydroformylation 
method. Previously, it was demonstrated that electron-withdrawing sulfonamides undergo 
efficient exchange and hydroformylation using I (Chapter 1).5d However, the 3,5-
bis(trifluoromethyl)benzenesulfonamide protecting group used was exotic and hard to 
remove. In order to make this method more useful, anilines were explored as potential 
substrates. In particular, PMP-protected amines were interesting because they are 
commonly used and can be deprotected to the free amine without difficulty.11  
 First the exchange of 2.8 with I was tested. Equilibrium was reached in 2 h and 
the Keq was determined to be 3.8 ± 0.5 (Scheme 2.7).  
10Worthy, A. D.; Joe, C. L.; Lightburn, T. E.; Tan, K. L. J. Am. Chem. Soc. 2010, 132, 14757-14759.      
11Carswell, E. L.; Snapper, M. L.; Hoveyda, A. H. Angew Chem., Int. Ed. 2006, 45, 7230-7233. 
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Scheme 2.7 Exchange of 2.8 with I. 
 
 
 As pre-exchanging amine substrates greatly increased regioselectivity in previous 
studies (Chapter 1),5d 2.8 was pre-exchanged with I to form 2.9 prior to 
hydroformylation. Because it was determined to be unstable and hard to isolate, the 
aldehyde was reduced to the corresponding alcohol 2.10, immediately after 
hydroformylation. The normal product, 2.11, was never seen in any reaction and attempts 
to synthesize it independently failed. Thus, it is believed to be unstable under the reaction 
conditions. 
 A pressure screen using I was first attempted in order to maximize the amount of 
iso product formed. Running the reaction at a pressure above 50 psi H2/CO resulted in at 
least 40% conversion in each case, but 2.10 was not detected in the crude 1H NMR. It is 
possible that at higher pressures of H2/CO the reaction was favoring formation of the 
normal product, 2.11. At 50 psi, almost 50% conversion was achieved with 37% isolated 
2.10 (Table 2.1).  
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Table 2.1 Pressure Screen with I. 
 
 
 Performing a catalyst loading screen showed that increasing the amount of I in the 
reaction increased the conversion as well as the amount of 2.10 formed. With less 
amounts of I, the unselective background reaction is much more competitive (Table 2.2). 
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Table 2.2 Catalyst Loading Screen with I.  
 
  
 At this point, an acid screen was run to ensure that exchange was fast enough 
during the reaction to achieve iso-selective hydroformylation. The highest amount of 2.10 
formed was achieved with 0.05% p-toluenesulfonic acid (p-TsOH). The difference 
between conversion and amount of 2.10 formed is low which means that minimal 
amounts of normal product are being formed (Table 2.3).  
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Table 2.3 Acid Loading Screen. 
 
  
 Eager to test II, a temperature screen was performed to optimize the balance 
between conversion and enantioselectivity. Fortunately, using 10% of II resulted in 
increased conversion and yields of the β-amino alcohol compared to I. Larger ligands are 
known to be more active in hydroformylation due to a higher concentration of the 
monophosphine complex. Performing the reaction at 55 °C resulted in almost complete 
conversion, albeit, with moderate enantioselectivites. Decreasing the temperature lowered 
the conversion of 2.8, but increased the enantioselectivity of the reaction. The conversion 
and yield of 2.10 did not change between 45 °C and 35 °C, but 35 °C did give slightly 
better enantiomeric 
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Table 2.4 Temperature Screen with II. 
 
 
 
  
excess for 2.10. Decreasing to 30 °C did not affect the enantioselectivity but continued to 
lower the conversion (Table 2.4). 
Scheme 2.8 Increasing the Reaction Time. 
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 When expanding the substrate scope, the substrates were shown to react under 
remarkably mild conditions for the hydroformylation of disubstituted olefins. In most 
cases, however, complete conversion is not achieved which has been attributed to II 
decomposing before the reaction is complete. This is supported by the observation that 
running the reaction for longer times does not increase the conversion (Scheme 2.8), 
whereas increasing the amount of II improves conversion (Scheme 2.9). 
Scheme 2.9 Increasing the Amount of II. 
 
  
 Interestingly trans olefins, (Table 2.5, Entries 2 and 4), provide lower 
enantioselectivities than the corresponding cis olefins (Table 2.5, Entries 1 and 3). 
Elucidating the reason for this difference has not yet been accomplished. However, using 
the crystal structure of the ligand and simple modeling, a proposed stereochemical model 
was developed (Figure 2.6). First to minimize steric interactions with the ligand, the PMP 
protecting group was oriented out into space. Then by comparing the interaction of the 
rhodium with each face of the olefin with both the cis and trans substrates, it was obvious 
that the major enantiomer can come from the two intermediates with less steric 
interactions. It is interesting to note that in the case of the trans olefin, the model leading 
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Figure 2.6 Proposed Stereochemical Model. 
 
 
to the minor enantiomer appears more favorable than the corresponding model for the cis 
olefin. It is possible that in the case of the trans olefin the energy difference between the 
two faces of the olefin bond to rhodium are closer in energy than the two intermediates 
possible for the cis olefin. This hypothesis is consistent with the decreased 
enantioselectivity observed with the trans olefin. 
 When examining the substrate scope, the phthalimide substrate was the only 
substrate that showed a significant discrepancy between conversion and amount of iso 
product (Table 2.5, Entry 8). Amides are known to be able to direct hydroformylation so 
the phthalimide may be directing formation of the normal isomer which is subsequently  
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decomposing and causing the mass balance to be skewed.12 The terminal substrate also 
likely forms more normal product than the other substrates due to its reactive nature. A 
trisubstituted olefin was attempted but even at 95 °C, only starting material, 2.13, and 
hydrogenated starting material (~20%) were observed (Scheme 2.10). 
 
Scheme 2.10 Hydroformylation of 4-methoxy-N-(3-methylbut-2-en-1-yl)aniline. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
12For examples of amide directed hydroformylation see: (a) Ojima, I.; Zhang, Z. J. Org. Chem. 1988, 53, 
4422-4425. (b) Ojima, I.; Zhang, Z. J. Organomet. Chem. 1991, 417, 253-276. (c) Ojima, I.; Korda, A.; 
Shay, W. R. J. Org. Chem. 1991, 56, 2024-2030. (d) Dickson, R. S.; Bowen, J.; Campi, E. M.; Jackson, W. 
R.; Jonasson, C. A. M.; McGrath, F. J.; Paslow, D. J.; Polas, A.; Renton, P.; Gladiali, S. J. Mol. Cat. A 
1999, 150, 122-146. 
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Table 2.5 Substrate Scope. 
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2.4 Conclusions 
 
 Building off of our previously successful catalytic directing group, I, 
enantioenriched catalytic directing group, II, was designed and synthesized. It retains the 
essential features to direct hydroformylation to obtain good regioselectivity while also 
providing a chiral environment to induce stereoselectivity. Under mild conditions, a 
variety of disubstituted olefins react to give good yields and excellent enantioselectivites. 
Thus, the first enantioselective reaction performed with a catalytic directing group was 
developed. 
2.5 Experimental 
General Considerations 
 
 Unless otherwise noted, all reagents were obtained from commercial suppliers 
and used without further purification. Lithium reagents were titrated against 2-pentanol 
using 1, 10-phenanthroline as the indicator. Flash column chromatography was 
performed using EMD Silica Gel 60 (230-400 mesh) and ACS grade solvents as received 
from Fisher Scientific. All experiments were performed in oven or flame-dried glassware 
under an atmosphere of nitrogen or argon using standard syringe and cannula techniques, 
except where otherwise noted. All reactions were run with dry, degassed solvents 
dispensed from a Glass Contour Solvent Purification System (SG Water, USA LLC). 1H, 
13C, and 31P NMR were performed on either a Varian Gemini 400 MHz or a Varian Unity 
Inova 500 MHz spectrometers. Deuterated solvents were purchased from Cambridge 
Isotope Labs and stored over 3Å molecular sieves. C6D6 was degassed by three 
successive freeze-pump-thaw cycles and stored over 3Å molecular sieves in a dry box 
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under a nitrogen atmosphere. All NMR chemical shifts are reported in ppm relative to 
residual solvent for 1H and 13C and external standard (neat H3PO4) for 
31P NMR.  
Coupling constants are reported in Hz. All IR spectra were gathered on a Bruker Alpha 
FT-IR equipped with a single crystal diamond ATR module and values are reported in 
cm1. Analytical chiral supercritical fluid chromatography (SFC) was performed on a 
Berger Instruments Supercritical Chromatograph equipped with an Alcott auto sampler 
and a Knauer UV detector with methanol as the modifier. HRMS and X-ray crystal 
structure data were generated in Boston College facilities. Analytical chiral high-
performance liquid chromatography (HPLC) was performed on a Shimadzu-LC-2010A 
HT. Hydroformylation was performed in an Argonaut Technologies Endeavor Catalyst 
Screening System using 1:1 H2/CO supplied by Airgas, Inc. 
 
Ligand Synthesis and Characterization 
 
2-isopropyl quinoline13 was prepared according to a literature procedure and matches 
reported spectra. 
 
 
 
(S)-2-isopropyl-1,2,3,4-tetrahydroquinoline, 2.6. [Ir(COD)Cl]2 (68.0 mg, 0.102 mmol) 
and (R)-(+)-5,5'-dichloro-6,6'-dimethoxy-2,2'-bis(diphenylphosphino)-1,1'-biphenyl (132  
mg, 0.204 mmol) were dissolved in 5 mL THF in a glovebox and stirred for 20 minutes. 
The solution was brought out of the box and was added to a solution of 2-isopropyl 
13Lachance, N.; Roy, P.; Leblanc, Y. US Patent 20050277644, 2005. 
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quinoline (8.71 g, 50.9 mmol) and iodine (258 mg, 1.02 mmol) in 50 mL THF. The 
solution was added to a Parr bomb and cooled to 4 °C (cold room). The system was 
purged 3 times with hydrogen (charged to 400 psi and then depressurized). The vessel 
was pressurized to 400 psi hydrogen, and the reaction was stirred for 36 h. The reaction 
was concentrated and purified on silica (3-5% EtOAc in Hexanes) to yield a yellow oil 
(8.51 g, 95%). The compound was 94% ee by SFC analysis (OD-H, 1% methanol as 
modifier, 1.5 mL/min, 150 psi. trminor = 12.8 min and trmajor = 13.6 min). 
Crystalization to higher ee: 
HCl (5.0 mL, conc.) and water (72 mL) were heated to 50 °C and (S)-2-isopropyl-1,2,3,4- 
tetrahydroquinoline (7.18 g, 41.0 mmol) was added followed by (+)-3-bromocamphor-8- 
sulfonic acid ammonium salt (13.4 g, 40.9 mmol). The temperature was raised to 90 
°C. Water (500 mL), ethanol (35 mL), and HCl (25 mL, conc.) were added. The  
suspension was hot filtered, and the filtrate was allowed to cool overnight. The crystals 
were collected, and the parent compound was recovered by suspending the crystals in 
ethyl acetate and washing with 1 M Na2CO3 (3×50 mL). The organic layer was dried over 
MgSO4, filtered, and concentrated to yield the title compound (3.51 g, 49%) 
in 98% ee as determined by SFC. 1H NMR (CDCl3, 500 MHz) δ 7.06-7.02 (m, 2H), 6.68 
(ddd, 1H, J = 8.0, 7.0, 1.0), 6.54 (dd, 1H, J = 7.5, 1.0), 3.82 (br s, 1H), 3.14-3.10 (m, 
1H), 2.89-2.80 (m, 2H), 2.02-1.97 (m, 1H), 1.81-1.70 (m, 2H), 1.09 (d, 3H, J = 7.0), 1.06 
(d, 3H, J = 7.0); 13C NMR (CDCl3, 125 MHz) δ 145.1, 129.2, 126.8, 121.5, 116.8, 114.0, 
Chapter 2, Page 143 
 
57.3, 32.6, 26.7, 24.6, 18.7, 18.3; IR: 3415, 2956, 2870, 2842, 1606, 1483, 1308, 1273, 
1253, 741, 713 cm-1; HRMS (DART-TOF) calcd. for C12H18N [M+H]
+: 176.1439, found: 
176.1448; [α]D
20 = +65.3 (c = 0.915, CH2Cl2, l = 50 mm). 
 
 
 
(S)-8-(diphenylphosphino)-2-isopropyl-1,2,3,4-tetrahydroquinoline, 2.7. To a 250 
mL, three-neck round-bottom flask was added THF (60 mL) and (S)-2-isopropyl-1,2,3,4-
tetrahydroquinoline (5.80 g, 33.1 mmol).  The solution was cooled to 78 C and nBuLi 
(18.8 mL, 1.76 M, 33.1 mmol) was added slowly maintaining the internal temperature at 
or below 70 C.  Upon completion of the nBuLi addition, the reaction was warmed in an 
ice water bath to 0 C, and CO2 was bubbled through the solution.  The red solution color 
faded quickly.  CO2 bubbling was continued for 45 min, and the solvent was removed 
under high vacuum to yield a foamy yellow semi-solid.  The residue was redissolved in 
THF (60 mL) and cooled to 78 C.  tBuLi (27.2 mL, 1.40 M, 38.1 mmol) was added, 
maintaining the internal temperature at or below 70 C.  The solution was warmed to 
20 C for 30 min before being recooled to 78C.  Chlorodiphenylphosphine (6.73 mL, 
36.4 mmol) was added as a solution in THF (10 mL) maintaining the internal temperature 
at or below 70 C.  The solution was stirred overnight, allowing the reaction to warm 
with the cold bath.  HCl was added (52 mL, 6.3 M) and stirred for 45 min.  The solution 
was basified to pH >10 with 10 M NaOH and extracted with EtOAc. The organics were 
dried over MgSO4, filtered, and concentrated.  The unreacted starting material was 
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removed by Kugelrohr distillation (120 C at 0.05 mmHg).  The undistilled material was 
suspended in minimal amount of ethanol, and the product precipitated as a white solid 
(5.88 g, 49%). 1H NMR (CDCl3, 500 MHz) δ 7.38-7.27 (m, 10H), 6.97 (d, 1H, J = 7.0), 
6.61 (app t, 1H, J = 7.0), 6.50 (app t, 1H, J = 7.0), 4.66 (d, 1H, J = 7.0), 3.04-3.02 (m, 
1H), 2.83-2.74 (m, 2H), 1.90-1.86 (m, 1H), 1.63-1.58 (m, 2H), 0.81 (d, 3H, J = 6.5), 0.78 
(d, 3H, J = 6.5);  13C NMR (CDCl3, 125 MHz) δ 147.7, 147.5, 135.8 (d, J = 7.4), 135.6 
(d, J = 7.4), 133.8 (d, J = 7.4), 133.7 (d, J = 7.4), 132.14, 132.11, 128.7, 128.6, 128.5, 
128.4, 120.99, 120.96, 117.4, 117.3, 116.1, 116.0, 57.6, 57.5, 32.5, 27.0, 24.2, 18.2; 31P 
NMR (CDCl3, 202 MHz) δ 20.7; IR: 3050, 2955, 2870, 2840, 1586, 1489, 1455, 1433, 
1277, 1091, 738, 694, 502 cm-1; HRMS (DART-TOF) calcd. for C24H26NP [M+H]
+: 
360.1881, found: 360.1870; []D
20 = +80.9 (c = 0.415, CH2Cl2,  l = 50 mm). 
 
 
 
(S)-2-isopropyl-8-(phenylphosphino)-1,2,3,4-tetrahydroquinoline. A dry 100 mL 
round-bottom flask was charged with (S)-8-(diphenylphosphino)-2-isopropyl-1,2,3,4-
tetrahydroquinoline (2.50 g, 6.96 mmol) and THF (25 mL).  The solution was sparged 
with argon for 30 min, and lithium wire (145 mg, 20.9 mmol) was added.  The solution 
was sparged with argon for an additional 30 min during which time the solution turned 
orange. (Note: you must use argon for this reaction as lithium metal will react with 
nitrogen).  The solution was stirred overnight under argon.  Degassed water (2.5 mL) was 
added and stirred for 15 min, resulting in a colorless solution.  The solvent was removed 
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under high vacuum, and the residue was quickly extracted with CH2Cl2, dried over 
MgSO4, filtered, and concentrated. Distillation (125 C at 0.05 mmHg) resulted in an air 
sensitive clear oil (1.31 g, 66%) as a 1:1 mixture of diastereomers.  The compound was 
stored under argon. 1H NMR (CDCl3, 500 MHz) δ 7.45-7.41 (m, 2H), 7.37-7.27 (m, 4H), 
7.06-7.05 (m, 1H), 6.64-6.58 (m, 1H), 5.10 (d, 1H, J = 219), 4.31 (br s, 1H), 3.09-3.05 
(m, 0.5H), 2.96-2.92 (m, 0.5H), 2.84-2.74 (m, 2H), 1.91-1.84 (m, 1H), 1.65-1.54 (m, 2H), 
0.84 (d, 1.5H, J = 7.0), 0.82 (d, 1.5H, J = 7.0), 0.78 (d, 1.5H, J = 7.0), 0.74 (d, 1.5H, J = 
7.0); 13C NMR (CDCl3, 125 MHz) δ 147.74, 147.71, 147.2, 147.1, 136.2, 136.1, 136.0, 
135.9, 132.3, 132.2, 132.1, 132.0, 131.4, 131.3, 128.70, 128.67, 128.66, 128.64, 128.01, 
127.98, 116.2, 116.1, 115.7, 115.6, 57.7, 32.6, 32.5, 32.4, 27.2, 27.1, 24.6, 24.0, 18.4, 
18.14, 18.12, 18.0; 31P NMR (CDCl3, 202 MHz) δ 61.4, 62.1; IR: 3421, 2957, 2930, 
2871, 2842, 1588, 1490, 1457, 1434, 1285, 759, 737, 695 cm-1; HRMS (DART-TOF) 
calcd. for C18H23NP [M+H]
+: 284.1568, found: 284.1561; []D
20 = +53.4 (c = 0.730, 
CH2Cl2, l = 50mm)  
 
Synthesis of II-(OiPr) 
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(4S)-2-isopropoxy-4-isopropyl-1-phenyl-2,4,5,6-tetrahydro-1H-
[1,3]azaphospholo[4,5,1-ij]quinoline, II-(OiPr). (S)-2-isopropyl-8-(phenylphosphino)-
1,2,3,4-tetrahydroquinoline (1.30 g, 4.59 mmol) was dissolved in THF (25 mL).  The 
solution was cooled to 78 C and PhLi (4.89 mL, 1.97 M, 9.64 mmol) was added 
dropwise.  After stirring for 30 min, the flask was transferred to an ice water bath and 
stirred for an additional 30 min.  The dianion solution was added via syringe pump over 1 
h to a solution of dichloromethyl methyl ether (448 μL, 5.05 mmol) in THF (150 mL) at 
0 C.  The reaction was stirred for 90 min, and the solvent was removed under high 
vacuum.  The resulting residue was brought into a glovebox and extracted with pentane 
(3×10 mL).  The pentane extract was filtered through glass fiber filter paper to remove 
LiCl.  The crude mixture was distilled (150 C at 0.05 mmHg) to yield a yellow oil (492 
mg, 33%) that was a mixture of four diastereomers [31P NMR (C6D6, 202 MHz) δ 6.0, 
23.2, 25.2, 30.3].  To the distillate was added iPrOH (3 mL) in benzene (3 mL) over 
4Å mol. sieves in a glove box. The solution was allowed to sit for 20 h before being 
filtered. The sieves were washed with benzene. The filtrate was concentrated and 
resubjected to iPrOH (3 mL) in benzene (3 mL) over 4Å mol. sieves.  The 
filtration/resubjection cycle was repeated.  The resulting residue was dissolved in pentane 
(0.3 mL) and crystallized at 37 C.  More material was recrystallized from the mother 
liquor, and the white solids were combined (181 mg, 34%). 1H NMR (CDCl3, 500 MHz) 
δ 7.42-7.40 (m, 1H), 7.38-7.35 (m, 2H), 7.03-7.00 (m, 3H), 6.98-6.96 (m, 2H), 6.73-6.70 
(m, 1H), 5.14 (d, 1H, J = 13.0), 4.01-3.98 (m, 1H), 3.40-3.37 (m, 1H), 2.44-2.42 (m, 2H), 
1.86-1.82 (m, 2H), 1.61-1.55 (m, 2H), 1.17 (d, 3H, J = 6.0), 1.08 (d, 3H, J = 6.0), 0.64 
Chapter 2, Page 147 
 
(d, 3H, J = 7.0), 0.50 (d, 3H, J = 6.5); 13C NMR (CDCl3, 125 MHz) δ 151.3, 136.9, 
136.8, 132.1, 132.0, 130.7, 130.6, 130.0, 128.5, 120.0, 119.4, 117.9, 98.3, 67.3, 57.5, 
28.8, 24.2, 23.3, 21.6, 21.4, 19.3, 16.0; 31P NMR (C6D6, 202 MHz) δ 22.0 ; IR 3052, 
2962, 2929, 2870, 1582, 1455, 1383, 1310, 1288, 1183, 1082, 999, 740, 695 cm-1; 
HRMS (DART-TOF) calcd. for C22H29NOP [M+H]
+: 354.1987, found: 354.2000. []D
20 
= +139.4 (c = 0.340, C6H6, l = 50 mm). 
Note: Table 2.5 substrates were exchanged with the mixture of four II-OMe 
diastereomers prior to hydroformylation, which effected conversion to one 
thermodynamically favored diastereomer of substrate-bound ligand. 
Ligand, II-OiPr, Bound to Rhodium Complex 
trans-[Rh(1)(CO)2(Cl)]2. Chlorodicarbonylrhodium (I) dimer (2.7 mg, 6.9 x 10
-3 mmol) 
and II-OiPr (9.9 mg, 2.8 x 10-2 mmol) were weighed out in a glove box, dissolved in 
benzene-d6, and allowed to stand for 12 h in a sealed, screw-top NMR tube.  The orange 
solution was concentrated and dissolved in a minimal amount of benzene/pentane (1:1).  
The solution was placed in a vial with small holes in the cap and was allowed to slowly 
evaporate in a glovebox, yielding yellow needles suitable for x-ray diffraction analysis.  
A single crystal was taken and stored under nitrogen until ready for x-ray diffraction 
analysis. 
X-ray Crystallographic Procedures. Single crystals obtained as described above were 
used for structural determination. The X-ray intensity data were measured at 100(2) K 
(Oxford Cryostream 700) on a Bruker SMART APEX CCD-based X-ray diffractometer 
system equipped with a Mo-target X-ray tube (λ = 0.71073Å) operated at 2000 W power. 
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The crystals were mounted on a goniometer head with silicone oil. The detector was 
placed at a distance of 6.00 cm from the crystal. For each experiment a total of 2400 
frames were collected with a scan width of 0.3° in  and an exposure time of 20 s/frame. 
The frames were integrated with the Bruker SAINT software package using a narrow-
frame integration algorithm to a maximum 2θ angle of 56.54° (0.75 Å resolution). The 
final cell constants are based upon the refinement of the XYZ-centroids of several 
thousand reflections above 20 σ(I). Analysis of the data showed negligible decay during 
data collection. Data were corrected for absorption effects using the empirical method 
(SADABS). 
 The structures were solved and refined by full-matrix least squares procedures on 
F
2 
using the Bruker SHELXTL (version 6.12) software package. The coordinates of 
heavy atoms were found in direct method E maps. The remaining atoms were located 
after an alternative series of least-squares cycles and difference Fourier maps. Hydrogen 
atoms were included in idealized positions for structure factor calculations.  Anisotropic 
displacement parameters were assigned to all non-hydrogen atoms. Relevant 
crystallographic data are summarized in Table 2.6. Selected bond lengths are given in 
Table 2.7. 
 
Crystallographic Tables for CCDC #833149 
Table 2.6.  Crystal data and structure refinement. 
Empirical formula  C45 H56 Cl N2 O3 P2 Rh 
Formula weight  873.22 
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Temperature  100(2) K 
Wavelength  0.71073Å 
Crystal system  Orthorhombic 
Space group  P 21 21 21 
Unit cell dimensions (Å) a = 9.199(2)  = 90 
 b = 14.760(3)  = 90 
 c = 31.273(7)   = 90 
Volume 4246.3(16) Å3 
Z 4 
Density (calculated) 1.366 g/cm3 
Absorption coefficient 0.582 mm-1 
F(000) 1824 
Crystal size 0.12 x 0.02 x 0.02 mm3 
Theta range for data collection 2.39 to 28.40. 
Index ranges -12<=h<=12, -19<=k<=19, -41<=l<=41 
Reflections collected 51112 
Independent reflections 10497 [R(int) = 0.0955] 
Completeness to theta = 28.40 99.3%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9885 and 0.9335 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 10497 / 462 / 481 
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Goodness-of-fit on F2 1.054 
Final R indices [I>2sigma(I)] R1 = 0.0511, wR2 = 0.0858 
R indices (all data) R1 = 0.0706, wR2 = 0.0916 
Absolute structure parameter -0.06(2) 
Extinction coefficient na 
Largest diff. peak and hole 0.602 and -0.870 e- Å-3 
 
Table 2.7.   Selected bond lengths [Å] and angles []. 
_____________________________________________________  
Rh(1)-C(45)  1.811(4) 
Rh(1)-P(1)  2.3004(11) 
Rh(1)-P(2)  2.3191(11) 
Rh(1)-Cl(1)  2.3445(10) 
O(3)-C(45)  1.158(4) 
C(45)-Rh(1)-P(1) 87.38(12) 
C(45)-Rh(1)-P(2) 93.07(12) 
P(1)-Rh(1)-P(2) 178.17(4) 
C(45)-Rh(1)-Cl(1) 177.31(12) 
P(1)-Rh(1)-Cl(1) 90.92(4) 
P(2)-Rh(1)-Cl(1) 88.69(3) 
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_____________________________________________________________ 
Figure 2.6 Perspective drawing of trans-[Rh(II-OiPr)2(CO)(Cl)] (CCDC # 833149).  
Atoms are represented by thermal ellipsoids at the 50% probability level. 
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Substrate Synthesis and Characterization 
The following compounds were made according to literature procedures and matched 
reported spectra: (Z)-3-phenylprop-2-en-1-ol14, (Z)-(3-chloroprop-1-enyl)benzene15, 1,4-
but-2-enediol cyclic sulfite16,17, and (Z)-3-cyclohexylprop-2-en-1-ol18, (Z)-ethyl 7-
hydroxyhept-5-enoate.19 
 
N-(but-2-ynyl)-4-methoxyaniline.20 To p-anisidine (2.80 g, 22.7 mmol) in CH3CN (13 
mL) was added 1-bromo-2-butyne (658 μL, 7.58 mmol). The mixture was stirred 
overnight at room temperature. Saturated aqueous NH4Cl (15 mL) was added, and the 
mixture was separated. The aqueous layer was extracted with Et2O (3×20 mL). The 
combined organic layers were washed with brine (20 mL), dried over MgSO4, filtered, 
and concentrated. Column chromatography (10% EtOAc/Hex) afforded a light yellow oil 
(855 mg, 64%). 1H NMR (CDCl3, 400 MHz) δ 6.80-6.83 (m, 2H), 6.66 (dd, 2H, J = 9.0, 
2.4), 3.83 (q, 2H, J = 2.2), 3.76 (s, 3H), 3.60 (bs, 1H), 1.80-1.81 (m, 3H); 13C NMR 
(CDCl3, 101 MHz) δ 152.6, 141.4, 114.8, 114.6, 78.8, 76.4, 55.6, 34.8, 3.4; IR: 3384, 
2917, 2932, 1513, 1463, 1235, 1036, 821 cm–1; HRMS (DART-TOF) calcd. for  
 
 
14Kim, I. S.; Dong, G. R.; Jung, Y. H. J. Org. Chem. 2007, 72, 5424-5426.                                                          
15Bergman, J. M.; Coleman, P. J.; Fraley, M. E.; Garbaccio, R. M.; Hartman, G. D.; Li, C.; Neilson, L. A.; 
Olson, C. M.; Tasber, E. S. WO 2006007491, 2006.                                                                                       
16Chaudhari, S. S.; Akamanchi, K. G. Synlett 1999, 11, 1763-1765.                                                               
17Shellhamer, D. F.; Anstine, D. T.; Gallego, K. M.; Ganesh, B. R.; Hanson, A. A.; Hanson, K. A.; 
Henderson, R. D.; Prince, J. M.; Heasley, V. L. J. Chem. Soc. Perkin Trans 2 1995, 7, 1569.                                
18Reed, S. A.; White, M. C. J. Am. Chem. Soc. 2008, 130, 3316-3318.                                                                        
19Ely, R. J.; Morken, J. P.  J. Am. Chem. Soc. 2010, 132, 2534-2535.                                                                 
20Saito, A.; Oda, S.; Fukaya, H.; Hanzawa, Y. J. Org. Chem. 2009, 74, 1517-1524. 
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C11H14NO [M+H]
+: 176.1075, found: 176.1069. 
 
 
(Z)-N-(but-2-enyl)-4-methoxyaniline (10% E isomer), 2.8.21 A round-bottom flask was 
charged with Lindlar’s catalyst (121 mg) and purged with argon. N-(but-2-ynyl)-4-
methoxyaniline (855 mg, 4.88 mmol) in EtOH (9 mL) was added followed by quinoline 
(46.0 μL, 0.390 mmol). The flask was evacuated and refilled with H2 four times, fitted 
with a H2 balloon, and stirred at room temperature under H2 for 3.5 h. The reaction was 
filtered through a plug of silica and concentrated. Column chromatography (20% 
EtOAc/Hex) yielded a light yellow oil (754 mg, 87%). 1H NMR (CDCl3, 400 MHz) δ 
6.79 (app dd, 2H, J = 9.0, 2.4), 6.61 (app dd, 2H, J = 8.8, 2.4), 5.53-5.69 (m, 2H), 3.76 (s, 
3H), 3.73-3.75 (m, 2H), 3.37 (bs, 1H), 1.71 (d, 3H, J = 6.3); 13C NMR (CDCl3, 100 
MHz) δ 152.2, 142.6, 127.9, 126.9, 114.8, 114.3, 55.8, 41.8, 13.1; IR: 3290, 2934, 2015, 
1608, 1512, 1413, 1249, 1032, 837 cm–1; HRMS (DART-TOF) calcd. for C11H16NO 
[M+H]+:178.1232, found: 178.1234. 
 
 
(E)-N-(but-2-enyl)-4-methoxyaniline, 2.12.20 To p-anisidine (6.13 g, 49.8 mmol) in  
CH3CN (29 mL) was added crotyl chloride (1.61 mL, 16.6 mmol). The mixture was 
21Walters, M. A.; Hoem, A. B.; J. Org. Chem. 1994, 59, 2645-2647. 
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stirred overnight at 23 °C. Saturated aqueous NH4Cl (15 mL) was added, and mixture 
was separated. The aqueous layer was extracted with Et2O (320 mL). The combined  
organic layers were washed with brine (20 mL), dried over MgSO4, filtered, and 
concentrated. Column chromatography yielded a light yellow oil (1.02 g, 35%). 1H NMR 
(CDCl3, 500 MHz) δ 6.79-6.83 (m, 2H), 6.60-6.63 (m, 2H), 5.70-5.75 (m, 1H), 5.59-5.65 
(m, 1H), 3.76 (s, 3H), 3.66 (d, 2H, J = 5.9), 3.44 (bs, 1H), 1.73 (dd, 3H, J = 6.4, 1.2); 13C 
NMR (CDCl3, 100 MHz) δ 152.1, 142.5, 128.4, 127.7, 114.8, 114.3, 55.8, 47.0, 17.8; IR: 
3386, 2935, 2832, 1512, 1464, 1235, 1038, 966, 819 cm–1; HRMS (DART-TOF) calcd. 
for C11H16NO [M+H]
+: 178.1232, found: 178.1230. 
 
 
3-cyclohexylprop-2-yn-1-ol.18 To a solution of cyclohexylacetylene (2.40 mL, 18.5 
mmol) in THF (23 mL) at –78 °C was added nBuLi as a solution in hexanes (12.5 mL, 
1.48 M) dropwise over 10 min. The mixture was stirred at –78 °C for 40 min, and 
paraformaldehyde (778 mg, 25.9 mmol) was added. The mixture was allowed to warm to 
23 °C and stirred for 16 h. Saturated aqueous NH4Cl (2 mL) was added, followed by 
Et2O (70 mL). The mixture was dried over Na2SO4, filtered through a plug of Celite, and 
concentrated. The resulting oil was distilled under vacuum (70 °C at 1.25 mmHg) to yield 
a colorless oil (2.00 g, 78%). 1H NMR (CDCl3, 400 MHz) δ 4.25-4.27 (m, 2H), 2.36-2.40 
(m, 1H), 1.78-1.81 (m, 2H), 1.65-1.72 (m, 2H), 1.51-1.58 (m, 2H), 1.37-1.45 (m, 2H), 
1.25-1.34 (m, 3H); 13C NMR (CDCl3, 100 MHz) δ 90.6, 78.1, 51.4, 32.6, 29.1, 25.8, 
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24.9; IR: 3327 (br), 2929, 2854, 1448, 1148, 1017, 986 cm–1; HRMS (DART-TOF) 
calcd. for C9H15O [M+H]
+:139.1123, found: 139.1125. 
 
 
(Z)-(3-chloroprop-1-enyl)cyclohexane (10% (E)-isomer).15 (Z)-3-cyclohexylprop-2-en-
1-ol (642 mg, 4.58 mmol) was dissolved in DMF (3 mL). Collidine (1.11 g, 9.16 mmol), 
lithium chloride (388 mg, 9.16 mmol), and methanesulfonyl chloride (461 μL, 5.95 
mmol) were added. After stirring for 12 h, the reaction was diluted with Et2O (100 mL), 
and washed with H2O, saturated aqueous NH4Cl, and brine (50 mL each). The organic 
layer was dried over MgSO4, filtered, and concentrated. Column chromatography (5% 
EtOAc/Hex) gave a colorless oil (591 mg, 81%). 1H NMR (CDCl3, 400 MHz) δ 5.44-
5.56 (m, 2H), 4.11 (dd, 2H, J = 7.0, 2.2), 2.28-2.38 (m, 1H), 1.62-1.76 (m, 5H), 1.05-1.36 
(m, 5H); 13C NMR (CDCl3, 101 MHz) δ 141.3, 123.2, 39.9, 36.3, 33.0, 25.8, 25.7; IR: 
2953, 2925, 2853, 2034, 1970, 1511, 1459, 1260, 1032, 798, 410 cm–1. 
 
 
(Z)-N-(3-cyclohexylallyl)-4-methoxyaniline (5% (E)-isomer), 2.15.22 K2CO3 (289 mg, 
7.56 mmol) and p-anisidine (1.16 g, 9.45 mmol) were diluted with DMF (8 mL), and (Z)- 
 
22Correa, A.; Tellitu, I.; Domínguez, E.; SanMartin, R.  J. Org. Chem.  2006, 71, 8316 – 8319. 
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(3-chloroprop-1-enyl)cyclohexane (502 mg, 3.15 mmol) was added.  The reaction was 
heated to 80 °C and stirred overnight. The reaction was cooled and filtered. Water (20 
mL) was added, and the mixture was separated. The aqueous layer was extracted with  
EtOAc (330 mL). The combined organic layers were washed with brine (30 mL), dried 
over Na2SO4, filtered, and concentrated. Column chromatography (10% EtOAc/Hex) 
yielded a yellow oil (508 mg, 66%). 1H NMR (CDCl3, 400 MHz) δ 6.79 (app dd, 2H, J = 
9.0, 2.4), 6.61 (app dd, 2H, J = 9.0, 2.4), 5.38-5.47 (m, 2H), 3.75 (s, 3H), 3.73 (d, 2H, J = 
5.1), 3.64 (d, 2H, J = 5.9), 3.36 (bs, 1H), 2.29-2.37 (m, 1H), 1.61-1.74 (m, 5H), 1.05-1.35 
(m, 5H); 13C NMR (CDCl3, 126 MHz) δ  152.2, 142.6, 138.9, 125.0, 114.9, 114.3, 55.8, 
42.3, 36.7, 33.3, 26.0, 25.8; IR: 2925, 2850, 1512, 1448, 1245, 1179, 1037, 821 cm–1; 
HRMS (DART-TOF) calcd. for C16H24NO [M+H]
+: 246.1858, found: 246.1860. 
 
 
(E)-N-(3-cyclohexylallyl)-4-methoxyaniline, 2.16.23 AuBr3 (91.7 mg, 0.210 mmol) was 
suspended in THF (2 mL), and p-anisidine (505 mg, 4.10 mmol) was added. The mixture 
was stirred under argon at room temperature for 5 min. Cyclohexylallene (298 μL, 2.05 
mmol) was added. After 4 h, the mixture was filtered through a silica plug and 
concentrated. Column chromatography (10% EtOAc/Hex) yielded a slightly yellow oil 
(189 mg, 38%). 1H NMR (CDCl3, 400 MHz) δ 6.79 (app dd, 2H, J = 9.0, 2.4), 6.60 (app  
dd, 2H, J = 9.0, 2.4), 5.66 (dd, 1H, J = 15.5, 6.5), 5.54 (dtd, 1H J = 15.5, 5.9, 1.0), 3.75 
23Nishina, N.; Yamamoto, Y. Tetrahedron 2009, 65, 1799-1808. 
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(s, 3H), 3.65 (dd, 2H, J = 5.9, 1.0), 3.42 (bs, 1H), 1.92-2.20 (m, 1H), 1.63-1.75 (m, 5H), 
1.03-1.32 (m, 5H); 13C NMR (CDCl3, 100 MHz) δ 152.1, 142.5, 139.1, 124.5, 114.8,  
114.3, 55.8, 47.2, 40.4, 32.9, 26.1, 26.0; IR: 2923, 2845, 1512, 1447, 1234, 1039, 971, 
818 cm–1; HRMS (DART-TOF) calcd. for C16H24NO [M+H]
+: 246.1858, found: 
246.1860. 
 
 
3-phenylprop-2-yn-1-ol.18 The same procedure as 3-cyclohexylprop-2-yn-1-ol was  
followed. The resulting oil was distilled under vacuum (93 °C at 1.25 mmHg) to yield a 
colorless oil (3.64 g, 99%). 1H NMR (CDCl3, 400 MHz) δ 7.42-7.47 (m, 2H), 7.29-7.35 
(m, 3H), 4.51 (d, 2H, J = 4.3), 1.69 (bs, 1H); 13C NMR (CDCl3, 100 MHz) δ 131.7, 
128.5, 128.3, 122.5, 87.1, 85.7, 51.7; IR: 3341, 3061, 2866, 1490, 1442, 1032, 953, 756, 
691, 524 cm–1; HRMS (DART-TOF) calcd. For C9H9O [M+H]
+: 133.0653, found: 
133.0652. 
 
 
(Z)-4-methoxy-N-(3-phenylallyl)aniline, 2.17.20 To p-anisidine (1.58 g, 12.8 mmol) in 
CH3CN (2 mL) was added (Z)-(3-chloroprop-1-enyl)benzene (501 mg, 3.28 mmol). The 
mixture was stirred overnight at room temperature. Saturated aqueous NH4Cl (15 mL) 
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was added, and the mixture was separated. The aqueous layer was extracted with Et2O 
(3×20 mL). The combined organic layers were washed with brine (20 mL), dried over 
MgSO4, filtered, and concentrated. Column chromatography (10% EtOAc/Hex) yielded a 
yellow oil (369 mg, 47%). 1H NMR (CDCl3, 400 MHz) δ 7.25-7.29 (m, 2H), 7.14-7.21 
(m, 3H), 6.68 (app d, 2H, J = 9.0), 6.49-6.56 (m, 1H), 6.47 (dd, 2H, J = 9.0, 2.4), 5.71 
(dt, 1H, J = 11.7, 6.5), 3.90 (dd, 2H, J = 6.5, 1.8), 3.64 (s, 3H), 3.46 (bs, 1H); 13C NMR 
(CDCl3, 100 MHz) δ 152.3, 142.1, 136.7, 131.3, 130.0, 128.8, 128.3, 127.1, 114.9, 114.4, 
55.8, 43.2; IR: 3388, 3022, 2931, 2832, 1512, 1446, 1237, 1074, 820, 700, 517 cm–1; 
HRMS (DART-TOF) calcd. for C16H18NO [M+H]
+: 240.1388, found: 240.1390. 
 
 
(Z)-4-(benzyloxy)but-2-en-1-ol.24  In a dry box, a flame-dried 250 mL round-bottom 
flask was charged with sodium hydride (467 mg, 19.5 mmol).  The flask was capped with 
a rubber septum and brought out of the dry box.  Dry THF (65 mL) was added via 
syringe, and the vessel was brought to 0 °C.  The commercially available (Z)-but-2-ene-
1,4-diol (1.64 mL, 20.0 mmol) was added dropwise to the stirring suspension, resulting in 
vigorous bubbling.  Once addition was complete, the reaction was allowed to warm to 
room temperature over the course of 30 min.  Benzyl bromide (16.2 mmol, 1.92 mL) was 
added to the flask via syringe, and the reaction was allowed to stir overnight.  The 
reaction was concentrated, and the crude residue was diluted with Et2O (150 mL).  The  
organic layer was washed with H2O (3×75 mL), dried over MgSO4, filtered, and 
24Schmidt, B.; Pohler, M.; Costisella, B. Tetrahedron 2002, 58, 7951-7958. 
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concentrated in vacuo.  The crude mixture was purified by silica gel chromatography 
(30% EtOAc/Hex) to yield a pale yellow oil (1.82 g, 48%).  1H NMR (CDCl3, 400 MHz) 
δ 7.29–7.36 (m 5H), 5.79-5.83 (m, 1H), 5.73-5.77 (m, 1H), 4.53 (s, 2H), 4.16-4.18 (m,  
2H), 4.09-4.10 (m, 2H), 1.92 (br s, 1H); 13C NMR (CDCl3, 100 MHz) δ 138.1, 132.5, 
128.7, 128.5, 128.1, 128.0, 72.7, 65.9, 59.0; IR: 3409, 1736, 1241, 1070, 1042, 736, 697 
cm-1; HRMS (DART-TOF) calcd. for C11H15O2 [M+H]
+: 179.1072, found: 179.1079. 
 
 
(Z)-(((4-chlorobut-2-en-1-yl)oxy)methyl)benzene.15  To a 25 mL, flame-dried, round-
bottom flask was added LiCl (374 mg, 8.82 mmol), 2,4,6-collidine (1.16 mL, 8.81 
mmol), and methanesulfonyl chloride (412 μL, 5.35 mmol). (Z)-4-(benzyloxy)but-2-en-1-
ol (786 mg, 4.11 mmol) was added to the flask dropwise as a solution in DMF (3.0 mL).  
The reaction was allowed to stir overnight.  The mixture was diluted with Et2O (100 mL), 
and the organics were washed with H2O (3×40 mL), saturated NH4Cl (3×40 mL), and 
brine (40 mL).  The combined organics were dried over MgSO4, filtered, and 
concentrated.  The crude mixture was purified by silica gel chromatography (10% 
EtOAc/Hex) to yield a pale orange oil (716 mg, 88%).  1H NMR (CDCl3, 500 MHz) δ 
7.30–7.37 (m, 5H), 5.82-5.83 (m, 2H), 4.55 (s, 2H), 4.15-4.16 (m, 2H), 4.11-4.12 (m, 
2H); 13C NMR (CDCl3, 125 MHz) δ 138.1, 131.0, 128.7, 128.6, 128.0, 127.9, 72.6, 65.3, 
39.4; IR: 2857, 1736, 1453, 1240, 1072, 736, 697 cm-1; HRMS (DART-TOF) calcd. for 
C11H17ClNO [M+NH4]
+: 214.0994, found: 214.0999.  
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(Z)-N-(4-(benzyloxy)but-2-en-1-yl)-4-methoxyaniline, 2.18.  To a 25 mL, flame-dried, 
round-bottom flask was added p-anisidine (2.54 g, 20.7 mmol).  The vessel was charged 
with (Z)-(((4-chlorobut-2-en-1-yl)oxy)methyl)benzene (1.04 g, 5.30 mmol) as a solution 
in DMF (6 mL).  The reaction was allowed to stir overnight.  The reaction was diluted 
with Et2O (150 mL), washed with H2O (3×50 mL) and saturated NH4Cl (3×50 mL), dried 
over MgSO4, filtered, and concentrated.  The crude mixture was purified by silica gel 
chromatography (15% EtOAc/Hex) to yield a dark orange oil (553 mg, 37%). 1H NMR 
(CDCl3, 500 MHz) δ 7.29-7.38 (m, 5H), 6.80 (d, 2H, J = 9.0), 6.59 (d, 2H, J = 8.8), 5.78-
5.80 (m, 2H), 4.56 (s, 2H), 4.16 (d, 2H, J = 5.1), 3.77 (s, 3H), 3.75 (d, 2H, J = 4.9); 13C 
NMR (CDCl3, 125 MHz) δ 152.6, 142.4, 138.3, 131.1, 128.9, 128.6, 128.0, 127.9, 115.1, 
114.6, 72.7, 65.9, 56.0, 42.5; IR: 1509, 1232, 1070, 1030, 817, 735, 697 cm-1; HRMS 
(DART-TOF) calcd. for C18H22N1O2 [M+H]
+: 284.1651, found: 284.1649. 
 
 
(Z)-4-(4-methoxyphenylamino)but-2-en-1-ol.25 1,4-but-2-enediol cyclic sulfite (1.50 g, 
11.2 mmol) was dissolved in DMF (6 mL). K2CO3 (3.72 g, 26.9 mmol) and p-anisidine 
(2.76 g, 22.4 mmol) were added. The reaction was heated to 100 °C for 48 h. The 
25Friedrich, M.; Savchenko, A. I.; Wachtler, A.; de Meijere, A.  Eur. J. Org. Chem.  2003, 11, 2138-2143. 
Chapter 2, Page 161 
 
reaction was cooled to room temperature, and H2O (30 mL) was added. The mixture was 
separated, and the aqueous layer was extracted with Et2O (325 mL). The combined 
organic layers were washed with H2O (25 mL), dried over MgSO4, filtered, and 
concentrated. Column chromatography (15% EtOAc/Hex) yielded a light yellow oil (1.02 
g, 47%). 1H NMR (CDCl3, 400 MHz) δ 6.79 (app dd, 2H, J = 9.0, 2.4), 6.61 (app dd, 2H, 
J = 9.0, 2.4), 5.68-5.82 (m, 2H), 4.26 (dd, 2H, J = 6.3, 1.2), 3.74-3.75 (m, 5H), 2.78 (bs, 
2H); 13C NMR (CDCl3, 101 MHz) δ 152.6, 141.9, 131.5, 129.5, 114.8, 58.7, 55.7, 42.3; 
IR: 3361, 2939, 2833, 1512, 1235, 1034, 821 cm–1; HRMS (DART-TOF) calcd. for 
C11H16NO2 [M+H]
+: 194.1181, found: 194.1181. 
 
 
(Z)-N-(4-(tert-butyldiphenylsilyloxy)but-2-enyl)-4-methoxyaniline, 2.19.26 To 
imidazole (222 mg, 3.30 mmol) and DMF (0.6 mL) in a round-bottom flask was added 
(Z)-4-(4-methoxyphenylamino)but-2-en-1-ol (421 mg, 2.17 mmol) dissolved in DMF 
(0.6 mL). After stirring for 10 minutes, tert-butyldiphenylchlorosilane (610 μL, 2.39 
mmol) was added in one portion. After stirring at room temperature for 45 min, H2O (20 
mL) was added. The mixture was separated, and the aqueous phase was extracted with 
Et2O (3×15 mL). The combined organic layers were washed with H2O (25 mL) and brine 
(25 mL). The resulting organic layer was dried over MgSO4, filtered, and concentrated. 
Column chromatography (7.5% EtOAc/Hex) yielded a yellow oil (587 mg, 63%). 1H  
26Havas, F.; Leygue, N.; Danel, M.; Mestre, B.; Galaup, C.; Picard, C. Tetrahedron 2009, 76, 7673-7686. 
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NMR (CDCl3, 400 MHz) δ 7.59-7.62 (m, 4H), 7.27-7.37 (m, 6H), 6.67 (app dd, 2H, J = 
9.0, 2.4), 6.41 (app dd, 2H, J = 9.0, 2.4), 5.65-5.70 (m, 1H), 5.45-5.51 (m, 1H), 4.23 (dt, 
2H, J = 6.3, 0.8), 3.65 (s, 3H), 3.45 (dt, 2H, J = 6.7, 0.8), 3.19 (bs, 1H), 0.97 (s, 9H); 13C 
NMR (CDCl3, 100 MHz) δ 152.3, 142.2, 135.6, 133.6, 131.4, 129.7, 128.4, 127.7, 114.8, 
114.3, 60.2, 55.8, 42.1, 26.8, 19.2; IR: 2931, 2857, 1513, 1428, 1236, 1074, 1040, 820, 
703, 505 cm–1; HRMS (DART-TOF) calcd. for C27H34NO2Si [M+H]
+: 432.2359 found: 
432.2345. 
 
 
(Z)-2-(4-chlorobut-2-en-1-yl)isoindoline-1,3-dione.27 To a flame-dried round-bottom 
flask was added potassium phthalamide (2.65 g, 14.3 mmol), followed by DMF (50 mL) 
under nitrogen.  The stirring suspension was charged with (Z)-1,4-dichlorobut-2-ene 
(3.06 mL, 29 mmol).  The mixture was allowed to stir at room temperature overnight.  
The reaction was diluted with EtOAc (200 mL) and extracted with H2O (6×75 mL).  The 
combined organics were dried over anhydrous MgSO4, filtered, and concentrated by 
rotary evaporation.  The crude material was purified by silica gel chromatography (20% 
EtOAc/Hex) to afford the product as a colorless solid (929 mg, 28%).  1H NMR (CDCl3, 
500 MHz) δ 7.86 (dd, 2H, J = 5.4, 2.9), 7.73 (dd, 2H, J = 5.4, 3.2), 5.83-5.89 (m, 1H), 
5.69-5.75 (m, 1H), 4.38 (dd, 2H, J = 7.3, 1.2), 4.32 (d, 2H, J = 7.8) 13C NMR (CDCl3,  
125 MHz) δ 168.0, 134.3, 132.3, 130.1, 127.4, 123.6, 38.8, 34.3; IR: 1699, 1429, 1242, 
27Newman, A.; Grundt, P.; Luedtke, R. R. US Patent 2006106030, 2006. 
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1120, 1065, 764, 711, 530 cm-1; HRMS (DART-TOF) calcd. for C12H11ClNO2 [M+H]
+: 
236.0478, found: 236.0485. 
 
 
(Z)-2-(4-((4-methoxyphenyl)amino)but-2-en-1-yl)isoindoline-1,3-dione, 2.20.20  p-
Anisidine (3.12 g, 25.4 mmol) was added to a flame-dried, 25 mL, round-bottom flask.  
The flask was charged with (Z)-2-(4-chlorobut-2-en-1-yl)isoindoline-1,3-dione (854 mg, 
3.62 mmol) as a solution in CH3CN (9.1 mL).  The reaction mixture was allowed to stir at 
room temperature overnight.  The reaction was diluted with Et2O (100 mL), and washed 
successively with H2O (350 mL) and saturated NH4Cl (3×50 mL).  The combined 
organics were dried over anhydrous MgSO4, filtered, and concentrated by rotary 
evaporation.  The crude mixture was purified by silica gel chromatography (30% 
EtOAc/Hex) to yield the title compound as a yellow solid (761 mg, 65%). 1H NMR 
(CDCl3, 500 MHz) δ 7.85 (dd, 2H, J = 6.9, 3.9), 7.72 (dd, 2H, J = 6.9, 3.7), 6.80 (d, 2H, J 
= 11.2), 6.68 (d, 2H, J = 11.5), 5.79-5.81 (m, 1H), 5.59-5.61 (m, 1H), 4.39 (d, 2H, J = 
9.1, 1.5), 3.95 (d, 2H, J = 8.3), 3.75 (s, 3H); 13C NMR (CDCl3, 125 MHz) δ 168.2, 152.6, 
142.5, 134.2, 132.4, 131.9, 125.8, 123.5, 115.1, 114.8, 56.0, 42.0, 35.1; IR: 1705, 1511, 
1390, 1322, 1234, 821, 715 cm-1; HRMS (DART-TOF) calcd. for C19H19N2O3 [M+H]
+: 
323.1396, found: 323.1394. 
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(Z)-ethyl-7-chlorohept-5-enoate.15 To a 25 mL, flame-dried, round-bottom flask was 
added LiCl (499 mg, 11.0), 2,4,6-collidine (1.45 mL, 11.0 mmol), and methanesulfonyl 
chloride (552 μL, 7.18 mmol). (Z)-4-(benzyloxy)but-2-en-1-ol (951 mg, 5.52 mmol) was 
added to the flask dropwise as a solution in DMF (3.0 mL).  The reaction was allowed to 
stir overnight.  The mixture was diluted with Et2O (100 mL), and the organics were 
washed with water (3×40 mL), saturated NH4Cl (3×40 mL), and brine (40 mL).  The 
combined organics were dried over MgSO4, filtered, and concentrated.  The crude 
mixture was purified by silica gel chromatography (3:1 Hex: EtOAc) to afford a pale 
orange oil (816 mg, 78%).  1H NMR (CDCl3, 400 MHz) δ 5.52-5.63 (m, 2H), 4.12 (q, 
2H, J = 7.4), 4.07 (d, 2H, J = 7.2), 2.25 (t, 2H, J = 7.4), 2.08-2.14 (m, 2H), 1.65-1.70 (m, 
2H), 1.17-1.21 (m, 3H); 13C NMR (CDCl3, 125 MHz) δ 173.6, 135.3, 126.5, 60.5, 39.4, 
33.7, 26.6, 24.6, 14.4; IR: 2980, 1732, 1375, 1249, 1180, 758, 730 cm-1; HRMS (DART-
TOF) calcd. for C9H16ClO2 [M+H]
+: 191.0839, found: 191.0835. 
 
 
(Z)-ethyl 7-((4-methoxyphenyl)amino)hept-5-enoate, 2.21.20  A flame-dried, 25 mL, 
round-bottom flask was charged with p-anisidine (3.68 g, 29.9 mmol). (Z)-ethyl 7-
chlorohept-5-enoate (816 mg, 4.28 mmol) was added to the reaction flask as a solution in 
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CH3CN (9.0 mL).  The reaction was allowed to stir at room temperature overnight.  The 
reaction was diluted with Et2O (150 mL) and washed with H2O (3×50 mL) and saturated 
aqueous NH4Cl (3×50 mL).  The combined organics were dried over anhydrous MgSO4, 
filtered, and concentrated.  The crude material was purified by silica gel chromatography 
(20% EtOAc/Hex) to afford an orange oil (684 mg, 57%).  1H NMR (CDCl3, 500 MHz) 
δ 6.77-6.79 (m, 2H), 6.58-6.60 (m, 2H), 5.49-5.61 (m, 2H), 4.13 (q, 2H, J = 7.1), 3.74 (s, 
3H), 3.70 (dd, 2H, J = 6.4), 2.32 (t, 2H, J = 7.3), 2.17 (app q, 2H, J = 7.3), 1.72-1.75 (m, 
2H), 1.25 (t, 3H, J = 7.1); 13C NMR (CDCl3, 125 MHz) δ 173.7, 152.4, 142.7, 131.8, 
128.4, 115.1, 114.6, 60.5, 56.0, 42.4, 33.9, 27.1, 24.9, 14.5; IR: 2936, 1727, 1511, 1234, 
1035, 820 cm-1; HRMS (DART-TOF) calcd. for C16H24NO3 [M+H]
+: 278.1756, found: 
278.1749. 
 
 
N-allyl-4-methoxyaniline, 2.22.22 Allyl chloride (5.29 mL, 65.0 mmol) was added 
dropwise to a flame-dried 500 mL round-bottom flask containing a solution of 4-
methoxyaniline (8.00 g, 65.0 mmol) and potassium carbonate (21.5 g, 156 mmol) in 
DMF (148 mL).  The solution was heated to 80 °C and was stirred at this temperature 
overnight.  The reaction was cooled to room temperature, filtered, and diluted with 
EtOAc (300 mL).    The organic layer was washed with water (4×100 mL), dried over 
anhydrous MgSO4, filtered, and concentrated in vacuo.  The crude product was purified 
by silica gel chromatography (5% EtOAc/Hex) to afford an orange oil (7.76 g, 73%). 1H 
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NMR (CDCl3, 400 MHz) δ 6.82 (d, 2H, J = 8.8), 6.62 (d, 2H, J = 8.8), 5.94-6.04 (m, 
1H), 5.31 (dd, 1H, J = 17.2, 1.6), 5.19 (dd, 1H, J = 10.4, 1.6), 3.77 (s, 3H), 3.75 (app. dt, 
2H, J = 5.6, 1.6), 3.57 (br. s, 1H); 13C NMR (CDCl3, 100 MHz) δ 152.3, 142.5, 136.0, 
116.2, 115.0, 114.4, 55.9, 47.6; IR: 3396, 1509, 1230, 1178, 1035, 916, 816 cm-1; HRMS 
(DART-TOF) calcd. for C12H14NO [M+H]
+: 164.1075, found: 164.1077. 
 
Equilibrium Experiment (Scheme 2.7) 
 
  
 In a glove box, a solution of iPrOH (91 L, 1.2 mmol) in C6D6 (1.67 M) was 
made.  The solution was dispensed into three NMR tubes (see table below for amounts).  
A second solution of (Z)-N-(but-2-enyl)-4-methoxyaniline, 2.8, (71 mg, 0.40 mmol), I 
(19 mg, 6.9 x 10-2 mmol), and p-TsOH (350 L, 5.0  10-4 M in C6H6; note C6H6 was 
removed prior to mixing with substrate and I) in C6D6 (1.4 mL) was made. The solution 
was dispensed into three NMR tubes (see table below for amounts).  An additional 
amount of C6D6 was added to each tube to make the total volume 0.7 mL.  
31P NMR were 
taken immediately, and the NMR tubes were heated to 45 C.  Spectra were acquired at 
45 min intervals until equilibrium was reached.  All three samples reached equilibrium 
within 2 h (average Keq = 3.8 with standard deviation = 0.5). 
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Table 2.8 
 
Experiment 
Isopropanol 
Solution 
mmol 
isopropanol 
Substrate 
Solution 
mmol 
substrate 
Ratio 
I:2.8 
Keq 
A 60 L 0.10 400 L 0.11 26:74 3.4 
B 150 L 0.25 400 L 0.11 45:55 3.3 
C 300 L 0.50 400 L 0.11 53:47 4.5 
    
Optimization Data 
General Hydroformylation Optimization Procedure. The Endeavor was charged with 
500 µL of benzene per reaction well to fill the void volume between reactor wall and 
reaction tube, and oven-dried glass reaction vials were placed into the wells. The 
Endeavor was sealed and purged with nitrogen (4×100 psi). The necessary injection(s) 
were made (see below). The Endeavor was purged with nitrogen (1×100 psi), stirring was 
started at 250 rpm, and the Endeavor was heated to and held at the reaction temperature 
for 10 minutes. Stirring was stopped, the Endeavor was charged with the appropriate 
pressure of H2/CO, stirring was re-initiated at 700 rpm, and the Endeavor was maintained 
at constant reaction temperature and pressure of H2/CO for 15 h. The Endeavor was 
vented to ambient pressure and cooled to ambient temperature. The reaction vials were 
removed from the Endeavor, a solution of trimethoxybenzene in EtOAc (1.00 x 102 µL, 
0.2003 M) was added, and the sample was concentrated. The resulting residue was 
dissolved in MeOH (2 mL) and added to NaBH4 (22.7 mg, 0.600 mmol) in a flame-dried 
flask. The reaction was stirred for 1.5 h. H2O (3 mL) was added, and the layers were 
separated. The organic layer was extracted with EtOAc (3×10 mL), dried over NaSO4, 
filtered, and concentrated.  1H NMRs were taken to determine conversion. The reaction 
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was chromatographed (1% MeOH/CH2Cl2) to determine isolated yield. SFC or HPLC 
analysis of the products was used to determine enantioselectivities. 
Pressure Screen with I (Table 2.1) 
(Z)-N-(but-2-enyl)-4-methoxyaniline, 2.8, (35 mg, 0.20 mmol) and I (7.7 mg, 3.0 x 10-2 
mmol) were mixed in C6D6 (0.6 mL) and heated to 45 °C for 12 h in a sealed NMR tube. 
The solution was concentrated in a dry glove box to remove MeOH in the solution. 
During this pre-exchange, I converts to 2.9. The resulting residue was dissolved in 
benzene (1.5 mL), mixed with 2 mol % Rh(acac)(CO)2 (1.1 mg, 4.0 x 10
-3 mmol), and 
injected into the Endeavor followed by 0.5 mL benzene to wash the injection port. The 
reactions were run at 45 °C at the following pressures: 25, 50, 75 and 100 psi H2/CO. 
Catalyst Loading Screen with I (Table 2.2) 
(Z)-N-(but-2-enyl)-4-methoxyaniline, 2.8, (35 mg, 0.20 mmol) and I were mixed in C6D6 
(0.6 mL) and heated to 45 °C for 12 h in a sealed NMR tube. The solution was 
concentrated in a dry glove box to remove MeOH in the solution. During this pre-
exchange, I converts to 2.9. The resulting residue was dissolved in benzene (1.5 mL), 
mixed with 2 mol % Rh(acac)(CO)2 (1.1 mg, 4.0 x 10
-3 mmol), and injected into the 
Endeavor followed by 0.5 mL benzene to wash the injection port. The reactions were run 
at 45 °C and 50 psi H2/CO with the following ligand loadings: 5% (2.6 mg, 1.0 x 10
-2 
mmol), 10% (5.1 mg, 2.0 x 10-2 mmol), 15% (7.7 mg, 3.0 x 10-2 mmol). 
Acid Loading Screen (Table 2.3) 
(E)-N-(but-2-enyl)-4-methoxyaniline, 2.12, (35 mg, 0.20 mmol), I (5.1 mg, 2.0 x 10-2 
mmol), and the appropriate amount of p-toluenesulfonic acid in benzene (7.7 x 10-4 M 
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solution) were mixed in C6D6 (0.6 mL) and heated to 45 °C for 12 h in a sealed NMR 
tube. The solution was concentrated in a dry glove box to remove MeOH in the solution. 
During this pre-exchange, I converts to 2.9. The resulting residue was dissolved in 
benzene (1.5 mL), mixed with 2 mol % Rh(acac)(CO)2 (1.1 mg, 4.0 x 10
-3 mmol), and 
injected into the Endeavor followed by 0.5 mL benzene to wash the injection port. The 
reactions were run at 45 °C and 50 psi with the following acid loadings: 0.02% (52 μL, 
4.0 x 10-5 mmol), 0.05% (130 μL, 1.0 x 10-4 mmol), 0.1% (260 μL, 2.0 x 10-4 mmol), and 
0.2% (520 μL, 4.0 x 10-4 mmol).  
Temperature Screen with II (Table 2.4) 
(Z)-N-(but-2-enyl)-4-methoxyaniline, 2.8, (35.0 mg, 0.20 mmol), II-OMe (6.5 mg, 2.0 x 
10-2 mmol), and p-toluenesulfonic acid in benzene (130 μL, 1.0 x 10-4 mmol, 7.7 x 10-4 M 
solution) were mixed in C6D6 (0.6 mL) and heated to 45 °C for 12 h in a sealed NMR 
tube. The solution was concentrated in a dry glove box to remove MeOH in the solution 
and redissolved in C6D6. The solution was heated to 45 °C for 4 h before being 
concentrated again in a glove box. During this pre-exchange, the four diastereomers of 
II-OMe converge to one substrate-bound ligand peak. The resulting residue was 
dissolved in benzene (1.5 mL), mixed with 2 mol % Rh(acac)(CO)2 (1.1 mg, 4.0 x 10
-3 
mmol), and injected into the Endeavor followed by 0.5 mL benzene to wash the injection 
port. The reactions were run with 50 psi H2/CO at the following temperatures: 30, 35, 45, 
and 55 °C. 
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Increasing the Reaction Time (Scheme 2.8) 
The procedure for Table 2.4 was followed running substrate 2.8 (0.4 mmol) at 35 °C for 
24 hours. 
Increasing the Amount of II (Scheme 2.9) 
The procedure for Table 2.4 was followed running substrate 2.8 (0.4 mmol) at 35 °C with 
15 mol % I (21 mg, 0.06 mmol).  
Reaction of 4-methoxy-N-(3-methylbut-2-en-1-yl)aniline (Scheme 2.10) 
4-methoxy-N-(3-methylbut-2-en-1-yl)aniline (38 mg, 0.20 mmol) and I (5.7 mg, 2.0 x 10-
2 mmol) were mixed in C6D6 (0.6 mL) and heated to 45 °C for 12 h in a sealed NMR 
tube. The solution was concentrated in a dry glove box to remove MeOH in the solution. 
During this pre-exchange, I converts to 2.9. The resulting residue was dissolved in 
benzene (1.5 mL), mixed with 2 mol % Rh(acac)(CO)2 (1.1 mg, 4.0 x 10
-3 mmol), and 
injected into the Endeavor followed by 0.5 mL benzene to wash the injection port. 
Substrate Scope (Table 2.5) 
General Hydroformylation Procedure. The Endeavor was charged with 500 µL of 
benzene per reaction well to fill the void volume between reactor wall and reaction tube, 
and oven-dried glass reaction vials were placed into the wells. The Endeavor was sealed 
and purged with nitrogen (4×100 psi). The necessary injection(s) were made (see below). 
The Endeavor was purged with nitrogen (1×100 psi), stirring was started at 250 rpm, and 
the Endeavor was heated to and held at 35 ˚C for 10 minutes. Stirring was stopped, the 
Endeavor was charged with 50 psi H2/CO, stirring was re-initiated at 700 rpm, and the 
Endeavor was maintained at constant reaction temperature of 35 C and pressure of 50 
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psi H2/CO for 15 h. The Endeavor was vented to ambient pressure and cooled to ambient 
temperature. The reaction vials were removed from the Endeavor, a solution of 
trimethoxybenzene in EtOAc (1.00 x 102 µL, 0.2003 M) was added, and the sample was 
concentrated. The resulting residue was dissolved in MeOH (2 mL) and added to NaBH4 
(22.7 mg, 0.600 mmol) in a flame-dried flask. The reaction was stirred for 1.5 h. H2O (3 
mL) was added, and the layers were separated. The organic layer was extracted with 
EtOAc (3×10 mL), dried over NaSO4, filtered, and concentrated.  
1H NMRs were taken 
to determine conversion. The reaction was chromatographed (1% MeOH/CH2Cl2) to 
determine isolated yield. SFC or HPLC analysis of the products was used to determine 
enantioselectivities. 
Procedure A: (Z)-N-(but-2-enyl)-4-methoxyaniline, 2.8, (35 mg, 0.20 mmol), II-OMe 
(9.8 mg, 3.0 x 10-2 mmol), and p-toluenesulfonic acid in benzene (130 μL, 1.0 x 10-4 
mmol, 7.70 x 10-4 M solution) were mixed in C6D6 (0.6 mL) and heated to 45 °C for 12 h 
in a sealed NMR tube. The solution was concentrated in a dry glove box to remove 
MeOH in the solution and redissolved in C6D6. The solution was heated to 45 °C for 4 h 
before being concentrated again in a glove box. During this pre-exchange, the four 
diastereomers of II-OMe converge to one substrate-bound ligand peak. The resulting 
residue was dissolved in benzene (1.5 mL), mixed with 2 mol % Rh(acac)(CO)2 (1.1 mg, 
4.0 x 10-3 mmol), and injected into the Endeavor followed by 0.5 mL benzene to wash the 
injection port. 
Procedure B: The same procedure as Procedure A using 1.75 mol % Rh(acac)(CO)2 
(0.90 mg, 3.5 x 10-3 mmol) and 0.03% p-TsOH (83 μL, 6.0 × 10
-5 mmol). 
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Procedure C: The procedure is the same as Procedure A using 1.5 mol % Rh(acac)(CO)2 
(0.77 mg, 3.0 x 10-3 mmol).  
Procedure D.  Same as procedure A except 1.75 mol % Rh(acac)(CO)2 (0.90 mg, 3.5 x 
10-3 mmol) was used. 
Scale-up Procedure.  (Z)-N-(but-2-enyl)-4-methoxyaniline, 2.8, (502 mg, 2.83 mmol), 
II-OMe (138 mg, 0.425 mmol), and p-toluenesulfonic acid in benzene (1.84 mL, 1.42 x 
10-3 mmol, 7.7 x 10-4 M solution) were mixed in C6D6 (9.4 mL) and heated to 45 °C for 3 
h in a sealed tube. The solution was concentrated in a dry glove box to remove MeOH in 
the solution. During this pre-exchange, the four diastereomers of II-OMe converge to 
one substrate-bound ligand peak. The resulting residue was dissolved in benzene (21.3 
mL), mixed with 2 mol % Rh(acac)(CO)2 (14.6 mg, 5.60 x 10
-2 mmol), and 3 mL of the 
solution was injected into seven Endeavor wells followed by 1.0 mL benzene to wash 
each injection port.  
Hydroformylation Regioselectivities 
 Under the reaction conditions, the undesired normal products probably cyclize to 
a p-methoxyphenyl protected aminal which could not be detected in crude NMRs or 
isolated. Trying to make and isolate this product through other methods also failed. The 
amount of undesired regioisomer was estimated by two calculations: the difference 
between conversion and yield of iso product by 1H NMR (Table 2.9, Column 6) and the 
difference between conversion and isolated yield (Table 2.9, Column 7). The selectivities 
are generally greater than 4:1.  These numbers probably underestimate the actual 
regioselectitives because it does not account for side reactions or decomposition of the 
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aldehyde during hydroformylation.  Notably, previous work in our group in the 
hydroformylation of allylic alcohols and sulfonamides afford regioselectivites 
of >95:5.5a,d  As mentioned previously, the lower regioselectivity for the phthalimide 
protected substrate may result from directed hydroformylation from the phthalimide 
functional group. Similarly the terminal substrate may have a lower regioselectivity due 
to background reaction that prefers the normal isomer.        
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Table 2.9 
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Hydroformylation Results and Product Characterization 
Table 2.5, Entry 1:  
 
 
(S)-2-((4-methoxyphenylamino)methyl)butan-1-ol, 2.10. Procedure A was followed. 
Chromatography (1% MeOH/CH2Cl2) yielded a pale yellow oil (27 mg, 69%). SFC (OD-
H, 4.0 mL/min, 3.0% MeOH, 220 nm, 150 bar, 35 C) trmajor =17.80 min and trminor
 
=19.16 min, 92% ee; 1H NMR (CDCl3, 400 MHz) δ 6.78-6.82 (m, 2H), 6.66-6.70 (m, 
2H), 3.80 (dd, 1H, J = 10.8, 3.9), 3.75 (s, 3H), 3.63-3.68 (m, 1H), 3.30 (bs, 1H), 3.20-
3.24 (m, 1H), 3.12 (dd, 1H, J = 12.1, 8.4), 1.77-1.82 (m, 1H), 1.39 (q, 2H, J = 7.2), 0.96-
1.00 (m, 3H); 13C NMR (CDCl3, 100 MHz) δ 152.6, 142.4, 115.1, 114.8, 66.1, 55.8, 
48.9, 41.8, 22.3, 11.6; IR: 3379, 2961, 2925, 1513, 1464, 1236, 1038, 822 cm-1; HRMS 
(DART-TOF) calcd. for C12H20NO2 [M+H]
+: 210.1494, found: 210.1498. []D
20 = +8.7 
(c = 0.240, CHCl3, l = 50 mm). 
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Table 2.5, Entry 2:  
 
 
(S)-2-((4-methoxyphenylamino)methyl)butan-1-ol. Procedure A was followed. 
Chromatography (1% MeOH/CH2Cl2) yielded a pale yellow oil (28 mg, 74%). SFC (OD-
H, 4.0 mL/min, 3.0% MeOH, 220 nm, 150 bar, 35 ˚C) 80% ee. 
 
Table 2.5, Entry 3: 
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(S)-3-cyclohexyl-2-((4-methoxyphenylamino)methyl)propan-1-ol. Procedure A was 
followed. Chromatography (1% MeOH/CH2Cl2) yielded a pale yellow oil (42 mg, 75%). 
SFC (OD-H, 1.0 mL/min, 6.0% MeOH, 220 nm, 150 bar, 50 ˚C) trminor =11.27 min and 
trmajor
 =12.10 min, 86% ee; 1H NMR (CDCl3, 500 MHz) δ 6.80 (dd, 2H, J = 6.6, 2.5), 
6.64-6.67 (m, 2H), 3.77-3.79 (m, 1H), 3.75 (s, 3H), 3.61 (dd, 1H, J = 10.8, 7.3), 3.19 (dd, 
1H, J = 12.0, 3.9), 3.06 (dd, 1H, J = 12.0, 8.6), 1.93-2.20 (m, 1H), 1.64-1.75 (m, 5H), 
1.28-1.35 (m, 1H), 1.11-1.28 (m, 5H), 0.84-0.93 (m, 2H); 13C NMR (CDCl3, 100 MHz) δ 
152.7, 142.5, 115.2, 114.9, 67.1, 55.8, 49.9, 37.3, 37.1, 35.1, 33.7, 33.6, 26.6, 26.3, 26.3; 
IR: 3376, 2921, 2849, 1512, 1448, 1235, 1037, 819 cm-1; HRMS (DART-TOF) calcd. 
for C17H28NO2 [M+H]
+: 278.2120, found: 278.2117. []D
20 = +4.3 (c = 0.140, CHCl3, l = 
50 mm). 
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Table 2.5, Entry 4: 
 
 
 (S)-3-cyclohexyl-2-((4-methoxyphenylamino)methyl)propan-1-ol. Procedure A was 
followed. Chromatography (1% MeOH/CH2Cl2) yielded a pale yellow oil (34 mg, 62%). 
SFC (OD-H, 1.0 mL/min, 6.0% MeOH, 220 nm, 150 bar, 50 ˚C) 76 % ee.  
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Table 2.5, Entry 5: 
 
 
(S)-2-benzyl-3-(4-methoxyphenylamino)propan-1-ol. Procedure A was followed. 
Column chromatography (1% MeOH/CH2Cl2) yielded a pale yellow solid (24 mg, 45%). 
SFC (OD-H, 1.0 mL/min, 5.0% MeOH, 220 nm, 150 bar, 50 ˚C) trmajor= 20.83 min, 
trminor= 24.87 min, 79% ee; 
1H NMR (CDCl3, 400 MHz) δ 7.10-7.28 (m, 5H), 6.69 (d, 
2H, J = 8.8), 6.49 (d, 2H, J = 8.8), 3.70 (dd, 1H, J = 3.9, 10.8), 3.67 (s, 3H), 3.58 (dd, 1H, 
J = 6.5, 10.8), 3.05-3.15 (m, 2H), 2.70-3.05 (br s, 2H), 2.50-2.70 (m, 2H), 2.05-2.15 (m, 
1H) ; 13C NMR (CDCl3, 100 MHz) δ 152.8, 141.8, 139.7, 129.0, 128.5, 126.2, 115.3, 
114.8, 65.6, 55.8, 48.6, 41.9, 36.1; IR: 3373, 2926, 1510, 1454, 1235, 1033, 820, 743, 
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701, 521 cm-1; HRMS (DART-TOF) calcd. for C17H22NO2 [M+H]
+: 272.1651, found: 
272.1641. []D
20 = +50.0 (c = 0.108, CHCl3, l = 50 mm). 
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Table 2.5, Entry 6: 
 
 
(S)-4-(benzyloxy)-2-(((4-methoxyphenyl)amino)methyl)butan-1-ol. Procedure B was 
followed and yielded a light yellow oil (44 mg, 70%). SFC (AS-H, 2.0 mL/min, 3.0% 
MeOH, 240 nm, 150 bar, 50 °C) trminor =6.53 min and trmajor
 =6.96 min, 92% ee; 1H NMR 
(CDCl3, 500 MHz) δ 7.30-7.37 (m, 5H), 6.76 (d, 2H, J = 9.0), 6.59 (d, 2H, J = 9.0), 4.59 
(s, 2H), 3.74 (s, 3H), 3.68-3.70 (m, 2H), 3.55-3.62 (m, 2H), 3.13 (d, 2H, J = 6.5), 1.99-
2.03 (m, 1H), 1.71-1.75 (m, 2H); 13C NMR (CDCl3, 125 MHz) δ 152.6, 142.5, 138.1, 
128.7, 128.0, 128.0, 115.1, 114.9, 73.5, 68.7, 65.7, 56.0, 48.5, 38.8, 30.3; IR: 3362, 1511, 
1032, 820, 699 cm-1; HRMS (DART-TOF) calcd. for C19H26NO3 [M+H]
+: 316.1919, 
found: 316.1913. []D
20 = +18.0 (c = 0.205, CHCl3, l = 50 mm). 
MeO
N
H
OBn
OH
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Table 2.5, Entry 7: 
 
 
(S)-4-(tert-butyldiphenylsilyloxy)-2-((4-methoxyphenylamino)methyl)butan-1-ol. 
Procedure C was followed. Chromatography (1% MeOH/CH2Cl2) yielded a pale yellow 
oil (62 mg, 67%). HPLC (OD-H, 1.0 mL/min, 5.0% iPrOH: 95% Hexanes, 240 nm) 
trminor = 15.3 min and trmajor = 21.5, 90% ee; 
1H NMR (CDCl3, 400 MHz) δ 7.67 (dd, 4H, 
J = 8.1, 1.5), 7.37-7.46 (m, 6H), 6.77-6.78 (m, 2H), 6.61 (dd, 2H, J = 6.9, 2.2), 3.76-3.81 
(m, 2H), 3.75 (s, 3H), 3.67-3.72 (m, 2H), 3.13 (d, 2H, J = 6.4), 2.03-2.10 (m, 1H), 1.64 
(q, 2H, J = 6.1), 1.07 (s, 9H); 13C NMR (CDCl3, 100 MHz) δ 152.4, 142.4, 135.5, 133.4, 
129.8, 127.7, 114.9, 114.7, 65.8, 62.2, 55.8, 48.4, 38.0, 32.7, 26.8, 19.1; IR: 3352, 2932, 
1513, 1236, 1110, 822, 703, 613, 509 cm-1; HRMS (DART-TOF) calcd. for 
C28H38NO3Si [M+H]
+: 464.2621, found: 464.2622. []D
20 = +12.3 (c = 0.140, CHCl3, l = 
50 mm). 
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Table 2.5, Entry 8: 
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(S)-2-(4-hydroxy-3-((4-methoxyphenylamino)methyl)butyl)isoindoline-1,3-dione. 
Procedure C was followed except only 1 equivalent of NaBH4 was used in reduction to 
prevent reduction of the phthalimide protecting group. Column chromatography resulted 
in a pale yellow solid (39 mg, 55%). HPLC (AS-H, 1.0 mL/min, 10.0% iPrOH: 90% 
Hexanes, 240 nm) trmajor = 89.6 and trminor = 142.3 min, 93% ee; 
1H NMR (CDCl3, 500 
MHz) δ 7.82 (dd, 2H, J = 5.4, 3.1), 7.70 (dd, 2H, J = 5.5, 3.1), 6.73 (d, 2H, J = 8.8), 6.61 
(d, 2H, J = 8.8), 3.76-3.81 (m, 2H), 3.74 (d, 2H, J = 6.1), 3.71 (s, 3H), 3.19 (d, 2H, J = 
6.1), 1.86-1.88 (m, 1H), 1.74-1.78 (m, 2H); 13C NMR (CDCl3, 125 MHz) 168.7, 152.7, 
142.4, 134.2, 132.2, 123.4, 115.1, 115.0, 65.5, 55.9, 48.4, 37.9, 36.2, 28.7; IR : 3378, 
2927, 1703, 1512, 1398, 1234, 1037, 720 cm-1; HRMS (DART-TOF) calcd. for 
C20H23N2O4 [M+H]
+: 355.1658, found: 355.1646. []D
20 = +24.0 (c = 0.105, CHCl3, l = 
50 mm). 
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Table 2.5, Entry 9: 
 
 
(S)-ethyl 7-hydroxy-6-((4-methoxyphenylamino)methyl)heptanoate. Procedure A was 
followed. Column chromatography gave a pale yellow oil (42 mg, 68%). SFC (AS-H, 1.0 
mL/min, 3.0% MeOH, 240 nm, 150 bar, 50 °C) trminor =8.25 min and trmajor
 =8.95 min, 
90% ee; 1H NMR (CDCl3, 500 MHz) δ 6.78-6.80 (m, 2H), 6.65-6.67 (m, 2H), 4.12 (q, 
2H, J = 7.2), 3.75 (s, 3H), 3.62-3.78 (m, 2H), 3.10-3.18 (m, 2H), 2.31 (t, 2H, J = 7.4), 
1.82-1.92 (m, 1H), 1.61-1.66 (m, 2H), 1.33-1.42 (m, 4H), 1.25 (t, 3H, J = 7.0); 13C NMR 
(CDCl3, 125 MHz) δ 173.8, 153.0, 142.2, 115.5, 115.0, 66.4, 60.5, 56.0, 49.5, 40.1, 34.3, 
29.3, 26.8, 25.3, 14.4; IR: 3362, 2933, 1731, 1513, 1251, 1034 cm-1; HRMS (DART-
TOF) calcd. for C17H28NO4 [M+H]
+: 310.2018, found: 310.2021. []D
20 =  +18.0 (c = 
0.110, CHCl3, l = 50 mm). 
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Table 2.5, Entry 10: 
 
 
(S)-3-(4-methoxyphenylamino)-2-methylpropan-1-ol.  Procedure C was followed. 
Column chromatography gave a pale yellow oil (25 mg, 64%). SFC (OD-H, 4.0 mL/min, 
3.0% MeOH, 220 nm, 150 bar, 50 °C) trmajor =17.55 min and trminor
 =19.94 min, 73% ee; 
1H NMR (CDCl3, 400 MHz) δ 6.78 (d, 2H, J = 9.0), 6.63 (d, 2H, J = 8.8), 3.75 (d, 3H), 
3.67 (dd, 1H, J = 10.8, 4.7), 3.59 (dd, 1H, J = 10.6, 7.2), 3.08-3.10 (m, 2H), 1.94-2.07 (m, 
1H), 0.96 (d, 3H, J = 6.8); 13C NMR (CDCl3, 100 MHz) δ 152.7, 142.6, 115.1, 115.1, 
68.2, 56.0, 50.7, 35.5, 15.2; IR: 3365, 2929, 1512, 1234, 1034, 819 cm-1; HRMS 
(DART-TOF) calcd. for C11H18NO2 [M+H]
+: 196.1338, found: 196.1340. []D
20 =  +2.2 
(c = 0.110, CHCl3, l = 50 mm). 
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Proof of Stereochemistry 
 
 
 
(S)-β-Cyclohexylmethyl-γ-Boc-amino alcohol.11,27 To (S)-3-cyclohexyl-2-((4-
methoxyphenylamino)methyl)propan-1-ol (136 mg, 0.490 mmol, 86% ee) in 1:1 
MeOH/CH2Cl2 (7 mL) at 0 C was added iodobenzene diacetate (632 mg, 1.96 mmol) in 
MeOH (7 mL). After stirring at 0 C for 30 min, 1 M HCl (7 mL) was added, and the 
mixture was stirred for 1 h. The reaction was diluted with CH2Cl2 (20 mL), and the layers 
were separated. The aqueous layer was washed with CH2Cl2 (3×20 mL), and the 
combined organics were washed with 1M HCl (20 mL). The combined aqueous layers 
were neutralized by adding solid Na2CO3 until pH 10 was reached. CH2Cl2 (20 mL) and 
di-tert-butyl dicarbonate (0.450 mL, 1.96 mmol) were added, and the mixture was stirred 
vigorously overnight. The layers were separated, and the aqueous layer was washed with 
CH2Cl2 (3×20 mL). The combined organic layers were washed with brine (20 mL), dried 
over Na2SO4, filtered, and concentrated. Column chromatography (20-40% EtOAc/Hex) 
yielded a yellow oil (8.8 mg, 7%). []D
20 = +10.5 (c = 0.440, CHCl3, l = 50 mm). Known 
compound: (S) []D
rt = +23.0 (c = 0.50, CHCl3).
27 
 
 
27Chi, Y.; English, E. P.; Pomerantz, W. C.; Horne, W. S.; Joyce, L. A.; Alexander, L. R.; Fleming, W. S.; 
Hopkins, E. A.; Gellman, S. H. J. Am. Chem. Soc. 2007, 129, 6050-6055. 
MeO
N
H
OH
BocHN
OH
1)Ph(I)(OAc)2
2)Boc2O
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(S)-3-(N-Acetylamino)-2-benzyl-1-propanol.11,28 To (S)-2-benzyl-3-(4-
methoxyphenylamino)propan-1-ol (58.6 mg, 0.220 mmol, 79% ee) in 1:1 MeOH/CH2Cl2 
(3.2 mL) at 0 C was added iodobenzene diacetate (268 mg, 0.860 mmol) in MeOH (3.2 
mL). After stirring at 0 C for 30 min, 1 M HCl (3.2 mL) was added, and the mixture was 
stirred for 1 h. The reaction was diluted with CH2Cl2 (10 mL), and the layers were 
separated. The aqueous layer was washed with CH2Cl2 (3×10 mL), and the combined 
organics were washed with 1 M HCl (10 mL). The combined aqueous layers were 
neutralized by adding solid Na2CO3 until pH 10 was reached. CH2Cl2 (5 mL) and acetic 
anhydride (21.0 μL, 0.220 mmol) were added, and the mixture was stirred vigorously 
overnight. The layers were separated, and the aqueous layer was washed with CH2Cl2 
(3×10 mL). The combined organic layers were washed with brine (10 mL), dried over 
Na2SO4, filtered, and concentrated. Column chromatography (5% MeOH/CH2Cl2) 
yielded a yellow oil (2.7 mg, 6%). []D
20 = +17.2 (c = 0.135, CHCl3, l = 50 mm). Known 
compound: (R) []D
20 = -24.2 (c = 1.59, CHCl3)
28 
 
 
 
 
28Banfi, L.; Guanti, G.; Riva, R. Tetrahedron: Asymmetry 1999, 10, 3571-3592. 
MeO
N
H
Ph
OH
1) Ph(I)(OAc)2
2)Ac2O AcHN
Ph
OH
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Chapter 3. Selective Functionalization of Diols 
3.1 Methods for Accelerating Reaction Rates in Organocatalysis 
 Reversible covalent bonding is a common mode of activation used in 
organocatalysis. Many methods have focused on making a more active intermediate in 
order to accelerate the reaction, for example, enamine (Scheme 3.1),1a,c,e,f iminium  
Scheme 3.1 Enamine Activation Using Proline.1a  
 
(Scheme 3.2),1b,d,e,f and N-heterocyclic carbene catalysis.1g Another approach for 
accelerating reactions is pre-organization of the substrate via reversible covalent bonding. 
Scheme 3.2 Iminium Activation.1b 
 
 
1(a) List, B.; Lerner, R. A.; Barbas III, C. F. J. Am. Chem. Soc. 2000, 122, 2395-2396. (b) Ahrendt, K. A.; 
Borths, C. J.; MacMillan, D. W. C. J. Am. Chem. Soc. 2000, 122, 4243-4244. (c) Mukherjee, S.; Yang, J. 
W.; Hoffmann, S.; List, B. Chem. Rev. 2007, 107, 5471–5569. (d) Erkkila, A.; Majander, I.; Pihko, P. M. 
Chem. Rev. 2007, 107, 5416–5470.  (e) Melchiorre, P.; Marigo, M.; Carlone, A.; Bartoli, G. Angew. Chem., 
Int. Ed. 2008, 47, 6138–6171. (f) Pihko, P. M.; Majander, I.; Erkkila, A. Asymmetric Organocatalysis; 
Springer-Verlag: Berlin, 2010, pp 29-75. (g) Moore, J. L.; Rovis, T. Asymmetric Organocatalysis; 
Springer-Verlag: Berlin, 2010, 291, pp 77-144. 
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These reactions achieve rate enhancement through induced intramolecularity.2 The 
favorable binding of the substrate to a catalyst comes at a significant entropic cost. 
However, the subsequent step is accelerated, because it does not have to pay this penalty. 
For example, Sammakia and co-workers have shown that aldehydes and ketones can be 
used as intramolecular activation catalysts in the alcoholysis of α–hydroxy esters.3 The 
transesterification of α –hydroxy esters occurs up to 1700 times faster than the 
corresponding methyl ether substrate. The intermediate observed during the reaction 
demonstrates the importance of the α-hydroxyl group in the reaction (Scheme 3.3). 
Scheme 3.3 α-Hydroxy Ester Alcoholysis. 
 
 
 Similarly, boric acid has been shown to be particularly good at catalyzing the site 
selective esterification of α–hydroxycarboxylic acids.4 The boric acid initially exchanges 
with the alcohol allowing the intramolecular cyclization to form the activated ester before  
 
2Tan, K. L. ACS Catal. 2011, 1, 877-886.  
3(a) Sammakia, T.; Hurley, T. B. J. Am. Chem. Soc. 1996, 118, 8967–8968. (b) Sammakia, T.; Hurley, T. 
B. J. Org. Chem. 1999, 64, 4652–4664. (c) Sammakia, T.; Hurley, T. B. J. Org. Chem. 2000, 65, 974–978. 
4(a) Ishihara, K.; Ohara, S.; Yamamoto, H. J. Org. Chem. 1996, 61, 4196–4197. (b) Ishihara, K. 
Tetrahedron 2009, 65, 1085–1109. 
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alcoholysis. The order of the steps in the mechanism is what allows for the selective 
esterification (Scheme 3.4). 
Scheme 3.4 Site Selective Boric Acid-Catalyzed Esterification. 
  
3.2 Development of Organocatalyst 3.1  
 Previously, our group has developed catalytic directing groups I and II for the 
regio-, diastero-, and enantioselective hydroformylation of olefins (Chapter 1 and 2).5 
These catalytic directing groups use reversible covalent bonding and induced 
intramolecularity to achieve selectivity and rate acceleration. In order to expand our 
methodology into electrophile transfer, organocatalyst 3.1 was designed taking into 
account the features that had made I and II successful. Therefore, the substrate binding 
site was retained. A hydrogen-bonding organocatalyst developed by the Hoveyda and 
5(a) For a review of catalytic directing groups: Rousseau, G.; Breit, B. Angew. Chem., Int. Ed. 2011, 50, 
2450-2494 and the references within. (b) Worthy, A. D.; Joe, C. L.; Lightburn, T. L.; Tan, K. L. J. Am. 
Chem. Soc. 2010, 132, 14757-14759. (c) Lightburn, T. E.; De Paolis, O. A.; Cheng, K. H.; Tan, K. L. Org. 
Lett. 2011, 13, 2686-2689. 
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Snapper groups, which uses N-methylimidazole as a catalyst for silylation, was also used 
as inspiration.6 Thus, instead of a catalyst binding site, N-methylimidazole was built into 
the molecule. The backbone of the molecule originates from amino alcohols so the source 
of chirality is cheap, diverse, and readily derivatized (Figure 3.1).  
Figure 3.1 Organocatalyst Design. 
 
 
3.3 Application of Organocatalyst 3.1 to Selective Functionalization  
 In order to show the power of this catalytic directing group, it was important to 
choose a problem that has been difficult to solve using traditional strategies. While the 
use of organocatalysts has been successfully applied to many problems in organic 
synthesis, the functionalization of a less reactive group in the presence of a more reactive 
one is still a challenge.7,8 Due to their ability to bind a substrate with the desired  
6Zhao, Y.; Rodrigo, J.; Hoveyda, A. H.; Snapper, M. L. Nature 2006, 443, 67-70. 7Comprehensive 
Asymmetric Catalysis; Jacobsen, E. N., Pfaltz, A.,Yamamoto, H., Eds.: Springer-Verlag: Berlin Heidelberg, 
1999; Vols. I-III. 8(a) Jordan, P. A.; Miller, S. J. Angew. Chem., Int. Ed. 2012, 51, 2907-2911. (b) Yoshida, 
K.; Furuta, T.; Kawabata, T. Angew. Chem., Int. Ed. 2011, 50, 4888-4892. (c) Kawabata, T.; Furuta, T. 
Chem. Lett. 2009, 38, 640-647. (d) Ohshima, T.; Iwasaki, T.; Maegawa, Y.; Yoshiyama, A.; Mashima, K. 
J. Am. Chem. Soc. 2008, 130, 2944-2945. (e) Lewis, C. A.; Miller, S. J. Angew. Chem., Int. Ed. 2006, 45, 
5616-5619. (f) Griswold, K. S.; Miller, S. J. Tetrahedron 2003, 59, 8869-8875. (g) Kurahashi, T.; Mizutani, 
T.; Yoshida, J. Tetrahedron 2002, 58, 8669-8677. (h) Hu, G.; Vasella, A. Helv. Chim. Acta 2002, 85, 4369-
4391. 
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functional group near the catalytically active residue, enzymes are capable of performing 
site selective catalysis.9 Taking inspiration from enzymes, Miller discovered a peptide 
based catalyst through a library screen that is capable of functionalizing a secondary 
alcohol in the prescence of a primary alcohol in a glucose derived substrate (Table 3.1).8f 
The selectivity is believed to be a result of the catalyst hydrogen bonding to the more 
accessible primary hydroxyl allowing the 4-O to be acylated. Using similar peptide based 
catalysts, Miller and co-workers have shown that selective derivitizations of natural 
products is possible.10 
Table 3.1 Miller’s Selective Functionalization of a Glucose Derivative. 
 
  
9(a)  hi odea           Melan o n          i      Angew. Chem., Int. Ed. 2008, 47      -          
 hi odea           Melan o n          i      Nature 2007, 446, 1008-1016. (c) Koeller, K. M.; Wong, C.-H. 
Chem. Rev. 2000, 100, 4465-4493.                                                                                                               
10(a) Lewis, C. A.; Miller, S. J. Angew. Chem., Int. Ed. 2006, 45, 5616-5619. (b) Lewis, C. A.; Merkel, J.; 
Miller, S. J. Bioorg. Med. Chem. Lett. 2008, 18, 6007-6011. (c) Lewis, C. A.; Longcore, K. E.; Miller, S. J.; 
Wender, P. A. J. Nat. Prod. 2009, 72, 1864-1869. (d) Pathak, T. P.; Miller, S. J. J. Am. Chem. Soc. 2012, 
134, 6120-6123. (e) Fowler, B. S.; Laemmerhold, K. M.; Miller, S. J. J. Am. Chem. Soc. 2012, 134, 9755-
9761. 
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 Similarly, Kawabata and co-workers have demonstrated that very selective 4-O-
acylation was possible using their catalyst B (Scheme 3.5).8c The selectivity is believed to 
occur through hydrogen bonding to the substrate which orients the 4-hydroxyl near the 
activated acylating reagent (Figure 3.2). 
Scheme 3.5 Kawabata Selective Funcationalization of a Glucose Derivative. 
 
Figure 3.2 Proposed Selectivity Model Using Catalyst B. 
 
 
 Both of these catalysts are modeled after enzymes in which multiple noncovalent 
interactions are used to bind a substrate selectively. These catalysts, while smaller than 
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enzymes, are large compared to most small molecule organic catalysts because of the 
need for multiple noncovalent interactions.  
 Taylor has shown selective acylation of sugar derivatives using a commercially 
available borinate ester which covalently binds cis diols to activate them for 
functionalization with high selectivitites (Scheme 3.6).11 Our group believed that we 
could also be successful in a site selective reaction using a small organocatalyst, 3.1, 
which benefits from a reversible covalent bond. 
Scheme 3.6  aylor’s Borinate  ster  atalyzed Acylation  
 
 To prove the viability of using 3.1 to functionalize a less reactive group in the 
presence of a more reactive one, a simple system was tested. The functionalization of a 
secondary alcohol in the presence of a primary alcohol was interesting since a primary 
alcohol is about two orders of magnitude more reactive.12 For example, the silylation of a 
1,2-diol with chlorotriethylsilane (TESCl), N,N-diisopropylethylamine (DIPEA), and 
catalytic N-methylimidazole (NMI) is very selective for the less hindered primary alcohol 
(Scheme 3.7). In order to reverse this selectivity, an energy difference of >3 kcal/mol  
11Lee, D.; Taylor, M. S. J. Am. Chem. Soc. 2011, 133, 3724-3727. Gouliaras, C.; Lee, D.; Chan, L.; Taylor, 
M. S. J. Am. Chem. Soc. 2011, 133, 13926-13929. Lee, D.; Williamson, C. L.; Chan, L.; Taylor, M. S. J. 
Am. Chem. Soc. 2012, 134, 8260-8267.                                                                                                                                                        
12Reginato, G.; Ricci, A.; Roelens, S.; Scapecchi, S. J. Org. Chem. 1990, 55, 5132-5139. 
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between the two pathways would need to be overcome. Because of this differential 
reactivity, obtaining the secondary protected product usually requires bis-protection 
followed by selective deprotection of the primary protected alcohol.13  
Scheme 3.7 Silylation of a 1,2-Diol. 
 
  
 As primary alcohols are more accessible, 3.1 should preferentially bind to the 
primary alcohol leaving the secondary alcohol free. The catalytic N-methylimidazole 
subunit attached to 3.1 can then facilitate functionalization of the secondary alcohol 
through activation of an electrophilic reagent and intramolecular delivery.14 This direct 
functionalization of a secondary alcohol would eliminate the need for bis-protection and 
selective deprotection, as well as the byproducts generated from these steps.   
 Using this strategy, the selectivity of the reaction arises from a combination of the 
binding selectivity as well as the rate of functionalization (Figure 3.3). Under the reaction 
conditions, 3.3 and 3.4 should be in equilibrium. As mentioned previously, the primary 
alcohol bound, 3.3, should be more favorable. However, k2 will most likely be greater 
than k1 since the primary alcohol is more reactive towards functionalization. To favor the 
pathway through 3.5, 3.1 could be designed to decrease the rate of functionalization of  
13Kobayashi, S.; Alizadeh, B. H.; Sasaki, S. -Y.; Oguri, H.; Hirama, M. Org. Lett. 2004, 6, 751-754. 14It is 
also possible that the N-methylimidazole subunit acts as a general base. 
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the primary alcohol to form 3.6, k2, while increasing the rate of functionalization to form 
3.5, k1 (mismatched vs matched case, respectively). This matched/ mismatched case 
could originate from stereoselectivity caused by the rigidness of the covalent bond 
between 3.1 and 3.2. After the functionalization step, exchange with methanol would give 
3.1 or another molecule of substrate, 3.2, could exchange on to enter back into the 
equilibrium between 3.3 and 3.4.    
Figure 3.3 Application of the Curtin-Hammett Principle. 
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 To begin a simple and inexpensive synthesis of catalytic directing group 3.11 was 
completed starting from ʟ-valinol (Scheme 3.8). First N-methylimidazole is lithiated with 
nBuLi and trapped with N,N-dimethylformamide to yield 3.9. Reductive amination of 3.9 
with valinol gives amino alcohol 3.10. 3.10 was closed with N,N-dimethylformamide 
dimethylacetal in methanol to give catalytic directing group 3.11 in a diastereomeric ratio 
of 70:30.   
Scheme 3.8 Synthesis of 3.11. 
 
  
 After being synthesized, 3.11 was exchanged with iPrOH in the presence of N,N-
diisopropylethylamine hydrochloride as the acid source. A Keq of 0.13 was found which 
indicates that MeOH has an 8 fold higher binding affinity than iPrOH (Scheme 3.9). The 
reaction reached equilibrium after only 10 minutes at room temperature. (Without acid, it 
takes 72 h to reach equilibrium.) It was encouraging that the exchange was rapid at room 
temperature because exchange has to be fast in order to compete with the unselective 
intermolecular reaction. Also promising and as predicted, there was a large preference to 
bind the least sterically hindered alcohol. Both of these features of 3.11 are important in 
order to obtain selectivity. 
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Scheme 3.9 Exchange Study with 3.11. 
 
 
3.4 Initial Studies of Selective Functionalization of 1,2-Diols15 
 Initially 1-phenyl-1,2-ethanediol was used as the test substrate and tert-
butyldimethylsilyl chloride (TBSCl) was used as the electrophile. When NMI was used 
as the catalyst, there was a strong preference for the primary alcohol to be functionalized 
resulting in 3.14 (Scheme 3.10, Eq. 1). The secondary product, 3.15, was not detected by 
GC. When 3.11 was used as the catalyst, the selectivity for 3.15 increased to 4% (Scheme 
3.10, Eq. 2). The low levels of selectivity are most likely due to the large size of the TBS 
group contributing to a high energetic barrier to secondary alcohol functionalization. 
Scheme 3.10 Silylation of 3.13 with TBSCl. 
 
15This work was done with Omar De Paolis. 
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 In order to lower this barrier, chlorotriethylsilane (TESCl) was tried under the 
reaction conditions with NMI. The inherent selectivity was 99:1 for 3.16 (Scheme 3.11, 
Eq. 1). Although this still represents a strong preference for primary alcohol 
functionalization, a small amount of the secondary product, 3.17, was observed. Reaction 
with 3.11 gave a ratio of 88:12 favoring the primary product, 3.16 (Scheme 3.11, Eq. 2). 
This change in selectivity represented a 10-fold increase compared to the reaction with 
NMI. It is important to mention that although bis-silylation is possible, in these initial 
screens with TESCl, it was always observed to be <5% of the reaction mixture. 
Scheme 3.11 Silylation of 3.13 with TESCl. 
 
 
 At this point, there was concern that because 3.11 is a chiral catalyst a 
matched/mismatched case might be occurring in which the two enantiomers of 3.13 were 
reacting differently. In order to test this hypothesis, the individual enantiomers of 3.13 
were synthesized  si ng  aco sen ’s hydrolytic kinetic resol t ion of epo ides 16 Each of 
16Schaus, S. E.; Brandes, B. D.; Larrow, J. F.; Tokunaga, M.; Hansen, K. B.; Gould, A. E.; Furrow, M. E.; 
Jacobsen E. N. J. Am. Chem. Soc. 2002, 124, 1307-1315. 
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the enantiomers was tested separately in the reaction. Interestingly, while (S)-3.13 gave a 
90:10 ratio, strongly favoring formation of the primary functionalized product, 3.16 
(Scheme 3.12, Eq. 1), (R)-3.13 gave a ratio of 59:41 (Scheme 3.12, Eq. 2). 
Scheme 3.12 Selectivity of Each Enantiomer of 3.13. 
 
Table 3.2 Variation of Amino Alcohol Backbone. 
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 To increase the selectivity for the secondary product, 3.17, other catalysts were 
synthesized to see if any would give improved selectivities. When the catalysts were 
screened against (R)-3.13, there was a clear trend that increasing the size of the R group 
increased the selectivity for 3.17 (Table 3.2). 
3.5 Stereoselective Functionalization of Diols17 
 Because we predicted that binding selectivity and stereoselectivity would be 
necessary to obtain site selectivity, we decided to test how effective the catalyst was in an 
enantioselective reaction. Therefore, an enantioselective desymmetrization reaction was 
performed. Previously, meso-1,2-diols have been desymmetrized using organocatalysts to 
catalyze acylation,18 phosphorylation,19 sulfonylation,20 and silylation.21 Peptide based 
catalysts that achieve selectivity through non-covalent interactions which pre-organize 
the substrate and catalyst prior to electrophile transfer have been used for all of these 
electrophilic transfer reactions. Acylation has also been catalyzed by amine, alcohol, and 
phosphine organocatalysts.18a,c Silyl transfer has been accomplished using a diamine 
mediator and peptide based catalysts (Scheme 3.13).21 Ishikawa and co-workers showed  
17Sun, X.; Worthy, A. D.; Tan, K. L. Angew. Chem., Int. Ed. 2011, 50, 8167-8171.                                    
18(a) Oriyama, T.; Imai, K.; Sano, T.; Hosoya, T. Tet. Lett. 1998, 39, 3529–3532.  For reviews on acyl 
transfer using organocatalysts see the following: (b) Jarvo, E. R.; Miller, S. J. Tetrahedron 2002, 58, 2481–
2495. (c) Spivey, A. C.; Arseniyadis, S. Top. Curr. Chem. 2010, 291, 233–280. (d) Marinetti, A.; Voituriez, 
A. Synlett 2010, 174–194 .                                                                                                                           
19(a) Sculimbrene, B.; Morgan, A.; Miller, S. J. Am. Chem. Soc. 2002, 124, 11653–11656. (b) Jordan, P. A.; 
Kayser-Bricker, K. J.; Miller, S. J. Proc. Natl. Acad. Sci. USA 2010, 107, 20620–20624.                        
20Fiori, K. W.; Puchlopek, A. L. A.; Miller, S. J. Nat. Chem. 2009, 1, 630–634.                                            
21(a) Isobe, T.; Fukuda, K.; Araki, Y.; Ishikawa, T. Chem. Commun. 2001, 243–244. (b) Zhao, Y.; Mitra, A. 
W.; Hoveyda, A. H.; Snapper, M. L. Angew.Chem., Int. Ed. 2007, 46, 8471–8474. (c) Zhao, Y.; Rodrigo, 
J.; Hoveyda, A. H.; Snapper, M. L. Nature 2006, 443, 67–70. (d) You, Z.; Hoveyda, A. H.; Snapper, M. L. 
Angew. Chem., Int. Ed. 2009, 48, 547–550.  (e) Rodrigo, J. M.; Zhao, Y.; Hoveyda, A. H.; Snapper, M. L. 
Org. Lett. 2011, 13, 3778-3781. For a review on asymmetric Si-O coupling of alcohols: (f) Weickgenannt, 
A.; Mewald, M.; Oestreich, M. Org. Biomol. Chem. 2010, 8, 1497–1504. 
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the kinetic resolution of indanol and tetralol with moderate enantioselectivities, but the 
chiral base used could not be used catalytically (Scheme 3.13, Eq 1).21a Hoveyda and 
Snapper developed a peptide-based catalyst which is able to desymmetrize diols and 
triols (Scheme 3.12, Eq 2).21c,d The chemistry was expanded to kinetic resolutions and 
regiodivergent reactions on a racemic mixture (Scheme 3.12, Eq 3 and 4).21b,e Notably, 
this is also a site selective reaction; however, the secondary alcohols have to have similar 
reactivity to achieve high selectivity (Eq 4). 
Scheme 3.13 Asymmetric Silyl Transfer Reactions. 
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 It was believed that our catalytic directing group, which pre-organizes the 
substrate and catalyst using a more rigid covalent bond, could lead to increased reactivity 
and selectivity. 
Figure 3.4 Catalytic Cycle of Desymmetrization of Meso-1,2-Diols. 
 
  
 It was imagined that catalytic directing group 3.11 could bind 3.18, reversibly, 
and silylation of 3.18 could occur through intramolecular transfer or deprotonation. The 
release of 3.19 by exchange with methanol regenerates 3.11 (Figure 3.4). Notably, 
selectivity could come from substrate binding, silyl transfer, or a combination of both.  
 The reaction was run with TBSCl and 20% catalyst. N, N-Diisopropylethylamine 
was chosen to quench the hydrogen chloride generated during the reaction because it is a 
hindered base that should be slow to promote silylation. DIPEA·HCl, which is generated 
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during the reaction, was added as an acid to catalyze the initial exchange between 
substrate and catalyst. 
 To start, a series of catalysts similar to 3.11 were tested in the reaction. First the R 
group on the catalyst backbone was varied (Table 3.3). Larger R groups gave increased 
selectivity. However, the catalysts exist as a mixture of diastereomers, complicating the 
analysis of selectivity. We were concerned that the two diastereomers might show the 
opposite sense of absolute stereochemistry. Thus, we wanted to explore catalysts that 
would exist as a single diastereomer.  
Table 3.3 Initial Catalyst Optimization. 
 
  
 In order to try to force the catalyst to favor one diastereomer, another stereocenter 
was installed on the methylene linker between the ring and the N-methylimidazole 
subunit. Both the (S,S) and (S,R)-catalysts were synthesized. The syntheses of these 
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catalysts were similar to the synthesis of 3.11. To make the (S,S) series, after 3.9 was 
condensed with an amino alcohol, the desired nucleophile was added into the imine to 
obtain 3.20; cyclization of the amino alcohol gave 3.21 (Scheme 3.14). To obtain the 
(S,R)-catalysts, valinol was condensed with the desired aldehyde and lithiated NMI was 
added to the resulting imine to obtain 3.22 (Scheme 3.15). Closure of 3.22 gave III. The 
syntheses focused on using valinol as the amino acid core since it gave good results in 
Table 3.3. Catalyst optimization around tert-leucine was not pursued because it is much 
more expensive.  
Scheme 3.14 Synthesis of 3.21. 
 
 Both of the (S,S)-catalysts that were synthesized existed as one diastereomer in 
solution. The yields and enantioselectivities obtained from the reactions with the (S,S)-
catalysts were lower than when 3.11 was used as the catalyst (Table 3.3 and Table 3.4). 
These results suggest that the addition of this stereocenter improperly gears the imidazole 
ring making the silylation more difficult.   
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Scheme 3.15 Synthesis of III. 
 
  All of the (S,R)-catalysts gave improved yields compared to the (S,S)-catalysts. 
When R= Ph, the diastereomeric ratio was poor along with the enantioselectivity. 
However, when R was Me, moderate enantioselectivities were achieved. When R was 
iPr, the catalyst, III, is one diastereomer and gives 3.19 in good yield and excellent  
Table 3.4 (S,S) and (S,R) Catalysts. 
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enantioselectivity (Table 3.4). Attempts to synthesize R= tBu were unsuccessful due to 
difficulty closing the ring in the last step. It is believed that the steric clash between the 
two substituents makes the ring closure very unfavorable. 
3.6 Desymmetrization of Meso-1,2-Diols 
 With an effective catalyst developed, the optimal reaction time was explored. The 
reaction time of 24 h (4 °C) that had been used for catalyst testing was determined to be 
unnecessary when III was used. At room temperature, the reaction reaches completion 
after 4 h and retains high enantioselectivity (Table 3.5). 
Table 3.5 Time Course with III. 
 
 
 A catalyst loading screen showed that while 5% catalyst resulted in a sluggish 
reaction and lowered enantioselectivities, 10% gave similar results to using 20% catalyst 
(Table 3.6).  
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Table 3.6 Catalyst Loading Screen. 
 
 N,N-Diisopropylethylamine was originally chosen as a base because it is hindered 
and thus, would be slow to promote the silylation by itself. If it were to promote the 
silylation, it would lead to racemic product which would degrade the enantioselectivity of 
the reaction. Another hindered base, 1,2,2,6,6-pentamethylpiperidine (PMPP), was also 
tested in the reaction. Using PMPP, gave a comparable yield with slightly higher 
enantioselectivies indicating that DIPEA had been promoting some background reaction 
(Scheme 3.16).  
Scheme 3.16 1,2,2,6,6-Pentamethylpiperdine as the Base. 
 
 A time course was performed with PMPP·HCl to ensure that this acid would 
allow the reaction to proceed at a similar rate to the reaction with DIPEA·HCl. At 2 h, the 
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conversion is not complete, but at 4 h, yields similar to previous reactions are obtained 
(Table 3.7). 
Table 3.7 Time Screen with PMPP and PMPP·HCl.  
 
 
 In an effort to decrease the amount of TBSCl necessary for an efficient reaction 
while still maintaining high enantioselectivity, a concentration screen was run. One 
concern was that III might catalyze the intermolecular reaction in which 3.18 is not 
bound before functionalization. Decreasing the catalyst concentration could decrease the 
rate of the intermolecular reaction compared to the intramolecular reaction. With 2 
equivalents of TBSCl, a concentration of 0.4 M gave the best enantioselectivities and 
good yields. Lower concentration resulted in a sluggish reaction; higher concentration 
started to degrade the enantioselectivity of the reaction (Table 3.8). 
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Table 3.8 Concentration Screen. 
 
  
 With the optimized conditions in place, the reaction was run with control catalyst 
3.23 in order to support the hypothesis that covalent bonding is the mode of catalysis that 
is operating under these conditions. Not only was the enantioselectivity poor, but the 
conversion was also very low (Scheme 3.17). This implies that III is not a good silylation 
catalyst without the ability to covalently bind the substrate. As further support, running 
the reaction with III in tBuOH gave comparable results to the reaction run in THF which 
is inconsistent with a hydrogen-bonding mechanism (Scheme 3.18). 
Scheme 3.17 Reaction with a Control Catalyst. 
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Scheme 3.18 Reaction Run in tBuOH. 
 
  
 The substrate scope was expanded to other cyclic and acyclic meso-1,2-diols. 
Heteroatoms (3.24) and unsaturation (3.25) in cyclic substrates were well tolerated (Table 
3.9). Medium rings 3.28 and 3.29, while less reactive, also gave good results. The slower 
reaction rate for medium rings is believed to be due to ring distortion, which twists the 
cis-diols into more of a trans configuration. (Note: trans-diols do not react under these 
conditions.) Due to increased freedom of rotation compared to the cyclic substrates, 
acyclic substrates, such as 3.30, are also slower to react. The reaction of (1R,2S,Z)-
cyclooct-5-ene-1,2-diol gives 3.32 with low enantioselectivity which is believed to be 
due to the transannular effect causing the ring to twist the alcohols away from each other 
(Scheme 3.19). 
Scheme 3.19 Reaction of (1R,2S,Z)-cyclooct-5-ene-1,2-diol. 
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Table 3.9 Substrate Scope. 
 
 
 It is also important to note that (1R,3S)-cyclopentane-1,3-diol, even with 4.0 
equivalents of TBSCl, reacts slowly and affords low enantioselectivities (Scheme 3.20). 
An acyclic 1,3-diol, (2R,4S)-pentane-2,4-diol, has even worse reactivity than the cyclic 
diol and gives < % yield   his i s most likely d e  to the catalyst’s ina il ity to transfer the 
electrophile if the alcohol is not in close proximity to the NMI subunit. While this limits 
the scope of substrates for this catalyst, it was encouraging because the catalyst was 
Chapter 3, Page 252 
 
designed to be a site selective catalyst. A catalyst that is stereoselective and sensitive to 
proximity effects is less likely to be promiscuous.  
Scheme 3.20 Reaction of cis-1,3-Diol. 
 
 
Table 3.10 Silyl Reagent Screen. 
 
 
 Other silyl reagents were tested under the reaction conditions with 3.18 to 
determine if they would also work. Impressively, the smaller and more reactive 
chlorotriethylsilane (TESCl) gave slightly better yields while still maintaining high 
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enantioselectivities. The bigger tert-butyldiphenylsilyl chloride (TBDPSCl) was less 
reactive, but also maintained good enantioselectivity. The very reactive 
dimethylphenylsilyl chloride (DMPSCl) gave only moderate enantioselectivities which 
may be due to background silylation (Table 3.10). 
Table 3.11 Enhancing the Reactivity of Challenging Substrates. 
 
 
 As TESCl had been shown to be more reactive while still achieving high 
enantioselectivities, it was used to enhance the reactivity of some challenging substrates. 
(2R,3S)-butane-2,3-diol, which previously needed 36 h for complete conversion, showed 
complete conversion to 3.38 after 4 h. (3R,4S)-hexa-1,5-diene-3,4-diol and (1R,2S)-1,2-
diphenylethane-1,2-diol are deactivated towards silylation and did not react with TBSCl. 
When TESCl was used, both were converted to product (3.39 and 3.40, respectively) in 
under 8 h with good enantioselectivities (Table 3.11).  
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 The exchange characteristics of III were also studied. Consistent with exchange 
studies performed with I and 3.11, a Keq of 0.12 was found when III was exchanged with 
iPrOH (Scheme 3.21).  
Scheme 3.21 Exchange of III with iPrOH. 
 
 When III was exchanged with 3.18, the Keq was determined to be 0.20 after 2 h. 
As there are two alcohols in 3.18, this number was expected. The more interesting piece 
of data resulting from this exchange was that the two diastereomers, 3.42 and 3.43, which 
originate from each alcohol binding to III, exist in a 60:40 ratio (Scheme 3.22). Since one 
diastereomer is not strongly favored over the other, this most likely means that 3.18 
binding to III is not the selectivity determining step of the reaction. Therefore, selectivity 
must be arising from the functionalization step. One explanation for the selectivity is if 
the (R)-diol binds III, the other alcohol is placed near the NMI subunit so it can be 
functionalized. In contrast, when the (S)-diol binds III, the other alcohol may be 
positioned away from the NMI subunit so it is unable to be functionalized. This is only 
true, however, if the reaction occurs under exchange conditions at equilibrium. It is 
possible that one diastereomer is kinetically favored to bind III. If silylation is fast and 
the reaction occurs under kinetic control, it is possible that binding could be the source of 
selectivity. Based on our observations that the exchange is rapid (Scheme 3.9), while 
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silylation is much slower, we believe that it is not likely that binding is the source of 
selectivity. 
Scheme 3.22 Exchange of III with 3.18.  
 
  
 In order to determine if product exchange onto III was competitive, the exchange 
of 3.19 with III was performed. Equilibrium was reached in 2 h with a Keq of 0.02. The 
Keq of 3.19 was 10 fold less than with 3.18 (Scheme 3.22 and 3.23). This indicates that 
product inhibition is not a significant problem during the reaction. 
Scheme 3.23 Exchange of III with 3.19. 
 
   
 Attempts to crystalize III were unsuccessful. However, by taking advantage of its 
ability to bind alcohols, a crystalline alcohol, 3.45, was exchanged onto III (Scheme 
3.24). 3.46 was crystallized, and an X-ray crystal structure was obtained which showed 
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that the C-O bond was oriented up along with both iPr groups. The NMI subunit was 
oriented underneath the ring of the catalyst (Figure 3.5). 
Scheme 3.24 Exchange of III with 3.45. 
 
 
Figure 3.5 Crystal Structure of 3.46 (CCDC # 832192). 
 
 
Chapter 3, Page 257 
 
 The crystal structure allowed us to design models that would rationalize the 
enantioselectivity of the reaction. In the solid state, the NMI subunit is positioned 
underneath the ring. Models of the substrate bound catalyst oriented similar to the crystal 
structure show the hydrogen of the free alcohol could be positioned over the nitrogen in 
the ring. It is believed that the basic nitrogen in the ring could assist by deprotonating the 
alcohol before the NMI subunit swings up to transfer the functional group. When the (R)-
alcohol is bound to the catalyst, the other alcohol is lined up well for this transformation. 
However, when the (S)-alcohol is bound in a conformation in which the other alcohol 
could be functionalized, there are two eclipsing hydrogens that could make this 
conformation unfavorable (Figure 3.6). 
Figure 3.6 Selectivity Models. 
 
 
3.7 Developing a Site Selective Functionalization Reaction 
 Having shown that III was able to catalyze a stereoselective reaction, we returned 
to developing a site selective reaction. Optimization was approached with the information 
gained from developing the desymmetrization reaction while remaining cognizant that a 
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very different problem was being addressed. Because we had seen optimal results with 
III in the desymmetrization reaction, we decided to test it in the site selective reaction 
(Scheme 3.25). 
Scheme 3.12 Reaction of 3.11 with Individual Enantiomers. 
 
 
Scheme 3.25 Reaction of III with Individual Enantiomers. 
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 Both enantiomers of 3.47 were tested with III. When comparing these 
selectivities with the ones previously seen with catalyst 3.11, it is interesting to note that 
the selectivities switch. The catalysts seemed to be matched to different enantiomers of 
substrate. With III and (S)-hexane-1,2-diol, the reaction favored the secondary product, 
3.49, in about 59:41 ratio. The (R)-hexane-1,2-diol strongly favors the primary product, 
3.48 (Scheme 2.25). 
 The results with III are consistent with what was seen in the desymmetrization of 
meso diols. In that reaction, it was hypothesized that when the (R)-alcohol was bound to 
III, the free alcohol was oriented over the amine in the ring allowing it to be 
deprotonated and subsequently functionalized. However, when the (S)-alcohol was bound 
to III, in the only conformation that the free alcohol could possibly be functionalized, 
two hydrogens are eclipsing each other (Figure 3.6 and 3.7). It is believed this 
unfavorable interaction causes this conformation to be disfavored so the free alcohol is 
not functionalized when the (S)-alcohol is bound. When the secondary alcohols are bound 
in the site selective reaction, the desymmetrization models predict that the (R)-diol would 
be able to silylate the primary alcohol easily while the (S)-diol would be less favorable. 
Simple models of the primary alcohols bound show that the secondary alcohol in the (S)-
diol could be deprotonated similarly. When the (R)-diol is in the confirmation in which 
the nitrogen could deprotonate the alcohol, there are two hydrogens pointing at each other 
over the ring (Figure 3.7). This unfavorable interaction makes secondary 
functionalization of the (R)-diol disfavored.  
 
Chapter 3, Page 260 
 
Figure 3.7 Selectivity Models. 
 
 
 At this point, a solvent screen was run on the racemic substrate to determine if 
solvent had an effect on the selectivity. By isolating both products and determining their 
enantioselectivities, the approximate selectivity ratio for each enantiomer can be 
calculated. Most solvents gave results comparable to THF except for MeOtBu and 
tBuOH. MeOtBu gave very low selectivities for both the enantiomers. Running the 
reaction in tBuOH, however, greatly increased the enantioselectivity of 3.48. This 
increase in enantioselectivity corresponds to the (S)-enantiomer forming mostly 3.49 
(Table 3.12). In this case, the R and S ratios were calculated based on isolated yields so a 
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loss of small amounts of material during isolation greatly affected these ratios. Future 
results were calculated based on GC yields and are more correct. 
Table 3.12 Solvent Screen. 
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Table 3.13 Individual Enantiomer Selectivity in tBuOH. 
 
 
 Each enantiomer was run in tBuOH to directly measure the selectivity of each. 
(R)-3.47 gave similar selectivity to what was previously seen with THF, very high 
selectivity for 3.48. (S)-3.47 gave an 83:17 ratio favoring 3.49. The reaction catalyzed by 
NMI was also run in tBuOH to ensure that the solvent was not changing the inherent 
selectivity of the reaction, and it was not (Table 3.13). 
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Table 3.14 Temperature Screen with t-Amyl Alcohol. 
 
 
 In order to test solvents similar to tBuOH, t-amyl alcohol was tested in the 
reaction. Less sterically hindered alcoholic solvents, such as iPrOH, and MeOH, cannot 
be used in the reaction as they bind the catalyst and would inhibit exchange. t-Amyl 
alcohol gave slightly better results than t-BuOH. The benefit of using t-amyl alcohol was 
that lower temperatures could be explored, whereas, t-BuOH would freeze. At 4 °C, the 
reaction gave almost 90:10 selectivity for 3.49. Decreasing the temperature to -6 °C did 
not increase the selectivity further (Table 3.14).  
 In order to see if fine tuning the group on the methylene linker between NMI and 
the ring could increase the selectivity further, a few derivatives were synthesized. 
Previously smaller groups at this position, such as methyl, gave lower selectivities and 
often existed as multiple diastereomers in solution. Larger groups, such as t-butyl, were 
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unable to be synthesized. A series of catalysts with cyclic alkyl substituents at this 
position were synthesized. These groups were explored as they are branched like an iPr 
group, but are tied back making them slightly smaller. The catalyst in which R= 
cyclopropyl exists as an 80:20 mixture of diastereomers and gives about a 1:1 ratio of 
3.48 to 3.49. When R= cyclopentyl, however, the catalyst gives the same results as III 
(Table 3.15). Unfortunately, the cyclobutyl version of this catalyst could not be made, 
and the cyclohexyl version did not exchange efficiently. 
Table 3.15 Screen of Catalysts with Cyclic R groups. 
 
  
 When you compare IV and III using other substrates, such as (S)-1-cyclohexane-
1,2-diol, 3.50, the difference is more obvious. Catalyst IV gives almost 90:10 selectivity 
for 3.52 and much higher yields (Table 3.16, Entry 2 compared with Entry 1). The 
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reaction with NMI and (R)-3.50 are shown for comparision and are still highly selective 
for 3.51 (Table 3.16, Entry 1 and 4, respectively). 
Table 3.16 Catalyst Screen with (S)-Cyclohexylethane-1,2-diol. 
 
 
 The control catalyst, 3.53, which lacks a substrate binding site gives primarily 
3.51 with low conversions for both enantiomers of substrate (Scheme 3.26, Eq 1 and 2).  
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Scheme 3.26 Control Catalyst with (S) and (R)-1-Cyclohexane-1,2-diol. 
 
 With optimized conditions in hand, the substrate scope was expanded. The 
racemic substrates were run to obtain both valuable enantioenriched products, the 
primary and the secondary functionalized. This type of reaction is refered to as a 
regiodivergent reaction on a racemic mixture.21e,22 If desired, an enantiopure diol can also 
be run in this reaction to obtain high yields and good selectivities for the secondary 
functionalized product. When optimizing each substrate, both III and IV were tested, as 
they gave similar results with (S)-hexane-1,2-diol, 3.47, but different with (S)-1- 
cyclohexane-1,2-diol, 3.50. It is important to note that exact reaction times are necessary 
 
22(a) Miller, L. C.; Sarpong, R. Chem. Soc. Rev. 2011, 40, 4550-4562.  
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to prevent conversion of the secondary protected product into bis-protected product over 
time. Most of the substrates gave good yields and excellent enantioselectivities for the 
secondary product. The primary product is also obtained with good yields, albeit with 
slightly lower enantioselectivities. This is because although the (R)-enantiomer is 
extremely selective to form the primary functionalized product, the (S)-enantiomer forms 
the secondary functionalized product in about a 90:10 ratio for most substrates (Table 
3.18). Both bulkyl and small alkyl groups are tolerated as well as protected alcohols. The 
OPh substrate, 3.58, suffers from bis-silylation being competitive with mono-silylation so 
the yields are somewhat diminished. The vinyl substrate, 3.59, is the least selective which 
has been attributed to its small size and the fact that it deactivates the functionalization of 
the secondary alcohol (Table 3.17). Similarly, it is believed that the 1-phenyl-1,2-diol 
substrate was less selective due to deactivation of the secondary alcohol (Scheme 3.27). 
Notably, a benzyl group in 3.56 still allows for selective secondary alcohol 
functionalization (Table 3.17). 
Scheme 3.27 Reaction Run with 1-Phenyl-1,2-ethanediol. 
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Table 3.17 Substrate Scope. 
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 When attempting to silylate the bulky 3,3-dimethylbutane-1,2-diol, no secondary 
silylation product was obtained (Scheme 3.28). The halogenated substrates, 3.60 and 
3.61, were the most selective with the (S)-enantiomer forming the secondary product in 
an impressive 95:5 ratio (Table 3.18).The selectivities for each enantiomer of substrate 
could be calculated based on the yields and enantioselectivities of each product (Table 
3.18). 
Scheme 3.28 Reaction of 3,3-dimethylbutane-1,2-diol. 
 
  
Table 3.18 Calculated Selectivities for Each Enantiomer of Substrate. 
Substrate (R)-1a (R)-2a (S)-1a (S)-2a 
3.13 95 5 41 59 
3.50 99 1 12 88 
3.47 99 1 13 87 
3.54 99 1 11 89 
3.55 96 4 17 83 
3.56 98 2 10 90 
3.57 >99 <1 14 86 
3.58 98 2 14 86 
3.59 97 3 27 73 
3.60 99 1 6 94 
3.61 99 1 5 95 
aApproximate (R)-enantiomer and (S)-enantiomer selectivities calculated based on isolated yields and ees 
from Table 3.17. 
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 If the reaction is run to low conversion, a kinetic resolution of 1-cyclohexane-1,2-
diol is possible to isolate the primary functionalized product, 3.51, in good yields and 
higher enantioselectivity (Scheme 3.29). As the rate of functionalization of the (R)-diol 
with IV is much faster than the (S)-diol, the (R)-diol is most likely matched with the 
catalyst to silylate the primary alcohol.  
Scheme 3.29 Kinetic Resolution of 1-Cyclohexylethane-1,2-diol. 
 
 
 Some exchange reactions were run with III to learn more about how binding 
selectivity may be affecting the reaction. The exchange of III with simple alcohols was 
performed first. The exchange of III with HOiPr gave a ratio of 57:43 of III to 3.41 at 
equilibrium which corresponds to a Keq of 0.12 (Scheme 3.30). This Keq is consistent 
with previous exchange reactions and is expected due to the size difference between a 
secondary alcohol and MeOH.  
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Scheme 3.30 Exchange of III with HOiPr. 
 
  
 The exchange of III with HOnBu gave a ratio of 67:33 (III to 3.62) at equilibrium 
which gives a Keq of 0.98. As HOnBu is a primary alcohol, the equilibrium was expected 
to be slightly less than one (Scheme 3.31). 
Scheme 3.31 Exchange of III with HOnBu. 
 
  
 Next the exchange of each product with III was studied. As expected for both 
enantiomers, the free primary alcohols have higher binding affinities than the secondary 
alcohols. However comparing the individual enantiomers of 3.48 to each other shows 
some interesting results. The Keq of (S)-3.48 is 1.9 times the Keq of (R)-3.48 (Scheme 
3.32, Entry 1 and 2). Because (R)-3.48 is the favored primary product that results from 
the reaction of 3.47 with III, it is interesting that it has a lower binding affinity. The Keq 
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of (R)-3.49 is 1.2 fold the Keq of (S)-3.49 (Scheme 3.32, Entry 3 and 4). Again the 
favored product of the reaction has a lower binding affinity than its enantiomer, but the 
difference is less drastic. Secondary alcohol exchange, which is already less favorable 
than primary alcohol exchange, appears to be more sensitive to the stereocenter in the 
molecule.  
Scheme 3.32 Product Exchange with III. 
 
 
 When comparing the primary vs. secondary binding for each enantiomer, another 
interesting set of data appears. At equilibrium, the Keq of (S)-3.49 is 9.6 times the Keq of 
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(S)-3.48 (Scheme 3.32, Entry 2 and 4). As methanol has a binding affinity 8 times that of 
a secondary alcohol, this difference seemed reasonable (Scheme 3.30). In contrast, (R)-
3.49 is 21.7 times more favorable to bind than (R)-3.48 (Scheme 3.32, Entry 1 and 3). 
(R)-3.48 must have a very unfavorable interaction with III that causes binding to be 
much more difficult. Because of the large difference in binding affinity for one 
enantiomer over the other, we believe it is possible that this catalyst could be developed 
into a chiral separation technology in the future. 
 Because the enantiomers of product are sterically and electronically different than 
the substrates, an exchange reaction with each enantiomer of the hexane-1,2-diol 
substate, 3.47, was also performed. (R)- and (S)-3.47 led to a similar ratio of 3.64 to 3.65 
(Scheme 3.33). 
Scheme 3.33 Exchange of III with 3.47. 
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 Since the two individual enantiomers had been exchanged with III, it was 
possible to identify all of the products of the exchange of racemic 3.47 with III. When 
exchanging racemic 3.47 with III, within 10 min, 55% of III was converted to the 
primary alcohol bound to the catalyst. After 24 h, equilibrium was reached with 67% 
conversion of III. The ratio of primary to secondary alcohol bound products was 79:21. 
This was consistent with the ratio of primary to secondary alcohol bound products seen 
with the exchange of the individual enantiomers (Scheme 3.33). The ratio of 3.68 to 3.66 
was 56:44 (Scheme 3.34). This means that at equilibrium (S)-3.47 is more favorable to 
bind the secondary alcohol than (R)-3.47. This is consistent with the exchange data seen 
with the product exchange but is a less dramatic difference (Scheme 3.32). 
Scheme 3.34 Exchange of (±)-3.47 with III. 
 
 
 Consistent with the desymmetrization, the exchange data indicates that the 
binding of each enantiomer to III does not determine the difference in their selectivity. 
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Both enantiomers show that the primary alcohol preferentially binds to III. This binding 
of the primary alcohol preferentially over the secondary alcohol certainly does contribute 
to the selective functionalization of the secondary alcohol.     
 The exchange information also corresponds with the optimal reaction conditions 
that were discovered for each enantiomer. In the beginning of the reaction, before the 
exchange is at equilibrium, only the primary alcohol has exchanged onto III. This is 
important for the (S)-diol to selectively form the secondary functionalized product. Thus, 
a pre-stir before adding the TESCl does not help the selectivity for the (S)-enantiomer. 
However, when running the reaction under the kinetic resolution conditions, the reaction 
was pre-stirred for 45 minutes in order to get optimal selectivities for the (R)-enantiomer. 
During this pre-stir, the secondary alcohol exchanges onto the III so it can direct the 
functionalization of the primary alcohol. 
3.8 The Different Selectivities of 3.11 and III.12 
 During the optimization of the reaction of 3.13, the difference in selectivity of 
3.11 and III was discovered (Scheme 3.12 and 3.35). This difference will be discussed 
here in the context of the reaction with 3.13. 
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Scheme 3.12 Reaction of 3.11 with Individual Enantiomers. 
 
 
Scheme 3.35 Reaction of III with Individual Enantiomers. 
 
 The experimental results which show that the two catalysts are matched to give 
secondary functionalization with different enantiomers led us to believe that they may be 
functionalizing the diols through different mechanisms. Remembering that III exists as 
one diastereomer in which the C-O bond is oriented up and that 3.11 exists as two 
diastereomers, we hypothesized that the diastereomer where the C-O bond is oriented 
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down may be responsible for the secondary functionalization of the (R)-diol in the 
reaction with 3.11. Some of the optimization that was done with the 1-phenyl-1,2-diol is 
important for this discussion. For example, the reaction of 3.13 with 3.11 does not seem 
to be affected by the catalyst loading (Table 3.19). This is not true of the reactions done 
with III. Increasing the amount of III, increased the selectivity. 
 Intriguingly, this indicates that 3.11 may be matched with the (R)-diol and can 
accelerate the secondary functionalization reaction, whereas, III may be acting by 
decelerating the primary functionalization reaction compared to the secondary 
functionalization with the (S)-diol. This could be due to the steric size difference in the 
two catalysts and the difference in the freedom of rotation of the N-methylimidazole. If 
III is more rigid as well as being sterically hindered, the rate of silylation may be slower 
for both alcohols. 
Table 3.19 Catalyst Loading Screen. 
 
Chapter 3, Page 278 
 
 As shown previously, to increase the selectivity for the secondary product, 3.17, 
other catalysts were synthesized to see if any would give improved selectivities. When 
the catalysts were run with (R)-3.13, there was a clear trend that increasing the size of the 
R group corresponded to an increase in the diastereomer ratio of the catalyst and an 
increase in the selectivity for 3.17 (Table 3.2).  
Table 3.2 Variation of Amino Alcohol Backbone. 
 
 
 When trying to optimize the catalyst to force it to be one diastereomer, the (S,S) 
and (S,R) catalysts were tested in the reaction. Unfortunately, the (S,S)-catalysts gave 
much worse selectivity in the site selective silylation compared with the simple amino 
alcohol based catalysts even when one diastereomer was present (Table 3.20 and Table 
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3.2). Most of the (S,R)-catalysts did not give good selectivities for 3.17. However, 
catalyst III was more selective for secondary functionalization than any of the catalysts 
that were previously tested, but only when the (S)-enantiomer of substrate was used 
(Table 3.20). It was previously rationalized using models why the (R)-enantiomer is 
matched with III to form primary functionalized product and does not favor secondary 
functionalization (Figure 3.7). We believe that during this catalyst optimization we  
Table 3.20 (S,S)- and (S,R)-Catalysts. 
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switched the mechanism from acceleration of the secondary functionalization pathway to 
deceleration of the primary functionalization pathway. 
 Going forward with catalyst III, (S)-1-phenyl-1,2-ethanediol was used to optimize 
the reaction conditions. Simply decreasing the temperature to 4 °C increased the 
selectivity to 60:40 (Scheme 3.36). 
Scheme 3.36 Decreasing the Reaction Temperature. 
 
  
  Next, the base was changed to 1,2,2,6,6-pentamethylpiperidine which in the 
desymmetrization reaction seemed to catalyze less background reaction than N, N-
diisopropylethylamine. Indeed, as before, the reaction with PMPP gave better selectivity 
than when DIPEA was used. However, when the reaction temperature was lowered using 
PMPP as the base, there was no increase in selectivity. This implies that background 
reaction is sufficiently suppressed using PMPP as the base so decreasing the temperature 
is not necessary. If DIPEA is used, decreasing the temperature to 4 °C gives 
approximately the same results as using PMPP. Either reaction condition allows the 
intramolecular reaction to outcompete the intermolecular reaction. Using crystallized 
Chapter 3, Page 281 
 
catalyst, instead of distilled catalyst, also increased the selectivity of the reaction 
significantly. Clearly, the selectivity is very sensitive to the purity of the III (Table 3.21). 
Table 3.21 1,2,2,6,6-Pentamethylpiperidine as the Base. 
 
. 
 A reagent screen was performed at this point to see if it affected the selectivity. 
Using TESBr gave similar results to using TESCl. TESNO2 gave much lower 
selectivities, and the very reactive TESOTf was unselective and gave high amounts of bis 
silylation. A variety of temperatures were screened with TESOTf, but they all resulted in 
similar undesirable results (Table 3.22). 
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Table 3.22 Electrophile Screen. 
 
 
  At this point, as shown previously, hexane-1,2-diol was used for further 
optimization because it was realized that the 1-phenyl-1,2-diol was a less selective 
substrate in the reaction with III. With III, 1-phenyl-1,2-diol never acheieved selectivity 
over 60:40 for secondary functionalization (Table 3.18). In the future, our group will 
focus on making a catalyst that would exist as one diastereomer in which the C-O bond is 
oriented down. We believed this may allow for secondary functionalization of the (R)-
diol with high selectivity. 
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3.9 Conclusions 
 A new set of organocatalysts were developed that benefit from reversible covalent 
bonding and induced intramolecularity. The desymmetrization of meso-1,2-diols was 
accomplished using organocatalyst III, which was synthesized easily and cheaply. 
Experimental results indicate that the selectivity and increased reactivity are a result of 
the ability of III to pre-organize the substrate through a reversible, covalent bond. A 
variety of cyclic and acylic substrates were shown to react efficiently with good 
enantioselectivities under mild conditions. Other silylating reagents were also shown to 
be effective under the reaction conditions.  he  catalyst’s a il ity to f nc tionalize cis-1,2-
diols selectively indicated it might be successfully applied to site selective catalysis. 
Thus, the selective functionalization of a secondary alcohol in the presence of a primary 
alcohol was developed using a combination of binding selectivity and stereoselectivity. 
The (S)-enantiomer forms the secondary functionalized product while the (R)-enantiomer 
forms the primary functionalized product with high selectivity. As the enantiomers 
preferentially form different functionalized products, a regiodivergent reaction on a 
racemic mixture resulted giving two valuable enantioenriched products. 
3.10 Experimental 
General Considerations 
Unless otherwise noted, all reagents were obtained from commercial suppliers and used 
without further purification.  Lithium reagents were titrated against 2-pentanol using 
1,10-phenanthroline as the indicator.  Flash column chromatography was performed 
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using EMD Silica Gel 60 (230-400 mesh) and ACS grade solvents as received from 
Fisher Scientific.  All experiments were performed in oven or flame-dried glassware 
under an atmosphere of nitrogen or argon using standard syringe and cannula techniques, 
except where otherwise noted.  All reactions were run with dry, degassed solvents 
dispensed from a Glass Contour Solvent Purification System (SG Water, USA LLC).  1H 
and 13C NMR were performed on either a Varian Gemini 400 MHz, Varian Gemini 500 
MHz or a Varian Unity Inova 500 MHz spectrometer.  Deuterated solvents were 
purchased from Cambridge Isotope Labs and stored over 3Å molecular sieves.  C6D6 was 
degassed by three successive freeze-pump-thaw cycles and stored over 3Å molecular 
sieves in a dry box under a nitrogen atmosphere.  All NMR chemical shifts are reported 
in ppm relative to residual solvent for 1H and 13C NMR.  Coupling constants are reported 
in Hz.  All IR spectra were gathered on a Bruker Alpha FT-IR equipped with a single 
crystal diamond ATR module and values are reported in cm1. All GC analyses were 
performed on an Agilent Technologies 7890A GC System. HRMS and X-ray crystal 
structure data were generated in Boston College facilities.  Analytical chiral high-
performance liquid chromatography (HPLC) was performed on a Shimadzu-LC-2010A 
HT. 
Initial Studies of Selective Functionalization of 1,2-Diols 
Catalyst Synthesis 
N-methyl-imidazole-2-carboxaldehyde, 3.9, 23 was made following literature procedures 
and matched reported spectra. 
23Plater, M. J.; Barnes, P.; McDonald, L. K.; Wallace, S.; Archer, N.; Gelbrich, T.; Horton, P. N.; 
Hursthouse, M. B. Org. Biomol. Chem. 2009, 7, 1633-1641.  
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(S)-2-((1-methyl-1H-imidazol-2-yl)methylamino)propan-1-ol.24 To a solution of N- 
methyl-imidazole-2-carboxaldehyde (650 mg, 8.7 mmol) in methanol (17 mL) was added  
(S)-alaninol (960 mg, 8.7 mmol) and 4Å molecular sieves (1.7 g). After refluxing for 24 
hours, the reaction was cooled to room temperature, and NaBH4 (340 mg, 8.7 mmol) was 
added. The reaction was stirred at room temperature for 2 hours, followed by quenching 
with dropwise addition of concentrated HCl (0.44 mL). The resulting mixture was further 
neutralized with Na2CO3 (1.4 g). The precipitated salts were filtered off, and the filtrate 
was concentrated. Flash column chromatography (CH2Cl2:MeOH = 10:1) afforded pure 
product as a colorless oil (1.0 g, 70%). 1H NMR (CDCl3   00 M z  δ 6  7  d      J = 
1.2), 6.78 (d, 1H, J = 1.2), 3.91 (d, 1H, J = 14.4), 3.76 (d, 1H, J = 14.4), 3.60 (s, 3H), 
3.53 (dd, 1H, J = 11.0, 3.9), 3.26-3.30 (m, 1H), 2.82 (qt, 1H, J = 10.3, 3.9), 1.04 (d, 3H, J 
= 6.4); 13C NMR (C6D6   26 M z   δ 147.0, 126.9, 121.2, 65.5, 54.9, 42.9, 32.7, 17.3;  
IR: 3201, 2872, 1636, 1499, 1452, 1283, 1048, 736, 662 cm–1; HRMS (DART-TOF) 
calcd. for C8H16N3O [M+H]
+: 170.1293, found: 170.1292. []D
20 = +33.0 (c = 1.10, 
CHCl3, l = 50 mm). 
 
 
 
 
24Suzuki, Y.; Takahashi, H. Chem. Pharm. Bull. 1983, 31, 2895-2898. 
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(4S)-2-methoxy-4-methyl-3-((1-methyl-1H-imidazol-2-yl)methyl)oxazolidine (66:34 
dr). To a solution of (S)-2-(((1-methyl-1H-imidazol-2-yl)methyl)amino)propan-1-ol (1.0 
g, 6.0 mmol) in anhydrous methanol (24 mL) under argon was added N,N-
dimethylformamide dimethyl acetal (0.80 mL, 6.0 mmol). The reaction was stirred at 
room temperature for 2 hours, and the solvent was removed under vacuum. The residue 
was redissolved in anhydrous methanol (24 mL), and reaction was stirred at room 
temperature for another 2 hours. 1H NMR analysis showed that all the substrate was 
consumed and product had formed. The solvent was removed under vacuum. The flask 
was brought into a dry glove box under nitrogen atmosphere, and the residue was 
extracted with degassed pentane. The pentane was removed under vacuum, and 
Kugelrohr distillation (170 °C at 0.05 mmHg) afforded pure product as a colorless oil 
(330 mg, 26%). 1H NMR (C6D6, 500 M z   δ 7     s  0 3     7  3  d  0 66   J = 0.1), 
6.37 (s, 0.34H), 6.36 (s, 0.34H), 5.24 (s, 0.66H), 5.17 (s, 0.34H), 3.98 (t, 0.34H, J = 7.3), 
3.78 (t, 0.66H, J = 6.8), 3.68-3.72 (m, 2H), 3.36-3.43 (m, 0.66H), 3.32-3.34 (m, 0.34H), 
3.28 (s, 0.66H), 3.23 (s, 0.66H), 3.14 (s, 0.34H), 3.07 (s, 0.34H), 2.94-2.96 (m, 1H), 0.74 
(d, 1H, J = 6.1), 0.71 (d, 2H, J = 5.9); 13C NMR (C6D6   26 M z  δ     7          2     
121.7, 114.7, 111.7, 109.0, 73.1, 72.6, 57.9, 54.9, 53.1, 51.4, 47.1, 43.4, 38.3, 32.7, 17.5, 
16.8; IR: 2928, 1501, 1458, 1284, 1162, 1113, 1066, 1017, 975, 742 cm–1; HRMS 
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(DART-TOF) calcd. for C19H14N3O [M-OMe]: 180.1137, found: 180.1142. []D
20 = 
+11.6 (c = 1.09, C6H6, l = 50 mm). 
 
 
(S)-4-Methyl-2-(((1-methyl-1H-imidazol-2-yl)methyl)amino)pentan-1-ol.24 To a 
solution of N-methyl-imidazole-2-carboxaldehyde (1.65 g, 15.0 mmol) in benzene (30 
mL) was added (S)-leucinol (1.20 g, 10.0 mmol) and 3Å molecular sieves (1.40 g). After 
refluxing for 24 hours, the reaction was cooled to room temperature and the solvent was 
removed in vacuo. The resulting residue was redissolved in MeOH (30 mL), and NaBH4 
(570 mg, 15.0 mmol) was added. The reaction was stirred at room temperature for 2 
hours, followed by quenching with dropwise addition of concentrated HCl (0.510 mL ). 
The resulting mixture was further neutralized with Na2CO3 (1.70 g). The precipitated 
salts were filtered off, and the filtrate was concentrated. Flash column chromatography 
(CH2Cl2:MeOH = 10:1) afforded the pure product as a yellow oil (1.58 g, 75%). 
1H 
NMR (CDCl3   00 M z   δ 6  0  d  l   J = 1.0), 6.73 (d, lH, J = 1.0), 3.84 (d, lH, J = 
14.5), 3.76 (d, lH, J = 14.5), 3.56 (s, 3H), 3.26-3.30 (m, 1H), 2.65-2.69 (m, 1H), 1.58-
1.65 (m, 1H), 1.25-1.31 (m, lH), 1.14-1.19 (m, 1H), 0.82 (d, 3H, J = 6.5), 0.79 (d, 3H, J 
= 6.5); 13C NMR (CDCl3   2  M z   δ   6     26  6   2  2  63     7     2 6        32 6  
24.8, 22.8, 22.7; IR: 3281, 2952, 2867, 1500, 1466, 1051, 735 cm-1; HRMS calcd. for 
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C11H22N3O [M+H]
+: 212.1762, found: 212.1761. 
 
 
(4S)-4-Isobutyl-2-methoxy-3-((1-methyl-1H-imidazol-2-yl)methyl)oxazolidine (75:25 
dr). To a solution of (S)-4-methyl-2-(((1-methyl-1H-imidazol-2- 
yl)methyl)amino)pentan-1-ol (0.70 g, 3.3 mmol) in anhydrous methanol (13 mL) under 
argon was added N,N-dimethylformamide dimethyl acetal (0.40 mL, 3.3 mmol). The 
reaction was stirred at room temperature for 2 hours, and the solvent was removed under 
vacuum. The residue was redissolved in anhydrous methanol (13 mL), and the reaction 
was again stirred at room temperature for 2 hours until 1H NMR analysis showed all the 
substrate was consumed. The solvent was removed under vacuum. The flask was brought 
into a dry glove box under nitrogen atmosphere, and the residue was extracted with 
degassed pentane. The pentane was removed under vacuum, and Kugelrohr distillation 
(180 °C at 0.05 mmHg) afforded the pure product as a pale green oil (190 mg, 23%). 1H 
NMR (C6D6   00 M z   δ 7  2  d  0 2    J = 1.0), 7.09 (d, 0.75H, J = 1.0), 6.34 (d, 
0.25H, J = 1.0), 6.32 (d, 0.75H, J = 1.0), 5.29 (s, 0.75H), 5.17 (s, 0.25H, J = 1.0), 3.87-
3.92 (m, 0.75H), 3.84-3.86 (m, 0.25H), 3.76-3.81 (m, 0.5H), 3.75 (d, 0.75H, J = 13.5), 
3.68 (d, 0.75H, J = 13.5), 3.49-3.55 (m, 0.75H), 3.40-3.44 (m, 0.25H), 3.19 (s, 0.75H), 
3.11 (s, 2.25H), 3.01-3.09 (m, lH), 3.04 (s, 2.25H), 2.97 (s, 0.75H), 1.15-1.28 (m, 2.25H), 
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1.05-1.11 (m, 0.75H), 0.75 (d, 0.75H, J = 6.5), 0.72 (d, 0.25H, J = 6.5), 0.70 (d, 0.75H, J 
= 6.5), 0.67 (d, 0.25H, J = 6.5); 13C NMR (CDCl3   26 M z   δ     6   26  7   20 7  
114.0, 112.6, 110.6, 71.1, 70.9, 70.5, 70.1, 57.5, 56.1, 52.3, 50.8, 47.2, 42.6, 42.1, 41.5, 
37.5, 31.9, 25.5, 23.6, 23.5, 22.1, 21.7; IR: 2953, 1500, 1284, 1160, 1076, 1036, 736 cm-
1; HRMS calcd. for C12H20N3O [M-OMe]: 222.1606, found: 222.1611. 
 
 
(S)-3-methyl-2-((1-methyl-1H-imidazol-2-yl)methylamino)butan-1-ol, 3.10.24 To a 
solution of N-methyl-imidazole-2-carboxaldehyde (2.1 g, 2.0 x 101 mmol) in (40 mL) 
was added (S)-valinol (2.2 g, 2.0 x 101 mmol) and 4Å molecular sieves (4.0 g). After 
refluxing for 24 hours, the reaction was cooled to room temperature, and NaBH4 (760 
mg, 2.0 x 101 mmol) was added. The reaction was stirred at room temperature for 2 
hours, followed by quenching with dropwise addition of concentrated HCl (1.0 mL). The 
resulting mixture was further neutralized with Na2CO3 (3.3 g). The precipitated salts were 
filtered off, and the filtrate was concentrated. Flash column chromatography 
(CH2Cl2:MeOH = 10:1) afforded the pure product as a colorless oil (2.3 g, 58%). 
1H 
NMR (CDCl3, 500 MHz)  6.86 (d, 1H, J = 1.5), 6.77 (d, 1H, J = 1.2), 3.90 (d, 1H, J = 
14.7), 3.78 (d, 1H, J = 14.9), 3.62 (dd, 1H, J = 11.2, 3.7), 3.58 (s, 3H), 3.39 (dd, 1H, J = 
11.0, 7.3), 2.40-2.44 (m, 1H), 1.71-1.78 (m, 1H), 0.92 (d, 3H, J = 6.8), 0.87 (d, 3H, J = 
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6.8); 13C NMR (CDCl3, 125 MHz)  147.4, 126.9, 121.3, 65.1, 61.6, 44.0, 32.6, 30.0, 
19.5, 19.0; IR: 3199, 2955, 2871, 1500, 1465, 1283, 1043, 734, 705, 661 cm–1; HRMS 
(DART-TOF) calcd. for C10H20N3O [M+H]
+: 198.1606, found:198.1606. []D
20 = +19.0 
(c = 1.0, CH2Cl2, l = 50 mm). 
 
 
(4S)-4-isopropyl-2-methoxy-3-((1-methyl-1H-imidazol-2-yl)methyl)oxazolidine, 3.11 
(70:30 dr). To a solution of (S)-3-methyl-2-(((1-methyl-1H-imidazol-2-
yl)methyl)amino)butan-1-ol (860 mg, 4.4 mmol) in anhydrous methanol (18 mL) under 
argon was added N,N-dimethylformamide dimethyl acetal (580 L, 4.4 mmol). The 
reaction was stirred at room temperature for 2 hours, and the solvent was removed under 
vacuum. The residue was redissolved in anhydrous methanol (18 mL), and the reaction 
was further stirred at room temperature for 2 more hours until 1H NMR analysis showed 
complete conversion. The solvent was removed under vacuum. The flask was brought 
into a dry glove box under nitrogen atmosphere, and the residue was extracted with 
degassed pentane. The pentane was removed under vacuum, and Kugelrohr distillation 
(130 °C at 0.05 mmHg) afforded pure product as colorless oil (490 mg, 47%). 1H NMR 
(C6D6   00 M z  δ 7     d  0 3   J = 1.2), 7.12 (d, 0.7H, J = 1.0), 6.36 (d, 0.3H, J = 1.0), 
6.35 (d, 0.7H, J = 1.2), 5.34 (s, 0.3H), 5.21 (s, 0.7H), 4.02 (d, 0.3H, J = 13.9), 3.90 (t, 
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0.6H, J = 8.1), 3.84 (d, 0.3H, J = 13.9), 3.79 (t, 0.7H), 3.74 (d, 0.7H, J = 13.4), 3.67-3.70 
(m, 0.7H), 3.65 (d, 0.7H, J = 13.7), 3.17 (s, 0.9H), 3.09 (s, 2.1H), 3.07 (s, 2.1H), 2.98 (s, 
09H), 2.82-2.86 (m, 1H), 1.67 (dt, 0.7H, J = 20.5, 6.8), 1.58 (ddd, 0.3H, J = 13.9, 6.8, 
3.7), 0.72 (d, 0.3H, J = 6.8), 0.69 (d, 0.7H, J = 6.8), 0.65 (d, 0.7H, J = 6.8), 0.58 (d, 0.3H, 
J = 7.1); 13C NMR (CDCl3   26 M z  δ                2  7   2  2   2  6   2  3         
111.9, 68.3, 67.1, 65.6, 64.7, 53.0, 51.8, 49.3, 43.9, 32.5, 32.4, 30.7, 28.7, 20.1, 19.9, 
17.5, 15.4; IR: 2956, 1500, 1466, 1284, 1158, 1123, 1080, 1062, 986, 741 cm–1; HRMS 
(DART-TOF) calcd. for C11H18N3O [M-OMe]: 208.1450, found: 208.1459. []D
20 = -
7.09 (c = 0.71, CDCl3, l = 50 mm). 
 
 
(S)-3,3-dimethyl-2-((1-methyl-1H-imidazol-2-yl)methylamino)butan-1-ol.24 To a 
solution of N-methyl-imidazole-2-carboxaldehyde (750 mg, 6.8 mmol) in methanol (14 
mL) was added (S)-tert-leucinol (0.80 g, 6.8 mmol) and 4Å molecular sieves (1.4 g). 
After refluxing for 24 hours, the reaction was cooled to room temperature, and NaBH4 
(260 mg, 6.8 mmol) was added. The reaction was stirred at room temperature for 2 hours, 
followed by quenching with dropwise addition of concentrated HCl (0.34 mL). The 
resulting mixture was further neutralized with Na2CO3 (1.1 g). The precipitated salts were 
filtered off, and the filtrate was concentrated. Flash column chromatography 
Chapter 3, Page 292 
 
(CH2Cl2:MeOH = 10:1) afforded the pure product as a colorless oil (720 mg, 50%). 
1H 
NMR (CDCl3, 500 MHz)  6.97 (d, 1H, J = 1.5), 6.88 (d, 1H, J = 1.0), 4.20 (br s, 2H), 
4.15 (d, 1H, J = 15.9), 3.97 (d, 1H, J = 15.6), 3.82 (dd, 1H, J = 11.2, 3.7), 3.45 (s, 3H), 
3.51 (dd, 1H, J = 11.2, 8.1), 2.45 (dd, 1H, J = 8.1, 3.7), 0.94 (s, 9H); 13C NMR (CDCl3, 
125 MHz)  147.7, 126.0, 121.6, 68.7, 62.1, 46.0, 35.1, 32.9, 27.2; IR: 3333, 2950, 2868, 
1501, 1476, 1283, 1110, 1045, 736 cm–1; HRMS (DART-TOF) calcd. for C11H22N3O 
[M+H]+: 212.1763, found: 212.1764. []D
20 = +5.0 (c = 1.0, CH2Cl2, l = 50 mm). 
 
 
(4S)-4-tert-butyl-2-methoxy-3-((1-methyl-1H-imidazol-2-yl)methyl)oxazolidine 
(85:15 dr). To a solution of (S)-3,3-dimethyl-2-(((1-methyl-1H-imidazol-2-
yl)methyl)amino)butan-1-ol (0.70 g, 3.3 mmol) in anhydrous methanol (13 mL) under 
argon was added N,N-dimethylformamide dimethyl acetal (0.40 mL, 3.3 mmol). The 
reaction was stirred at room temperature for 2 hours. The residue was redissolved in 
anhydrous methanol (13 mL), and the reaction was again stirred at room temperature for 
2 hours until 1H NMR analysis showed all the substrate was consumed and product had 
formed. The solvent was removed under vacuum. The flask was brought into a dry glove 
box under nitrogen atmosphere, and the residue was extracted with degassed pentane. 
The pentane was removed under vacuum, and Kugelrohr distillation (180 °C at 0.05 
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mmHg) afforded the pure product as a colorless oil (190 mg, 23%). 1H NMR (C6D6, 500 
M z   δ 7 2   s       6 3   s             s  0         2   s  0       3     d      J = 13.4), 
3.85-3.89 (m, 1H), 3.78-3.81 (m, 1H), 3.65 (d, 1H, J = 13.4), 3.15 (s, 0.5H), 3.13 (s, 
2.5H), 3.01 (s, 2.5H), 3.00 (s, 0.5H), 2.65-2.68 (m, 1H), 0.85 (s, 1.4H), 0.83 (s, 7.6H); 
13C NMR (CDCl3   26 M z   δ     2   27 3   2  7   20               0  72 3  6     66 3  
65.1, 53.2, 52.5, 51.8, 38.1, 34.6, 33.5, 33.3, 26.7, 26.4; IR: 2955, 2905, 1499, 1477, 
1285, 1147, 1132, 1082, 1066, 993, 740 cm–1; HRMS (DART-TOF) calcd. for 
C12H20N3O [M-OMe]: 222.1606, found: 222.1612. []D
20 = -7.09 (c = 0.71, CDCl3, l = 
50 mm). 
 
 
(S)-3-Methyl-2-(((S)-1-(1-methyl-lH-imidazol-2-yl)ethyl)amino)butan-1-ol.24 To a 
solution of N-methyl-imidazole-2-carboxaldehyde (3.42 g, 31.0 mmol) in benzene (90 
mL) was added (S)-valinol (3.20 g, 10.0 mmol) and 3Å molecular sieves (1.40 g). After 
refluxing for 24 hours, the reaction was cooled to room temperature, and the solvent was 
removed in vacuo. The resulting residue was redissolved in anhydrous Et2O (180 
mL). The solution was cooled to -78 °C and MeLi (31.0 mL, 3.0 M in dimethoxyethane, 
93.0 mmol) was added dropwise. The reaction was allowed to stir for 24 hours before 
quenching with aqueous NH4Cl. The organic layer was separated, and the aqueous layer 
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was extracted with ethyl acetate (3x100 mL ). The combined organic layers were dried 
over MgSO4, filtered, and concentrated. Flash column chromatography (CH2Cl2:MeOH = 
10:1) afforded pure product as a yellow oil (2.50 g, 38%). 1H NMR (CDCl3   00 M z   δ 
6.84 (d, 1H, J = 1.5), 6.70 (d, 1H, J = 1.5), 4.04 (q, 1H, J = 6.5), 3.63 (s, 3H), 3.52-3.55 
(m, 1H), 3.31 (dd, 1H, J = 6.5, 11.0), 2.22-2.25 (m, 1H), 1.61-1.65 (m, 1H), 1.36 (d, 3H, 
J = 6.5), 0.85 (d, 3H, J = 7.0), 0.78 (d, 3H, J = 7.0); 13C NMR (CDCl3   2  M z   δ 
150.8, 126.8, 120.9, 62.2, 60.7, 47.9, 32.7, 29.3, 21.4, 19.4, 18.8; IR: 3311, 2956, 1467, 
1280, 1049, 725 cm-1; HRMS calcd. for C11H22N3O [M+H]
+: 212.1762, found: 212.1769. 
 
 
(4S)-4-Isopropyl-2-methoxy-3-((S)-1-(1-methyl-1H-imidazol-2-yl)ethyl)oxazolidine 
(99:1 dr). To a solution of (S)-3-methyl-2-(((S)-1-(1-methyl-lH-imidazol-2- 
yl)ethyl)amino)butan-1-ol (4.3 g, 18 mmol) in anhydrous methanol (36 mL) under 
nitrogen atmosphere was added N,N-dimethylformamide dimethyl acetal (12 mL, 9.0 x 
101 mmol). The reaction was stirred at 50 °C overnight, concentrated, and redissolved in 
methanol. After stirring for 2 hours, 1H NMR analysis showed complete 
conversion to product. The solvent was removed under vacuum, and Kugelrohr 
distillation (130 °C at 0.05 mmHg) afforded the product as a colorless oil (3.7 g, 73%). 
1H NMR (CDCl3, 500 M z   δ 7 0   d   H, J = 1.5), 6.35 (d, 1H, J = 1.5), 5.52 (s, 1H), 
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3.64-3.75 (m, 3H), 3.11 (s, 3H), 2.81-2.85 (m, 1H), 2.83 (s, 3H), 1.59-1.66 (m, 1H), 1.55 
(d, 3H, J = 7.0), 0.77 (d, 3H, J = 7.0), 0.75 (d, 3H, J = 7.0); 13C NMR (CDCl3, 125 MHz) 
δ     0   26     20           66    6              2  32 0  30           7 6   3    IR: 2954, 
1281, 1155, 1056, 971, 728 cm-1; HRMS calcd. for C12H20N3O [M-OMe]: 222.1606, 
found: 222.1615. 
 
 
(S)-3-methyl-2-((S)-2-methyl-1-(1-methyl-1H-imidazol-2-yl)propylamino)butan-1-ol, 
3.20.24 N-methyl-2-imidazolecarboxaldehyde (1.62 g, 14.7 mmol) and (S)-valinol (1.52 g, 
14.7 mmol) were refluxed in toluene for 3 hours. The solution was concentrated in vacuo. 
The resulting crude imine was dissolved in tetrahydrofuran (86 mL) and cooled to –78 
C. Isopropyl magnesium chloride (22.8 mL, 45.6 mmol, 2.0 M in THF) was added 
dropwise. After stirring for 16 hours and allowing the solution to warm to room 
temperature, the reaction was quenched by slowly adding H2O (5 mL). The layers were 
separated, and the organic layer was washed with H2O (100 mL) and brine (100 mL). The 
organic layers were concentrated. Column chromatography (1% NEt3 and 10% MeOH in 
CH2Cl2) yielded a slightly yellow oil (86:14 diastereomer ratio). Rapid stirring of the oil 
with hexanes (3 mL) resulted in the precipitation of a slightly yellow solid that was one 
diastereomer (1.50 g, 43%). 1H NMR (CDCl3   00 M z   δ 6     d      J = 1.0), 6.76 (d, 
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1H, J = 1.2), 3.61 (s, 3H), 3.57 (dd, 1H, J = 11.0, 3.9), 3.43 (d, 1H, J = 7.6), 3.34-3.37 
(m, 1H), 3.17-3.21 (bs, 1H), 2.07 (dd, 1H, J = 11.0, 4.2), 1.99 (dt, 1H, J = 21.0, 6.8), 
1.55-1.62 (m, 2H), 1.07 (d, 3H, J = 6.8), 0.86 (d, 3H, J = 6.8), 0.79-0.87 (m, 6H); 13C 
NMR (CDCl3   26 M z   δ   0 7   27     20 3  63 2  60 3        3  6  32    2  7        
19.0; IR: 3219, 2958, 2198, 1467, 1281, 1047, 724, 439 cm–1; HRMS (DART-TOF) 
calcd. for C13H26N3O [M+H]
+: 240.2076, found: 240.2079. []D
20 = -27.9 (c = 1.0, 
CHCl3, l = 50 mm).  
 
 
(4S)-4-isopropyl-2-methoxy-3-((S)-2-methyl-1-(1-methyl-1H-imidazol-2-
yl)propyl)oxazolidine, 3.21 (99:1 dr) . (S)-3-methyl-2-((S)-2-methyl-1-(1-methyl-1H-
imidazol-2-yl)propylamino)butan-1-ol (1.01g, 4.18 mmol) was dissolved in methanol (17 
mL) and sparged with nitrogen for 5 minutes. N,N-dimethylformamide dimethyl acetal 
(2.79 mL, 20.9 mmol) was added in one portion, and the solution was stirred 13 hours at 
50 C. The solution was concentrated under high vacuum. The yellow residue was 
dissolved in methanol (17 mL) and another portion (2.79 mL, 20.9 mmol) of N,N-
dimethylformamide dimethyl acetal was added. After 3 hours, the solution was 
concentrated and stored in a dry glovebox. The yellow residue was distilled (150 C at 
0.25 torr) to yield a slightly yellow oil (994 mg, 84%). 1H NMR (C6D6   00  M z   δ 7 20 
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(s, 1H), 6.37 (s, 0.05H), 6.30 (s, 0.95H), 5.41 (s, 0.05H), 5.35 (s, 0.95H), 3.97 (ddd, 1H, J 
= 13.2, 5.6, 1.2), 3.80 (dd, 1H, J = 7.8, 2.2), 3.65 (d, 0.08H, J = 10.8), 3.51 (t, 1H, J = 
7.8), 3.43 (d, 0.92H, J = 10.3), 3.33 (s, 2.83H), 3.10 (s, 0.17H), 3.08 (s, 0.17H), 2.88 (s, 
2.83H), 2.58-2.65 (m, 1H), 2.16-2.22 (m, 1H), 1.32 (d, 2.7H, J = 6.6), 1.25 (d, 0.3H, J = 
6.6), 1.09 (d, 0.3H, J = 6.8), 1.03 (d, 2.7H, J = 6.6), 0.95 (d, 2.7H, J = 6.9), 0.90-0.92 (m, 
0.3H), 0.82 (d, 2.7H, J = 6.6), 0.74 (d, 0.3H, J = 6.4); 13C NMR (C6D6   26  M z   δ 
147.5, 128.9, 120.4, 114.9, 66.7, 62.5, 61.6, 51.4, 32.7, 32.3, 31.8, 21.8, 21.0, 20.7, 17.6; 
IR: 2955, 2871, 1473, 1383, 1366, 1282, 1168, 1136, 1054, 959, 727 cm–1; HRMS 
(DART-TOF) calcd. for C14H24N3O [M-OMe]: 250.1919, found: 250.1920. []D
20 = -
12.5 (c = 1.20, CDCl3, l = 50 mm). 
 
 
(S)-3-Methyl-2-(((R)-(1-methyl-1H-imidazol-2-yl)(phenyl)methyl)amino)butan-1-
ol.24 To a solution of benzaldehyde (2.0 mL, 2.0 x 101 mmol) in benzene (30 mL) was 
added (S)-valinol (2.0 g, 2.0 x 101 mmol) and 3Å molecular sieves (1.4 g). After 
refluxing for 24 hours, the reaction was cooled to room temperature, and the solvent was 
removed in vacuo. 1H NMR analysis showed that the imine had formed. The resulting 
residue was redissolved in Et2O (20 mL). In another oven-dried glass reaction flask, to a 
solution of N-methylimidazole (5.6 mL, 7.0 x 101 mmol) in anhydrous Et2O (50 mL) 
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under nitrogen atmosphere was added n-butyllithium (7.0 mL, 10 M in hexanes, 7.0 x 101 
mmol) dropwise at -78 °C. The solution was stirred at -78 °C for 30 minutes, and then 
slowly cannula transferred into the solution of pre-formed imine at -78 °C. The resulting 
mixture was stirred at -78 °C for 2 hours and then at room temperature overnight. 
Aqueous NH4Cl was added slowly to quench the reaction. The organic layer was 
separated, and the aqueous layer was extracted with Et2O (3x50 mL). The combined 
organic layers were dried over MgSO4, filtered, and concentrated. Flash column 
chromatography (3:1, Hex/EtOAc to 100% EtOAc) afforded pure product as a yellow oil 
(3.8 g, 70%). 1H NMR (CDCl3, 500 M z  δ 7   -7.28 (m, 5H), 6.97 (d, 1H, J = 1.0), 
6.77 (d, 1H, J = 1.0), 4.91 (s, 1H), 3.63 (dd, 1H, J = 3.5, 11.0), 3.40 (dd, 1H, J = 8.0, 
11.0), 3.26 (s, 3H), 2.49-2.53 (m, 1H), 1.67-1.71 (m, 1H), 0.96 (d, 3H, J = 6.5), 0.90 (d, 
3H, J = 6.5); 13C NMR (CDCl3   2  M z  δ     3    0     2      27     27 6   26    
121.6, 63.7, 62.9, 59.4, 32.6, 31.7, 19.3; IR: 3339, 2955, 2870, 1492, 1281, 1048, 700 
cm-1; HRMS calcd. For C16H24N3O [M+H]
+: 274.1919, found: 274.1925. 
 
 
(4S)-4-isopropyl-2-methoxy-3-((R)-(1-methyl-1H-imidazol-2-
yl)(phenyl)methyl)oxazolidine (56:44 dr). To a solution of (S)-3-methyl-2-(((R)-(1-
methyl-1H-imidazol-2-yl)(phenyl)methyl)amino)butan-1-ol (1.0 g, 4.0 mmol) in 
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anhydrous methanol (16 mL) under nitrogen atmosphere was added N,N-
dimethylformamide dimethyl acetal (0.53 mL, 4.0 mmol). The reaction was stirred at 50 
°C overnight, concentrated, and redissolved in MeOH (16 mL). After stirring for 2 hours, 
1H NMR analysis showed complete conversion to product. The solvent was removed 
under vacuum and extraction with degassed pentanes afforded the product as an orange 
oil (820 mg, 65%). 1H NMR (CDCl3   00 M z   δ 7 66-7.96 (m, 1.12H), 7.44-7.47 (m, 
0.88H), 6.92-7.12 (m, 3H), 6.29 (d, 0.44H, J = 1.5), 6.22 (s, 0.56H), 6.19 (d, 0.56H, J = 
1.5), 5.88 (s, 0.44H), 5.17 (s, 0.44H), 5.01 (s, 0.56H), 4.00 (t, 0.56H, J = 8.0), 3.90 (t, 
0.44H, J = 8.0), 3.10-3.15 (m, 0.44H), 3.05-3.08 (m, 0.56H), 3.01 (s, 1.32H), 2.86 (s, 
1.68H), 2.82 (s, 1.68H), 2.74 (s, 1.32H), 1.70-1.77 (m, 1H), 0.91 (d, 1.68H, J = 7.0), 0.81 
(d, 1.32H, J = 6.5), 0.75 (d, 1.32H, J = 6.5), 0.37 (d, 1.68H, J = 7.0); 13C NMR (CDCl3, 
 2  M z   δ   7      6      0     3  2   2      2      2  3   20 6      6  119.5, 112.4, 
111.7, 66.7, 65.3, 64.3, 63.9, 59.6, 59.3, 52.3, 51.1, 31.6, 31.5, 30.5, 29.5, 29.4, 29.3, 
19.5, 19.2, 19.1, 17.2, 14.3, 14.2; IR: 2953, 1490, 1279, 1157, 1055, 962, 700 cm-1; 
HRMS ca1cd. for C17H22N3O [M-OMe]: 284.1762, found: 284.1748. 
 
 
(S)-3-Methyl-2-(((R)-1-(l-methyl-lH-imidazol-2-yl)ethyl)amino)butan-1-ol.24 To a 
stirring solution of (S)-valinol (2.0 g, 2.0 x 101 mmol) in anhydrous Et2O (10 mL) under 
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nitrogen atmosphere was added a solution of acetaldehyde (1.1 mL, 2.0 x 101 mmol) in 
anhydrous Et2O (10 mL). MgSO4 (4.0 g) was added, and the solution was stirred 
at room temperature for 1 hour. 1H NMR analysis showed that the imine had formed. 
In another oven-dried flask, to a solution of N-methylimidazole (5.6 mL, 7.0 x 101 mmol) 
in anhydrous Et2O (50 mL) under nitrogen atmosphere was added n-butyllithium (7.0 
mL, 10 M in hexanes, 7.0 x 101 mmol) dropwise at -78 °C. The solution was stirred at -
78 °C for 30 minutes, and then slowly cannula transferred into the solution of pre-formed 
imine at -78 °C. The resulting mixture was stirred at -78 °C for 2 hours and 
then at room temperature overnight. Aqueous NH4Cl was added slowly to quench the 
reaction. The organic layer was separated, and the aqueous layer was extracted with 
Et2O (3x50 mL). The combined organic layers were dried over MgSO4, filtered, 
and concentrated. Flash column chromatography (3:1 Hex/EtOAc to 100% EtOAc) 
afforded pure product as a yellow oil (970 mg, 23%). 1H NMR (CDCl3   00 M z   δ 6    
(d, 1H, J = 1.2), 6.72 (d, 1H, J = 1.2), 3.90 (q, 1H, J = 7.0), 3.55 (s, 3H), 3.47 (dd, 1H, J 
= 3.5, 11.0), 3.30 (dd, 1H, J = 8.5, 11.0), 2.25-2.29 (m, 1H), 1.56-1.61 (m, 1H), 1.31 (d, 
3H, J = 7.0), 0.873 (d, 3H, J = 6.5), 0.871 (d, 3H, J = 6.5); 13C NMR (CDCl3, 125 MHz) 
δ     7   26     2  2  63 3  62          32    3     2  6     2        IR: 3234, 2957, 1492, 
1281, 1121, 1052, 725 cm-1; HRMS calcd. for C11H22N3O [M+H]
+: 212.1762, found: 
212.1764. 
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(4S)-4-Isopropyl-2-methoxy-3-((R)-1-(1-methyl-1H-imidazol-2-yl)ethyl)oxazolidine 
(90:10 dr). To a solution of (S)-3-methyl-2-(((R)-1-(1-methyl-lH-imidazol-2- 
yl)ethyl)amino)butan-1-ol (902 mg, 4.30 mmol) in anhydrous methanol (17 mL) under 
nitrogen atmosphere was added N,N-dimethylformamide dimethyl acetal (0.570 mL, 4.30 
mmol). The reaction was stirred at room temperature for 2 hours, and the solvent was 
removed under vacuum. The residue was redissolved in anhydrous methanol (17 mL), 
and another 0.5 equivalents of N,N-dimethylformamide dimethyl acetal was added to the 
mixture. The reaction was again stirred at room temperature for 2 hours until 1H NMR 
analysis showed all the substrate was consumed. The solvent was removed under 
vacuum. The flask was brought into a dry glove box under nitrogen atmosphere, and the 
residue was extracted with degassed pentanes to afford the pure product as a yellow oil 
(380 mg, 35%). 1H NMR (CDCl3   00 M z   δ 7 0   d   0.1H, J = 1.5), 7.02 (d, 0.9H, J = 
1.0), 6.33 (d, 0.1H, J = 1.5), 6.31 (d, 0.9H, J = 1.0), 5.53 (s, 0.1H), 5.33 (s, 0.9H), 3.97 
(q, 0.1H, J = 6.5), 3.88 (q, 0.9H, J = 6.5), 3.64-3.72 (m, 1.8H), 3.56-3.62 (m, 0.2H), 3.13 
(s, 2.7H), 3.08-3.10 (m, 1H), 3.09 (s, 2.7H), 2.95 (s, 0.3H), 2.84 (s, 0.3H), 1.83 (d, 0.3H, 
J = 6.5), 1.51 (d, 2.7H, J = 6.5), 1.36-1.43 (m, 1H), 0.59 (d, 2.7H, J = 7.0), 0.56 (d, 
0.3H, J = 7.0), 0.41 (d, 2.7H, J = 7.0), 0.38 (d, 0.3H, J = 7.0); 13C NMR (CDCl3, 125 
M z   δ   7 7   26     20 4, 114.3, 112.0, 107.7. 67.6, 67.0, 61.2, 60.1, 52.2, 51.7, 50.4, 
Chapter 3, Page 302 
 
48.7, 46.0, 38.2, 31.4, 30.8, 30.4, 28.7, 19.0, 18.7, 17.1, 15.6, 13.5, 11.3; IR: 2954, 1496, 
1281, 1153, 1068, 970, 728 cm-1; HRMS calcd. for C12H20N3O [M-OMe]: 222.1606, 
found: 222.1615. 
 
 
(S)-3-methyl-2-((R)-2-methyl-1-(1-methyl-1H-imidazol-2-yl)propylamino)butan-1-ol, 
3.22.24 To a stirring solution of (S)-valinol (6.8 g, 66 mmol) in anhydrous Et2O (66 mL) 
under nitrogen atmosphere was added a solution of isobutyraldehyde (4.8 g, 66 mmol) in 
anhydrous Et2O (66 mL). MgSO4 (13 g) was added, and solution was stirred at room 
temperature overnight. 1H NMR analysis showed that the imine had formed. In another 
oven-dried flask, to a solution of N-methylimidazole (19 g, 230 mmol) in anhydrous THF 
(160 mL) under nitrogen atmosphere was added n-butyllithium (23 mL, 10 M in hexanes, 
230 mmol) dropwise at –78 °C. The solution was stirred at –78 °C for 30 minutes, and 
then slowly cannula transferred into the solution of pre-formed imine at –78 °C. The 
resulting mixture was stirred at –78 °C for 2 hours and then at room temperature 
overnight. Aqueous NH4Cl was added slowly to quench the reaction. The organic layer 
was separated, and the aqueous layer was extracted with Et2O (3×100 mL). The 
combined organic layers were dried over MgSO4, filtered, and concentrated. Flash 
column chromatography (2:1 Hex/EtOAc to 100% EtOAc) afforded pure product as a 
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colorless oil (12 g, 76%). 1H NMR (CDCl3, 500 MHz)  6.93 (d, 1H, J = 1.2), 6.78 (d, 
1H, J = 1.2), 3.56-3.57 (m, 4H), 3.35 (d, 1H, J = 1.2), 3.34 (d, 1H, J = 3.9), 2.13-2.17 (m, 
1H), 1.87-1.93 (m, 1H), 1.62-1.68 (m, 1H), 0.98 (d, 3H, J = 6.8), 0.93 (d, 3H, J = 6.8), 
0.88 (d, 3H, J = 2.9), 0.87 (d, 3H, J = 2.9); 13C NMR (CDCl3, 125 MHz)  151.7, 127.0, 
121.3, 64.2, 62.9, 60.4, 34.0, 32.9, 31.7, 20.2, 19.5, 19.4, 17.7; IR: 2956, 2871, 1488, 
1468, 1280, 1045, 725 cm–1; HRMS (DART-TOF) calcd. for C13H26N3O [M+H]
+: 
240.2076, found: 240.2087. []D
20 = +40.0 (c = 1.0, CH2Cl2, l = 50 mm). 
 
 
(4S)-4-isopropyl-2-methoxy-3-((R)-2-methyl-1-(1-methyl-1H-imidazol-2-
yl)propyl)oxazolidine, III (99:1 dr). To a solution of (S)-3-methyl-2-(((R)-2-methyl-1-
(1-methyl-1H-imidazol-2-yl)propyl)amino)butan-1-ol (4.3 g, 18 mmol) in anhydrous 
methanol (36 mL) under nitrogen atmosphere was added N,N-dimethylformamide 
dimethyl acetal (12 mL, 9.0 x 101 mmol). The reaction was stirred at 50 °C overnight, 
concentrated, and redissolved in methanol. After stirring for 2 hours, 1H NMR analysis 
showed complete conversion to product. The solvent was removed under vacuum, and 
Kugelrohr distillation (130 °C at 0.05 mmHg) afforded the product as a colorless oil (3.7 
g, 73%). 1H NMR (CDCl3, 500 MHz)  7.12 (d, 1H, J = 1.2), 6.80 (s, 1H), 6.20 (d, 1H, J 
= 1.2), 3.70 (dd, 1H, J = 9.0, 8.1), 3.52 (dd, 1H, J = 7.8, 7.1), 3.29 (s, 3H), 3.22 (d, 1H, J 
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= 10.8), 2.78 (s, 3H), 2.55-2.64 (m, 2H), 1.63-1.72 (m, 1H), 1.34 (d, 3H, J = 6.4), 0.85 (d, 
3H, J = 6.8), 0.66 (d, 3H, J = 6.8), 0.63 (d, 3H, J = 6.6); 13C NMR (CDCl3, 125 MHz)  
148.8, 128.7, 120.1, 112.4, 66.1, 65.8, 60.5, 52.7, 33.7, 32.2, 29.5, 21.6, 21.0, 20.2, 16.9; 
IR: 2956, 1470, 1281, 1052, 964 cm–1; HRMS (DART-TOF) calcd. for C14H24N3O [M-
OMe]: 250.1919, found: 250.1926. []D
20 = -57.0 (c = 1.0, CH2Cl2, l = 50 mm). 
 
 
(4S)-2-isopropoxy-4-isopropyl-3-((S)-2-methyl-1-(1-methyl-1H-imidazol-2-
yl)propyl)oxazolidine, 3.41. In a dry glove-box, (4S)-4-isopropyl-2-methoxy-3-((R)-2-
methyl-1-(1-methyl-1H-imidazol-2-yl)propyl)oxazolidine (138 mg, 0.490 mmol) was 
dissolved in benzene (2.5 mL) in a scintillation vial and iPrO     2 μ       7 mmol  and 
10 molecular sieves (4 Å) were added. After sitting overnight, the sieves were filtered out 
of the solution and washed with benzene (3x1 mL).  The solution was concentrated to 
obtain a colorless oil (121 mg, 80%). 1H NMR (C6D6   00 M z  δ 7 20  d      J = 1.0), 
6.98 (s, 1H), 6.27 (d, 1H, J = 1.2), 4.35 (app heptet, 1H, J = 6.1), 3.80-3.83 (m, 1H), 
3.57-3.60 (m, 1H), 3.28 (d, 1H, J = 11.0), 2.85 (s, 3H), 2.66-2.73 (m, 1H), 2.58-2.62 (m, 
1H), 1.71-1.77 (m, 1H), 1.48 (d, 3H, J = 6.6), 1.30 (d, 3H, J = 6.1), 1.24 (d, 3H, J = 6.1), 
0.94 (d, 3H, J = 6.8), 0.75 (d, 3H, J = 6.8), 0.72 (d, 3H, J = 6.6); 13C NMR (C6D6, 126 
M z   δ     0   2      20 0    0 7  6     66    6     60    33 7  32 2  2  6  2  6  23 2  
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21.6, 21.1, 20.3, 17.0; IR: 2958, 2870, 1471, 1380, 1366, 1281, 1139, 1104, 1034, 980, 
950, 729 cm–1; HRMS (DART-TOF) calcd. for C14H24N3O [M-OiPr]: 250.1919, found: 
250.1911. []D
20 = -42.0 (c = 0.93, CDCl3, l = 50 mm). 
 
 
(S)-4-isopropyl-3-((R)-2-methyl-1-(1-methyl-1H-imidazol-2-yl)propyl)oxazolidine, 
3.23.25 To a stirring solution of (S)-3-methyl-2-(((R)-2-methyl-1-(1-methyl-1H-imidazol-
2-yl)propyl)amino)butan-1-ol (720 mg, 3.0 mmol) and paraformaldehyde (91 mg, 3.0 
mmol) in anhydrous toluene (30 mL), p-toluenesulfonic acid monohydrate (5.7 mg, 3.0 × 
10-2 mmol) was added. After refluxing overnight, reaction was cooled to room 
temperature, and CH2Cl2 (30 mL) was added. The resulting solution was concentrated. 
Flash column chromatography (100% EtOAc) afforded the product as a colorless oil (520 
mg, 68%). 1H NMR (CDCl3, 500 MHz)  7.00 (d, 1H, J = 1.2), 6.73 (d, 1H, J = 1.2), 
5.01 (d, 1H, J = 4.6), 4.34 (d, 1H, J = 4.4), 3.61 (s, 3H), 3.40-3.42 (m, 3H), 2.57 (dd, 1H, 
J = 12.7, 6.6), 2.17-2.27 (m, 1H), 1.65-1.75 (m, 1H), 1.12 (d, 3H, J = 6.6), 0.93 (d, 3H, J 
= 6.8), 0.86 (d, 3H, J = 6.6), 0.66 (d, 3H, J = 6.6); 13C NMR (CDCl3, 125 MHz)  147.9, 
127.9, 120.3, 81.8, 67.6, 67.2, 62.8, 33.1, 33.0, 31.0, 21.1, 20.2, 20.0, 18.1; IR: 2955,  
2868, 1468, 1279, 1140, 1084, 945, 724 cm–1; HRMS (DART-TOF) calcd. for 
25Agami, C.; Couty, F.; Rabasso, N. Tet. Lett. 2002, 43, 4633-4636.  
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C14H26N3O: [M+H]
+: 252.2076, found: 252.2075. []D
20 = +32.0 (c = 1.0, CH2Cl2, l = 50 
mm). 
 
 
N-((S)-1-hydroxy-3-methylbutan-2-yl)-N-((R)-2-methyl-1-(1-methyl-1H-imidazol-2-
yl)propyl)formamide, decomp-III. Hydrolysis of (S)-3-methyl-2-(((R)-2-methyl-1-(1-
methyl-1H-imidazol-2-yl)propyl)amino)butan-1-ol, catalyst III, (25 mg, 8.9 × 10-2 
mmol) by flash column chromatography (40:1, CH2Cl2:MeOH) afforded the product as a 
white solid (21 mg, 88%). 1H NMR (CDCl3, 500 MHz)  8.45 (s, 1H), 6.95 (d, 1H, J = 
1.2), 6.79 (d, 1H, J = 1.2), 5.54 (d, 1H, J = 11.2), 3.97 (ddd, 1H, J = 11.7, 4.4, 2.9), 3.76 
(dq, 1H, J = 11.7, 2.7), 3.60 (s, 3H), 3.49 (dt, 1H, J = 10.3, 2.7), 2.33-2.43 (m, 1H), 2.17 
(t, 1H, J = 4.9), 1.90-2.00 (m, 1H), 1.06 (d, 3H, J = 6.6), 0.83 (d, 6H, J = 6.4), 0.08 (d, 
3H, J = 6.8); 13C NMR (CDCl3, 125 MHz)  164.3, 144.9, 127.4, 120.9, 61.6, 60.3, 52.6, 
32.9, 29.3, 28.7, 20.3, 20.2, 20.0, 17.7; IR: 2963, 1648, 1490, 1248, 1080, 730 cm–1; 
HRMS (DART-TOF) calcd. for C14H26N3O2: [M+H]
+: 268.2025, found: 268.2034. 
[]D
20 = +48.0 (c = 1.0, CH2Cl2, l = 50 mm). 
Crystal Structure 
In order to get confirmation of the relative stereochemistry, III was hydrolyzed to the 
more crystalline compound decomp-III. It was crystallized out of pentanes at 25°C in a  
glove box.  
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Equilibrium Experiment of 3.11 with iPrOH (Scheme 3.9) 
In a glovebox, a solution of catalyst 3.11 (10.0 mg, 4.17 x 10-2 mmol) and N,N-
diisopropylethylamine hydrochloride (6.91 mg, 4.17 x 10-2 mmol) in anhydrous C6D6 
  00 μ   was made and dispensed into an NMR t  e   iPrOH (0.209 mmol,  00 μ    0   7 
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M solution in C6D6, 5 equiv) was added to the NMR tube. The reaction was monitored by 
1H NMR. After 15 hours, equilibrium was reached. A ratio of 48:52, 3.11 to 3.12 gave a 
Keq of 0.126. The equilibrium experiment was repeated with 10 eq iPrOH (0.417 mmol) 
which gave a ratio of 34:66, 3.11 to 3.12, and a Keq of 0.137. The average Keq was 0.131. 
Procedure for the Initial Studies of the Selective Functionalization of 1,2-Diols 
GC Method. An Agilent Technologies 7890A GC System equipped with a 7683B Series 
Injector was used to introduce samples into a J&W Scientific column (HP-5, 30 m, 0.320 
mm ID  0 2  μm  film    he G  wa s r n at  00 °  for  0 mi n tes  a nd then the 
temperature was ramped 8 °C/min. to a final temperature of 180 °C. Compounds were 
detected by FID and data was analyzed with Agilent Technologies GC Chemstation 
software. Retention times are reported in minutes. 
Scheme 3.10, Eq. 1 
In an oven-dried reaction vial, 1-phenyl-1,2-ethanediol, 3.13, (28 mg, 0.20 mmol) was 
dissolved in anhydrous THF (0.5 mL). N-methylimidazole  3 2 μ   4.0 x 10-2 mmol, 20 
mol %) was added, and the reaction was stirred at room temperature for 10 minutes. N,N-
Diisopropylethylamine   2 μ    0 2  mm ol  was added  followed  y addition of a sol ti on 
of tert-butylchlorodimethylsilane (33 mg, 0.20 mmol) in anhydrous THF (0.5 mL). After 
stirring at room temperature for 12 hours, the reaction was quenched by addition of N,N-
diisopropylethylamine  30 μ   and methanol    μ      he mi t re  was stirred at room 
temperature for 10 min and filtered through a Pasteur pipette packed with silica gel, 
followed by a flush with EtOAc (10 mL). GC analysis afforded the selectivity of the 
reaction. 
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Scheme 3.10, Eq. 2 
To an oven-dried reaction vial, a solution of 1-phenyl,-1,2-ethanediol, 3.13, (28 mg, 0.20 
mmol) and 3.11 (9.6 mg, 4.0 x 10-2 mmol, 20 mol %) in anhydrous THF (0.5 mL) was 
added. The reaction was stirred at room temperature for 10 minutes. N,N-
Diisopropylethylamine   2 μ    0 2  mm ol  was added  followed  y addition of a sol ti on 
of tert-butylchlorodimethylsilane (33 mg, 0.20 mmol) in anhydrous THF (0.5 mL). After 
stirring at room temperature for 12 hours, the reaction was quenched by addition of N,N-
diisopropylethylamine  30 μ   and methanol    μ      he mi t re  was stirred at room 
temperature for 10 min and filtered through a Pasteur pipette packed with silica gel, 
followed by a flush with EtOAc (10 mL). GC analysis afforded the selectivity of the 
reaction. 
 
 
2-((tert-Butyldimethylsilyl)oxy)-1-phenylethanol, 3.14. A 100 mL flask was charged 
with tert-butyldimethylsilyl chloride (545 mg, 3.62 mmol) in THF (18 mL). N,N-
Diisopropylethylamine (0.630 mL, 3.62 mmol), N-methylimidazole (5.80 x 10-2 mL, 
0.720 mmol) and 1-phenyl-1,2-ethanediol, 3.13, (501 mg, 3.62 mmol) in THF was slowly 
added as a mixture. The reaction was allowed to stir for 48 hours before quenching with 
MeOH. The resulting mixture was evaporated in vacuo and the crude product was 
purified on silica gel with 5% EtOAc/Hex to yield 631 mg (69%) of the title compound 
as a clear oil. 1H NMR (CDCl3   00 M z  δ 7 2 -7.39 (m, 5H), 4.74-4.77 (m, 1H), 3.78 
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(dd, lH, J = 4.0, 10.0), 3.56 (dd, 1H, J = 8.5, 10.0), 3.00 (d, 1H, J = 2.0), 0.93 (s, 9H), 
0.09 (s, 3H), 0.08 (s, 3H); 13C NMR (CDCl3   00 M z   δ   0 3   28.3, 127.7, 126.2, 
74.4, 68.9, 25.9, 18.3, -5.3, -5.4; IR: 3443, 3063, 2953, 2856, 1253, 1103, 833, 698 cm-1; 
HRMS calcd. for C14H25O2Si [M-H]
+: 253.1623, found: 253.1617. GC Method: 76.2 
min. 
 
 
2,2,3,3,8,8,9,9-Octamethyl-5-phenyl-4,7-dioxa-3,8-disiladecane. A 100 mL flask was 
charged with tert-butyldimethylsilyl chloride (2.40 g, 15.9 mmol) in THF (18 mL). N-
methylimidazole (1.30 mL, 15.9 mmol) and 1-phenyl-1,2-ethanediol, 3.13, (1.01 g, 7.24 
mmol) in THF was slowly added as a mixture. The reaction was allowed to stir for 48 
hours before quenching with MeOH. The resulting mixture was evaporated in vacuo and 
the crude product was purified on silica gel with 2% EtOAc/Hex to yield 1.30 g (49%) of 
the title compound as a clear oil. 1H NMR (CDCl3   00 M z   δ 7 26-7.38 (m, 5H), 4.73 
(dd, 1H, J = 5.5, 7.5), 3.70 (dd, 1H, J = 7.0, 10.5), 3.58 (dd, 1H, J = 5.0, 10.0), 0.92 (s, 
9H), 0.89 (s, 9H), 0.10 (s, 3H), 0.001 (s, 3H), -0.01 (s, 3H), -0.02 (s, 3H); 13C NMR 
(CDCl3   00 M z   δ   2      27     27 2   26    76    70 1, 26.0, 25.9, 18.4, 18.3, -4.6, -
4.8, -5.4, -5.5; IR: 2954, 2928, 2856, 1471, 1253, 1095, 830, 774 cm-1; HRMS calcd. for 
C20H42NO2Si2 [M+NH4]
+: 384.2763, found: 384.2754. GC Method: 91.7 min. 
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2-((tert-Butyldimethylsilyl)oxy)-2-phenylethanol, 3.15. A 100 mL flask was charged 
with 2,2,3,3,8,8,9,9-octamethyl-5-phenyl-4,7-dioxa-3,8-disiladecane (1.30 g, 3.55 mmol) 
in ethanol (7 mL), followed by addition of pyridinium p-toluenesulfonate (0.892 g, 3.55 
mmol). The reaction was allowed to stir for 13 hours before quenching with 
triethylamine. The crude mixture was evaporated in vacuo and the crude product was 
purified on silica gel eluting with 5% EtOAc/Hex to yield 647 mg (72%) of the title 
compound as a colorless oil. 1H NMR (CDCl3, 500 MHz) δ 7 26-7.35 (m, 5H), 4.76 (dd, 
1H, J = 4.5, 7.5), 3.57-3.60 (m, 2H), 2.07 (dd, 1H, J = 5.0, 8.5), 0.91 (s, 9H), 0.07 (s, 
3H), -0.09 (s, 3H); 13C NMR (CDCl3   00 M z   δ         2  3   27 7   26 3  7     6     
25.8, 25.6, 18.2, -4.5, -5.0; IR: 3433, 2953, 2856, 1252, 1098, 912, 776, 698 cm-1; 
HRMS calcd. for C14H25O2Si [M+H]
+: 253.1623, found: 253.1620. GC Method: 61.3 
min. 
Scheme 3.11, Eq. 1 
In an oven-dried reaction vial, 1-phenyl-1,2-ethanediol, 3.13, (28 mg, 0.20 mmol) was 
dissolved in anhydrous THF (1.0 mL). N-methylimidazole  3 2 μ   4.0 x 10-2 mmol, 20 
mol %) was added, and the reaction was stirred at room temperature for 10 minutes. N,N-
Diisopropylethylamine   2 μ    0 2  mm ol  was added  followed  y triethylchlorosilane 
 36 μ   0 20 mmol   After stirring at room temperat re  for  2 h o rs  the  reaction was 
quenched by addition of N,N-diisopropylethylamine  30 μ   and methanol    μ      he 
mixture was stirred at room temperature for 10 min and filtered through a Pasteur pipette 
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packed with silica gel, followed by a flush with EtOAc (10 mL). GC analysis afforded 
the selectivity of the reaction. 
Scheme 3.11, Eq. 2 
To an oven-dried reaction vial, a solution of 1-phenyl,-1,2-ethanediol, 3.13, (28 mg, 0.20 
mmol) and 3.11 (9.6 mg, 4.0 x 10-2 mmol, 20 mol %) in anhydrous THF (1.0 mL) was 
added. The reaction was stirred at room temperature for 10 minutes. N,N-
Diisopropylethylamine   2 μ    0 2  mm ol  was added  followed  y triethylchlorosilane 
 36 μ   0 20 mmol   After stirring at room temperat re  for  2 h o rs  the  reaction was 
quenched by addition of N,N-diisopropylethylamine  30 μ   and methanol    μ      he 
mixture was stirred at room temperature for 10 min and filtered through a Pasteur pipette 
packed with silica gel, followed by a flush with EtOAc (10 mL). GC analysis afforded 
the selectivity of the reaction. 
 
 
1-phenyl-2-((triethylsilyl)oxy)ethanol, 3.16. A 100 mL flask was charged with 
triethylchlorosilane (1.09 g, 7.24 mmol) in THF (18 mL). N-methylimidazole   7  μ    
7.24 mmol) and l-phenyl-1,2-ethanediol, 3.13, (1.0 g, 7.24 mmol) in THF (18 mL) was 
slowly added as a mixture. The reaction was allowed to stir for 48 hours before 
quenching with MeOH. The resulting mixture was evaporated in vacuo and the crude 
product was purified on silica gel with 2% EtOAc/Hex to yield 898 mg (49%) of the title 
compound as a clear oil. 1H NMR (CDCl3   00 M  z   δ 7 29-7.42 (m, 5H), 4.77-4.79 (m, 
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1H), 3.79 (dd, 1H, J = 3.5, 10.0), 3.59 (dd, 1H, J = 9.0, 10.5), 3.17 (d, 1H, J = 2.0), 1.01 
(t, 9H, J = 8.0), 0.66 (q, 6H, J = 8.0); 13C NMR (CDCl3   00 M z  δ   0     2  3  
127.7, 126.2, 74.5, 68.7, 6.7, 4.4; IR: 3456, 2954, 2876, 1454, 1104, 1005, 743, 699 cm-
1; HRMS (DART-TOF) calcd. for C14H25O2Si [M+H]
+: 253.1623, found: 253.1624. GC 
Method: 88.2 min. 
 
 
3,3,8,8-Tetraethyl-5-phenyl-4, 7-dioxa-3,8-disiladecane. A 100 mL flask was charged 
with triethylchlorosilane (2.40 g, 15.9 mmol) in THF (9 mL). N-methylimidazole (1.30 g, 
15.9 mmol) and 1-phenyl-1,2-ethanediol, 3.13, (1.01 g, 7.24 mmol) in THF (9 mL) was 
slowly added as a mixture. The reaction was allowed to stir for 96 hours before 
quenching with MeOH. The resulting mixture was evaporated in vacuo and the crude 
product was purified on silica gel with 2% EtOAc/Hex to yield 824 mg (31%) of the title 
compound as a clear oil. 1H NMR (CDCl3   00 M  z   δ 7 26-7.39 (m, 5H), 4.75 (dd, 1H, 
J = 5.0, 7.0), 3.72 (dd, 1H, J = 7.0, 10.0), 3.60 (dd, 1H, 5.0, 10.0), 0.92-0.97 (m, 18H), 
0.55-0.65 (m, 12H); 13C NMR (CDCl3   00 M z   δ   2     27     27 2   26    7     
69.6, 6.8, 6.7, 4.9, 4.4; IR: 2953, 2876, 1124, 1095, 1004, 723, 697 cm-1; HRMS 
calcd. for C20H39O2Si2 [M+H]
+: 367.2488, found: 367.2495. GC Method: 98.4 min. 
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2-Phenyl-2-((triethylsilyl)oxy)ethanol, 3.17. A 50 mL flask was charged with 3,3,8,8- 
tetraethyl-5-phenyl-4,7-dioxa-3,8-disiladecane (831 mg, 2.26 mmol) in ethanol (5 mL), 
followed by addition of pyridinium p-toluenesulfonate (572 mg, 2.26 mmol). The 
reaction was allowed to stir for 14 hours before quenching with triethylamine. The crude 
mixture was evaporated in vacuo and the crude product was purified on silica gel eluting 
with 2% EtOAc/Hex to yield 281 mg (49%) of the title compound as a clear oil. 1H NMR 
(CDCl3   00 M z   δ 7.26-7.33 (m, 5H), 4.76 (dd, 1H, J = 4.5, 7.5), 3.57-3.60 (m, 2H), 
2.12 (dd, 1H, J = 5.0, 8.5), 0.89 (t, 9H, J = 8.5), 0.59 (q, 6H, J = 8.5); 13C NMR (CDCl3, 
 00 M z   δ        128.2, 127.7, 126.2, 75.6, 68.9, 6.7, 4.8; IR: 3406, 2953, 2875, 1454, 
1098, 1004, 725, 698 cm-1; HRMS calcd. for C14H25O2Si [M+H]
+: 253.1623, found: 
253.1634. GC Method: 85.1 min. 
Reaction of 3.11 with Individual Enantiomers (Scheme 3.12, Eq 1) 
To an oven-dried reaction vial, a solution of (S)-1-phenyl-1,2-ethanediol, (S)-3.13, (28 
mg, 0.20 mmol), N,N-diisopropylethylamine hydrochloride (6.6 mg, 4.0 x 10-2 mmol, 20 
mol %), and 3.11 (9.6 mg, 4.0 x 10-2 mmol, 20 mol %) in anhydrous THF (3 mL) was 
added. The reaction was stirred at room temperature for 10 minutes. N,N-
Diisopropylethylamine   2 μ    0 2  mm ol  1.2 equiv) was added, followed by 
triethylchlorosilane  36 μ   0 20 mmol    0 eq iv ). After stirring at room temperature for 
12 hours, the reaction was quenched by addition of N,N-diisopropylethylamine  30 μ   
and methanol    μ      he mi t re  was stirred at room temperature for 10 min and filtered 
through a Pasteur pipette packed with silica gel, followed by a flush with EtOAc (10 
mL). GC analysis afforded the yield and selectivity of the reaction. 
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Reaction of 3.11 with Individual Enantiomers (Scheme 3.12, Eq 2) 
To an oven-dried reaction vial, a solution of (R)-1-phenyl-1,2-ethanediol, (R)-3.13, (28 
mg, 0.20 mmol), N,N-diisopropylethylamine hydrochloride (6.6 mg, 4.0 x 10-2 mmol, 20 
mol %), and 3.11 (9.6 mg, 4.0 x 10-2 mmol, 20 mol %) in anhydrous THF (3 mL) was 
added. The reaction was stirred at room temperature for 10 minutes. N,N-
Diisopropylethylamine   2 μ    0 2  mm ol    2 eq  iv ) was added, followed by 
triethylchlorosilane  36 μ   0 20 mmol    0 eq iv ). After stirring at room temperature for 
12 hours, the reaction was quenched by addition of N,N-diisopropylethylamine  30 μ   
and methanol    μ      he mi t re  was stirred at room temperat re  for  0 min and filtered 
through a Pasteur pipette packed with silica gel, followed by a flush with EtOAc (10 
mL). GC analysis afforded the yield and selectivity of the reaction. 
Catalyst Optimization Procedure with 3.13 (Table 3.2) 
To an oven-dried reaction vial, a solution of (R)-1-phenyl-1,2-ethanediol, (R)-3.13, (28 
mg, 0.20 mmol), N,N-diisopropylethylamine hydrochloride (6.6 mg, 4.0 x 10-2 mmol, 20 
mol %), and catalyst (20 mol %) in anhydrous THF (3 mL) was added. The reaction was 
stirred at room temperature for 10 minutes. N,N-Diisopropylethylamine   2  μ   0 2  
mmol, 1.2 equiv) was added, followed by triethylchlorosilane  36 μ   0 20 mmol    0 
equiv). After stirring at room temperature for 12 hours, the reaction was quenched by 
addition of N,N-diisopropylethylamine  30 μ   and methanol    μ      he  mi t re  was 
stirred at room temperature for 10 min and filtered through a Pasteur pipette packed with 
silica gel, followed by a flush with EtOAc (10 mL). GC analysis afforded the yield and 
selectivity of the reaction. 
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Table 3.2 
R= tBu (1.0 x 10-1 mg, 4.0 x 10-2 mmol, 20 mol %) 
R= iPr, 3.11, (9.6 mg, 4.0 x 10-2 mmol, 20 mol %) 
R= iBu (1.0 x 10-1 mg, 4.0 x 10-2 mmol, 20 mol %) 
R= Me (9.1 mg, 4.0 x 10-2 mmol, 20 mol %) 
R= H (8.5 mg, 4.0 x 10-2 mmol, 20 mol %) 
R= Ph (12 mg, 4.0 x 10-2 mmol, 20 mol %) 
 
Stereoselective Functionalization of Diols 
General Catalyst Optimization Procedure with 3.18 
To an oven-dried glass reaction vial, a solution of cis-1,2-cyclopentanediol, 3.18 (2.0 x 
101 mg, 0.20 mmol), catalyst (4.0 x 10-2 mmol, 20 mol %), and N,N 
diisopropylethylamine hydrochloride (6.6 mg, 4.0 x 10-2 mmol, 20 mol %) in anhydrous 
THF (0.25 mL) was added. The reaction was stirred at 4 °C for 10 minutes. N,N-
diisopropylethylamine (42 L, 0.24 mmol, 1.2 equiv) was added, followed by addition of 
a solution of tert-butylchlorodimethylsilane (120 mg, 0.80 mmol, 4.0 equiv) in anhydrous 
THF (0.25 mL). After stirring at 4 °C for 24 hours, the reaction was quenched by addition 
of N,N-diisopropylethylamine (100 L) and methanol (30 L). The mixture was stirred 
for 10 minutes and filtered through a Pasteur pipette packed with silica gel, followed by 
flush with EtOAc (15 mL). To the combined filtrate, 1,3,5-trimetho y e nzene   0 μ   of 
0.40M in EtOAc, 0.020 mmol) was added as  internal standard. Chiral GLC Analysis 
(Supelco Beta Dex 120 (30 m × 0.15 mm × 0.25 m film thickness), 78 °C for 100 min, 
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20 °C/min to 180 °C, 180 °C for 20 min, 15 psi.) of crude product afforded yields and 
enantioselectivities of 3.19. 
 
 
 
Major Prod c t 
 na ntiomer 
Minor Prod c t 
 na ntiomer 
Diol S  st rate 
Internal 
Standard  
G   Ret   ime    7 mi n    0 mi n  03   mi n  0    mi n 
Response 
Factora 
0 62 0 62   7    00  
aResponse factors were calculated against internal standard on GLC. b1,3,5-trimethoxybenzene was used as 
an  internal standard. 
 
Initial Catalyst Optimization (Table 3.3) 
R= Me (9.1 mg, 4.0 x 10-2 mmol, 20 mol %) 
R= iBu (1.0 x 10-1 mg, 4.0 x 10-2 mmol, 20 mol %) 
R= iPr, 3.11, (9.6 mg, 4.0 x 10-2 mmol, 20 mol %) 
R= tBu (1.0 x 10-1 mg, 4.0 x 10-2 mmol, 20 mol %) 
(S, S) and (S, R)-Catalysts (Table 3.4) 
R= (S)-Me (1.0 x 10-1 mg, 4.0 x 10-2 mmol, 20 mol %)  
R= (S)-iPr (11 mg, 4.0 x 10-2 mmol, 20 mol %) 
R= (R)-Me (1.0 x 10-1 mg, 4.0 x 10-2 mmol, 20 mol %) 
R= (R)-Ph (13 mg, 4.0 x 10-2 mmol, 20 mol %) 
R= (R)-iPr, III, (11 mg, 4.0 x 10-2 mmol, 20 mol %) 
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General Optimization Procedure: 
To an oven-dried glass reaction vial, a solution of cis-1,2-cyclopentanediol, 3.18 (2.0 x 
101 mg, 0.20 mmol), III (11 mg, 4.0 x 10-2 mmol, 20 mol %), and N,N-
diisopropylethylamine hydrochloride (6.6 mg, 4.0 x 10-2 mmol, 20 mol %) in anhydrous 
THF (0.25 mL) was added. The reaction was stirred at room temperature for 10 minutes. 
N,N-diisopropylethylamine (42 L, 0.24 mmol, 1.2 equiv) was added, followed by 
addition of a solution of tert-butylchlorodimethylsilane (120 mg, 0.80 mmol, 4.0 equiv) 
in anhydrous THF (0.25 mL). After stirring at room temperature for 4 hours, the reaction 
was quenched by addition of N,N-diisopropylethylamine (100 L) and methanol (30 L). 
The mixture was stirred at room temperature for 10 minutes and filtered through a 
Pasteur pipette packed with silica gel, followed by flush with EtOAc (15 mL). To the 
combined filtrate, 1,3,5-trimetho y e nzene   0 μ   of 0  0M i n  tOA c  0 020 mmol  was 
added as  internal standard. Chiral GLC Analysis (Supelco Beta Dex 120 (30 m × 0.15 
mm × 0.25 m film thickness), 78 °C for 100 min, 20 °C/min to 180 °C, 180 °C for 20 
min, 15 psi.) of crude product, 3.19, afforded yields and enantioselectivities. 
Time Course with III (Table 3.5) 
The General Optimization Procedure was followed except the reaction time was 8 hours 
for entry 2.  
Catalyst Loading Screen (Table 3.6) 
The General Optimization Procedure was followed using 5 mol % (2.8 mg, 1.0 x 10-2 
mmol), 10 mol % (5.6 mg, 2.0 x 10-2 mmol), and 20 mol % (11 mg, 4.0 x 10-2 mmol) of 
III. 
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1,2,2,6,6-Pentamethylpiperdine as the Base (Scheme 3.16) 
The General Optimization Procedure was followed using 1,2,2,6,6-pentamethylpiperidine 
(44 L, 0.24 mmol, 1.2 equiv) instead of N,N-diisopropylethylamine as the base. 
Time Screen with PMPP and PMPP·HCl (Table 3.7) 
To an oven-dried glass reaction vial, a solution of cis-1,2-cyclopentanediol, 3.18 (2.0 x 
101 mg, 0.20 mmol), III (11 mg, 4.0 x 10-2 mmol, 20 mol %), and 1,2,2,6,6-
pentamethylpiperidine hydrochloride (1.2 mg, 6.0 x 10-3 mmol, 3 mol %) in anhydrous 
THF (0.25 mL) was added. The reaction was stirred at room temperature for 10 minutes. 
1,2,2,6,6-pentamethylpiperidine (44 L, 0.24 mmol, 1.2 equiv) was added, followed by 
addition of a solution of tert-butylchlorodimethylsilane (121 mg, 0.80 mmol, 4.0 equiv) 
in anhydrous THF (0.25 mL). After stirring at room temperature for 2 or 4 hours, the 
reaction was quenched by addition of N,N-diisopropylethylamine (100 L) and methanol 
(30 L). The mixture was stirred at room temperature for 10 minutes and filtered through 
a Pasteur pipette packed with silica gel, followed by flush with EtOAc (15 mL). To the 
combined filtrate, 1,3,5-trimetho y e nzene   0 μ   of 0  0M i n  tOA c  0 020 mmol  was 
added as  internal standard. Chiral GLC Analysis (Supelco Beta Dex 120 (30 m × 0.15 
mm × 0.25 m film thickness), 78 °C for 100 min, 20 °C/min to 180 °C, 180 °C for 20 
min, 15 psi.) of crude product afforded yields and enantioselectivities. 
Concentration Screen (Table 3.8) 
The procedure for Table 3.7 was followed using 2.0 equiv TBSCl (120 mg, 0.80 mmol), 
running the reaction for 4 hours, and varying the concentration of the reaction. 
Concentrations: 0.2 M (1 mL), 0.4 M   00 μ       0 M  200 μ    
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Reaction with a Control Catalyst (Scheme 3.17) 
The procedure for Table 3.8 was followed using 3.23 (1.0 x 10-1 mg, 4.0 x 10-2 mmol, 20 
mol %) as the catalyst in THF (0.4 M). 
Reaction Run in tBuOH (Scheme 3.18) 
The procedure for Table 3.8 was followed using tBuOH (0.4 M) as the solvent. 
Reaction of (1R,2S,Z)-cyclooct-5-ene (Scheme 3.19) 
The procedure for Table 3.7 was followed using (1R,2S,Z)-cyclooct-5-ene, 3.31, (28 mg, 
0.20 mmol), and the reaction was run for 24 h at 4 °C. 
Substrate Synthesis 
The following compounds were made according to literature procedures and matched 
reported spectra: (1R,2S)-cyclohex-4-ene-1,2-diol26, (1R,2S)-cycloheptane-1,2-diol26, 
(1R,3S)-cyclopentane-1,3-diol27. 
General Procedure for Substrate Scope (Table 3.9) 
To an oven-dried glass reaction vial, a solution of cis-1,2-cyclopentanediol, 3.18, (41 mg, 
0.40 mmol), catalyst III (22 mg, 8.0 x 10-2 mmol, 20 mol %), and 1,2,2,6,6-
pentamethylpiperidine hydrochloride (2.3 mg, 1.2 x 10-2 mmol, 3 mol %) in anhydrous 
THF (0.50 mL) was added. The reaction was stirred at room temperature for 10 minutes. 
1,2,2,6,6-pentamethylpiperidine (87 L, 0.48 mmol, 1.2 equiv) was added, followed by 
addition of a solution of tert-butylchlorodimethylsilane (120 mg, 0.80 mmol, 2.0 equiv) 
in anhydrous THF (0.50 mL). After stirring at room temperature for 4 hours, the reaction  
 
26Alvarez, E.; Diaz, M. T.; Perez, R.; Ravelo, J. L.; Regueiro, A.; Vera, J. A.; Zurita, D.; Martin, J. D. J. 
Org. Chem. 1994, 59, 2848-2876. 27Chen,  Z.; Halterman, R. L. Organometallics 1994, 13, 3932-3942. 
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was quenched by addition of N,N-diisopropylethylamine (200 L) and methanol (60 L). 
The mixture was stirred at room temperature for 10 minutes and was concentrated. Flash 
column chromatography (Hex/EtOAc = 20/1) afforded pure product, 3.19, as a colorless 
oil (81 mg, 92%, 94% ee). Chiral GLC Analysis (Supelco Beta Dex 120 (30 m × 0.15 
mm × 0.25 m film thickness), 78 °C for 100 min, 20 °C/min to 180 °C, 180 °C for 20 
min, 15 psi.). 
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Table 3.9 Substrate Scope
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Desymmetrization Product Characterization 
 
Table 3.9, Entry 1. 
 
 
 
(1R,2S)-2-(tert-butyldimethylsilyloxy)cyclopentanol, 3.19. The general procedure was 
followed to yield a colorless oil (81 mg, 92%). GC (Supelco Beta Dex 120 (30 m x 0.15 
mm   0 2  μm film thickness   7  C for 100 min, 20 C/min to 180 C, 180 C for 20 
min, 15 psi., trmajor = 91.6 min, trminor = 94.4 min), 94% ee;
 1H NMR (CDCl3   00 M z   δ 
4.02-4.06 (m, 1H), 3.89-3.93 (m, 1H), 2.61 (d, 1H, J = 3.9), 1.59-1.88 (m, 5H), 1.42-1.51 
(m, 1H), 0.91 (s, 9H), 0.10 (s, 3H), 0.08 (s, 3H); 13C NMR (CDCl3   00 M z   δ 7     
73.7, 31.6, 31.1, 26.0, 20.2, 18.3, -4.4, -4.8; []D
20 = +18.7 (c = 0.52, CHCl3, l = 50 mm). 
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Table 3.9, Entry 2. 
 
 
 
(3R,4S)-4-((tert-butyldimethylsilyl)oxy)tetrahydrofuran-3-ol, 3.24. The general 
procedure was followed using 4 equivalents of tert-butylchlorodimethylsilane at 0.2 M 
and running 24 hours to yield a colorless oil (32 mg, 73%). GC (Supelco Beta Dex 120 
(30 m × 0.15 mm × 0.25 m film thickness), 75 °C for 260 min, 20 °C/min to 180 °C, 
180 °C for 20 min, 15 psi., trmajor = 223.3 min, trminor = 229.7 min), 92% ee; 
1H NMR 
(CDCl3, 500 MHz)  4.26 (dd, 1H, J = 11.5, 5.9), 4.08-4.12 (m, 1H), 3.87-3.92 (m, 2H), 
3.71 (dd, 1H, J = 9.5, 3.7), 3.57 (dd, 1H, J = 9.0, 5.6), 2.81 (d, 1H, J = 4.6), 0.90 (s, 9H), 
0.11 (s, 3H), 0.09 (s, 3H); 13C NMR (CDCl3, 125 MHz)  73.6, 72.5, 72.4, 71.2, 26.0, 
18.3, -4.5, -4.8; IR: 2953, 2930, 2858, 1254, 1131, 1069, 836, 779 cm–1; HRMS (DART-
TOF) calcd. for C11H23O3Si: [M+H]
+: 219.1417, found: 219.1421. []D
20 = +21.0 (c = 
1.1, CH2Cl2, l = 50 mm). 
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Table 3.9, Entry 3 
 
 
 
(1R,6S)-6-(tert-butyldimethylsilyloxy)cyclohex-3-enol, 3.25. The general procedure 
was followed running at 0.2 M in THF for 12 hours to yield a colorless oil (79 mg, 88%). 
GC  S pe lco Beta De   20  30 m   0    mm   0 2  μm film thickness      C for 70 
min, 20 C/min to 180 C, 180 C for 20 min, 15 psi., trmajor = 73.9 min, trminor = 74.1 
min), 90% ee; 1H NMR (CDCl3   00 M z  δ     -5.55 (m, 2H), 3.86-3.92 (m, 2H), 2.28-
2.30 (m, 2H), 2.18-2.22 (m, 3H), 0.90 (s, 9H), 0.08 (s, 6H); 13C NMR (CDCl3   00  δ 
124.0, 123.7, 70.0, 69.3, 31.5, 30.7, 26.0, 18.3, -4.3, -4.6; []D
20 = +24.2 (c = 1.0, CHCl3, 
l = 50 mm). 
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Table 3.9, Entry 4 
 
 
 
(2R,3S)-3-((tert-butyldimethylsilyl)oxy)-1,2,3,4-tetrahydronaphthalen-2-ol, 3.26. The 
general procedure was followed with (2R,3S)-1,2,3,4-tetrahydronaphthalene-2,3-diol (99 
mg, 0.60 mmol) at 0.2 M in THF for 8 hours to yield a colorless oil (140 mg, 85%). 
Chiral HPLC Analysis (Chiracel AS-H, hexanes/iPrOH = 99/1, 1.0 mL/min, 220 nm, 
trmajor= 4.9 min and trminor= 5.4 min) 95% ee; 
1H NMR (CDCl3   00 M z   δ 7 0 -7.26 (m, 
4H), 4.08-4.12 (m, 1H), 4.05-4.06 (m, 1H), 3.02 (t, 2H, J = 4.2), 2.99 (t, 1H, J = 8.3), 
2.87 (dd, 1H, J = 16.1, 5.4), 2.24 (d, 1H, J = 3.4), 0.90 (s, 9H), 0.12 (s, 3H), 0.11 (s, 3H); 
13C NMR (CDCl3   2  M z   δ  33     33     2  2   2  0   26 3   26    70    6 .8, 34.9, 
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34.5, 26.0, 18.3, -4.2, -4.5; IR: 2928, 1253, 1083, 980, 918, 831, 775, 742 cm-1; HRMS 
(DART-TOF) calcd. for C16H27O2Si: [M+H]
+: 279.1780, found: 279.1781. [α]D
25 = +27.0 
(c = 1.0, MeOH, l = 50 mm). 
 
 
 
 
Table 3.9, Entry 5. 
 
 
 
(1R,2S)-2-(tert-butyldimethylsilyloxy)cyclohexanol, 3.27. The general procedure was 
followed at 0.2 M in THF for 12 hours to yield a colorless oil (8.0 x 101 mg, 87%). GC 
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 S pe lco Beta De   20  30 m   0    mm   0 2  μm film thickness    0 C for 190 min, 
20 C/min to 180 C, 180 C for 20 min, 15 psi, trmajor = 167.4 min, trminor = 172.7 min), 
92% ee; 1H NMR (CDCl3   00  M z   δ 3 73-3.76 (m, 1H), 3.63-3.65 (m, 1H), 2.18-2.19 
(m, 1H), 1.72-1.79 (m, 2H), 1.65-1.72 (m, 2H), 1.56-1.62 (m, 2H), 1.44-1.51 (m, 1H), 
1.21-1.31 (m, 1H), 0.91 (s, 9H), 0.08 (s, 6H); 13C NMR (CDCl3   00 M z   δ 72 2  70    
30.7, 30.3, 26.0, 22.2, 21.3, 18.3, -4.3, -4.7; []D
20 = +12.1 (c = 1.1, MeOH, l = 50 mm). 
 
 
 
 
Table 3.9, Entry 6 
 
 
 
(1R,2S)-2-(tert-butyldimethylsilyloxy)cycloheptanol, 3.28. The general procedure was 
followed using 4 equivalents of tert-butylchlorodimethylsilane and 2 equivalents of 
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1,2,2,6,6-pentamethylpiperidine at 4 C for 24 hours to yield a colorless oil (39 mg, 
80%). GC  S pe lco Beta De   20  30 m   0    mm   0 2  μm film thickness      C for 
70 min, 20 C/min to 180 C, 180 C for 20 min, 15 psi, trmajor = 63.4 min, trminor = 63.7 
min), 90% ee; 1H NMR (CDCl3   00 M z   δ 3  0 -3.82 (m, 1H), 3.73-3.75 (m, 1H), 2.55 
(d, 1H, J = 4.4), 1.69-1.84 (m, 4H), 1.44-1.62 (m, 4H), 1.26-1.36 (m, 2H), 0.91 (s, 9H), 
0.083 (s, 3H), 0.081 (s, 3H); 13C NMR (CDCl3   26 M z   δ 7     73 7  3  2  3     2     
26.0, 22.6, 21.4, 18.3, -4.3, -4.8; []D
20 = +6.5 (c = 0.87, CHCl3, l = 50 mm). 
 
 
 
 
Table 3.9, Entry 7 
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(1R,2S)-2-(tert-butyldimethylsilyloxy)cyclooctanol, 3.29. The general procedure was 
followed using 4 equivalents of tert-butylchlorodimethylsilane and 2 equivalents of 
1,2,2,6,6-pentamethylpiperidine for 24 hours to yield a colorless oil (49 mg, 94%). GC 
 S pe lco Beta De   20  30 m   0    mm   0 2  μm film thickness     0 C for 30 min, 
20 C/min to 180 C, 180 C for 20 min, 15 psi, trmajor = 23.2 min, trminor = 23.9 min), 
86% ee; 1H NMR (CDCl3   00  M z   δ 3  2   dt      J = 9.0, 3.2), 3.71-3.73 (m, 1H), 
2.67-2.68 (m, 1H), 1.97-2.04 (m, 1H), 1.40-1.80 (m, 11H), 0.90 (s, 9H), 0.09 (s, 3H), 
0.08 (s, 3H); 13C NMR (CDCl3   00 M z   δ 7  7  73 7  30    2  2  27 0  26 0  2  7  2     
22.8, 18.3, -4.3, -4.7; []D
20 = +2.88 (c = 0.83, CHCl3, l = 50 mm). 
 
 
 
 
Table 3.9, Entry 8 
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(2R,3S)-3-(tert-butyldimethylsilyloxy)butan-2-ol, 3.30. The general procedure was 
followed using 4 equivalents of tert-butylchlorodimethylsilane and 2 equivalents of 
1,2,2,6,6-pentamethylpiperidine at 4 C for 36 hours to yield a colorless oil (32 mg, 
78%). GC (Supelco Beta Dex 120 (30 m   0    mm   0 2  μm film thickness    0 C for 
35 min, 20 C/min to 180 C, 180 C for 20 min, 15 psi, trmajor = 28.1 min, trminor = 29.1 
min), 91% ee; 1H NMR (CDCl3   00 M z   δ 3 6 -3.78 (m, 2H), 2.12-2.13 (m, 1H), 1.09 
(d, 3H, J = 5.7), 1.07 (d, 3H, J = 5.7), 0.90 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H); 13C NMR 
(CDCl3   00  M z   δ 72    7  3  26 0     2   7     7 2  -4.2, -4.7; []D
20 = +14.7 (c = 
0.19, CH2Cl2, l = 50 mm). 
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(1S,2S)-2-((tert-butyldimethylsilyl)oxy)cyclohexanol. The general procedure was 
followed with (±)-trans-1,2-cyclohexanediol (23 mg, 0.20 mmol) and running for 8 hours 
.The crude reaction was injected into the GC (Supelco Gamma Dex 120 (30 m × 0.15 mm 
× 0.25 μm film thickness), 100 °C for 85 min, 20 °C/min to 180 °C, 180 °C for 20 min, 
15psi, tr1 = 72.2 min, tr2 = 78.1 min) to show <5% yield. 
Reaction of a cis-1,3-Diol (Scheme 3.18) 
 
 
 
 
(1R,3S)-3-(tert-butyldimethylsilyloxy)cyclopentanol, 3.34. The general procedure was 
followed using 4 equivalents of tert-butylchlorodimethylsilane and 3.33 and running for 4 
hours. The crude reaction mixture was injected on the GC (Supelco Gamma Dex 120 (30 
m × 0.15 mm × 0.25 m film thickness), 95 °C for 60 min, 20 °C/min to 180 °C, 180 °C 
for 20 min, 16 psi, trmajor = 49.8 min, trminor = 50.9 min) to obtain a 26% yield and 15% ee. 
1H NMR (CDCl3, 500 MHz)  4.37-4.39 (m, 1H), 4.24-4.26 (m, 1H), 3.02 (d, 1H, J = 
10.3), 1.81-1.95 (m, 4H), 1.71-1.78 (m, 1H), 1.63-1.68 (m, 1H), 0.87 (s, 9H), 0.07 (s, 
6H); 13C NMR (CDCl3, 125 MHz)  75.1, 74.2, 44.6, 34.4, 34.3, 26.0, 18.1, -4.7, -4.8. 
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(2R,4S)-4-(tert-butyldimethylsilyloxy)pentan-2-ol. The general procedure was followed 
using 4 equivalents of tert-butylchlorodimethylsilane and running for 8 hours. The crude 
reaction was injected into the GC (Supelco Gamma Dex 120 (30 m × 0.15 mm × 0.25 m 
film thickness), 90 °C for 50 min, 20 °C/min to 180 °C, 180 °C for 20 min, 15 psi, tr1 = 
36.5 min, tr2 = 38.0 min) to show <5% yield. 
Silyl Reagent Screen (Table 3.10) 
 
Table 3.10, Entry 1. 
 
 
 
(1R,2S)-2-((triethylsilyl)oxy)cyclopentanol, 3.35. To an oven-dried glass reaction vial, a 
solution of cis-1,2-cyclopentanediol, 3.18 (61 mg, 0.60 mmol), catalyst III (34 mg, 0.12 
mmol, 20 mol %), and 1,2,2,6,6-pentamethylpiperidine hydrochloride (3.4 mg, 1.8 x 10-2 
mmol, 3 mol %) in anhydrous THF (3.0 mL) was added. The reaction was stirred at room 
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temperature for 10 minutes. 1,2,2,6,6-pentamethylpiperidine (130 L, 0.72 mmol, 1.2 
equiv) was added, followed by addition of triethylchlorosilane (120 L, 0.72 mmol, 1.2 
equiv). After stirring at room temperature for 1 hour, the reaction was concentrated. Flash 
column chromatography (Hex/EtOAc = 20/1) afforded pure product as a colorless oil 
(130 mg, 96%). Chiral GLC Analysis (Supelco Beta Dex 120 (30 m × 0.15 mm × 0.25 
m film thickness), 80 °C for 180 min, 20 °C/min to 180 °C, 180 °C for 20 min, 15 psi, 
trmajor = 160.5 min, trminor = 164.2 min) 90% ee. 
1H NMR (CDCl3, 500 MHz)  4.01 (dt, 
1H, J = 8.3, 4.9), 3.89 (dt, 1H, J = 8.3, 3.7), 2.65 (d, 1H, J = 3.4), 1.55-1.85 (m, 5H), 
1.39-1.48 (m, 1H), 0.95 (t, 9H, J = 8.0), 0.60 (q, 6H, J = 8.0); 13C NMR (CDCl3, 125 
MHz)  75.1, 73.7, 31.7, 31.2, 20.2, 6.9, 5.0; IR: 2955, 2876, 1123, 1096, 1005, 742, 728 
cm–1; HRMS (DART-TOF) calcd. for C11H25O2Si: [M+H]
+: 217.1624, found: 217.1629. 
[]D
20 = +18.0 (c = 1.0, CH2Cl2, l = 50 mm). 
A duplicate reaction of cis-1,2-cyclopentanediol, 3.18 (21 mg, 0.20 mmol) with the same 
procedure afforded the pure product as colorless oil (39 mg, 92%, 90% ee). 
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Table 3.10, Entry 2 
 
 
 
(1R,2S)-2-((tert-butyldiphenylsilyl)oxy)cyclopentanol, 3.36. To an oven-dried glass 
reaction vial, a solution of cis-1,2-cyclopentanediol, 3.18 (61 mg, 0.60 mmol), catalyst 
III (34 mg, 0.12 mmol, 20 mol %), and 1,2,2,6,6-pentamethylpiperidine hydrochloride 
(3.4 mg, 1.8 x 10-2 mmol, 3 mol %) in anhydrous THF (1.5 mL) was added. The reaction 
was stirred at room temperature for 10 minutes. 1,2,2,6,6-pentamethylpiperidine (130 L, 
0.72 mmol, 1.2 equiv) was added, followed by addition of tert-
butyl(chloro)diphenylsilane (620 L, 2.4 mmol, 4.0 equiv). After stirring at room 
temperature for 48 hours, the reaction was concentrated. Flash column chromatography 
(Hex/EtOAc = 80/1) afforded pure product as a colorless oil (150 mg, 71%). Chiral 
HPLC Analysis (Chiracel OD-H, Hexanes/iPrOH = 99/1, 1.0 mL/min, 220 nm, trminor = 
4.9 min and trmajor = 5.7 min), 88% ee; 
1H NMR (CDCl3, 500 MHz)  7.65-7.69 (m, 4H), 
7.42-7.45 (m, 2H), 7.25-7.40 (m, 4H), 4.03-4.07 (m, 1H), 3.86-3.90 (m, 1H), 2.73 (d, 1H, 
J = 2.9), 1.54-1.83 (m, 5H), 1.29-1.38 (m, 1H), 1.08 (s, 9H); 13C NMR (CDCl3, 125 
MHz)  136.0, 135.8, 133.9, 133.6, 130.1, 130.0, 128.0, 127.9, 76.7, 73.6, 31.1, 31.0, 
27.2, 20.0, 19.4; IR: 2931, 1105, 821, 740, 700, 611, 504 cm–1; HRMS (DART-TOF) 
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calcd. for C21H27OSi: [M-OH]
+: 323.1831, found: 323.1822. []D
20 = +12.0 (c = 1.0, 
CH2Cl2, l = 50 mm). 
 
 
 
A duplicate reaction of cis-1,2-cyclopentanediol, 3.18 (21 mg, 0.20 mmol) with the same 
procedure afforded the pure product as colorless oil (53 mg, 78%, 92% ee). 
Table 3.10, Entry 3 
 
 
 
(1R,2S)-2-((dimethyl(phenyl)silyl)oxy)cyclopentanol, 3.37. To an oven-dried glass 
reaction vial, a solution of cis-1,2-cyclopentanediol, 3.18 (21 mg, 0.20 mmol), catalyst 
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III (11 mg, 4.0 × 10-2 mmol, 20 mol %), and 1,2,2,6,6-pentamethylpiperidine 
hydrochloride (1.2 mg, 6.0 × 10-3 mmol, 3 mol %) in anhydrous THF (2.0 mL) was 
added. The reaction was stirred at room temperature for 10 minutes. 1,2,2,6,6-
pentamethylpiperidine (44 L, 0.24 mmol, 1.2 equiv) was added, followed by dropwise 
addition of a solution of chloro(dimethyl)phenylsilane (0.40 mL, 0.24 mmol, 1.2 equiv) 
in anhydrous THF (2.0 mL) over 2 hours by syringe pump. The reaction was 
concentrated. Flash column chromatography (Hex/EtOAc = 20/1) afforded the pure 
product as a colorless oil (34 mg, 72%). Chiral HPLC Analysis (Chiracel OD-H, 
Hexanes/iPrOH = 99.8/0.2, 0.50 mL/min, 220 nm, trminor = 25.3 min and trmajor = 27.0 
min), 80% ee; 1H NMR (CDCl3, 500 MHz)  7.55-7.57 (m, 2H,), 7.35-7.40 (m, 3H), 
3.98-4.02 (m, 1H), 3.85-3.88 (m, 1H), 2.58 (dd, 1H, J = 3.7, 0.5), 1.44-1.82 (m, 5H), 
1.35-1.44 (m, 1H), 0.40 (s, 3H), 0.39 (s, 3H); 13C NMR (CDCl3, 125 MHz)  137.8, 
133.6, 130.0, 128.2, 75.7, 73.7, 31.3, 31.0, 20.1, -1.0, -1.1; IR: 2961, 1253, 1117, 1093, 
891, 830, 787, 741, 700 cm–1; []D
20 = +14.0 (c = 1.0, CH2Cl2, l = 50 mm). 
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A duplicate reaction of cis-1,2-cyclopentanediol, 3.18 (21 mg, 0.20 mmol) with the same 
procedure afforded pure product as colorless oil (33 mg, 70%, 79% ee). 
Silylation with TESCl (Table 3.11) 
General procedure. To an oven-dried glass reaction vial, a solution of substrate (0.20 
mmol), catalyst III (11 mg, 4.0 x 10-2 mmol, 20 mol %), and 1,2,2,6,6-
pentamethylpiperidine hydrochloride (1.2 mg, 6.0 x 10-3 mmol, 3 mol %) in anhydrous 
THF (4.0 mL) was added. The reaction was stirred at room temperature for 10 minutes. 
1,2,2,6,6-pentamethylpiperidine     μ    0 2  mm ol    2 eq iv ) was added, followed by 
addition of triethylchlorosilane (0.40 mL, 0.24 mmol, 1.2 equiv). After stirring at room 
temperature for 4 hours, the reaction was concentrated. Flash column chromatography 
(Hex/EtOAc = 20/1) afforded the pure product. 
 
 
Chapter 3, Page 339 
 
(2R,3S)-3-((triethylsilyl)oxy)butan-2-ol, 3.38. meso-2,3-Butanediol (18 mg, 0.20 mmol) 
was silylated using the general procedure. Pure product was isolated as a colorless oil (34 
mg, 83%). Chiral GLC Analysis (Supelco Beta Dex 120 (30 m × 0.15 mm × 0.25 μm 
film thickness), 85 °C for 50 min, 20 °C/min to 180 °C, 180 °C for 20 min, 15 psi, trmajor 
= 41.4 min, trminor = 42.5 min) 92% ee. 
1H NMR (CDCl3, 500 MHz) δ 3.68-3.87 (m, 2H), 
2.20 (d, 1H, J = 3.9), 1.08 (d, 6H, J = 6.1), 0.96 (t, 9H, J = 7.8), 0.60 (q, 6H, J = 7.8); 13C 
NMR (CDCl3, 125 MHz) δ 71.8, 71.3, 17.6, 17.1, 7.0, 5.1; IR: 2956, 2877, 1239, 1106, 
1003, 908, 725 cm-1; HRMS (DART-TOF) calcd. for C10H25O2Si: [M+H]
+: 205.1624, 
found: 205.1626. [α]D
20 = +12.2 (c = 1.0, CH2Cl2, l = 50 mm). 
 
 
 
 
A duplicate reaction of meso-2,3-butanediol (54 mg, 0.60 mmol) with the same procedure 
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afforded the pure product, 3.38, as a colorless oil (110 mg, 85%, 92% ee). 
 
 
(3R,4S)-4-((triethylsilyl)oxy)hexa-1,5-dien-3-ol, 3.39. meso-1,5-Hexadiene-3,4-diol (23 
mg, 0.20 mmol) was silylated using the general procedure. Pure product was isolated as a 
colorless oil (38 mg, 83%). Chiral GLC Analysis (Supelco Beta Dex 120 (30 m × 0.15 
mm × 0 2  μ m film thickness    0 °  for   00 mi n  20 °C/min to 180 °C, 180 °C for 20 
min, 15psi, trmajor = 85.4 min, trminor = 87.4 min) 91% ee. 
1H NMR (CDCl3   00 M z   δ 
5.77-5.84 (m, 2H), 5.28 (dt, 1H, J = 17.4, 1.5), 5.23 (dt, 1H, J = 17.4, 1.5), 5.19-5.20 (m, 
1H), 5.16-5.18 (m, 1H), 4.10-4.12 (m, 1H), 4.04-4.08 (m, 1H), 2.32 (d, 1H, J = 4.4), 0.94 
(t, 9H, J = 8.1), 0.60 (q, 6H, J = 8.1); 13C NMR (CDCl3   2  M z  δ  36     36 6    7 3  
116.8, 77.1, 76.2, 7.0, 5.1; IR: 2955, 2877, 1459, 1416, 1238, 1003, 922, 829, 725 cm-1; 
HRMS (DART-TOF) calcd. for C12H23OSi: [M-OH]
+: 211.1518, found: 211.1527. [α]D
20 
= +4.1 (c = 1.0, CH2Cl2, l = 50 mm). 
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A duplicate reaction of meso-1,5-Hexadiene-3,4-diol (69 mg, 0.60 mmol) was silylated 
using the general procedure. Pure product, 3.39, was isolated as a colorless oil (110 mg, 80%, 
92% ee). 
 
 
(1R,2S)-1,2-diphenyl-2-((triethylsilyl)oxy)ethanol, 3.40. meso-1,2-Diphenylethane-1,2- 
diol (43 mg, 0.20 mmol) was silylated for 8 hours using the general procedure. Pure 
product was isolated as a colorless oil (53 mg, 81%). Chiral HPLC Analysis (Chiracel 
OJ-H, Hexanes/iPrOH = 99/1, 1.0 mL/min, 220 nm, trmajor = 7.3 min and trminor = 8.6 min) 
92% ee. 1H NMR (CDCl3   00 M z   δ 7  6 -7.27 (m, 10H), 4.75 (dd, 1H, J = 5.9, 2.9), 
4.70 (d, 1H, J = 5.9), 2.33 (d, 1H, J = 3.2), 0.77 (t, 9H, J = 7.8), 0.39 (q, 6H, J = 7.8); 13C 
NMR (CDCl3   2  M z   δ   0      0 7   27      27  6   27  0   27 7   27 6   27    
79.3, 78.9, 6.8, 4.8; IR: 2953, 2876, 1097, 1005, 837, 740, 700 cm-1; HRMS (DART-
TOF) calcd. for C10H25O2Si: [M+H]
+: 329.1937, found: 329.1926. [α]D
20 = +6.6 (c = 1.0, 
CH2Cl2, l = 50 mm). 
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A duplicate reaction of meso-1,2-diphenylethane-1,2-diol (130 mg, 0.60 mmol) was 
silylated using the general procedure. Pure product, 3.40, was isolated as a colorless oil (160 
mg, 83%, 87% ee). 
Absolute Stereochemical Proof 
The absolute stereochemistry of the products was determined by comparing the optical 
rotations to known values. The optical rotations of the silylated products in this paper 
were determined to be opposite in sign to the optical rotations of the products reported by 
the Hoveyda and Snapper groups18. The absolute stereochemistry of (1R,2S)-2-
((triethylsilyl)oxy)cyclopentanol, (1R,2S)-2-((tert-butyldiphenylsilyl)oxy)cyclopentanol, 
and (1R,2S)-2-((dimethyl(phenyl)silyl)oxy)cyclopentanol was assigned by analogy. 
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Catalyst Equilibrium Experiment with iPrOH (Scheme 3.21) 
 
 
In a glovebox, a solution of catalyst III (21 mg, 7.5 x 10-2 mmol) and 1,2,2,6,6-
pentamethylpiperidine hydrochloride (0.40 mg, 2.0 x 10-2 mmol) in anhydrous THF-d8 
 2 0 μ   was made   00 μ  of the sol ti on was added to a NMR t  e  2  μ  of an 
internal standard solution of 1,3,5-trimethoxybenzene (5.0 x 10-3 mmol, 0.20 M in THF) 
was added to the NMR tube. iPrO   0 2  mm ol   2  μ    2 M sol ti on in   F -d8) and 
MeOH (5.0 x 10-2 mmol  2  μ    2 M sol ti on in   F -d8) was added to the NMR tube. 
THF-d8  22  μ   was added to the NMR t  e  to reach a total volume of 0.5 mL. The 
reaction was monitored by 1H NMR. After 12 hours, equilibrium was reached. A ratio of 
70:30, III to 3.41 gave a Keq of 0.119. 
3.41 Equilbrium Experiment with MeOH 
 
 
An equilibrium experiment in the reverse direction of the above reaction was performed. 
In a glovebox, a solution of catalyst 3.41 (23 mg, 7.3 x 10-2 mmol) and 1,2,2,6,6-
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pentamethylpiperidine hydrochloride (0.80 mg, 4.0 x 10-3 mmol) in anhydrous THF-d8 
 2 0 μ   was made   0 μ   of the catalyst sol t ion and   0 μ   of the acid sol t ion was 
added to each of two NMR t  es     μ   of an internal standard sol tion of 1,3,5-
trimethoxybenzene (3.0 x 10-3 mmol, 0.20 M in THF) and iPrOH (6.3 x 10-2 mmol, 63 
μ    M sol  ti on in   F -d8) was added to each NMR tube as well. MeOH (0.08 mmol, 80 
μ    M sol  ti on in   F -d8) was added to NMR tube 1, and MeOH (0.12 mmol, 120 μ   
1M solution in THF-d8) was added to NMR tube 2, followed by THF-d8  27  μ  and 23  
μ   respectively to t  e    a nd 2  to reach a total vol m e of 0 6  m     h e reaction was 
monitored by 1H NMR. After 12 hours, equilibrium was reached. For tube 1, a ratio of 
16:84, 3.36 to III and gave a Keq of 0.121. For tube 2, a ratio of 10:90, 3.36 to III gave a 
Keq of 0.117. The average Keq for the two runs is 0.119 ± 0.002.  
Catalyst Equilibrium Experiment with 3.18 (Scheme 3.22) 
 
 
 
In a glovebox, catalyst III (5.6 mg, 2.0 x 10-2 mmol), 1,2,2,6,6-pentamethylpiperidine 
hydrochloride (0.60 mg, 3.0 x 10-3 mmol), and cis-1,2-cyclopentanediol, 3.18, (1.0 x 101 
mg, 0.10 mmol) were dissolved in THF-d8 (0.45 mL) and added to a NMR tube. 1,3,5-
Trimethoxybenzene, as an internal standard, (0.050 mL, 1.0 x 10-2 mmol, 0.20 M 
solution in THF) was added to the NMR tube. The exchange reaction was followed by 
1H NMR. The reaction reached equilibrium in 3 hours with 40% starting catalyst III 
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remaining and a 60:40 ratio of diastereomers (3.42 and 3.43). The Keq was determined to 
be 0.193. This reaction was repeated to give a Keq of 0.205. The average Keq is 0.199 ± 
0.006. The spectrum of the experiment and an NMR of III in THF-d8 are attached in the 
spectra section. 
Exchange of III with 3.19 (Scheme 3.23) 
 
 
Catalyst III (1.9 mg, 6.8 x 10-3 mmol, 20 mol %), 3.19 (7.4 mg, 3.0 x 10-2 mmol), and 
1,2,2,6,6-pentamethylpiperidine hydrochloride (2.0 x 10-1 mg, 1.0 x 10-3 mmol, 3 mol %) 
were mixed in THF-d8 and monitored by 
1H NMR. After 2 h, equilibrium was reached 
with a ratio of 76:24, III to 3.44, and a Keq of 0.02 ± 0.001. 
 
Exchange of III with 3.45 (Scheme 3.24) 
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(2R,4S)-2-((4-bromobenzyl)oxy)-4-isopropyl-3-((R)-2-methyl-1-(1-methyl-1H-
imidazol-2-yl)propyl)oxazolidine, 3.46. To an oven-dried reaction vial was added a 
solution of (4S)-4-isopropyl-2-methoxy-3-((R)-2-methyl-1-(1-methyl-1H-imidazol-2- 
yl)propyl)oxazolidine, III, (56 mg, 0.20 mmol), 4-bromobenzoyl alcohol, 3.45, (41 mg, 
0.22 mmol, 1.1 equiv.), and 1,2,2,6,6-pentamethylpiperidine hydrochloride (1.2 mg, 6.0 x 
10-3 mmol, 3 mol %) in 1.0 mL anhydrous THF. After stirring at room temperature for 8 
hours, solvent was removed under high vacuum, and the residue was redissolved in 1.0 
mL anhydrous THF. Removal and addition of solvent was repeated every 8 hours, until 
1H NMR showed complete conversion. Recrystallization of crude product with Et2O at 
4°C afforded pure product 3.46. 
 
Crystal Structure of 3.46, CCDC# 832192 (Figure 3.5) 
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Developing a Site Selective Functionalization Reaction 
The following compounds were made according to literature procedure: 1-benzyloxy-2,3-
propanediol, 3.5728, III17,and (S)-1-cyclohexylethane-1,2-diol, (S)-3.5016. 
Catalyst Synthesis 
 
 
2-(((1-Methyl-lH-imidazol-2-yl)methyl)amino)ethanol.24 To a solution of N-
methylimidazole-2-carboxaldehyde (2.0 g, 18 mmol) in methanol (40 mL) was added 
ethanolamine (1.1 mL, 18 mmol) and 3Å molecular sieves (1.4 g). After refluxing for 24 
hours, the reaction was cooled to room temperature, and NaBH4 (1.0 g, 27 mmol) was 
added. The reaction was stirred at room temperature for 2 hours, followed by quenching 
with dropwise addition of concentrated HCl (0.88 mL). The resulting mixture was further 
neutralized with Na2CO3 (2.9 g). The precipitated salts were filtered off, and the filtrate 
was concentrated. Flash column chromatography (CH2Cl2:MeOH = 9:1) afforded the 
pure product as a yellow oil (1.9 g, 68%). 1H NMR (CDCl3   00 M z   δ 6     d       J = 
1.0), 6.74 (d, 1H, J = 1.0), 5.79 (s, 2H), 3.89 (s, 2H), 3.62 (t, 2H, J = 5.0), 3.58 (s, 3H), 
2.82 (t, 2H, J = 5.0); 13C NMR (CDCl3   2  M z   δ     7   26     2  6         0    
43.8, 32.9; IR: 3280, 2947, 1496, 1282, 1049, 748, 655 cm-1; HRMS calcd. for 
C7H14N3O [M+H]
+: 156.1136, found: 156.1141. 
 
 
 
28Tsujigami, T.; Sugai, T.; Ohta, H. Tet. Asymm. 2001, 12, 2543-2549. 
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2-Methoxy-3-((1-methyl-1H-imidazol-2-yl)methyl)oxazolidine. To a solution of 
2-(((1-methyl-1H-imidazol-2-yl)methyl)amino)ethanol (0.50 g, 3.2 mmol) in anhydrous 
methanol (11 mL) under argon was added N,N-dimethylformamide dimethyl acetal (0.51 
mL, 3.8 mmol). The reaction was stirred at room temperature for 2 hours, and the solvent 
was removed under vacuum. The residue was redissolved in anhydrous methanol (11 
mL), and the reaction was again stirred at room temperature for 2 hours. The solvent was 
removed under vacuum. The flask was brought into a dry glove box under nitrogen 
atmosphere, and the residue was extracted with degassed pentane to afford the pure 
product as a colorless oil (320 mg, 51%). 1H NMR (C6D6   00 M z   δ 7 0   d   H, J = 
1.0), 6.38 (d, 1H, J = 1.0), 5.09 (s, 1H), 3.74 (d, 1H, J = 13.0), 3.65 (d, 1H, J = 13.0), 
3.63-3.67 (m, 1H), 3.53-3.57 (m, 1H), 3.09 (s, 3H), 2.99 (s, 3H), 2.73-2.77 (m, 1H), 2.56-
2.60 (m, 1H); 13C NMR (CDCl3   26 M z   δ     6   20    111.6, 107.1, 64.8, 51.1, 
49.1, 46.1, 37.6; IR: 2948, 2894, 1500, 1284, 1046, 953, 736 cm-1; HRMS calcd. for 
C8H12N2O [M-OMe]: 166.0980, found: 166.0980. 
 
 
(S)-2-(((1-Methyl-1H-imidazol-2-yl)methyl)amino)-2-phenylethanol.24 To a solution 
of N-methyl-imidazole-2-carboxaldehyde (1.37 g, 10.0 mmol) in benzene (30 mL) was 
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added (S)-glycinol (1.10 g, 10.0 mmol) and 3Å molecular sieves (1.40 g). After refluxing 
for 24 hours, the reaction was cooled to room temperature, and the solvent was removed 
in vacuo. The resulting residue was redissolved in MeOH (30 mL) and NaBH4 (378 mg, 
10.0 mmol) was added. The reaction was stirred at room temperature for 2 hours, 
followed by quenching with dropwise addition of concentrated HCl (0.51 mL). The 
resulting mixture was further neutralized with Na2CO3 (1.67 g). The precipitated salts 
were filtered off, and the filtrate was concentrated. Flash column chromatography 
(CH2Cl2:MeOH = 10:1) afforded the pure product as a yellow oil (1.88 g, 81%). 
1H 
NMR (CDCl3   00 M z   δ 7 2 -7.37 (m, 5H), 6.84 (d, 1H, J = 1.0), 6.72 (d, 1H, J = 
1.0), 3.82-3.86 (m, 1H), 3.66-3.69 (m, 3H), 3.55 (dd, 1H, J = 9.5, 11.0), 3.45 (s, 3H); 13C 
NMR (CDCl3   2  M z   δ   6      0     2      27 6   27     26     2  0  66    6  3  
55.9, 43.3, 32.6; IR: 3299, 2914, 2842, 1493, 1283, 1050, 758, 702 cm-1; HRMS calcd. 
for C13H18N3O [M+H]
+: 232.1449, found: 232.1454. 
 
 
(4S)-2-Methoxy-3-((1-methyl-lH-imidazol-2-yl)methyl)-4-phenyloxazolidine (60:40 
dr). To a solution of (S)-2-(((1-methyl-1H-imidazol-2-yl)methyl)amino)-2-phenylethanol 
(1.88 g, 8.10 mmol) in anhydrous methanol (30 mL) under argon was added N,N-
dimethylformamide dimethyl acetal (1.09 mL, 8.10 mmol). The reaction was stirred at 
room temperature for 2 hours, and the solvent was removed under vacuum. The residue 
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was redissolved in anhydrous methanol (13 mL), and the reaction was stirred at 
room temperature for 1 hour. The solvent was removed under vacuum. The flask 
was brought into a dry glove box under nitrogen atmosphere, and the residue was 
extracted with degassed pentane to afford the pure product as a pale yellow oil (1.95 g, 
88%). 1H NMR (C6D6   00 M z   δ 7 2 -7.26 (m, 1.2H), 7.15-7.18 (m, 0.8H), 6.99-7.09 
(m, 3H), 6.98 (d, 0.4H, J = 1.0), 6.96 (d, 0.6H, J = 1.0), 6.22 (d, 0.4H, J = 1.0), 6.20 (d, 
0.6H, J = 1.0), 5.60 (s, 0.6H), 5.39 (s, 0.4H), 4.18 (t, 0.6H, J = 8.0), 4.09 (t, 0.4H, J = 
8.0), 3.95-3.98 (m, 1H), 3.87 (dd, 0.6H, J = 7.0, 8.0), 3.72 (dd, 0.4H, J = 8.0, 9.5), 3.67-
3.70 (m, 0.8H), 3.70 (d, 0.6H, J= 14.0), 3.65 (d, 0.6H, J= 14.0), 3.20 (s, 0.4H), 3.15 (s, 
0.6H), 2.77 (s, 0.6H), 2.72 (s, 0.4H); 13C NMR (CDCl3   26 M z   δ     2    3      0 6  
138.9, 128.2, 127.1, 120.5, 120.4, 113.1, 110.5, 109.1, 106.5, 73.2, 72.3, 66.0, 63.3, 52.7, 
50.9, 44.9, 44.0, 41.8, 37.5, 32.0, 31.6; IR: 2943, 1498, 1453, 1283, 1155, 1042, 731, 700 
cm-1; HRMS calcd. for C14H16N3O [M-OMe]: 242.1293, Found: 242.1308. 
 
 
(S)-2-(((R)-cyclopentyl(1-methyl-1H-imidazol-2-yl)methyl)amino)-3-methylbutan-1-
ol (94:6 dr).24,29 Cyclopentene (7.5 g, 110 mmol) and tris(2,4-ditert-butyl-
phenyl)phosphite (890 mg, 1.4 mmol) were distributed evenly into five Endeavor 
reaction vials that were purged with nitrogen. Rh(acac)(CO)2 (99 mg, 1.8 x 10
-2 mmol) 
was dissolved in benzene (22 mL) and also distributed evenly into the five reaction vials.  
29Trzeciak, A. M.; Ziolkowski, J. J. J. Organomet. Chem. 1994, 479, 213-216. 
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The vials were purged 3 times with 1:1 H2/CO, pressurized to 150 psi, and heated to 80 
°C. The reactions were stirred for 6 hours maintaining constant temperature and pressure. 
Four of the vials containing the crude cyclopentanecarboxaldehyde were combined and 
used in the next step without purification. To a stirring solution of (S)-valinol (9.1 g, 88 
mmol) in anhydrous THF (180 mL) under nitrogen atmosphere was added a solution of 
crude cyclopentanecarboxaldehyde (88 mmol) in benzene (18 mL). MgSO4 (18 g) was 
added, and the solution was stirred at room temperature for 3 hours to form the imine 
which closes to the oxazolidine in situ. In another oven-dried flask, to a solution of N-
methylimidazole (25 g, 310 mmol) in anhydrous THF (180 mL) under nitrogen 
atmosphere was added n-butyllithium (31 mL, 10 M in hexanes, 310 mmol) dropwise at -
78 °C. The solution was stirred at -78 °C for 30 minutes, and then was slowly cannula 
transferred into the solution of formed oxazolidine at -78 °C. The resulting mixture was 
stirred overnight and gradually warmed to room temperature. Saturated aqueous NH4Cl 
solution was added slowly to quench the reaction. The organic layer was separated, and 
the aqueous layer was extracted with Et2O (3×200 mL). The combined organic layers  
were dried over MgSO4 and concentrated. Column chromatography (CH2Cl2/MeOH = 
30:1) afforded the product as colorless oil (12 g, 63%).  1H NMR (CDCl3, 500 MHz)  
0.77 (d, 0.18H, J = 6.8), 0.82 (d, 0.18H, J = 6.8), 0.87 (d, 2.82H, J = 6.8), 0.91 (d, 2.82H, 
J = 6.8), 1.20-1.32 (m, 0.54H), 1.33-1.74 (m, 8.46H), 2.13-2.22 (m, 1.88H), 2.24-2.27 
(m, 0.12H), 3.26 (d, 0.06H, J = 7.1), 3.28 (d, 0.94H, J = 5.9), 3.30 (d, 0.94H, J = 2.9), 
3.32 (d, 0.06H, J = 4.4), 3.61 (s, 2.82H), 3.62 (s, 0.18H), 3.72 (d, 1H, J = 7.6), 6.72 (d, 
0.06H, J = 1.2), 6.76 (d, 0.94H, J = 1.2), 6.93 (d, 0.94H, J = 1.2); 13C NMR (CDCl3, 125 
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MHz)  38.1, 38.3, 38.4, 38.6, 44.4, 44.5, 44.6, 48.6, 48.7, 48.9, 49.8, 50.1, 52.1, 65.0, 
77.7, 78.0, 79.3, 81.6, 82.0, 82.7, 139.7, 140.2, 146.1, 146.2, 169.8, 170.6; IR: 3201, 
2952, 2868, 1486, 1467, 1280, 1107, 1047, 835, 724 cm–1; HRMS (ESI+) calcd. for 
C15H28N3O [M+H]
+: 266.2227, found: 266.2247. []D
20 = +46.7 (c = 1.0, CH2Cl2, l = 50 
mm). 
Note: The mixture of diastereomers can be taken forward because only one precipitates 
during purification in the next step.  
 
 
 
(2R,4S)-3-((R)-cyclopentyl(1-methyl-1H-imidazol-2-yl)methyl)-4-isopropyl-2-
methoxyoxazolidine, IV (99:1 dr). To a solution of (S)-2-(((R)-cyclopentyl(1-methyl-
1H-imidazol-2-yl)methyl)amino)-3-methylbutan-1-ol (7.4 g, 28 mmol) in anhydrous 
MeOH (56 mL) under nitrogen atmosphere was added N,N-dimethylformamide dimethyl 
acetal (19 mL, 140 mmol). The reaction was stirred at 50 °C overnight. The solvent was 
removed under vacuum, and the residue was redissolved in anhydrous MeOH (56 mL) in 
order to convert the small amount of dimethylamine bound catalyst to methanol bound 
catalyst. The reaction was stirred at 50 °C for 2 hours, and the solvent was removed 
under vacuum. The residue was moved into a dry box and was dissolved in anhydrous 
pentane (250 mL). The solution was cooled to -40 °C overnight, and a dark yellow oil 
formed on the bottom of the flask. The top clear organic layer was decanted off and was 
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concentrated to approximately 100 mL. The solution was cooled to -40 °C overnight 
during which the product precipitated as a white solid. The solid was filtered and washed 
with a small portion of cold pentane to afford pure product (3.9 g, 46%). 1H NMR 
(CDCl3, 500 MHz)  0.69 (d, 3H, J = 7.1), 0.73-0.80 (m, 1H), 0.87 (d, 3H, J = 6.9), 1.46-
1.78 (m, 7H), 2.33-2.40 (m, 1H), 2.75 (ddd, 1H, J = 8.8, 6.9, 5.1), 2.92 (s, 3H), 2.97-3.06 
(m, 1H), 3.34 (s, 3H), 3.48 (d, 1H, J = 11.0), 3.59 (t, 1H, J = 7.8), 3.75 (t, 1H, J = 8.3), 
6.27 (d, 1H, J = 1.2), 6.72 (s, 1H), 7.16 (d, 1H, J = 1.2); 13C NMR (CDCl3, 125 MHz)  
16.8, 20.1, 25.6, 26.0, 29.5, 31.8, 32.2, 32.3, 45.1, 52.3, 58.8, 65.4, 66.0, 112.6, 120.2, 
128.5, 149.1; IR: 2952, 2870, 1650, 1482, 1192, 1174, 1122, 1074, 1052, 962 cm–1. 
Elemental Anaylsis: C17H29N3O2 requires: C = 66.42%, H = 9.51%, N = 13.67%, found: 
C = 66.51%, H = 9.28%, N = 13.82%. []D
20 = -37.3 (c = 1.0, CH2Cl2, l = 50 mm). 
 
 
 
(S)-4-isopropyl-3-((R)-2-methyl-1-(1-methyl-1H-imidazol-2-yl)propyl)oxazolidine, 
3.53.25 To a stirring solution of (S)-2-(((R)-cyclopentyl(1-methyl-1H-imidazol 
-2-yl)methyl)amino)-3-methylbutan-1-ol (0.50 g, 1.9 mmol) and paraformaldehyde (57 
mg, 1.9 mmol) in anhydrous toluene (19 mL), p-toluenesulfonic acid monohydrate (3.6 
mg, 1.9 × 10-2 mmol) was added. After refluxing overnight, reaction was cooled to room 
temperature, and CH2Cl2 (30 mL) was added. The resulting solution was concentrated. 
Flash column chromatography (100% EtOAc) afforded the product as colorless oil (280 
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mg, 54%). 1H NMR (CDCl3, 500 MHz)  0.88 (d, 3H, J = 6.8), 0.92 (d, 3H, J = 6.6), 
1.51-1.73 (m, 8H), 2.02-2.07 (m, 1H), 2.57-2.60 (m, 1H), 2.70-2.73 (m, 1H), 3.47 (d, 2H, 
J = 6.3), 3.61 (d, 1H, J = 10.5), 3.68 (s, 3H), 4.42 (d, 1H, J = 4.6), 5.06 (d, 1H, J = 4.4), 
6.78 (d, 1H, J = 1.0), 7.02 (d, 1H, J = 1.2); 13C NMR (CDCl3, 126 MHz)  18.1, 19.8, 
25.1, 25.4, 30.9, 31.0, 31.7, 33.1, 44.4, 61.5, 66.5, 67.6, 82.3, 120.3, 127.6, 148.4; IR: 
2953, 2867, 1650, 1479, 1279, 1171, 1133, 1082, 943, 724 cm–1; []D
20 = +24.4 (c = 
0.98, CH2Cl2, l = 50 mm). 
Substrate Synthesis 
 
 
4-methylpentane-1,2-diol, 3.54.30 Sodium metaperiodate (6.11 g, 28.5 mmol), 4-methyl-
1-pentene (6.00 mL, 4.80 x 101 mmol), and lithium bromide (1.65 g, 1.90  x 101 mmol) 
were dissolved in acetic acid (79 mL) and heated to 95 C for 14 hours during which time 
the solution turned dark red. The reaction was diluted with EtOAc (100 mL) and washed 
with saturated aqueous Na2S2O3 (30 mL), H2O (30 mL), and saturated aqueous NaHCO3 
(30 mL). The organic layer was dried over Na2SO4, filtered, and concentrated. The crude 
oil was dissolved in MeOH (120 mL) and K2CO3 (13.1 g, 95 mmol) was added. The 
mixture was stirred at 25 C for 15 hours. The methanol was removed under reduced 
pressure, and the mixture was dissolved in water and extracted with EtOAc (3x50 mL). 
The combined organic layers were washed with H2O (50 mL) and brine (50 mL). The 
organic layer was dried over Na2SO4, filtered, and concentrated. Column chromatography  
30Emmanuvel, L.; Shaikh, T. M.; Sudalai, A. Org. Lett. 2005, 7, 5071-5074. 
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was performed (20-50% EtOAc/Hex) resulting in a yellow oil which was distilled (150 
C at 1 mmHg) to yield a colorless oil (2.39 g, 43%). 1H NMR (CDCl3, 500 MHz)  0.86 
(d, 3H, J = 6.6), 0.88 (d, 3H, J = 6.6), 1.13 (ddd, 1H, J = 18.3, 8.6, 4.4), 1.33 (ddd, 1H, J 
= 19.6, 8.8, 5.6), 1.67-1.75 (m, 1H), 2.30-2.37 (m, 2H), 3.34 (dd, 1H, J = 11.0, 7.8), 3.57 
(dd, 1H, J = 11.0, 2.5), 3.70-3.75 (m, 1H); 13C NMR (CDCl3, 126 MHz)  22.3, 23.5, 
24.7, 42.3, 68.4, 70.6; IR: 3341, 2954, 2870, 1468, 1067, 1027, 579 cm–1; HRMS 
(DART-TOF) calcd. for C6H18N1O2: [M+NH4]
+: 136.1338, found: 136.1341. 
 
 
 
1-cyclohexylethane-1,2-diol, 3.50.30 The same procedure used for 4-methylpentane-1,2-
diol was used to yield a colorless oil which solidified upon standing (1.30 g, 49%). 1H 
NMR (CDCl3, 500 MHz)  1.00-1.08 (m, 2H), 1.13-1.29 (m, 3H), 1.38-1.45 (m, 1H), 
1.63-1.69 (m, 2H), 1.72-1.79 (m, 2H), 1.86-1.89 (m, 2H), 2.00-2.01 (m, 1H), 3.43-3.47 
(m, 1H), 3.51-3.55 (m, 1H), 3.69-3.73 (m, 1H); 13C NMR (CDCl3, 126 MHz)  26.2,  
26.3, 26.6, 28.8, 29.1, 40.9, 65.0, 76.7; IR: 3339, 2922, 2852, 1449, 1050, 1015, 892, 605 
cm–1; HRMS (DART-TOF) calcd. for C8H20N1O2: [M+NH4]
+: 162.1494, found: 
162.1490. 
 
 
 
3-phenylpropane-1,2-diol, 3.56.30 The same procedure used for 4-methylpentane-1,2-
diol was used to yield a colorless oil (2.98 g, 37%).1H NMR (CDCl3, 500 MHz)  2.27 
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(bs, 2H), 2.74-2.83 (m, 2H), 3.51-3.55 (m, 1H), 3.70 (dd, 1H, J = 11.2, 2.4), 3.94-3.98 
(m, 1H), 7.23-7.26 (m, 3H), 7.32-7.34 (m, 2H); 13C NMR (CDCl3, 126 MHz)  39.9, 
66.7, 73.2, 126.7, 128.7, 129.5, 138.0; IR: 3362, 2925, 1496, 1454, 1089, 1068, 1030, 
744, 700, 555 cm–1; HRMS (DART-TOF) calcd. for C9H16N1O2: [M+NH4]
+: 170.1181, 
found: 170.1189. 
Reaction of III with Individual Enantiomers (Scheme 3.25) 
To an oven-dried reaction vial, a solution of hexane-1,2-diol, 3.47, (24 mg, 0.20 mmol), 
p-toluenesulfonic acid (1.0 mg, 6.0 x 10-3 mmol, 3 mol %), and III (12 mg, 4.0 x 10-2 
mmol, 20 mol %) in anhydrous THF (3 mL) was added. The reaction was stirred for 10 
minutes at 4 °C. 1,2,2,6,6-Pentamethylpiperidine   3 μ    0 2  mm ol    2 eq  iv ) was 
added, followed by triethylchlorosilane  36 μ   0 20 mmol    0 eq iv ). After stirring at 4 
°C for 12 hours, the reaction was quenched by addition of N,N-diisopropylethylamine (30 
μ   and methanol    μ      he  mi t re  was stirred for  0 mi n and filtered thro g h a 
Pasteur pipette packed with silica gel, followed by a flush with EtOAc (10 mL). GC 
analysis afforded the yield and selectivity of the reaction. 
Scheme 3.25, Eq 1 
(S)-hexane-1,2-diol, (S)-3.47, was used as the substrate in the reaction. 
Scheme 3.25, Eq 2 
(R)-hexane-1,2-diol, (R)-3.47, was used as the substrate in the reaction. 
Solvent Screen (Table 3.12) 
To an oven-dried reaction vial, a solution of hexane-1,2-diol, 3.47, (24 mg, 0.20 mmol), 
p-toluenesulfonic acid (1.0 mg, 6.0 x 10-3 mmol, 3 mol %), and III (12 mg, 4.0 x 10-2 
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mmol, 20 mol %) in anhydrous solvent (3 mL) was added. The reaction was stirred for 10 
minutes at 4 °C. N,N-Diisopropylethylamine   2 μ   0 2  mm ol    2 eq iv ) was added, 
followed by triethylchlorosilane  36 μ   0 20 mmol    0 eq iv ). After stirring at 4 °C for 
12 hours, the reaction was quenched by addition of N,N-diisopropylethylamine  30 μ   
and methanol    μ      he mi t re  was stirred for  0 mi n and filtered thro gh a Paste r  
pipette packed with silica gel, followed by a flush with EtOAc (10 mL). GC analysis 
afforded the yield and selectivity of the reaction. The following solvents were tested in 
the reaction: THF, EtOAc, MeOtBu, CH3CN, ClCH2Cl, tBuOH (run at room 
temperature). 
Individual Enantiomer Selectivities in tBuOH (Table 3.13) 
To an oven-dried reaction vial, a solution of hexane-1,2-diol, 3.47, (24 mg, 0.20 mmol), 
p-toluenesulfonic acid (1.0 mg, 6.0 x 10-3 mmol, 3 mol %), and III (12 mg, 4.0 x 10-2 
mmol, 20 mol %) in anhydrous tBuOH (3 mL) was added. The reaction was stirred for 10 
minutes at 25 °C. N,N-Diisopropylethylamine   2 μ   0 2  mm ol    2 eq iv) was added, 
followed by triethylchlorosilane  36 μ   0 20 mmol    0 eq iv ). After stirring at 25 °C for 
12 hours, the reaction was quenched by addition of N,N-diisopropylethylamine  30 μ   
and methanol    μ      he mi t re  was stirred for  0 mi n and filtered thro gh a Paste r  
pipette packed with silica gel, followed by a flush with EtOAc (10 mL). GC analysis 
afforded the yield and selectivity of the reaction. 
Table 3.13, Entry 1 
(R)-hexane-1,2-diol, (R)-3.47, was used as the substrate in the reaction. 
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Table 3.13, Entry 2 
(S)-hexane-1,2-diol, (S)-3.47, was used as the substrate in the reaction. 
Table 3.13, Entry 3 
(S)-hexane-1,2-diol, (S)-3.47, was used as the substrate and N-methylimidazole  3 2 μ   
4.0 x 10-2 mmol, 20 mol %) was used in the catalyst in the reaction. 
t-Amyl Alcohol Temperature Screen (Table 3.14) 
To an oven-dried reaction vial, a solution of (S)-hexane-1,2-diol, 3.47, (24 mg, 0.20 
mmol), p-toluenesulfonic acid (1.0 mg, 6.0 x 10-3 mmol, 3 mol %), and III (12 mg, 4.0 x 
10-2 mmol, 20 mol %) in anhydrous t-amyl alcohol (3 mL) was added. The reaction was 
stirred for 10 minutes. N,N-Diisopropylethylamine   2 μ    0 2  mm ol    2 eq iv ) was 
added, followed by triethylchlorosilane (4.0 x 101 μ   0 2  mm ol    2 eq iv ). After 
stirring at a constant temperature for 12 hours, the reaction was quenched by addition of 
N,N-diisopropylethylamine  30 μ   and methanol    μ      he mi t re  was stirred for  0 
min and filtered through a Pasteur pipette packed with silica gel, followed by a flush with 
EtOAc (10 mL). GC analysis afforded the yield and selectivity of the reaction. The 
reaction was run at the following temperatures: -6 °C, 4 °C, and 25 °C. 
Screen of Catalysts with Cyclic R Groups (Table 3.15) 
To an oven-dried reaction vial, a solution of (S)-hexane-1,2-diol, (S)-3.47, (24 mg, 0.20 
mmol), p-toluenesulfonic acid (1.0 mg, 6.0 x 10-3 mmol, 3 mol %), and catalyst (20 mol 
%) in anhydrous t-amyl alcohol (3 mL) was added. The reaction was stirred for 10 
minutes at 4 °C. N,N-Diisopropylethylamine   2 μ   0 2  mm ol    2 eq iv ) was added, 
followed by triethylchlorosilane (4.0 x 101 μ   0 2  mmol, 1.2 equiv). After stirring at 4 
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°C for 12 hours, the reaction was quenched by addition of N,N-diisopropylethylamine (30 
μ   and methanol    μ      he  mi t re  was stirred for  0 mi n and filtered thro g h a 
Pasteur pipette packed with silica gel, followed by a flush with EtOAc (10 mL). GC 
analysis afforded the yield and selectivity of the reaction. 
R= iPr, III, (12 mg, 4.0 x 10-2 mmol, 20 mol %) 
R= Cyclopropyl (12 mg, 4.0 x 10-2 mmol, 20 mol %) 
R= Cyclopentyl, IV, (13 mg, 4.0 x 10-2 mmol, 20 mol %) 
Catalyst Screen with (S)-1-Cyclohexyl-1,2-ethanediol (Table 3.16) 
In a dry box, a solution of (S)-1-cyclohexylethane-1,2-diol, (S)-3.50, (29 mg, 0.20 mmol), 
catalyst, and N,N-diisopropylethylamine hydrochloride (6.6 mg, 4.0 x 10-2 mmol, 20 mol 
%) in anhydrous tert-amyl alcohol (3.0 mL) was prepared in an oven-dried glass reaction 
vial. The reaction was stirred at 4 °C for 10 minutes. N,N-diisopropylethylamine (45 L, 
0.26 mmol, 1.3 equiv) was added, followed by addition of chlorotriethylsilane (44 L, 
0.26 mmol, 1.3 equiv). The reaction was stirred at 4 °C for 30 minutes. MeOH (100 L) 
was added to quench the reaction. The solvent was removed under reduced pressure. 
1,3,5-trimethoxybenzene (100 µL, 2M solution in EtOAc, 0.020 mmol) was added as an 
internal standard. Chiral GC Analysis ((Supelco Gamma Dex 120 (30 m × 0.25 mm × 
0.25 µm film thickness), 115 °C for 180 min, 20 °C/min to 180 °C, 180 °C for 20 min, 15 
psi) of crude product afforded quantitative results of the reaction.  
Table 3.16, Entry 1 
N-methylimidazole  2   μ    3 0    0 -2 mmol, 15 mol %) was used in the catalyst in the 
reaction. 
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Table 3.16, Entry 2 
Catalyst III (8.9 mg, 3.0 x 10-2 mmol, 15 mol %) was used in the reaction. 
Table 3.16, Entry 3 
Catalyst IV (8.3 mg, 3.0 x 10-2 mmol, 15 mol %) was used in the reaction. 
Table 3.16, Entry 4 
(R)-Cyclohexane-1,2-diol, (R)-3.50, and catalyst IV (8.3 mg, 3.0 x 10-2 mmol, 15 mol %) 
were used in the reaction. 
Control Catalyst with (S)-Cyclohexane-1,2-diol (Scheme 3.26, Eq 1) 
In a dry box, a solution of (S)-1-cyclohexylethane-1,2-diol, (S)-3.50, (29 mg, 0.20 mmol), 
catalyst 3.53 (8.8 mg, 3.0 x 10-2 mmol, 15 mol %), and N,N-diisopropylethylamine 
hydrochloride (6.6 mg, 4.0 x 10-2 mmol, 20 mol %) in anhydrous tert-amyl alcohol (3.0 
mL) was prepared in an oven-dried glass reaction vial. The reaction was stirred at 4 °C 
for 10 minutes. N,N-diisopropylethylamine (45 L, 0.26 mmol, 1.3 equiv) was added, 
followed by addition of chlorotriethylsilane (44 L, 0.26 mmol, 1.3 equiv). The reaction 
was stirred at 4 °C for 30 minutes. MeOH (100 L) was added to quench the reaction. 
The solvent was removed under reduced pressure. 1,3,5-Trimethoxybenzene (100 µL, 
2M solution in EtOAc, 0.020 mmol) was added as an internal standard. Chiral GC 
Analysis ((Supelco Gamma Dex 120 (30 m × 0.25 mm × 0.25 µm film thickness), 115 °C 
for 180 min, 20 °C/min to 180 °C, 180 °C for 20 min, 15 psi) of crude product afforded 
quantitative results of the reaction. 
 
 
Chapter 3, Page 361 
 
Control Catalyst with (R)-Cyclohexane-1,2-diol (Scheme 3.26, Eq 2) 
In a dry box, a solution of (R)-1-cyclohexylethane-1,2-diol, (R)-3.50, (29 mg, 0.20 
mmol), catalyst 3.53 (8.8 mg, 3.0 x 10-2 mmol, 15 mol %), and N,N-
diisopropylethylamine hydrochloride (6.6 mg, 4.0 x 10-2 mmol, 20 mol %) in anhydrous 
tert-amyl alcohol (3.0 mL) was prepared in an oven-dried glass reaction vial. The 
reaction was stirred at 4 °C for 10 minutes. N,N-diisopropylethylamine (45 L, 0.26 
mmol, 1.3 equiv) was added, followed by addition of chlorotriethylsilane (44 L, 0.26 
mmol, 1.3 equiv). The reaction was stirred at 4 °C for 30 minutes. MeOH (100 L) was 
added to quench the reaction. The solvent was removed under reduced pressure. 1,3,5-
Trimethoxybenzene (100 µL, 2M solution in EtOAc, 0.020 mmol) was added as an 
internal standard. Chiral GC Analysis ((Supelco Gamma Dex 120 (30 m × 0.25 mm × 
0.25 µm film thickness), 115 °C for 180 min, 20 °C/min to 180 °C, 180 °C for 20 min, 15 
psi) of crude product afforded quantitative results of the reaction. 
Reaction of 1-Phenyl-1,2-ethanediol (Scheme 3.27) 
To an oven-dried reaction vial, a solution of 1-phenyl-1,2-ethane diol, 3.13 (140 mg, 1.0 
mmol), N,N-diisopropylethylamine hydrochloride (33 mg, 0.20 mmol, 20 mol %), and 
catalyst IV (46 mg, 0.15 mmol, 15 mol %) in anhydrous t-amyl alcohol (14 mL) was 
added. The reaction was stirred for 10 minutes at 4 °C. N,N-Diisopropylethylamine (160 
μ     2 mm ol    2 eq iv ) was added, followed by triethylchlorosilane    0 μ     2  mmol, 
1.2 equiv). After stirring at 4 °C for 25 mins, the reaction was quenched by addition of 
N,N-diisopropylethylamine  200 μ   and methanol   0 μ      he mi t re  was stirred for 
10 min and concentrated. Column Chromatography (0 to 20% EtOAc/Hex, using an 
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ISCO automated purification system) yielded 3.16 (140 mg, 56%) and 3.17 (69 mg, 27%) 
as colorless oils. Chiral HPLC Analysis for 3.16 : (OD-H, 1.0 mL/min, 0.5% iPrOH: 
95.5% Hexanes, 220 nm, trmajor = 8.53 min and trminor = 9.94 min) 45% ee.  
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Chiral HPLC Analysis for 3.17: (OD-H, 1.0 mL/min, 0.5% iPrOH: 95.5% Hexanes, 220 
nm, trmajor = 5.97 min and trminor = 6.78 min) 83% ee. 
 
 
 
A duplicate reaction gave 3.16 (150 mg, 59%, 45% ee) and 3.17 (57 mg, 23%, 79% ee). 
The average of the two runs gave 3.16 (57%, 45% ee) and 3.17 (25%, 81% ee). For 
characterization of both compounds, see above. 
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General Procedure for Substrate Scope (Table 3.17) 
In a dry box, a solution of 1-cyclohexylethane-1,2-diol, 3.50, (140 mg, 1.0 mmol), 
catalyst IV (46 mg, 0.15 mmol, 15 mol %), and N,N-diisopropylethylamine 
hydrochloride (33 mg, 0.20 mmol, 20 mol %) in anhydrous tert-amyl alcohol (14 mL) 
was prepared in an oven-dried glass reaction vial. The reaction was stirred at 0 °C for 10 
minutes. N,N-diisopropylethylamine (230 L, 1.3 mmol, 1.3 equiv) was added, followed 
by addition of chlorotriethylsilane (220 L, 1.3 mmol, 1.3 equiv). The reaction was 
stirred at 0 °C for 45 minutes. MeOH (500 L) was added to quench the reaction. The 
solvent was removed under reduced pressure. Column chromatography (0-20% EtOAc in 
Hexanes, using an ISCO automated purification system) afforded 1 (150 mg, 56%) and 2 
(110 mg, 41%) as colorless oils. 
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Table 3.17 Substrate Scope. 
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Calculated Selectivities for Each Enantiomer of Substrate (Table 3.18) 
Substrate (R)-2a-ja (R)-3a-ja (S)-2a-ja (S)-3a-ja 
3.13 95 5 41 59 
3.50 99 1 12 88 
3.47 99 1 13 87 
3.54 99 1 11 89 
3.55 96 4 17 83 
3.56 98 2 10 90 
3.57 >99 <1 14 86 
3.58 98 2 14 86 
3.59 97 3 27 73 
3.60 99 1 6 94 
3.61 99 1 5 95 
aApproximate (R)-enantiomer and (S)-enantiomer selectivities calculated based on isolated yields and ees 
from Table 3.25.  
 
Product Characterization 
 
Table 3.17, Entry 1 
 
 
(S)-2-cyclohexyl-2-(triethylsilyloxy)ethanol. The general procedure was followed using 
3.50 to yield a colorless oil (110 mg, 41%). Chiral GC Analysis (Supelco Beta Dex 120 
(30 m × 0.25 mm × 0.25 m film thickness), 145 °C for 100 min, 10 °C/min to 200 °C, 
200 °C for 10 min, 15 psi., trmajor = 44.4 min, trminor = 45.0 min) 97% ee. 
1H NMR 
(CDCl3, 500 MHz)  0.63 (q, 6H, J = 8.1), 0.98 (t, 9H, J = 8.1), 1.10-1.25 (m, 4H), 1.46-
1.53 (m, 1H), 1.65-1.84 (m, 7H), 3.49 (dt, 1H, J = 6.1, 3.7), 3.53-3.59 (m, 2H); 13C NMR 
(CDCl3, 126 MHz)  5.3, 7.1, 26.5, 26.6, 26.8, 29.0, 29.3, 41.4, 64.2, 77.4; IR:  3421, 
2924, 2876, 1450, 1238, 1118, 1006, 739 cm–1; HRMS (DART-TOF) calcd. for 
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C14H31O2Si1: [M+H]
+: 259.2093, found: 259.2099. []D
20 =  +8.7 (c = 1.1, CH2Cl2, l = 50 
mm). 
 
 
 
 
Table 3.17, Entry 1  
 
 
(R)-1-cyclohexyl-2-((triethylsilyl)oxy)ethanol. The general procedure was followed 
using 3.50 to yield the product as a colorless oil (120 mg, 47%). Chiral GC Analysis 
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(Supelco Gamma Dex 120 (30 m × 0.25 mm × 0.25 µm film thickness), 115 °C for 180 
min, 20 °C/min to 180 °C, 180 °C for 20 min, 15 psi, trmajor = 172.2 min, trminor = 169.2 
min) 81% ee. 1H NMR (CDCl3, 500 MHz)  0.59 (q, 6H, J = 7.8), 0.94 (t, 9H, J = 7.8), 
0.98-1.06 (m, 2H), 1.10-1.25 (m, 3H), 1.33-1.40 (m, 1H ), 1.57-1.65 (m, 2H), 1.69-1.75 
(m, 2H), 1.87-1.91 (m, 1H), 2.48 (d, 1H, J = 2.9), 3.34-3.38 (m, 1H), 3.44 (dd, 1H, J = 
9.8, 8.3), 3.67 (dd, 1H, J = 9.8, 3.2); 13C NMR (CDCl3, 125 MHz)  4.6, 6.9, 26.3, 26.4, 
26.7, 29.0, 29.1, 40.7, 65.2, 76.0; IR: 2921, 2875, 2852, 1450, 1112, 1079, 1004, 817, 
726 cm-1; HRMS (ESI+) calcd. for C14H30O2NaSi: [M+Na]
+: 281.1907, found: 281.1915. 
[]D
20 = -6.4 (c = 1.3, CH2Cl2, l = 50 mm). 
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Table 3.17, Entry 2 
 
 
(S)-2-(triethylsilyloxy)hexan-1-ol. The general procedure was followed using 3.47 and 
1.2 equiv of chlorotriethylsilane and N,N-diisopropylethylamine, 10 mol % III, and a 
reaction time of 1.5 hours to yield a colorless oil (88 mg, 38%). Chiral GC Analysis 
(Supelco Beta Dex 120 (30 m × 0.25 mm × 0.25 m film thickness), 95 °C for 120 min, 
20 °C/min to 200 °C, 200 °C for 20 min, 15 psi., trmajor = 106.1 min, trminor = 109.4 min) 
98% ee. 1H NMR (CDCl3, 500 MHz)  0.63 (q, 6H, J = 7.8), 0.88-0.91 (m, 3H), 0.98 (t, 
9H, J = 7.8), 1.23-1.34 (m, 4H), 1.47-1.52 (m, 2H), 1.91 (t, 1H, J = 6.4), 3.42-3.46 (m, 
1H), 3.54-3.59 (m, 1H), 3.71-3.76 (m, 1H); 13C NMR (CDCl3, 126 MHz)  5.3, 7.0, 23.0, 
23.3, 24.7, 43.5, 66.8, 71.4; IR:  3408, 2955, 2876, 1459, 1239, 1097, 1007, 727 cm–1; 
HRMS (DART-TOF) calcd. for C12H29O2Si1: [M+H]
+: 233.1937, found: 233.1934. 
[]D
20 = +11.4 (c = 1.1, CH2Cl2, l = 50 mm). 
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Table 3.17, Entry 2  
 
 
(R)-1-((triethylsilyl)oxy)hexan-2-ol. The general procedure was followed using 3.47 and 
1.2 equiv of chlorotriethylsilane and N,N-diisopropylethylamine, 10 mol % III, and a 
reaction time of 1.5 hours to yield a colorless oil (130 mg, 55%). Chiral GC Analysis 
(Supelco Beta Dex 120 (30 m × 0.25 mm × 0.25 µm film thickness), 95 °C for 120 min, 
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20 °C/min to 180 °C, 180 °C for 20 min, 15 psi, trmajor = 103.2 min, trminor = 102.1 min) 
78% ee. 1H NMR (CDCl3, 500 MHz)  0.60 (q, 6H, J = 7.8), 0.89 (t, 3H, J = 7.1), 0.94 
(t, 9H, J = 7.8), 1.22-1.45 (m, 6H), 2.44 (d, 1H, J = 3.2), 3.36 (dt, 1H, J = 2.0, 8.8), 3.59-
3.64 (m, 2H); 13C NMR (CDCl3, 125 MHz)  4.6, 6.9, 14.2, 23.0, 28.0, 32.7, 67.2, 72.1; 
IR: 2955, 2934, 2913, 2876, 1459, 1095, 1004, 803, 726 cm–1; HRMS (ESI+) calcd. for 
C12H28O2NaSi: [M+Na]
+: 255.1751, found: 255.1745. []D
20 = -3.6 (c = 1.1, CH2Cl2, l = 
50 mm).  
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Table 3.17, Entry 3 
 
 
(S)-4-methyl-2-(triethylsilyloxy)pentan-1-ol. The general procedure was followed using 
3.54 to yield a colorless oil (94 mg, 40%). Chiral GC Analysis (Supelco Beta Dex 120 
(30 m × 0.25 mm × 0.25 m film thickness), 95 °C for 120 min, 20 °C/min to 200 °C, 
200 °C for 20 min, 15 psi., trmajor = 80.4 min, trminor = 86.1 min) 98% ee. 
1H NMR 
(CDCl3, 500 MHz)  0.63 (q, 6H, J = 8.1), 0.90 (d, 3H, J = 6.6), 0.91 (d, 3H, J = 6.6) 
0.98 (t, 9H, J = 8.1), 1.38 (t, 2H, J = 6.8), 1.59-1.67 (m, 1H), 1.92 (t, 1H, J = 6.4), 3.39-
3.44 (m, 1H), 3.57 (ddd, 1H, J = 11.0, 6.1, 3.7), 3.82 (ddt, 1H, J = 9.8, 5.4, 1.2); 13C 
NMR (CDCl3, 126 MHz)  5.2, 7.0, 14.2, 23.0, 27.7, 40.0, 66.5, 73.1; IR:  3418, 2955, 
2876, 1466, 1087, 1046, 742 cm–1; HRMS (DART-TOF) calcd. for C12H29O2Si1: 
[M+H]+: 233.1937, found: 233.1943. []D
20 = +10.3 (c = 1.1, CH2Cl2, l = 50 mm). 
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Table 3.17, Entry 3 
 
 
(R)-4-methyl-1-((triethylsilyl)oxy)pentan-2-ol. The general procedure was followed 
using 3.54 to yield the product as a colorless oil (125 mg, 54%). Chiral GC Analysis 
(Supelco Beta Dex 120 (30 m × 0.25 mm × 0.25 µm film thickness), 95 °C for 90 min, 20 
°C/min to 180 °C, 180 °C for 20 min, 15 psi, trmajor = 75.9 min, trminor = 75.1 min) 82% ee. 
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1H NMR (CDCl3, 500 MHz)  0.60 (q, 6H, J = 7.8), 0.90 (d, 3H, J = 6.6), 0.92 (d, 3H, J 
= 6.6), 0.95 (t, 9H, J = 7.8), 1.11 (ddd, 1H, J = 13.5, 8.5, 4.2),1.36 (ddd, 1H, J = 14.2, 
8.8, 5.9), 1.74-1.82 (m, 1H), 2.40 (d, 1H, J = 3.2), 3.33 (dd, 1H, J = 9.8, 7.8), 3.58 (dd, 
1H, J = 9.8, 3.2), 3.71 (ddd, 1H, J = 16.4, 7.8, 3.2); 13C NMR (CDCl3, 125 MHz)  4.6, 
6.9, 22.4, 23.6, 24.8, 42.0, 67.6, 70.3; IR: 2954, 2912, 2876, 1096, 1049, 1004, 789, 726 
cm–1; HRMS (ESI+) calcd. for C12H28O2NaSi: [M+Na]
+: 255.1751, found: 255.1763. 
[]D
20 =  +0.94 (c = 1.2, CH2Cl2, l = 50 mm). 
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Table 3.17, Entry 4 
 
 
(S)-2-(triethylsilyloxy)propan-1-ol. The general procedure was followed using 3.55 and 
1.2 equiv chlorotriethylsilane and N,N-diisopropylethylamine with a reaction time of 25 
minutes. Column chromatography (3-20% Et2O in Hexanes) yielded a colorless oil (69 
mg, 36%). Chiral GC Analysis (Supelco Beta Dex 120 (30 m × 0.25 mm × 0.25 m film 
thickness), 80 °C for 100 min, 20 °C/min to 200 °C, 200 °C for 20 min, 15 psi., trmajor = 
45.2 min, trminor = 46.8 min) 93% ee. 
1H NMR (CDCl3, 500 MHz)  0.63 (q, 6H, J = 7.8), 
0.97 (t, 9H, J = 7.8), 1.14 (d, 3H, J = 6.4), 1.96 (dd, 1H, J = 7.6, 5.1), 3.37 (ddd, 1H, J = 
11.7, 6.6, 1.5), 3.48-3.53 (m, 1H), 3.89-3.95 (m, 1H); 13C NMR (CDCl3, 126 MHz)  
5.1, 7.0, 20.1, 68.4, 69.1; IR:  3408, 2955, 2877, 1459, 1238, 1005, 741 cm–1; HRMS 
(DART-TOF) calcd. for C12H29O2Si1: [M+H]
+: 233.1937, found: 233.1934. []D
20 = 
+18.6 (c = 1.0, CH2Cl2, l = 50 mm). 
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Table 3.17, Entry 4 
 
 
(R)-1-((triethylsilyl)oxy)propan-2-ol. The general procedure was followed using 3.50 
and 1.2 equiv chlorotriethylsilane and N,N-diisopropylethylamine with a reaction time of 
25 minutes. Column chromatography (3-20% Et2O in Hexanes) yielded a colorless oil 
(97 mg, 51%). Chiral GC Analysis (Supelco Beta Dex 120 (30 m × 0.25 mm × 0.25 µm 
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film thickness), 80 °C for 45 min, 20 °C/min to 180 °C, 180 °C for 20 min, 15 psi, trmajor 
= 36.8 min, trminor = 35.6 min) 70% ee. 
1H NMR (CDCl3, 500 MHz)  0.60 (q, 6H, J = 
7.8), 0.94 (t, 9H, J = 7.8), 1.10 (d, 3H, J = 6.4), 2.48 (d, 1H, J = 3.0), 3.32 (dd, 1H, J = 
9.8, 7.8), 3.57 (dd, 1H, J = 9.8, 3.4), 3.77-3.84 (m, 1H); 13C NMR (CDCl3, 125 MHz)  
4.6, 6.9, 18.4, 68.2, 68.4; IR: 2955, 2911, 2877, 1459, 1239, 1087, 1006, 801, 724 cm–1; 
HRMS (ESI+) calcd. for C9H22O2NaSi: [M+Na]
+: 213.1281, found: 213,1271. []D
20 = -
8.2 (c = 1.1, CH2Cl2, l = 50 mm). 
 
 
Chapter 3, Page 378 
 
 
 
Table 3.17, Entry 5 
 
 
(S)-3-phenyl-2-(triethylsilyloxy)propan-1-ol. The general procedure was followed 
using 3.56 with 1.2 equiv of chlorotriethylsilane and N,N-diisopropylethylamine and 10 
mol % III to yield a colorless oil (120 mg, 44%). Chiral HPLC Analysis (OD-H, 1.0 
mL/min, 10% iPrOH: 90% Hexanes, 220 nm, trmajor = 4.1 and trminor = 7.8 min) 96% ee. 
1H NMR (CDCl3, 500 MHz)  0.53 (dq, 6H, J = 16.1, 3.4), 0.90-0.93 (m, 9H), 1.91 (dd, 
1H, J = 7.0, 5.6), 2.80 (ddd, 2H, J = 19.6, 13.5, 6.1), 3.40-3.45 (m, 1H), 3.48-3.53 (m, 
1H), 3.92 (dddd, 1H, J = 13.7, 7.3, 4.6, 0.98), 7.16-7.20 (m, 3H), 7.24-7.28 (m, 2H); 13C 
NMR (CDCl3, 126 MHz)  5.1, 7.0, 40.8, 65.8, 79.2, 126.5, 128.6, 129.8, 138.4; IR: 
2953, 2912, 2876, 1455, 1238, 1103, 1004, 724, 698, 505 cm–1; HRMS (DART-TOF) 
calcd. for C15H27O2Si1: [M+H]
+: 267.1780, found: 267.1777. []D
20 = -12.6 (c = 1.0, 
CH2Cl2, l = 50 mm). 
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Table 3.17, Entry 5 
 
 
(R)-1-phenyl-3-((triethylsilyl)oxy)propan-2-ol. The general procedure was followed 
using 3.56, 1.2 equiv of chlorotriethylsilane and N,N-diisopropylethylamine, and 10 mol 
% III to yield the product as a colorless oil (130 mg, 50%). Chiral HPLC Analysis (OD-
H, 1.0 mL/min, 2% iPrOH: 98% Hexanes, 220 nm, trmajor = 5.50 min and trminor = 6.12 
min) 80% ee. 1H NMR (CDCl3, 500 MHz)  0.59 (q, 6H, J = 7.8), 0.94 (t, 9H, J = 7.8), 
2.42 (d, 1H, J = 3.9), 2.74 (dd, 1H, J = 13.7, 6.4), 2.78 (dd, 1H, J = 13.7, 7.1), 3.46 (dd, 
1H, J = 9.8, 6.8), 3.60 (dd, 1H, J = 10.0, 3.7), 3.85-3.90 (m, 1H), 7.18-7.22 (m, 3H), 
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7.27-7.30 (m, 2H); 13C NMR (CDCl3, 125 MHz)  4.6, 6.9, 39.8, 66.2, 73.0, 126.5, 
128.6, 129.5, 138.5; IR: 2953, 2911, 2876, 1239, 1111, 1031, 792, 727, 698 cm–1; 
HRMS (ESI+) calcd. for C15H26O2NaSi: [M+Na]
+: 289.1594, found: 289.1600. []D
20 = 
+2.6 (c = 1.0, CH2Cl2, l = 50 mm).  
 
 
 
 
Table 3.17, Entry 6 
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(R)-3-(benzyloxy)-2-(triethylsilyloxy)propan-1-ol. The general procedure was followed 
using 3.57,  1.2 equiv chlorotriethylsilane and N,N-diisopropylethylamine, 10 mol % III, 
and a reaction time of 1.5 hours to yield a colorless oil (120 mg, 40%).Chiral HPLC 
Analysis (OD-H, 1.0 mL/min, 0.5% iPrOH: 99.5% Hexanes, 240 nm, trmajor = 23.2 and 
trminor = 30.5 min) 99% ee. 
1H NMR (CDCl3, 500 MHz)  0.57-0.63 (q, 6H, J = 8.0), 
0.91-0.95 (m, 9H), 2.04-2.08 (m, 1H), 3.44-3.51 (m, 2H), 3.57-3.68 (m, 2H), 3.88-3.93 
(m, 1H), 4.51 (s, 2H), 7.25-7.35 (m, 5H); 13C NMR (CDCl3, 126 MHz)  4.8, 6.7, 64.9, 
71.0, 71.9, 73.5, 127.6, 127.7, 128.4, 138.0; IR:  3439, 2954, 2876, 1455, 1239, 1098, 
1005, 739, 698 cm–1; HRMS (DART-TOF) calcd. for C16H29O3Si1: [M+H]
+: 297.1886, 
found: 297.1881. []D
20 = +21.4 (c = 1.1, CH2Cl2, l = 50 mm). 
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Table 3.17, Entry 6 
 
 
(R)-1-(benzyloxy)-3-((triethylsilyl)oxy)propan-2-ol. The general procedure was 
followed using 3.57, 1.2 equiv chlorotriethylsilane and N,N-diisopropylethylamine, 10 
mol % III, and a reaction time of 1.5 hours to yield product as a colorless oil (170 mg, 
59%). Chiral HPLC Analysis (OD-H, 1.0 mL/min, 5% iPrOH: 95% Hexanes, 220 nm, 
trmajor = 7.87 min and trminor = 6.95 min) 73% ee. 
1H NMR (CDCl3, 500 MHz)  0.59 (q, 
6H, J = 7.8), 0.94 (t, 9H, J = 7.8), 2.48 (d, 1H, J = 4.9), 3.49 (dd, 1H, J = 9.5, 5.9), 3.53 
(dd, 1H, J = 9.5, 4.9), 3.62 (dd, 1H, J = 10.0, 5.9), 3.66 (dd, 1H, J = 10.0, 4.9), 3.82-3.87 
(m, 1H), 4.54 (s, 2H), 7.26-7.35 (m, 5H); 13C NMR (CDCl3, 125 MHz)  4.6, 6.9, 64.0, 
71.0, 71.3, 73.7, 127.9, 128.0, 128.6, 138.4; IR: 2953, 2910, 2875. 1089, 1004, 804, 728, 
696 cm–1; HRMS (ESI+) calcd. for C16H28O3NaSi: [M+Na]
+: 319.1700, found: 
319.1697. []D
20 = 0.53 (c = 1.1, CH2Cl2, l = 50 mm). 
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Table 3.17, Entry 7 
 
 
(R)-3-phenoxy-2-(triethylsilyloxy)propan-1-ol. The general procedure was followed 
using 3.58,  1.4 equiv of chlorotriethylsilane and N,N-diisopropylethylamine, and 15 mol 
% III to yield a colorless oil (87 mg, 31%). 1H NMR (CDCl3, 500 MHz)  0.68 (q, 6H, J 
= 7.8), 0.99 (t, 9H, J = 7.8), 2.00 (dd, 1H, J = 7.6, 5.4), 3.69 (dd, 1H, J = 11.3, 7.3), 3.75 
(ddd, 1H, J = 11.2, 5.4, 4.2), 3.94 (dd, 1H, J = 9.3, 6.1), 3.99 (dd, 1H, J = 9.3, 5.9), 4.11-
4.15 (m, 1H), 6.90 (dt, 2H, J = 8.8, 0.98), 6.96 (tt, 1H, J = 7.3, 0.98), 7.26-7.30 (m, 2H); 
13C NMR (CDCl3, 120 MHz)  5.1, 7.0, 64.6, 69.2, 71.3, 114.6, 121.1, 129.7, 158.5; IR:  
3415, 2954, 2876, 1600, 1497, 1244, 1130, 1048, 749, 690 cm–1; HRMS (DART-TOF) 
calcd. for C15H27O2Si1: [M+H]
+: 283.1730, found: 283.1730. []D
20 = +15.4 (c = 0.99, 
CH2Cl2, l = 50 mm). 
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Derivitization for ee31: The product (15 mg, 9.0 x 10-2 mmol) was dissolved in 300 µL of 
CH3CN and treated with 100 µL of hydrogen fluoride in pyridine. After 12 hours, column 
chromatography (1-10% MeOH in CH2Cl2) gave the known diol, (R)-3-phenoxypropane-
1,2-diol. Characterization of the diol matched known literature values. Absolute 
configuration was confirmed by comparison with a previous literature report.32 Chiral 
HPLC Analysis (OD-H, 1.0 mL/min, 15% iPrOH: 85% Hexanes, 240 nm) trmajor = 10.5 
and trminor = 20.0 min) 96% ee (as diol). 
 
 
 
 
31Boschelli, D.; Takemasa, T.; Nishitani, Y.; Masamune, S. Tet. Lett. 1985, 26, 5239-5242. 32Turgut, Y.; 
Aral, T.; Karakaplan, M.; Deniz, P.; Hosgoren, H. Syn Comm. 2010, 40, 3365-3377. 
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Table 3.17, Entry 7 
 
 
(R)-1-phenoxy-3-((triethylsilyl)oxy)propan-2-ol. The general procedure was followed 
using 3.58, 1.4 equiv of chlorotriethylsilane and N,N-diisopropylethylamine and 15 mol 
% III to yield product as a colorless oil (131 mg, 47%). Chiral HPLC Analysis (OD-H, 
1.0 mL/min, 10% iPrOH: 90% Hexanes, 220 nm, trmajor = 10.5 min and trminor = 5.09 min) 
78% ee. 1H NMR (CDCl3, 500 MHz)   0.61 (q, 6H, J = 7.8), 0.94 (t, 9H, J = 7.8), 2.55 
(d, 1H, J = 5.1), 3.74 (dd, 1H, J = 10.3, 5.1), 3.78 (dd, 1H, J = 10.3, 4.6), 3.99-4.05 (m, 
3H), 6.89-6.91 (m, 2H), 6.92-6.96 (m, 1H), 7.25-7.28 (m, 2H); 13C NMR (CDCl3, 125 
MHz)  4.6, 6.9, 63.7, 68.7, 70.5, 114.8, 121.2 129.7, 158.9; IR: 2953, 2876, 1599, 1495, 
1458, 1242, 1079, 1043, 1005, 802, 745, 727, 689 cm–1; HRMS (ESI+) calcd. for 
C15H26O3NaSi: [M+Na]
+: 305.1543, found: 305.1552. []D
20 = -0.19 (c = 1.1, CH2Cl2, l = 
50 mm). 
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Table 3.17, Entry 8 
 
 
(S)-2-(triethylsilyloxy)but-3-en-1-ol. The general procedure was followed using 3.59 
with 1.2 equiv of chlorotriethylsilane and N,N-diisopropylethylamine and a reaction time 
of 25 minutes to yield a colorless oil (71 mg, 35%). Chiral GC Analysis (Supelco Beta 
Dex 120 (30 m × 0.25 mm × 0.25 m film thickness), 90 °C for 100 min, 20 °C/min to 
180 °C, 180 °C for 20 min, 15 psi., trmajor = 41.4 min, trminor = 43.1 min) 93% ee. 
1H NMR 
(CDCl3, 500 MHz)  0.63 (q, 6H, J = 7.8), 0.97 (t, 9H, J = 7.8), 1.96-1.99 (m, 1H), 3.43-
3.55 (m, 2H), 4.20-4.24 (m, 1H), 5.17 (ddd, 1H, J = 10.5, 2.9, 1.2), 5.28 (ddd, 1H, J = 
17.4, 2.9, 1.7), 5.81 (dddd, 1H, J = 23.5, 10.5, 6.4, 1.7); 13C NMR (CDCl3, 126 MHz)  
5.1, 6.9, 67.0, 74.6, 116.5, 138.2; IR:  3415, 2955, 2877, 1459, 1098, 1007, 925, 743 cm–
1; HRMS (DART-TOF) calcd. for C10H23O2Si1: [M+H]
+: 203.1467, found: 203.1475. 
[]D
20 = +7.4 (c = 0.82, CH2Cl2, l = 50 mm). 
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Table 3.17, Entry 8 
 
 
(R)-1-((triethylsilyl)oxy)but-3-en-2-ol. The general procedure was followed using 3.59,  
1.2 equiv of chlorotriethylsilane and N,N-diisopropylethylamine and a reaction time of 25 
minutes to yield product as a colorless oil (120 mg, 57%). Chiral GC Analysis (Supelco 
Beta Dex 120 (30 m × 0.25 mm × 0.25 µm film thickness), 90 °C for 50 min, 20 °C/min 
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to 180 °C, 180 °C for 20 min, 15 psi, trmajor = 44.7 min, trminor = 43.0 min) 57% ee. 
1H 
NMR (CDCl3, 500 MHz)  0.60 (q, 6H, J = 7.8),  0.95 (t, 9H, J = 7.8), 2.57 (d, 1H, 3.4), 
3.42 (dd, 1H, J = 10.0, 7.8), 3.64 (dd, 1H, J = 10.0, 3.7), 4.13-4.18 (m, 1H), 5.17 (dt, 1H, 
J = 10.5, 1.5), 5.33 (dt, 1H, J = 17.4, 1.5), 5.80 (ddd, 1H, J = 17.1, 10.5, 5.6); 13C NMR 
(CDCl3, 125 MHz)  4.6, 6.9, 66.9, 73.3, 116.7, 136.8; IR: 2955, 2912, 2877, 1238, 
1102, 1004, 923, 795, 725 cm–1; HRMS (ESI+) calcd. for C10H22O2NaSi: [M+Na]
+: 
225.1281, found: 225.1285. []D
20 = +0.84 (c = 1.2, CH2Cl2, l = 50 mm). 
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Table 3.17, Entry 9 
 
 
(R)-3-chloro-2-(triethylsilyloxy)propan-1-ol. The general procedure was followed 
using 3.60 with a reaction time of 50 minutes to yield product as a colorless oil (99 mg, 
44%). Chiral GC Analysis (Supelco Beta Dex 120 (30 m × 0.25 mm × 0.25 µm film 
thickness), 110 °C for 105 min, 20 °C/min to 200 °C, 200 °C for 20 min, 15 psi, trmajor = 
56.4 min, trminor = 57.9 min) 97% ee. 
1H NMR (CDCl3, 500 MHz)  0.65 (q, 6H, J = 7.8),  
0.95-1.00 (m, 9H), 1.85 (t, 1H, J = 6.4), 3.46 (dd, 1H, J = 10.8, 5.1), 3.58 (dd, 1H, J = 
11.0, 7.1), 3.68-3.70 (m, 2H), 3.89-3.93 (m, 1H); 13C NMR (CDCl3, 125 MHz)  5.0, 6.9, 
44.7, 64.0, 72.8; IR: 3397, 2956, 2878, 1459, 1240, 1120, 1046, 1006, 742 cm–1; HRMS 
(ESI+) calcd. for C9H22ClO2Si: [M+H]
+: 225.1078, found: 225.1071. []D
20 = +8.3 (c = 
1.1, CH2Cl2, l = 50 mm).  
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Table 3.17, Entry 9 
 
 
(S)-1-chloro-3-(triethylsilyloxy)propan-2-ol. The general procedure was followed using 
3.60 with a reaction time of 50 minutes to yield product as a colorless oil (120 mg, 52%). 
Chiral GC Analysis (Supelco Gamma Dex 120 (30 m × 0.25 mm × 0.25 µm film 
thickness), 110 °C for 50 min, 20 °C/min to 200 °C, 200 °C for 20 min, 15 psi, trmajor = 
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45.1 min, trminor = 44.3 min) 90% ee. 
1H NMR (CDCl3, 500 MHz)  0.61 (q, 6H, J = 8.1), 
0.93-0.96 (m, 9H), 2.54 (d, 1H, J = 6.4), 3.54-3.61 (m, 2H), 3.66-3.72 (m, 2H), 3.80-3.86 
(m, 1H); 13C NMR (CDCl3, 125 MHz)  4.5, 6.9, 45.6, 63.3, 71.6; IR: 3425, 2955, 2877, 
1459, 1240, 1111, 1006, 804, 740 cm–1; HRMS (ESI+) calcd. for C9H22ClO2Si: [M+H]
+: 
225.1070, found: 225.1078. []D
20 = -1.5 (c = 1.1, CH2Cl2, l = 50 mm). 
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Table 3.17, Entry 10 
 
 
(R)-3-bromo-2-(triethylsilyloxy)propan-1-ol. The general procedure was followed 
using 3.61 to yield product as a colorless oil (110 mg, 41%). Chiral GC Analysis 
(Supelco Beta Dex 120 (30 m × 0.25 mm × 0.25 µm film thickness), 110 °C for 105 min, 
20 °C/min to 200 °C, 200 °C for 20 min, 15 psi, trmajor = 94.7 min, trminor = 97.2 min) 98% 
ee. 1H NMR (CDCl3, 500 MHz)  0.65 (q, 6H, J = 8.1),  0.96-0.99 (m, 9H), 1.85 (t, 1H, J 
= 6.4), 3.30-3.33 (m, 1H), 3.43-3.64 (m, 1H), 3.71 (dd, 2H, J = 6.1, 4.2), 3.92-3.96 (m, 
1H); 13C NMR (CDCl3, 125 MHz)  4.8, 6.7, 33.0, 64.3, 72.2; IR: 3382, 2955, 2971, 
2877, 1459, 1240, 1118, 1006, 969, 742, 728 cm–1; HRMS (ESI+) calcd. for 
C9H22BrO2Si: [M+H]
+: 269.0572, found: 269.0573. []D
20 = +6.1 (c = 1.1, CH2Cl2, l = 50 
mm). 
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Table 3.17, Entry 10 
 
 
(S)-1-bromo-3-(triethylsilyloxy)propan-2-ol. The general procedure was followed 
using 3.61 to yield product as a colorless oil (140 mg, 50%). Chiral GC Analysis 
(Supelco Gamma Dex 120 (30 m × 0.25 mm × 0.25 µm film thickness), 110 °C for 80 
min, 20 °C/min to 200 °C, 200 °C for 20 min, 15 psi, trmajor = 74.8 min, trminor = 73.6 min) 
90% ee. 1H NMR (CDCl3, 500 MHz)  0.61 (q, 6H, J = 7.8), 0.93-0.96 (m, 9H), 2.56 (d, 
1H, J = 6.4), 3.41-3.49 (m, 2H), 3.68 (dd, 1H, J = 10.0, 4.9), 3.72 (dd, 1H, J = 10.0, 4.9), 
3.80-3.85 (m, 1H); 13C NMR (CDCl3, 126 MHz)  4.5, 6.9, 34.7, 64.0, 71.3; IR: 2955, 
2876, 1459, 1240, 1108, 1006, 799, 727, 671 cm–1; HRMS (ESI+) calcd. for 
C9H22BrO2Si: [M+H]
+: 269.0572, found: 269.0576. []D
20 = -0.99 (c = 1.2, CH2Cl2, l = 
50 mm). 
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Reaction of 3,3-dimethylbutane-1,2-diol (Scheme 3.28) 
 
 
 
(R)-3,3-dimethyl-1-(triethylsilyloxy)butan-2-ol.The general procedure was followed 
using 1.2 equiv of chlorotriethylsilane and N,N-diisopropylethylamine and a reaction time 
of 45 minutes to yield only this product as a colorless oil (140 mg, 60%). Chiral GC 
Analysis (Supelco Gamma Dex 120 (30 m × 0.25 mm × 0.25 µm film thickness), 95 °C 
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for 50 min, 20 °C/min to 200 °C, 200 °C for 20 min, 15 psi, trmajor = 44.7 min, trminor = 
43.6 min) 52% ee. 1H NMR (CDCl3, 500 MHz)  0.60 (q, 6H, J = 8.1), 0.90 (s, 9H), 
0.93-0.96 (m, 9H), 2.65 (d, 1H, J = 2,2), 3.29-3.32 (m, 1H), 3.41-3.45 (m, 1H), 3.69 (dd, 
1H, J = 9.8, 3.2); 13C NMR (CDCl3, 126 MHz)  4.6, 6.9, 26.2, 33.4, 63.5, 78.9; IR: 
2954, 2877, 1460, 1239, 1108, 1067, 1003, 817, 726 cm–1; HRMS (ESI+) calcd. for 
C12H29O2Si: [M+H]
+: 233.1937, found: 233.1940. []D
20 = -10.0 (c = 1.1, CH2Cl2, l = 50 
mm). 
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Kinetic Resolution of 1-Cyclohexylethane-1,2-diol (Scheme 3.29) 
 
 
 
In a dry box, a solution of 1-cyclohexylethane-1,2-diol, 3.50, (140 mg, 1.0 mmol), 
catalyst IV (31 mg, 0.10 mmol, 10 mol %), and N,N-diisopropylethylamine 
hydrochloride (11 mg, 6.0 x 10-2 mmol, 6 mol %) in anhydrous tert-butanol (15 mL) was 
prepared in an oven-dried glass reaction vial. The reaction was stirred at room 
temperature for 45 minutes. N,N-diisopropylethylamine (120 L, 0.70 mmol, 0.70 equiv) 
was added, followed by addition of chlorotriethylsilane (100 L, 0.60 mmol, 0.60 equiv) 
in 4 portions every 15 minutes (dropwise addition was performed for each portion 
added). The reaction was stirred at room temperature for 1 hour (starting from the first 
addition of chlorotriethylsilane). Methanol (150 L) was added to quench the reaction. 
The solvent was removed under reduced pressure, Flash column chromatography 
(hexanes:EtOAc = 60:1) afforded pure product as a colorless oil (120 mg, 48%). Chiral 
GC Analysis (Supelco Gamma Dex 120 (30 m × 0.25 mm × 0.25 µm film thickness), 
115 °C for 180 min, 20 °C/min to 180 °C, 180 °C for 20 min, 15 psi, trmajor = 172.2 min, 
trminor = 169.5 min) 90% ee. []D
20 = -7.4 (c = 1.0, CH2Cl2, l = 50 mm). 
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Note: Making the racemic secondary products by literature methods requires multi-step 
reactions which are very low yielding in many cases. Therefore, the racemic secondary 
products were prepared by reacting the two enantiomers of catalyst III in the 
regiodivergent resolution and then mixing the reactions together to isolate the products.  
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Exchange of III with iPrOH (Scheme 3.30) 
 
 
In a glovebox, a solution of catalyst III (35 mg, 0.13 mmol) and N,N-
diisopropylethylamine hydrochloride (2.1 mg, 1.3 x 10-2 mmol) in anhydrous C6D6 (500 
μ   was made  200 μ  of the sol t ion was added to a NMR t  e   iPrOH (0.25 mmol, 130 
μ   2 M sol ti on in  6D6) and MeOH (5.0 x 10
-2 mmol  2  μ    2 M sol ti on in  6D6) 
was added to the NMR tube. C6D6    0 μ   was added to the NMR t  e  to reach a total 
volume of 0.5 mL. The reaction was monitored by 1H NMR. After 24 hours, equilibrium 
was reached. A ratio of 68:32, III to 3.41, gave a Keq of 0     Anothe r 200 μ  of the 
catalyst and acid solution was added to another NMR tube. iPrOH (5.0 x 10-1 mmol, 250 
μ   2 M sol ti on in  6D6) and MeOH (5.0 x 10
-2 mmol  2  μ    2 M sol ti on in  6D6) 
was added to the NMR tube. C6D6  2  μ   was added to the NMR t  e  to reach a total 
volume of 0.5 mL. The reaction was monitored by 1H NMR. After 24 hours, equilibrium 
was reached. A ratio of 57:43, III to 3.36, gave a Keq of 0.12. The average Keq for the 
two runs is 0.12 ± 0.01. 
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Exchange of III with nBuOH (Scheme 3.31) 
 
 
In a glovebox, a solution of catalyst III (35 mg, 0.13 mmol) and N,N-
diisopropylethylamine hydrochloride (2.1 mg, 1.3 x 10-2 mmol) in anhydrous C6D6 (500 
μ   was made  200 μ  of the sol t ion was added to a NMR t  e   nBuOH (0.15 mmol, 75 
μ   2 M sol ti on in C6D6) and MeOH (5.0 x 10
-2 mmol  2  μ    2 M sol ti on in  6D6) 
was added to the NMR tube. C6D6  200 μ   was added to the NMR t  e  to reach a total 
volume of 0.5 mL. The reaction was monitored by 1H NMR. After 24 hours, equilibrium 
was reached. A ratio of 67:33, III to 3.62, gave a Keq of 0     Anothe r 200 μ  of the 
catalyst and acid solution was added to another NMR tube. nBuOH (5.0 x 10-2 mmol, 25 
μ   2 M sol ti on in  6D6) and MeOH (5.0 x 10
-2 mmol  2  μ    2 M sol ti on in  6D6) 
was added to the NMR tube. C6D6  2 0 μ   was added to the NMR t  e  to reach a total 
volume of 0.5 mL. The reaction was monitored by 1H NMR. After 24 hours, equilibrium 
was reached. A ratio of 43:57, III to 3.62, gave a Keq of 0.86. The average Keq for the two 
runs is 0.92 ± 0.06. 
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III Exchange with (R)-3.48 (Scheme 3.32, Entry 1) 
 
 
In a glovebox, a solution of catalyst III (7.0 mg, 2.5 x 10-2 mmol) and N,N-
diisopropylethylamine hydrochloride (4.0 x 10-1 mg, 2.5 x 10-3 mmol, 10 mol %) in 
anhydrous C6D6   00 μ   was made and dispensed into an NMR t  e    R)-3.48 (44 mg, 
0.19 mmol, 7.6 equiv  in 2 0 μ    6D6 was added to the NMR t  e   MeO   2  μ    2     
10-2 mmol, 1 M in C6D6, 1 equiv  was added to the NMR t  e    2  μ   of  6D6 was 
added. The reaction was monitored by 1H NMR. After 23 hours, equilibrium was 
reached. A ratio of 8:92, 3.63 to III gave a Keq of 0.012.  
III Exchange with (S)-3.48 (Scheme 3.32, Entry 2) 
 
 
In a glovebox, a solution of catalyst III (7.0 mg, 2.5 x 10-2 mmol) and N,N-
diisopropylethylamine hydrochloride (4.0 x 10-1 mg, 2.5 x 10-3 mmol, 10 mol %) in 
anhydrous C6D6   00 μ   was made and dispensed into an NMR t  e    S)-3.48 (43 mg, 
0.19 mmol, 7.4 equiv  in 2 0 μ    6D6 was added to the NMR t  e   MeO   2  μ    2     
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10-2 mmol, 1 M in C6D6, 1 equiv  was added to the NMR t  e    2  μ   of  6D6 was 
added. The reaction was monitored by 1H NMR. After 23 hours, equilibrium was 
reached. A ratio of 13:87, 3.63 to III gave a Keq of 0.023. 
III Exchange with (R)-3.49 (Scheme 3.32, Entry 3) 
 
 
In a glovebox, a solution of catalyst III (14 mg, 5.0 x 10-2 mmol) and N,N-
diisopropylethylamine hydrochloride (8.0 x 10-1 mg, 5.0 x 10-3 mmol, 10 mol %) in 
anhydrous C6D6   00 μ   was made and dispensed into an NMR t  e    R)-3.49 (58 mg, 
0.25 mmol, 5 equiv  in 2 0 μ    6D6 was added to the NMR t  e   MeO    0 μ      0   
10-2 mmol, 1 M in C6D6, 1 equiv  was added to the NMR t  e    00 μ   of  6D6 was 
added. The reaction was monitored by 1H NMR. After 23 hours, equilibrium was 
reached. A ratio of 45:55, 3.63 to III gave a Keq of 0.26. 
III Exchange with (S)-3.49 (Scheme 3.32, Entry 4) 
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In a glovebox, a solution of catalyst III (14 mg, 5.0 x 10-2 mmol) and N,N-
diisopropylethylamine hydrochloride (8.0 x 10-1 mg, 5.0 x 10-3 mmol, 10 mol %) in 
anhydrous C6D6   00 μ   was made and dispensed into an NMR t  e    S)-3.49 (58 mg, 
0.25 mmol, 5 equiv  in 2 0 μ    6D6 was added to the NMR t  e   MeO    0 μ      0   
10-2 mmol, 1 M in C6D6, 1 equiv  was added to the NMR t  e    00 μ   of  6D6 was 
added. The reaction was monitored by 1H NMR. After 23 hours, equilibrium was 
reached. A ratio of 42:58, 3.63 to III gave a Keq of 0.22. 
III Exchange with (R)- and (S)-3.47 (Scheme 3.33) 
 
 
In a glovebox, a solution of catalyst III (8.4 mg, 3.0 x 10-2 mmol) and N,N-
diisopropylethylamine hydrochloride (5.0 x 10-1 mg, 3.0 x 10-3 mmol, 10 mol %) in 
anhydrous C6D6   00 μ   was made and dispensed into an NMR t  e   (R)-3.47 (18 mg, 
0.15 mmol, 3 equiv  in 2 0 μ    6D6 was added to the NMR t  e   MeO   2  μ      0   
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10-2 mmol, 2 M in C6D6, 1 equiv) was added to the NMR t  e   2  μ   of  6D6 was 
added. The reaction was monitored by 1H NMR. After 24 hours, equilibrium was reached 
and 57% of III had converted to products. A ratio of 18:82 of 3.64 to 3.65 resulted. The 
reaction was repeated using (S)-3.42. At equilibrium, a ratio of 20:80 of 3.64 and 3.65 
was reached with 56% conversion of III. 
Exchange of (±)-3.47 with III (Scheme 3.34) 
 
 
In a glovebox, a solution of catalyst III (14 mg, 5.0 x 10-2 mmol) and N,N-
diisopropylethylamine hydrochloride (8.0 x 10-1 mg, 5.0 x 10-3 mmol, 10 mol %) in 
anhydrous C6D6   00 μ   was made and dispensed into an NMR t  e   3.47 (18 mg, 0.15 
mmol, 3 equiv) in 2 0 μ    6D6 was added to the NMR t  e   MeO   2  μ      0    0
-2 
mmol, 2 M in C6D6, 1 equiv) was added to the NMR t  e   2  μ   of  6D6 was added. 
The reaction was monitored by 1H NMR. After 24 hours, equilibrium was reached. A 
ratio of 56:44, products to III gave a Keq of 0.70. The ratio of secondary to primary 
alcohols bound was 21:79. The ratio of 3.68 to 3.66 was 56:44. The reaction was repeated 
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using 5 equiv of 3.47 (3.0 x 101 mg, 0.25 mmol). At equilibrium, a ratio of 67:33 of 
products to III corresponds to a Keq of 0.78. The ratio of secondary to primary bound 
alcohols was 18:82. The average Keq was calculated to be 0.74 ± 0.06. 
 
The Difference in Selectivity of 3.11 and III 
GC Method for Selective Functionalization of 3.13 
GC Method. An Agilent Technologies 7890A GC System equipped with a 7683B Series 
Injector was used to introduce samples into a J&W Scientific column (HP-5, 30 m, 0.320 
mm ID  0 2  μm  film    he G  wa s r n at  00 °  for  0 mi n tes  a nd then the 
temperature was ramped 8 °C/min. to a final temperature of 180 °C. Compounds were 
detected by FID and data was analyzed with Agilent Technologies GC Chemstation 
software. Retention times are reported in minutes. 
Reaction of III with Individual Enantiomers (Scheme 3.35, Eq 1) 
To an oven-dried reaction vial, a solution of (S)-1-phenyl-1,2-ethanediol, (S)-3.13, (28 
mg, 0.20 mmol), N,N-diisopropylethylamine hydrochloride (3.3 mg, 2.0 x 10-2 mmol, 10 
mol %), and III (11 mg, 4.0 x 10-2 mmol, 20 mol %) in anhydrous THF (3 mL) was 
added. The reaction was stirred at room temperature for 10 minutes. N,N-
Diisopropylethylamine   2 μ    0 2  mmol, 1.2 equiv) was added, followed by 
triethylchlorosilane  36 μ   0 20 mmol    0 eq iv ). After stirring at room temperature for 
12 hours, the reaction was quenched by addition of N,N-diisopropylethylamine  30 μ   
and methanol    μ      he mi t re  was stirred at room temperature for 10 min and filtered 
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through a Pasteur pipette packed with silica gel, followed by a flush with EtOAc (10 
mL). GC analysis afforded the yield and selectivity of the reaction. 
Reaction of III with Individual Enantiomers (Scheme 3.35, Eq 2) 
The procedure for Scheme 3.33, Eq 1 was followed using (R)-3.13 (28 mg, 0.20 mmol). 
Catalyst Loading Screen (Table 3.19) 
To an oven-dried reaction vial, a solution of (R)-1-phenyl-1,2-ethanediol, (R)-3.13, (28 
mg, 0.20 mmol), N,N-diisopropylethylamine hydrochloride (6.6 mg, 4.0 x 10-2 mmol, 20 
mol %), and 3.11 in anhydrous THF (3 mL) was added. The reaction was stirred at room 
temperature for 10 minutes. N,N-Diisopropylethylamine   2 μ    0 2  mm ol    2 eq iv ) 
was added, followed by triethylchlorosilane  36 μ   0 20 mmol    0 eq iv ). After stirring 
at room temperature for 12 hours, the reaction was quenched by addition of N,N-
diisopropylethylamine  30 μ   and methanol    μ      he mi t re  was stirred at room 
temperature for 10 min and filtered through a Pasteur pipette packed with silica gel, 
followed by a flush with EtOAc (10 mL). GC analysis afforded the yield and selectivity 
of the reaction. 
Table 3.19, Entry 1 
10 mol % 3.11 (5.1 mg, 2.0 x 10-2 mmol) was used in the reaction. 
Table 3.19, Entry 2 
20 mol % 3.11 (10.2 mg, 4.0 x 10-2 mmol) was used in the reaction. 
Table 3.19, Entry 3 
50 mol % 3.11 (25.4 mg, 0.10 mmol) was used in the reaction. 
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(S,S) and (S,R)-Catalysts Table (3.20) 
To an oven-dried reaction vial, a solution of (R)-1-phenyl-1,2-ethanediol, (R)-3.13, (28 
mg, 0.20 mmol), N,N-diisopropylethylamine hydrochloride (3.3 mg, 2.0 x 10-2 mmol, 10 
mol %), and catalyst (20 mol %) in anhydrous THF (3 mL) was added. The reaction was 
stirred at room temperature for 10 minutes. N,N-Diisopropylethylamine   2  μ   0 2  
mmol, 1.2 equiv) was added, followed by triethylchlorosilane  36 μ   0 20 mmol    0 
equiv). After stirring at room temperature for 12 hours, the reaction was quenched by 
addition of N,N-diisopropylethylamine  30 μ   and methanol    μ      he  mi t re  was 
stirred at room temperature for 10 min and filtered through a Pasteur pipette packed with 
silica gel, followed by a flush with EtOAc (10 mL). GC analysis afforded the yield and 
selectivity of the reaction. Each reaction was repeated with (S)-3.13. 
Table 3.20 
R= (S)-Me (1.0 x 10-1 mg, 4.0 x 10-2 mmol, 20 mol %)  
R= (S)-iPr (11 mg, 4.0 x 10-2 mmol, 20 mol %) 
R= (R)-Me (1.0 x 10-1 mg, 4.0 x 10-2 mmol, 20 mol %) 
R= (R)-iPr, III, (11 mg, 4.0 x 10-2 mmol, 20 mol %) 
R= (R)-Ph (13 mg, 4.0 x 10-2 mmol, 20 mol %) 
Decreasing the Reaction Temperature (Scheme 3.36) 
To an oven-dried reaction vial, a solution of (S)-1-phenyl-1,2-ethanediol, (S)-3.13, (28 
mg, 0.20 mmol), N,N-diisopropylethylamine hydrochloride (3.3 mg, 2.0 x 10-2 mmol, 10 
mol %), and III (12 mg, 4.0 x 10-2 mmol, 20 mol %) in anhydrous THF (3 mL) was 
added. The reaction was stirred at 4 °C for 10 minutes. N,N-Diisopropylethylamine (42 
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μ   0 2  mm ol    2 eq iv ) was added, followed by triethylchlorosilane  36 μ   0 20 
mmol, 1.0 equiv). After stirring at 4 °C for 12 hours, the reaction was quenched by 
addition of N,N-diisopropylethylamine  30 μ   and methanol    μ      he  mi t re  was 
stirred at 4 °C for 10 min and filtered through a Pasteur pipette packed with silica gel, 
followed by a flush with EtOAc (10 mL). GC analysis afforded the yield and selectivity 
of the reaction. 
1,2,2,6,6-Pentamethylpiperidine as the Base (Table 3.21) 
To an oven-dried reaction vial, a solution of (S)-1-phenyl-1,2-ethanediol, (S)-3.13, (28 
mg, 0.20 mmol), p-toluenesulfonic acid (1.0 mg, 6.0 x 10-3 mmol, 3 mol %), and III (12 
mg, 4.0 x 10-2 mmol, 20 mol %) in anhydrous THF (3 mL) was added. The reaction was 
stirred for 10 minutes. 1,2,2,6,6-Pentamethylpiperidine   3 μ    0 2  mm ol    2 eq iv ) 
was added, followed by triethylchlorosilane  36 μ   0 20 mmol    0 eq iv ). After stirring 
at a constant temperature for 12 hours, the reaction was quenched by addition of N,N-
diisopropylethylamine  30 μ   and methanol    μ      he mi t re  was stirred for  0 mi n 
and filtered through a Pasteur pipette packed with silica gel, followed by a flush with 
EtOAc (10 mL). GC analysis afforded the yield and selectivity of the reaction. 
Table 3.21, Entry 1 
The reaction was run at 4 °C. 
Table 3.21, Entry 2 
The reaction was run at 25 °C. 
Table 3.21, Entry 3 
The reaction was run at 25 °C using crystallized III. 
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Electrophile Screen (Table 3.22) 
To an oven-dried reaction vial, a solution of (S)-1-phenyl-1,2-ethanediol, (S)-3.13, (28 
mg, 0.20 mmol), p-toluenesulfonic acid (1.0 mg, 6.0 x 10-3 mmol, 3 mol %), and III (12 
mg, 4.0 x 10-2 mmol, 20 mol %) in anhydrous THF (3 mL) was added. The reaction was 
stirred for at room temperature for 10 minutes. 1,2,2,6,6-Pentamethylpiperidine   3 μ    
0.24 mmol, 1.2 equiv) was added, followed by the electrophile. After stirring at room 
temperature for 12 hours, the reaction was quenched by addition of N,N-
diisopropylethylamine  30 μ   and methanol    μ     The mixture was stirred for 10 min 
and filtered through a Pasteur pipette packed with silica gel, followed by a flush with 
EtOAc (10 mL). GC analysis afforded the yield and selectivity of the reaction. 
Table 3.22, Entry 1 
  SB r  3  μ    0 20 mmol, 1.0 equiv) was used as the electrophile. 
Table 3.22, Entry 2 
TESNO2 was used as the electrophile and the reaction was run in dimethylformamide (3 
mL). TESNO2 was made in situ from TES l  3  μ   0 20 mmol    0 eq iv ) and NH4NO3 
(48 mg, 0.60 mmol, 3.0 equiv) 
Table 3.22, Entry 3 
TESO f      μ    0 20 mmol    0 e q iv ) was used as the electrophile. 
Table 3.22, Entry 4 
TESO f      μ    0 20 mmol    0 e q iv ) was used as the electrophile at 4 °C. 
Table 3.22, Entry 5 
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TESO f      μ    0 20 mmol    0 e q iv ) was used as the electrophile at -60 to 10 °C. 
Table 3.22, Entry 6 
TESO f      μ    0 20 mmol    0 e q iv ) was used as the electrophile at 60 °C. 
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